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Background:
Menorrhagia (excessive periods) is a very common reason for consultation with
general practitioner, and the most common reason for referral to gynaecology clinic.
The clinical definition is blood loss exceeding 80mls per period but measurement is
seldom undertaken in routine clinical practice. Research has shown that many
women presenting with menorrhagia have volume of blood loss in the normal range
and that women's concerns are mainly the impact of periods on their lives, less about
the volume of blood loss. The clinical definition of menorrhagia requires
reconsideration, to better reflect the contemporary menorrhagia complaint.
Aim:
To examine the multi-faceted menorrhagia complaint in terms of: subjective account
of menstrual periods and symptoms, psychosocial measures, socio-demographic
factors, and objective measurement of the menstrual loss.
Study design:
The research comprises three overlapping parts: (1) a cross-sectional survey with (2)
an embedded detailed prospective menstrual collection study, and (3) a follow-up
(cohort) study of the earliest recruits to the survey group, the latter undertaken by
case-note review. Local Ethical Research Committee approval was obtained for the
study.
Study population:
All women aged 25 to 49 years newly referred for menstrual problems to
collaborating consultants at gynaecology clinics at Edinburgh and Glasgow Royal
Infirmaries, and Glasgow Western Infirmary. Problems eligible for inclusion in the
survey were excessive periods, period pain, premenstrual changes, 'period problems'
(non-specific) and irregular periods. Only those with putatively heavy periods




Survey data were collected using the brief Clinic Questionnaire (ascertaining
minimal essential data from as many as possible of the eligible clinic population); a
more detailed Menstrual Evaluation Questionnaire; and the Menstrual Background
Questionnaire (addressing contraceptive and obstetric history, and general health).
The SF-36 quality-of-life questionnaire was also used. A Menstrual Chart was
developed for the menstrual collection, and both total menstrual fluid loss and blood
loss volume were measured. The case note review follow-up was undertaken for all
women recruited before March 1998, for the 8 months after recruitment to the study,
extracting data on tests and investigations performed, diagnoses and treatments, and
outcome at 8 months.
Results:
The 952 women recruited were representative, in terms of age, socio-economic status
and referral condition, of all 1506 eligible referrals. The 226 who had their menstrual
loss measured were socio-demographically representative of all 865 women eligible
for this stage. Case notes were found and reviewed for 665 (89%) of the 748
recruited early enough to be followed-up. The study sample is described in terms of
socio-demographic factors, referral reasons, subjective report of periods, quality-of-
life, well-being and clinic outcome, and for the relevant subset, menstrual loss
volumes. Prior hypotheses with regard to associations between these factors are
evaluated and reported. Methodological issues in menorrhagia assessment and
measurement are considered.
Conclusions:
The current focus on volume of blood loss in menorrhagia complaint is unhelpful,
since it ignores the associated symptoms and social disability that play a key role in
leading a woman to seek help for her periods. The 80 ML criterion is of dubious
clinical utility as it is neither sensitive nor specific for adverse impact of periods,
compromised iron status, or pathology.
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1.1 INTRODUCTION TO THE RESEARCH PROJECT
1.1.1 Overview of menstrual problems
Since earliest times there have been anecdotal reports of the discomfort and
inconvenience that some women experience during menstruation (Drife 2000a), but
never before have women been exposed to such a large number of menstruations per
life-course. Whereas in primitive societies women would have experienced about 40
to 50 menstrual periods, provided they escaped obstetric fatality, it was estimated in
the 1970s that contemporary women experienced in excess of 400 cycles (and
periods) during a typical reproductive life-course (Short 1976). The repeated
hormonal swings (and the cascade of cellular events in response to these), and
repeated menstruation (some of it possibly retrograde) that are the consequence, are
believed to be implicated in a number of reproductive pathologies - endometriosis,
cysts, reproductive and breast cancers (Dennis 1992). An important contemporary
question has been posed: is life-time menstruation on such a scale 'healthy' or
'normal'? (Blanchard 2003; Coutinho & Segal 1999; Dennis 1992; Kaunitz & 2000;
Short 1976; Thomas & Ellertson 2000; Wilbush 1988) The repeating menstruations
are often accompanied by severe menstrual symptoms. So a more specific question,
whose answer may be of greater relevance to women, and their reproductive health
advisers, is whether this 'over-use' of the physiological process of menstruation, per
se, leads to covert physiological dysfunction and is hence the cause of menstrual
problems.
There have been a number of large scale population studies addressing aspects of
menstruation (Andersch et al. 1986; Andersch & Hahn 1981; Andersch & Milsom
1982; Brown et al. 1988; Corrado 1990; Gath et al. 1987; Hallberg et al. 1966;
Kauraniemi 1969; Kjerulff et al. 1996; McCance et al. 1937; Rybo et al. 1985;
Shapley et al. 2004; Snowden & Christian 1983; Treloar et al. 1967; Warner &
Bancroft 1990; Widholm & Kantero 1971). From the surveys undertaken there is
considerable evidence of menstrual co-morbidity - heavy bleeding with pain,
premenstrual syndrome with pain and/or heavy periods, irregularity with heavy
bleeding (Bancroft et al. 1993; Brooks-Gunn 1985; Corrado 1990; Granleese 1990;
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Hurskainen et al. 2001; Marshall 1998; Warner 1998; Warner & Bancroft 1988;
Warner & Bancroft 1990; Warner 1995).
Survey-type research endeavour has mainly assessed not menstrual problems but
menstrual descriptors (Andersch et al. 1986; Andersch & Hahn 1981; Andersch &
Milsom 1982; Brown et al. 1988; Gath et al. 1987; McCance et al. 1937; Shapley et
al. 2004; Warner & Bancroft 1990), or been directed at the elucidation of reference
ranges for the menstrual parameters (Hallberg et al. 1966; Kauraniemi 1969;
McCance et al. 1937; Rybo et al. 1985; Snowden & Christian 1983; Treloar et al.
1967; Widholm & Kantero 1971). Other studies have concentrated on women
consulting for menstrual reasons (Bancroft et al. 1993; Shapley et al. 2000; Shapley
et al. 2003; Warner 1995; Wood et al. 1979), resulting in various organic
explanations being proposed for excessively heavy periods (Lumsden 1985) or
severe dysmenorrhoea (Rees 1988; Turnbull 1985). One survey addressed the extent
of problem with premenstrual syndrome (Warner & Bancroft 1990), one assessed
menstrual disorder (Kjerulff et al. 1996), and the market research poll asked women
to identify from a list, which included heavy periods and period pain, 'any health
problems you have ever had' (Corrado 1990). There is therefore a dearth of surveys
of the prevalence of subjective report of menstrual problem, and of associated
factors.
1.1.2 Introduction to research project
Among women in their late reproductive years, menorrhagia (excessive periods) is a
very common reason for consultation with general practitioner (Prentice 1999a;
Royal College of General practitioners et al. 1990; Vessey et al. 1992), and the most
common reason for referral to gynaecology clinic (Bradlow et al. 1992; Coulter
1995; Coulter et al. 1989; Prentice 1999a). The clinical definition of menorrhagia is
blood loss exceeding 80mls per period. Laboratory measurement of blood loss that
has been undertaken has shown that many women presenting with menorrhagia have
volume of blood loss well within the normal range (Bonnar & Sheppard 1996;
Chimbira et al. 1980; Coulter 1995; Fraser et al. 1984; Higham et al. 1990;
Hurskainen et al. 1998; Janssen et al. 1995; Prentice 1999a). Qualitative research
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suggests that women's concerns are often not about the volume of blood loss, but the
impact of periods on their daily lives (Byles et al. 1997; Marshall 1998; O'Flynn &
Britten 2000).
It has been observed that in the past there has been frequent attribution of women's
menstrual symptoms to psyche, in the absence even of minimum evidence (Laws
1992; Lennane & Lennane 1973; Scambler & Scambler 1993). The complex
interplay of physiological, psychological, cultural and individual history factors
means that past menorrhagia research projects have tended to obtain either objective
measurements of menstrual blood loss, but scant psychological or individual data, for
example (Cole et al. 1971; Fraser et al. 1984; Flaynes et al. 1977; Higham et al. 1990;
Janssen et al. 1995), or they have assessed subjective report of symptoms, or
occasionally problem, and perhaps also psychological factors, but have not obtained
objective measurement of blood loss (Bancroft et al. 1993; Brown et al. 1988; Gath
et al. 1987; Kjerulff et al. 1996; Shapley et al. 2000; Shapley et al. 2003; Shapley et
al. 2004; Warner & Bancroft 1990). Attributions to psyche that have been proposed
have therefore been made in the absence ofcorresponding research evidence (Gath et
al. 1987; Greenberg 1983; Hallberg et al. 1966; Levitt & Lubin 1967; Rogers 1950;
Shapley et al. 2000; Shapley et al. 2002; Shapley et al. 2003). Ideally, prospective
data would be necessary to support an assertion of psychosomatic origin for
complaint, since reverse causation means that months of troubling menstruation
could be the cause of psychological distress. This could happen even with
moderately severe symptoms, if persisting over a long time-frame, particularly if
periods are unpredictable and hence difficult to accommodate. That some such
mechanism is a possible scenario is supported by findings of marked improvement in
psychological well-being after hysterectomy (Gath et al. 1982).
It would appear therefore that:
(i) quantitative menstrual research has tended to address menstrual descriptors or
parameters, whereas the conceptualisation of menstrual problem has been on the
whole neglected; and
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(ii) the 80mL blood loss criterion for monorrhagia is not relevant to contemporary
menorrhagia complaint; and
(iii) there has in the past been attribution of complaint of menorrhagia to
psychosomatic factors in the absence of a supporting evidence base.
The key aim of this research project is therefore to reconsider the clinical definition
of menorrhagia. In order to do this, a multi-faceted examination of the contemporary
menorrhagia complaint is required, encompassing subjective account of menstrual
periods and other menstrual symptoms, assessment of health, psychosocial and
socio-demographic factors, and prospective measurement of the menstrual loss. The
initial study would be predominantly descriptive and hypothesis generating.
In the remainder of this chapter there will be an overview of physiological and
epidemiological understandings of menstruation, together with a reflection on the
transition from menstruation to menstrual complaint, while in Chapter 2
methodological issues in menstrual research are reviewed. A systematic search was
used in the first instance, but to limit length this was followed by selection, by means
of scanning all abstracts, of papers that addressed issues of definition or
methodology. The literature review is followed by specification of the research
design in Chapter 3. In 3.8.4 a number of general prior hypotheses have been
specified, for the purposes of sample size calculation, these having been identified
from the literature and previous research.
Chapters 4 to 9 report results, each chapter incorporating some immediate and
chapter-specific discussion. Chapter summaries are provided at the end of each
chapter, for ease of cross-referencing. Chapter 4 reports on recruitment, and
background description of the study sample, including basis for referral and quality-
of-life, while Chapter 5 describes menstrual problem and history, as well as clinic
outcome. Chapters 6 and 7 report on quantification of menstrual loss, and exploration
of methodological issues that emerged regarding quantification. Chapter 8 examines
comparability of participants between centres, and across levels of participation, in
terms of background data reported in Chapters 4 to 6.
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Finally, Chapter 9 reports the key multivariate analyses modelling menorrhagia, and
examining basis for referral for heavy bleeding and the utility of the 80mL blood loss
criterion for menorrhagia. The chapter begins with a statement of the three themes to
be addressed: referral for heavy bleeding, measured volume of menstrual loss, and
subjective menorrhagia complaint. The reporting of the analyses is structured in
terms of nine research questions which are listed at the start of the chapter (9.1). The
detailing of these research questions is held over until this point in the thesis as it is
felt that the precise meanings of the questions, and the subtleties of the distinctions
between them, would be better appreciated once the basic description of the study
data, and of the assessment methods used, has been completed.
The thesis concludes with a final chapter (10) undertaking overview and integrative
discussion, followed by conclusions, including some ideas for further research.
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1.2 PHYSIOLOGICAL UNDERSTANDINGS OF MENSTRUAL
PROBLEMS
1.2.1 Heavy periods
Many mechanisms and part-explanations for heavy menstrual bleeding (or
menorrhagia) have been established (Mayou et al. 1995), but despite many years of
research the likelihood of being able to identify the entire mechanism for a specific
case of heavy periods is low (Smith 2000). Some of the causes described are
systemic disease, neoplasms (benign or malign), contraception (non-hormonal
IUCD), hormonal disturbance, and blood diseases (for example, clotting disorders)
(Fogel CI 1995). Hormonal disturbance can arise in a number ofways, ageing, stress,
liver or kidney disease, and in the case of obese women, via anovulation caused by
increased peripheral conversion ofandrostendione to oestrogen (Fogel CI 1995).
Bleeding in anovular cycles tends to be irregular, painless and heavy (Rees 1997).
These anovular cycles used to be thought a lot more common than they are (Smith
1998). It has been found that the proportion is only about 10% (Cameron et al.
1990). For a single episode of heavy bleeding early pregnancy loss may be the
explanation (Fogel CI 1995). Fibroids are a common cause of menorrhagia, but not
always a cause of heavy bleeding (Fogel CI 1995; Mayou et al. 1995). High rates of
subsequent hysterectomy in sterilised women has raised the question ofwhether
sterilisation could somehow be causally implicated in menorrhagia, for example
through reduction in excretion of oestrogen through occlusion of the Fallopian tubes
(Coulter 1998). Coulter notes the profound methodological problems of answering
this question through observational data (Coulter 1998). Only one study involved
before and after blood loss measurement, with no effects being found (Kasonde &
Bonnar 1976). However, the study involved only 25 women, and follow-up was only
6 to 12 months.
Fine detail of sub-mechanisms have been described - steroid receptor expression
throughout the menstrual cycle (Critchley 2000); local uterine haemostatic factors
(Sheppard 2000); specific factors in endometrial growth (Rees et al. 2000); and
angiogenesis (Smith 2000), but Smith comments 'surprisingly little is known about
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the factors which cause heavy or irregular bleeding' (Smith 2000). All these authors
note that further research is required (Critchley 2000; Rees et al. 2000; Sheppard
2000; Smith 2000).
Rees envisaged a categorisation for menorrhagia as local, systemic, iatrogenic or
essential (Rees 1987). Essential menorrhagia is that where no aetiology is known,
and at that time this comprised half of all cases. It is likely that for a number ofother
cases, where a cause is identified, this is some coincidental finding, such as fibroid,
and not actually causally implicated. The finer mechanism that seems to be found
most compelling is altered prostaglandin synthesis, because prostaglandins can have
action on myometrial contractility and on haemostasis (Smith et al. 1981). The
evidence is strengthened by the fact that menstrual blood and uterine tissues contain
very high levels ofprostaglandins, women with menorrhagia or dysmenorrhoea have
even higher levels, and inhibitors ofprostaglandin synthesis are used successfully as
treatments for these disorders (Rees 1997). Increased endometrial fibrinolysis is
another agreed cause of some menorrhagia, supported by the efficacy of
antifibrinolytic agents as treatment (Rees 1997). Recent findings have been
varicosities and uterine artery blood flow (Hurskainen et al. 1999).
1.2.2 Period pain
Period pain or dysmenorrhoea ('difficult monthly flow') has traditionally been
classified into two classes, primary and secondary. According to the original
classification the criterion for primary dysmenorrhoea is that the pain occurs in the
absence ofpathology (Akerlund 1998; Brosens et al. 2000). Onset ofprimary
dysmenorrhoea is typically about six months after menarche, with symptoms most
prevalent during the first two days of the period, and seldom associated with
menorrhagia (Rees 1997). It is salutary to realise that up until a few decades ago,
before the advent of intrauterine pressure readings which have confirmed the acute
pain being experienced in many cases (Lumsden 1985), young women claiming to
suffer severe dysmenorrhoea were frequently dismissed as neurotic(Laws 1992;
Lennane & Lennane 1973; Scambler & Scambler 1985). This is an example of the
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circumstance described earlier, inadequate technology to elucidate mechanism
resulting in a rebound but erroneous misattribution to psyche.
The classification 'primary dysmenorrhoea' is no longer accurate as mechanisms
have been identified to account for the dysmenorrhoea, predominantly abnormal
uterine activity associated with excessive prostaglandin production (Fogel CI 1995;
Rees 1997). On the other hand, although there have been findings of excessive levels
of leukotrienes, vasopressin and prostaglandins, it remains unknown what in turn
causes the raised levels (Rees 1997).
The criterion for secondary dysmenorrhoea is that the pain is secondary to some
pathology, such as endometriosis, pelvic inflammatory disease, adenomyosis,
fibroids and polyps (Rees 1997). Alternatively, it may also be iatrogenic, resulting
from use of the non-hormonal IUCD (Rees 1997). Secondary dysmenorrhoea may
have onset of symptoms prior to menses, and pain can last the whole period (Rees
1997). As already noted for heavy periods, these pathological findings could in some
cases be coincidental, as fibroids, polyps and possibly even early endometriosis do
not inevitably cause period pain. The mechanisms by which pain is produced are not
clear (Rees 1997). The role ofprostaglandins has already been noted. Secondary
dysmenorrhoea often occurs in conjunction with heavy periods, with 79% ofwomen
over 25years of age referred for dysmenorrhoea also reporting heavy periods
(Warner 1995) The onset of secondary dysmenorrhoea is typically after some years
ofpain-free menses (Fogel CI 1995; Rees 1997). However, there must be some
unfortunate women who suffer primary dysmenorrhoea, and by the time that is
resolved, which is often not until after the first pregnancy, they have developed some
condition which results in secondary dysmenorrhoea. This scenario has been
acknowledged in the case of young patients with endometriosis (Stones & Thomas
1998).
1.2.3 Irregular bleeding
In gynaecology text books there is a distinction between intermenstrual bleeding and
irregular cycles (Landgren & von Schoultz 1998). Irregular cycles are taken to be a
result of the approach of menopause, due to ageing of the ovary, and/or anovulation
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(Fogel CI & Woods NF 1995; Landgren & von Schoultz 1998). In the approach to
the menopause a woman can expect alterations in 'regularity, frequency, pattern,
volume and flow', all the consequence of failing ovarian response (Fraser 2000). A
number of the authors commented that women find changes to their bleeding patterns
very worrying (Landgren & von Schoultz 1998; Rees 1997). At this age there are
some risks that the changes in bleeding are a symptom of serious disease, so this
menstrual disturbance presents a challenge for the gynaecologist as well as the
woman herself (Fraser 2000)
1.2.4 Cyclic symptoms
Cyclic changes in emotional and physical state across the menstrual cycle are very
common, and for some women they are so marked as to be distressing (Gardner &
Sanders 1997). Complaint of troublesome cyclic symptoms (premenstrual syndrome,
PMS) can be classified into four levels (Joshi et al. 1998):
• physiological premenstrual symptoms - but not disruptive/severe/consistent
enough to be classified as PMS;
• primary PMS - disruptive symptoms that occur in four out of the six previous
cycles and where the symptoms have eased completely by the end of the period;
• secondary PMS - similar to primary PMS except that there is only partial
resolution of symptoms, probably because in addition to PMS the patient has an
underlying psychological disorder; and
• psychiatric disorder wrongly attributed to PMS.
Categorisation and assessment ofPMS has been the subject of much research effort,
and of endless and often very heated debate, leaving this health/research domain
fractured (Rapkin 2000). Many groups would argue that the third classification in the
list above is not PMS. The 'take-over' ofPMS by the nosological diagnostic system
for psychiatry, The American Psychiatric Association Diagnostic and Statistical
Manual ofMental Disorders, under the label premenstrual dysphoric disorder
(PMDD), means that 'primary PMS' which is expressed mainly somatically would
be left in diagnostic limbo, and much of'secondary PMS' would be declassified as
not 'PMS' (Joshi et al. 1998).
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Cyclic symptoms do not occur before menarche, during pregnancy, or post¬
menopausal^, so there is wide-spread acceptance they are related in some way to
ovarian function (Rapkin 2000). However, almost all women have ovarian cycles and
by no means all women have disabling PMS. What the additional factor or factors
are that result in severe PMS is not at all clear. Hence the assertion that 'the
syndrome has no known aetiology' (Joshi et al. 1998). Cyclic symptoms may be
experienced more severely if there is underlying psychological ill-health (Gardner &
Sanders 1997). There is a view that for some women the cyclic symptoms may be
secondary to very heavy or painful periods (Gardner & Sanders 1997).
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1.3 EPIDEMIOLOGY OF MENSTRUAL PROBLEMS
Women's self-reports of their menstrual experience are a worthy topic for study since
the individual's perception of change, problem, or abnormality is the first step on the
path to the gynaecology clinic. What has been established about the epidemiology of
menstrual problems, and in particular menorrhagia, complaint of heavy bleeding?
1.3.1 Issues in menstrual epidemiology
1.3.l.i Attitudes to menstrual morbidity
Concern has been expressed that our society inhibits women from complaining when
they experience menstrual distress (Drife, 1992; Scambler 1993), and that the
complaints of those who do seek help have not been taken as seriously as they should
have been (Laws 1992; Lennane & Lennane 1973). Historically menstrual
complaints have been regarded with considerable misgiving, with doubts as to the
validity of the majority of complaints (Gath et al. 1987). Where the patient was
unresponsive to treatment, or if no explanation could be found for the complaint, it
may have been dismissed as psychogenic: either as a ploy to avoid domestic or
employment commitments, or as resulting from an "unwholesome attitude to
menstruation" (Levitt & Lubin 1967) or a "neurotic" temperament. There are
tensions between menstruation as natural/normal and medicalisation of menstruation,
between medical 'disease' and lay illness, between what is biologically normal
(bleeding, menstrual discomfort) and what is socially unacceptable (being seen to
bleed, needing to rest during work hours), between femininity and sexuality (Shaw et
al. 1998). Many women hold strong and often disparate views about what is and
what is not appropriate menstrual behaviour (playing for sympathy versus soldiering
on and suffering in silence).
The powerful cultural attitudes around menstruation, health and illness are bound to
affect responses to surveys, depending on the way questions are framed and worded,
and the perceived purpose of the survey.
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Ascertainment
Key to good epidemiology is clear definition of the health condition being studied,
and an operationalisation of the definition that allows reliable and unbiased
ascertainment.
Defining the condition of interest
The four main menstrual problems do not have definitions amenable to survey.
Menorrhagia has a clear and objective definition expressed in terms of volume of
blood loss (Wyatt & O'Brien 2000). However, this is impracticable for community
survey, as would be clinical history-taking. Therefore the usual approach is to ask
how 'heavy' the menstrual loss is. There is no agreed definition for period pain
(Wyatt & O'Brien 2000). There is lack of consensus about the definition of
premenstrual syndrome and even more so about assessment (Wyatt & O'Brien 2000).
Prospective assessment is considered essential, but this would not be feasible for
large surveys. One-off methods of assessment such as Moos (Moos 1968) are now
largely discredited. Irregularity ofperiods is a composite of a number of
perturbations of the 'ideal' menstrual cycle, and so very difficult to assess precisely
by questionnaire.
Subjective reports of symptoms and problems
Symptoms versus problems There is a profound distinction between 'symptom', a
manifestation of the body or the emotions, and 'problem', which denotes an
evaluation of some health circumstance, and a decision that it is unacceptable/
intolerable/dangerous. In general surveys ask about symptoms, and it would be
perfectly valid to report an epidemiology of symptoms. However, all too often the
true condition of interest is a medical problem, perhaps for the purposes of
ascertaining potential demand for health services. In that case there would be a
dissonance between the focus of the research and the information being collected.
To take an example for menorrhagia, the condition of interest is complaint of
excessive bleeding, a problem. What is typically ascertained is the heaviness of the
menstrual loss, a symptom. Many a woman in her late reproductive years would
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describe her menstrual loss as heavy, without any connotation of that loss being
problematic. To add to the confusion, the response options offered for heaviness in
questionnaire surveys are typically Tight/moderate/heavy' (Hallberg et al. 1966;
Snowden & Christian 1983). For the sake of a less crude measuring scale,
particularly when used in clinical research where there may be danger of a ceiling
effect for the rating scale, some researchers add 'very heavy', giving 4 options
(Bancroft et al. 1993). However, such a change can materially affect the distribution
of responses, to all three lower categories, making very difficult any comparison
between surveys using the different approaches.
It should be noted also that a symptom response given in a community survey,
should be considered an 'elicited symptom' (Santer 2004), because it will almost
certainly have very different meaning to the same description proffered (or, symptom
reported) by a woman in the context of consulting her GP about her periods, or
attending gynaecology clinic.
Subjective reports There is most often no alternative to subjective report of
symptoms/ problems, but the weaknesses must be borne in mind. The main one is the
potential for confounding with individual response style. Symptom reporting in
general has been shown to be related to the personality dimension ofnegative
affectivity (sometimes called neuroticism, but the label negative affectivity is
preferred to avoid confusion with neurotic illness) (Watson & Pennebaker 1989).
Individuals with this dimension or personality more pronounced tend to score more
highly on any self-report health or symptom scale and are more likely to perceive
problems (for the same degree ofunderlying physical or emotional disturbance)
(Fender et al. 1999). Another weakness of subjective reports is the extent to which
they can be affected by cultural attitudes, health beliefs, previous health experiences,
setting, wording of questionnaire and similar factors.
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1.3.2 Overview of epidemiology
1.3.2.i Heavy periods
There is some doubt as to whether the appropriate epidemiology to be considered is
ofobjectively heavy bleeding (as measured) or of subjectively heavy periods (as
reported). There is a dearth of the former type of survey, and with regard to the latter,
insight is limited by the crude response scale that has generally been used, often
simply 'light/moderate/heavy'. In Hallberg's population survey ofnearly 500 women
the subjective assessment of periods was not reported for the various age or parity
groups, only that 31% ofwomen overall rated their periods as "heavy" (Hallberg et
al. 1966). In a survey undertaken by a market research company, 31% ofwomen
affirmed having ever had heavy periods which for them constituted 'a health
problem', as did 40 to 45% of those aged over 35 years (Corrado 1990). Other
'health problems' in the list were backache, headaches/migraine, depression and
anxiety. Among the subgroup who had ever had a problem with heavy periods,
considering only women with current symptoms (that is, heavy period in the last 4
months) brought the prevalence overall down to 20%. Analyses were not presented
adjusted for current hormonal contraception, but that concern notwithstanding, while
the survey comprised 70% parous women, among the subgroup with heavy periods
in the last 4 months, 82% were parous. In a recent community survey of 1425
women menorrhagia was defined as a response of 'heavy' periods, and the
prevalence was 52% overall (sample aged 18 to 54 years), 60% in those aged 35 to
44 years (Shapley et al. 2004). This survey also asked about increased periods (23%
and 29% for the same age groups as for menorrhagia) and prolonged periods (9%
and 9%).
Considering measured blood loss, parity has been found to be associated with a small
increase in average loss, and in the older age groups there is a slightly increased
proportion of women with excessive blood loss i.e. exceeding 80mls (Cole et al.
1971; Rybo et al. 1985). Duration ofperiod is related to overall blood loss and if it is
longer than seven days the bleeding is likely to be excessive (Rybo et al. 1985).
Other factors that have been found to be associated with heavy periods are parity,
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smoking, body mass index and chronic iron deficiency (this last as both cause and
effect) (Coulter 1998).
1.3.2.ii Period pain
Dysmenorrhoea is commonly described as a young woman's complaint and yet in a
study ofadolescent girls and their mothers the prevalence of "painful periods" among
1570 girls aged 16 to 20 years was 45% "occasionally" and 17% "continuously",
whereas for the mothers of all adolescents in the survey (n=6543) the corresponding
proportions were 70% and 8% (Widholm & Kantero 1971). In the Kauraniemi
survey (Kauraniemi 1969), using a more stringent criterion, the prevalence of
"regular" dysmenorrhoea was 9% overall, 12% in the youngest age band, 7% in the
oldest. These are the only two research surveys to include a substantial number of
women over 30 years of age. In the market research survey already mentioned, 38%
ofwomen affirmed having ever had painful periods as a health problem, with the rate
of affirmation being highest in those aged 30 to 34 years (43%) and, paradoxically,
given the question pertained to 'ever', lowest for those aged 40 to 45 years (35%)
(Corrado 1990). However, there were about 160 to 200 women per age-band, so
numbers were not large for comparisons between age groups (standard error for
difference between age group prevalences is approximately 5 percentage points, 95%
confidence interval plus/minus 10 percentage points). In discussions of the
epidemiology of "period pain" there is considerable confusion and blurring between
primary dysmenorrhoea and later-onset dysmenorrhoea.
Parity and age are both believed to alleviate primary dysmenorrhoea for a proportion
of sufferers, the latter via the effect of increasingly regular ovulation, the former via
the effect on the uterus of child-bearing. However it has been noted that period pain
is experienced by 30 to 40% of women in their thirties (Akerlund 1998). In the
market research poll, notwithstanding the same reservations as above regarding
confounding by hormonal contraception, 65% of women with painful periods in the
last 4 months were parous, compared to 70% overall (Corrado 1990). There is a grey
area between 'experience of period pain' and disabling symptoms, with the relative
proportions being quoted as 50% ofwomen: 10% (Fogel CI 1995).
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1.3.2.iii Irregularity of bleeding
Irregularity of cycles has been reported to reduce steadily from 43% among girls in
the first year after menarche to 20% for girls more than five years post-menarche
(Widholm & Kantero 1971), while their mothers were less likely to report irregular
cycles (9%). In another series of data, also collected before the oral contraceptive
pill was in widespread use, irregular cycles were common in the early years of
menstruation but then became less and less common, with maximal regularity at
about 36 years of age (Treloar et al. 1967). A second phase of irregularity
commenced approximately six years later, culminating in the menopause. A
community survey of 1425 women found changed pattern of cycle to be reported by
32% of the entire sample (18 to 54years) and by 53% of those aged 45 to 54 years
(Shapley et al. 2004). Similarly, intermenstrual bleeding was reported by 14% and
13%.
1.3.2.iv Cyclic symptoms
The epidemiology ofPMS is even more fraught than that for heavy periods and
period pain, with 20 to 95% ofwomen being said to experience perimenstrual
symptoms, 20 to 40% report some degree ofproblem with PMS, and 3 to 5% being
severely affected (Fogel CI 1995). PMS is experienced across the menstruating age
range, but it is agreed that the age group most troubled by PMS is women in their
thirties and forties (Fogel CI 1995). However, it has been noted that PMS can be
exacerbated pre-menopausally, and then just blur into symptoms of the menopause
(Gardner & Sanders 1997). There may therefore be an ascertainment/discrimination
problem in the oldest age groups of still-menstruating women.
1.3.3 Other factors related to problems with periods
1.3.3.i Contraception
Cross-sectional surveys would not be the design strategy of choice to elucidate any
concurrent effect of contraceptive method on menstruation, because of the self-
selected nature of the various groups of established contraceptive-users. Decisions
regarding method of contraception are likely to be influenced by a number of factors,
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one of which may be menstrual distress itself e.g. heavy periods are a contra¬
indication for non-hormonal intra-uterine devices (IUCD), and the reputation of oral
contraceptives is such that they may be taken solely for their menstrual effect (Fogel
CI 1995; Fraser 1986), thus selecting into the oral contraceptive group women at
high risk of reporting relatively heavy or painful periods. That said, surveys typically
show women using oral contraception to have less severe menstrual symptoms
(Brown et al. 1988; Warner & Bancroft 1990). In studies measuring blood loss it has
been shown that oral contraceptives reduce the duration of period and amount of
blood loss (Cole et al. 1971; Fraser 1986), and they are also believed to relieve
dysmenorrhoea (Fogel CI 1995). However in a survey of university entrants the
prevalence ofperiod pain among pill-users was high (41%, compared to 45% among
non-pill users) (Sheldrake & Cormack 1976). This could be explained if the
therapeutic effect of oral contraceptives is on severity rather than prevalence ofpain,
or if the pill-using group included more women prone to period pain, possibly
"selected in", in line with the scenario outlined above.
The after-effects of contraceptive method on menstruation are even harder to
ascertain than concurrent effects. The study of after-effects of oral contraceptive use
has largely been confined to issues of fertility while the possibility of menstrual
sequelae has on the whole been dismissed as a perceptual or adjustment problem.
The earlier surveys of the effect of female sterilisation on subsequent menstrual
reports involved women who had been sterilised on the grounds of multigravidity or
for medical or social indications, women whose health had possibly already been
compromised. Increased reporting of pain, and in the latter two surveys, of heavy
periods, has been found (Neil et al. 1975; Punnonen & Erkkola 1984; Ringrose
1974). Even when the severer criterion of hospital referrals for menstrual problems
was used a higher rate was found among women who had been sterilised, and
between methods a higher rate for diathermy (Vessey et al. 1983). The recent
development of a hormone-releasing IUCD, the levo-norgestrel LNG IUCD, and its
increasingly wide-spread use, has the potential to provide very effective reversible
contraception and to have a beneficial effect on heaviness ofperiods.
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1.3.3.ii Socioeconomic status
In the Corrado market research poll, rates of reporting ever having had heavy or
painful periods were very similar across the binary socio-economic class
classification used (Corrado 1990). However other research has shown that women
of lower social class are more likely to report menstrual problems and are more
likely to consult their GPs (Coulter 1998). The distinction between symptom and
'problem' has been noted, but assuming this higher rate ofproblems reflects more
severe symptoms, caution is required because there is likely to be some confounding
by the differing child-bearing patterns by class. Women of lower socio-economic
status complete their families sooner, and have higher age-specific rates of
sterilisation, so for them there is a longer span of years of repeated menstruation
prior to menopause.
1.3.3.iii Psychosomatic factors
There is all too much past evidence ofattribution of women's reproductive health
symptoms to psyche (Gath et al. 1987; Greenberg 1983; Hallberg et al. 1966; Harris
1989; Laws 1992; Lennane & Lennane 1973; Levitt & Lubin 1967; Rogers 1950;
Shapley et al. 2000; Shapley et al. 2002; Shapley et al. 2003; Stolberg 2000). This
was most likely to happen if no cause can be found for the complaint. It is salutary
to remember that many of the techniques required to identify a number of the
potential organic "causes" have come into routine clinical use only in recent years
e.g. laparoscopy and prostaglandin assays. So in the past there must have been many
incorrect diagnoses of "no organic cause" and, consequently, many misattributions to
psyche (Warner 1998). Or rather, misattributions entirely to psyche. Current
thinking is that in most cases complaint or problem is an interaction between
physiological processes, psychological/personality factors and feedback from others
(Mayou et al. 1995). It has been hypothesized that trends in psychosomatic
'disorders' are a reflection of cultural changes in medicine and clinical service ethos
(Porter 2004), and that reporting of common physical symptoms is a reflection of a
pattern of illness behaviour than may have origins in childhood, and which will be
influenced by concurrent stress and any physiological symptoms (Mechanic 1980).
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However, it has also been pointed out that findings of stress among clinic patients
should not be taken as indicative of causality with respect to symptoms experience,
since it is more likely to be related to the decision to consult (Mechanic 1961). Most
complaints will be subject to some degree ofpsychosomatic influence, even where a
'cause' is found (Mayou et al. 1995; Mechanic 1961). However, it was found that
women consulting their GP for heavy bleeding had no higher likelihood ofanxiety or
depression compared to a random sample from the same practice (Shapley et al.
2000).
A high prevalence ofpsychological problems and/or minor psychiatric problems
among women with menstrual distress has been reported (Gath et al. 1987;
Greenberg 1983; Hurskainen et al. 2001). However such a picture is common across
a range ofhealth symptoms, as evidenced by a survey across a range ofhospital
clinics, involving men as well as women (Mayou et al. 1995), and among medical
patients (Stoeckle et al. 1964). Counter to this, it has been pointed out that much of
the association between psychological morbidity and menstrual symptoms may be
due to reverse causation, with the menstrual symptoms and their impact on the
woman's life, repeating on a monthly cycle, eventually leading to secondary
psychological problems (Brooks-Gunn 1985; Coulter 1998; Warner 1998). This
possibility has been supported by findings of marked improvement in psychiatric
morbidity after hysterectomy for menstrual symptoms (Gath et al. 1982). In contrast,
in a recent longitudinal study (1513 women completed all three questionnaires) it
was found that psychological distress at baseline was associated with the subsequent
reporting of heavy periods in the following 6 months, and conversely that women
with heavy periods at baseline were no more likely than others to develop
psychological distress in the follow-up (Shapley et al. 2003). However, it needs to be
borne in mind that this survey reports an association with symptom reporting, not
with presentation of menstrual complaint, that negative affectivity is a possible
mediating factor (Watson & Pennebaker 1989), and that there is a general tendency
for periods to become heavier with age (Hallberg et al. 1966), so time may be a
confounding factor.
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1.4 FROM MENSTRUATION TO MENSTRUAL COMPLAINT
The most common menstrual symptoms are excessive periods (menorrhagia), period
pain, cycle-related changes in mood and/or physical health (PMS), or irregular
periods and/or inter-menstrual vaginal bleeding. Each of these can also be
characterised as a menstrual problem. For a particular woman it is likely to be mainly
the severity of the symptoms, along the continuum ofpossibilities, that transforms
what would otherwise be commonplace - another period - into a problem. However,
between women, taking into account also the lives they lead, the point of transition
may occur at markedly differing severities of symptoms (Scambler & Scambler
1993).
1.4.1 Factors influencing perception as problem
'Severity' may be an obvious factor transforming a symptom into a problem, but this
effect will be moderated or amplified by other factors, both individual (for example
sensitivity to pain; low embarrassment threshold regarding menstrual accidents;
phlegmatic personality) and context (background health; employment role and its
amenability to time out when pain is at its peak, or to wearing multiple sanitary
protection when the period is full flow; home circumstances; family commitments)
(Scambler & Scambler 1993). Attitudes to menstruation and overall menstrual
morbidity will also play their part (Brooks-Gunn 1985; Geller et al. 1999).
There is no published quantitative research on the interface between menstrual
symptom severity and perception as problem, perhaps because the distinction
between the two is usually overlooked. A clear example of the failure to distinguish
symptom and problem is subjective report of menstrual loss, in that the symptom
label 'heavy periods', or even having experienced this as a health problem, is used as
a short-hand for clinically presenting menstrual problem. The market research poll's
31% lifetime prevalence for the elicited symptom 'heavy periods as a health problem'
is in many publications cited as the point prevalence and/or as referring to clinical
complaint (problem) (Hurskainen et al. 1998; Prentice 2000; Smith 1998).
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Considering menstrual problems from the woman's perspective, it has been noted
that important factors in deciding if they are problematic are expectation (having an
ideal view ofperiods is not helpful), and impact on family life health and work
(Twaddle 2000). It was also noted that menstruation imposes an unavoidable cost,
for provision of sanitary protection (Drife 2000b; Twaddle 2000). The cost ofperiods
will escalate for a woman with excessive flow, as may laundry costs, and for those
suffering period pain effective pain-killers will also consume financial resources.
In this section the focus has been on 'severity in context', but that is just another way
of saying 'impact of symptoms' for the individual.
1.4.2 Factors influencing consulting and referral
Subsumed within factors influencing consulting and referral are the factors, whatever
they may be, influencing classification of the symptoms as problematic. However,
consultation/referral may occur in the absence of symptoms that are of themselves
problematic. For example, where there is concern that a symptom that is otherwise
tolerable is an early sign of serious disease. This may explain the fact that 57% of
referrals to gynaecology clinic for menorrhagia did not rate their menstrual loss as
even 'very heavy' (Bancroft et al. 1993).
The four period problems are very similar to each other in a number ofways:
• the symptoms are signs ofpotential clinical importance (although not so much so
for PMS);
• how much of a problem the symptoms are has relevance for management
strategy; and
• associated worry often plays a part in help-seeking.
The symptoms as 'signs' are important with respect to general practitioner referral to
gynaecology clinic, and also with respect to gynaecologist decisions regarding
investigation. To a lesser extent there may be lay understandings ofwhat symptoms
constitute such signs. That aside, pain and abnormal bleeding are for humans inborn
or inculcated signifiers of health 'danger' so for those patients with high
susceptibility to anxiety any unexplained change in these might be construed as a
potential 'sign'. Therefore even where symptoms are not of themselves intolerable,
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consultation with GP or referral to the gynaecology clinic may be necessary solely
for exclusion of serious disease. For these patients then, once pathology is excluded,
nothing more needs to be done.
In contrast, for patients where the symptoms, unexplained or not, are intolerable, and
seriously diminish quality of life, exclusion of serious pathology is not enough. Such
a woman will be hoping for some therapeutic intervention. These scenarios are
illustrated in the middle column of Table 1.1.
Menstrual problems also have in common the potential to provoke anxiety in the
sufferer. Even where there is no clinical concern, the GP may refer in the absence of
severe symptoms, if the patient is very anxious and investigation and reassurance are
judged to be potentially helpful. (Paradoxically, referral by the general practitioner to
a hospital clinic can confirm an anxious individual's fears.) Therefore, in the
population of referred patients anxiety is more likely to be apparent in the subgroup
with less severe symptoms, since they are more likely to be 'selected in' on the basis
of their anxiety. This hypothetical situation is shown in the final column of Table
1.1. Two dimensions of anxiety are used, as commonly used in psychology: trait
(general susceptibility to anxiety), and state (overlay anxiety in response some
provocation, in this case the current, possibly exacerbated, symptoms).
Table 1.1 Hypothetical scenario for menstrual problems in terms of impact
of symptoms, likely need for therapeutic intervention, and
associated anxiety in patient
Impact of Menstrual
Problem Symptoms
If no serious disease,
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Societal constraints around discussion of menstrual matters (Laws 1992; Scambler &
Scambler 1985) may make the clinical consultation difficult. The woman may not
find it easy to convey her menstrual experience, nor to articulate the impact of the
symptoms on her life. Certainly she will usually have had little opportunity to
compare experiences with other women, even those in her close social circle.
Therefore an individual woman is likely to have some difficulty in judging her
periods in relation to the population ofwomen similar to herself.
It has been found that those seeking help for menstrual problems are more likely to
have low self-esteem or to be depressed, and that those with symptoms but not
seeking help tend to have a low opinion ofmedical science or the medical profession
(Morse et al. 1988). In a study of referrals for menstrual disorders the best
independent predictors of referral were: family doctor's belief that surgery would be
necessary; patient preference for surgery; GP belief that patient wished surgery;
number ofprevious surgical operations; older age ofpatient; male GP (Coulter et al.
1994a). It has been found that the strongest predictor of consulting for increased
periods was interference with life caused by the periods, stronger than the heaviness
itself (Shapley et al. 2002).
1.4.3 Management of menstrual complaint
Menorrhagia is ofclinical concern because changed bleeding pattern in a pre¬
menopausal woman can be an indicator of organic pathology, of a benign or
malignant nature (Fraser 2000; Rees 1997). There is clear and urgent need to detect
and treat malignant disease, but even if the pathology is benign suitable intervention
may be required. If the pathology causes excessive menstrual loss then there may be
adverse effects on iron status and vigour (Fraser 1994; Milman et al. 1993). Even if
this does not pertain, efforts to contain excessive flow, and the consequences when
these efforts fail, can have an adverse impact on quality of life.
Like excessive menstrual loss, period pain (dysmenorrhoea) may indicate the
incidence ofpathology, especially if the pain has developed in adult life (Rees 1997;
Stones & Thomas 1998). Some degree of period pain is very common, but if the pain
is prolonged and/or acute, then daily-life may be intolerably affected. Therefore
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treatment may be required for some underlying serious or progressive pathology or,
even if no pathology is found, simply because of the disabling nature ofthe pain
symptoms.
The aetiology of PMS (cycle-related changes in emotional and physical health) has
been much debated, but it is very unlikely there has ever been a case attributed
directly to serious pathology. However, recurrent pain or recurrent adverse impact on
quality of life, due to uncontainable flow, either ofwhich may have a serious cause
(as noted above), may lead to reactive cycle-related emotional disturbance. Therefore
the possibility remains that what is presented as PMS, and therefore presumed to be
benign in origin, may be a sign of serious disease. When serious disease is not
implicated, the symptoms can be very disabling and disrupting, and may also be
prolonged, starting a week to ten days before the period, with no real reliefuntil
perhaps three to five days into the period. Furthermore, recurrent cyclic disturbance
may have potential longer-term serious consequences for relationships and family
life.
On occasion irregular menstruation (or inter-menstrual bleeding or spotting) may be
a consequence of serious pathology and so is ofpotential significance to the
clinician, especially if it has recent onset in the older woman (Fraser 2000; Landgren
& von Schoultz 1998; Rees 1997; Stones & Thomas 1998). Neither irregularity of
periods nor inter-menstrual bleeding/spotting are usually acutely disabling
symptoms, although they may cause some inconvenience with respect to containment
of vaginal bleeding. However, these symptoms, especially if they represent change
from a woman's usual pattern, may be worrying for the woman concerned.
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1.5 CHAPTER SUMMARY
Many factors play a part in the transition from symptom to menstrual problem, and in
the decision to seek help. Attitudes to menstruation and menstrual morbidity are
bound to be important. Cultural reticence about discussion of menstrual matters
probably makes it more difficult for the woman to convey her problem to her doctor.
What epidemiology there is tends to address the partitioned menstrual symptoms,
most usually heavy periods, period pain and PMS. In all cases the subjective nature
of reporting of symptoms, and varying severity thresholds used, makes the collection
and interpretation ofpopulation evidence very difficult. Subjective judgements are
very likely to be based on perception of impact of symptoms, and so will be largely
inextricable from social and reproductive life-course context.
The main surveys cited above are all quite old. In recent years women's "life-time"
experience ofnatural menstruation has been radically changed by the availability of
effective methods of contraception, both reversible and irreversible, for longer time-
spans during their reproductive years. New profiles of child-bearing became possible
from the 1960s onwards. Furthermore, menstrual experience is directly affected by
the use ofhormonal oral contraception, which for the time it is used disrupts the
endocrine cycle, suppresses ovulation in many cases, and, as is often not realised by
the individual user, substitutes "withdrawal bleeds" for natural menstruation. The
new LNG-IUS, which when used will usually be retained for years at a time, has
minimal systemic effect but does have a 'local' beneficial effect on periods if they
are heavy. We are now at the threshold of a new era for profiles of menstruation
through the reproductive life-course. There is need for a better understanding of
women's subjective experience ofmenstruation, and as these new profiles become
more and more common, a monitoring of societal changes in expectations.
There are many gaps in our knowledge of the prevalence of menstrual symptoms, of
the interrelationship between them, and of their relationship to socio-demographic
factors, in particular reproductive life-course. There is a dearth of knowledge about
the epidemiology of menstrual problems, and menstrual health care needs.








There will be situations in which there is a need to estimate blood volume,
specifically. However, for the general menorrhagia complaint it could be argued that
the impact on the daily life of a reasonably well-nourished woman suffering heavy
periods derives directly from the total volume of the menstrual fluid loss, because of
the containment challenge it poses. In this conceptualisation the volume of the blood
component adds little. Further consideration raises the possibility that the total
volume of menstrual loss is only a part explanation of menorrhagia complaint, but
that the pattern of flow, and the extent to which this leads to menstrual accidents, is
strongly implicated. Despite the fact that relatively few studies measure blood loss,
and among those that do very few assess personality or psychosocial factors, many
theories have been expounded as to the aetiology of subjective complaints of
excessive periods, and the psychosocial reasons why so many women with complaint
of menorrhagia are found on measurement to have normal menstrual blood loss
(Fraser et al. 1984; Hodges 1989). Research into menstrual problems, and
menorrhagia in particular, has been hampered by a number ofmethodological issues.
Some important factors have been noted in the previous chapter: attitudes to
menstruation and to menstrual morbidity, the subjective nature of menstrual
problems; vague definitions. In this chapter the focus will be on menorrhagia
research methodology.
2.1.1 Clinical definition of menorrhagia
2.1.1.i Objective definition
The objective definition for menorrhagia followed on from a Swedish study which
measured blood loss in a population sample of 476 women (Hallberg et al. 1966). It
found a significantly greater prevalence of impaired iron status among women with
losses exceeding 60 mL. Using estimates ofdaily dietary intake for Swedish women
then, 1966, and of likely daily and menstrual excretion of iron, it was calculated that
menstrual blood loss of 63 mL or more endangered iron status. After excluding
women with abnormal iron status or who considered themselves unhealthy or to have
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abnormal menstruation, it was found that the 95th percentile of blood loss for the 183
'healthy' women remaining was 76 mL. The authors concluded that the upper limit
of'normal' menstrual blood loss lay between 60 and 80 mLs, but the most extreme
endpoint of this range, 80 mL, was subsequently adopted as the threshold for
menorrhagia (Hallberg et al. 1966). On a single measured period this simply
identifies the 3%-4% of the 'healthy' population with greatest loss. It is well
recognised that the problem with a statistical definition of this sort is that symptoms
(losses) less than this may be statistically fairly common, but for some women may
not be tolerable, whereas other women with abnormally heavy losses may find them
manageable (Rose & Barker 1978).
2.1.1.ii Definition based on clinical history
The consensus among clinicians is that menorrhagia means 'excessively heavy
uterine bleeding', this judgement being based on the clinician's initial interpretation
of the woman's description of her perception of her menstrual loss (Fraser & Inceboz
2000). Excessively heavy in what sense? Is this the 80mL definition rather vaguely
gauged, or is it a shift away from that conceptualisation, to allowing some contextual
judgement? Perhaps it is a move towards judging 'excessively heavy' for someone
who has this background health, or needs to hold down that sort ofjob, or lives in
such home circumstances. It seems this must be what a lot ofclinicians do when
confronted with a patient distressed by her periods, but it would be helpful to have
the 'definition' articulated and discussed. This has been found in qualitative research
with primary care professionals, that they find the medical definitions of menstrual
disorder unhelpful, and would more information about standards ofnormality
(O'Flynn & Britten 2003). In another study addressing objective assessment ofblood
loss very few primary care professionals stated they would ever attempt objective
assessment for a patient, while one third rejected the notion of being so focussed on
the volume of loss (Chappie et al. 2000).
2.1.2 Lay'menorrhagia complaint'
Qualitative research of women presenting to their GP with menorrhagia found that
all used the term heavy to describe their periods, but the meaning that seemed to be
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conveyed by this term varied between duration ofperiod, impact and the look of the
blood, and at times denoted a relative judgement, that the period had increased. For
almost all women a change in the pattern of their bleeding had been important in
deciding to consult. Blood loss volume and measurement were dismissed as
irrelevant compared to how they felt during the period and all the efforts needed to
contain the period (O'Flynn & Britten 2000).
In another study with referrals to a gynaecology clinic the researcher characterised
the ways the interviewees perceived their loss to be problematic as amount of loss
but also duration ofperiod, frequency, unpredictability, clots and change from
'normal'. Other contributory factors reported were accompanying physical
symptoms, anxiety about symptoms and the consequences of their heavy periods
(Marshall 1998). Some interviewees expressed doubts as to whether the
gynaecologist would be interested in anything other than blood loss, whereas it
seemed to the researcher that most women had a range of symptoms that concerned
them. Other studies have given a similar picture of a broad profile of symptoms and
consequences of them (Byles et al. 1997). A holistic orientation to menstrual health
care has been urged, addressing reasons underlying women's decisions to consult
and the significance of the presenting problems in their lives (Scambler & Scambler
1993).
Therefore it appears that the lay menorrhagia complaint is deceptive. At first sight
the complaint is amount of loss, but closer reflection reveals that it is actually the
impact of volume that is more important: the restriction to activities, accidents,
impact on roles, clots, strain of containing the period. Yet closer reflection reveals
that the issues are not confined to volume and its impact, but involve other menstrual
symptoms as well, such pain, tiredness, breast tenderness. Scratch menorrhagia and
what you find beneath the surface is menstrual distress.
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2.2 ASSESSMENT OF MENORRHAGIA COMPLAINT
2.2.1 Quantifying volume
Menstrual loss volume has been measured in various ways over the past six decades
- for example before 1960 by using vaginal cups to contain flow for later
measurement, or estimation by weight of used products, by acid haematin or by iron
content. Baldwin in 1961 reported on the use of an injection of radio-active iron
about 10 days before menses was expected, and then measurement of radioactivity in
soaked used sanitary products (Baldwin et al. 1961). Cups and weighing would have
been measuring the total fluid volume, whereas haemoglobin-based methods would
have been measuring volumes ofwhole blood. The alkaline haematin method
developed by Hallberg (Hallberg & Nilsson 1964) has been the most widely-used
method (Bonnar & Sheppard 1996; Chimbira et al. 1980; Cole et al. 1971; Fraser et
al. 2001; Fraser et al. 1985; Haynes et al. 1977; Higham et al. 1990; Hurskainen et al.
1998; Reid et al. 2000; The Menorrhagia Research Group 2004; van Eijkeren et al.
1986).
The main barrier to measurement of blood loss is the cultural etiquette against
discussing, still less handling, women's used menstrual protection. Furthermore,
measurement involves a relatively complex laboratory procedure. To address these
problems other approaches to quantification of menstrual loss have been proposed,
with the two main contenders involving estimation of blood loss volume from data
that is more easily obtained. One alternative is estimation ofblood loss from the
simpler objective assessment, of total menstrual fluid loss volume (Fraser et al. 2001;
Fraser et al. 1985), and the other involves estimation of blood loss from recording of
subjective judgements of the degree of soaking/soiling of every menstrual protection
product used (Higham et al. 1990; Janssen et al. 1995; Wyatt et al. 2001).
2.2.1.i Objective measurement of blood volume
The Hallberg method requires retention of used sanitary products and soaking of
these in 5% sodium hydroxide (Hallberg & Nilsson 1964). This process extracts
haemoglobin, which is converted to haematin. Soaking time needs to be 24 to 48
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hours but this can be reduced if the products are mashed, so in some laboratories a
stomacher is used for this purpose. An aliquot of the filtered soaking solution is then
compared in terms ofoptical density (by means of a spectrophotometer) to a sample
of venous blood taken from the woman around the time of menses, and also diluted
with sodium hydroxide.
Many women with severe menorrhagia will experience flooding and leakage of
blood onto underwear or bedding, or will pass clots, which are often lost into the
toilet. Clearly these components of the menstrual blood loss are not collected, and
therefore the final measured volume will be less than the actual blood lost. There
have recently been efforts to adjust measured blood loss for the fraction lost in this
way (Hurskainen et al. 1998; The Menorrhagia Research Group 2004; Wyatt et al.
2001). However, as the size of the adjustment is based on women's reports of
numbers of used products uncollected (Hurskainen et al. 1998) and on their
subjective judgement of the size of clots lost (Hurskainen et al. 1998; Wyatt et al.
2001), size of spillages (Hurskainen et al. 1998), or of deepness ofblood colour of
toilet bowl water (Wyatt et al. 2001), this introduces toilet design, recall and
subjective elements into measurement ofmenstrual blood loss. Furthermore, no
scientific rationale has been advanced for the blood volume adjustments made for
specific sizes of clots or spillages (Hurskainen et al. 1998; The Menorrhagia
Research Group 2004; Wyatt et al. 2001). In the case of an uncollected sanitary
product the adjustment involved increasing the measured blood volume by the
average blood volume per sanitary product for the rest of the period (Hurskainen et
al. 1998). However, this may be a substantial under or over adjustment, depending
on whether the product was 'regular' or 'super' absorption, and on whether the
uncollected pad or tampon was used early or late in the period. Fraser has shown that
in women with menorrhagia it is not uncommon to observe changes in measured
daily blood loss volume in excess of40mL, from one day to the next, so greater
disparities may be expected between days that are further apart (Fraser et al. 1984). If
the quantity of sanitary protection used varied proportionately to total volume of
blood loss then the proposed adjustment would be reasonable, but most women
change regularly even on light days, managing containment of excess flow in the
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first instance by varying the capacity of the products they use, from 'regular' to
'super' or 'super plus' and back to 'regular'.
The purpose of measuring blood loss is to verify objectively the menorrhagia
complaint. Therefore even if blood volume measurement quality is maximised, by
taking care with regard to the factors above, the accuracy with which the of
menorrhagia has been quantified depends on the extent to which the menstrual loss
for the specific period collected is representative of the woman's menorrhagia
complaint. For some women there is marked variation in loss between periods.
Other factors potentially influencing the accuracy of measurement of blood loss in a
specific menstrual period are:
• type of sanitary protection
• completeness of containment of flow on sanitary protection
• collection ofall used products
• taking blood sample just prior to menses
• squeezing of soaked products to equalise concentration of haematin in
supernatant and products
• avoiding substantial evaporation of soaking solution
• laboratory technique
• optimising comparative performance of spectrophotometer.
2.2.1 .ii Objective measurement of total fluid volume
As has been shown by Fraser and Levin (Fraser et al. 2001; Fraser et al. 1985;
Levin & Wagner 1986) the menstrual loss consists of a mixture ofblood and non-
blood fluid, with blood comprising about half by volume (Fraser et al. 2001). The
non-blood fluid is believed to be endometrial transudate, and comprises about 50%
of the total menstrual loss, across a wide range of menstrual loss volumes (Fraser et
al. 2001).
Since it is likely that complaint ofexcessive periods reflects concerns about or
difficulties with containment of total flow, measuring total fluid volume of menstrual
loss has a sound conceptual rationale. This measurement also has potential clinical
utility as it is easier to achieve.
36 Menorrhagia Reconsidered
The volume of menstrual blood loss has been shown to be on average 48% to 50% of
the total menstrual fluid loss, for women with moderately heavy to very heavy blood
loss, that is, respectively >60mL to 99mL and >100mL measured blood loss (Fraser
et al. 2001; Fraser et al. 1985). Work on total fluid loss was originally undertaken to
ascertain whether the much more easily-measured total fluid loss could provide a
clinically satisfactory estimate (prediction) of the feature that was germane to the
clinical definition of menorrhagia, the volume of menstrual blood loss. Using logged
volumes this proved to be the case, with good prediction possible, despite individual
variation in proportion ofblood in the total menstrual loss (Fraser et al. 2001). Even
better estimation would be possible in assessment ofperiod-to-period changes in
blood loss, as might be required in n-of-1 trials of treatment. This is possible because
in such a scenario the patient acts as her own control, so pervasive individual
contributions to errors in prediction, across the group studied, are eliminated (Fraser
et al. 2001).
The methodology used in Fraser's study was research-driven and labour-intensive,
and would not be feasible for routine clinic use. However it is possible that some
simpler version of it could be adopted.
Factors potentially influencing the accuracy of measurement of total fluid in a
specific menstrual period are:
• accurate weighing ofproducts before use
• completeness ofcontainment of flow on sanitary protection
• collection of all used products
• evaporation ofwater content from pads/bags
• accidental wetting ofproducts with urine or while bathing/showering
• any other extraneous material included with the product, such as toilet paper
• accurate weighing of collection.
The methodology required for measurement of total fluid volume is so simple that it
is surprising that it has not been used much more widely.
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2.2.1.iii Estimating blood volume by menstrual charting
Although measurement of total fluid by weighing is considerably easier than
measurement ofblood volume by laboratory methods, both are inconvenient for
women, and there is often marked reluctance to collect used sanitary protection for
handling by a laboratory technician. A new development for quantifying menstrual
loss has been the menstrual chart, first reported in 1990 (Higham et al. 1990). The
menstrual chart typically requires the woman to record sanitary protection usage and
to match each pad or tampon used to a pictogram, indicating the amount ofvisible
blood. There were three pictograms for each type ofproduct. (Pictogram = pictorial
or diagrammatic presentation of values/statistics.) An accumulation of this record
yields a point score related to volume of menstrual blood loss. The points do not
accumulate to a predicted blood volume, but to a 'PBAC' score for which a cut-off
of 100 was equivalent to a cut-off of 80mL ofblood loss. The sensitivity and
specificity (for detecting blood volume >80mL) on the development data set were
good (86% and 89% respectively) (Higham et al. 1990).
Since the start of the present research project other charts have been produced, one
retaining the three pictograms (Janssen et al. 1995). This had slightly less good
performance than the original chart. The other new chart added two extra pictograms
for pads, and one for tampons (The Menorrhagia Research Group 2004; Wyatt &
O'Brien 2000). In this chart patients also have to specify the absorbency of each
product used. The method is not clearly described, and there is no indication as to
how the blood volume is calculated from the product usage data. The statistics on
performance are not interpretable.
The point scores used in all charts are ascertained by test wetting ofproducts to the
degrees of'soaking' represented by the pictograms, and then converting millilitres to
points (Higham et al. 1990; Janssen et al. 1995; The Menorrhagia Research Group
2004; Wyatt & O'Brien 2000). The relationship between total products/points and
measured blood volume tends to drift at higher volumes. Perhaps this does not matter
if the point is only to detect losses over or under 80mL. However this limits the
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charts use to confirmation of complaint, and rules it out for studies of treatment
effect.
It should be noted that the charting method retains a strong subjective component,
and this may have a greater effect in routine rather than research use, where the
products are not also being collected for blood loss measurement, as a check.
Performance in a founding study is not usually maintained on a further test data set.
For the Higham chart there was poor performance in a subsequent validation study
(Reid et al. 2000).
2.2.2 Assessing subjective menorrhagia complaint
A number of questionnaires have been developed for assessment of menorrhagia, but
none appears to have been adopted as a useful clinical or research tool.
2.2.2.1" Health Status Assessment
A health status assessment was developed in 1995, but despite excellent credentials
in terms of its development and validation it has not been adopted for routine use
(Ruta et al. 1995). The development sample comprised 351 women with
menorrhagia, 105 from primary care. The questionnaire has 15 items, asking about
periods and accidents, associated symptoms, product use and impact on usual
activities. The questionnaire had good internal consistency and test-retest reliability,
and was validated by comparison to SF-36 scores.
A menorrhagia outcomes questionnaire has also been developed (Lamping et al.
1998). It is designed for assessing outcome after surgical treatment for menorrhagia,
and so is not intended to assess the menorrhagia complaint per se. However, it is of
interest to consider the items included in the questionnaire, as they must have been
deemed pertinent to menorrhagia recovery. It comprises 18 items apart from the
demographics, and only two of them ask about bleeding symptoms (one for before,
and one for after). The woman is asked to compare herself to before in terms of
energy, irritability, depression, carrying out every-day activities, and sex life. The
menorrhagia complaint seems to have been envisaged as more than volume ofblood
loss.
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Some interesting work was undertaken exploring patient preferences for menorrhagia
treatments in terms ofutilities (Shaw et al. 1998). This was in two stages, the first
establishing by interviews with many patients the weights they attached to various
domains ofhealth. In order, the most important domains were family life, physical
health, interruption to work, practical difficulties, psychological effects, and effects
on social life. These weightings were then used to develop a health status scale.
There is one item for each domain, and the patient selects one of four possible
answers. The answers are assigned weights which are accumulated to achieve a final
the score representing the patient's health on a scale of 1-100. The interesting thing
about this scale is that only one item deals with bleeding. The others would be as
relevant for period pain or premenstrual symptoms. So it appears this menorrhagia
assessment could be giving a lot ofweight to associated menstrual symptoms, and to
background psychological health. Indeed, a very poor 'menorrhagia health status'
score could be achieved with modest menstrual loss, provided there was pain and/or
cyclic symptoms.
2.2.2.H Quality-of-life
General quality-of-life measures could be used for assessment in menorrhagia,
instead of disease specific measures. In recent years quality-of-life assessments have
assumed a central place in health services and outcome research. It is generally
agreed that these are a good approach to health assessment (Clark et al. 2002; Jones
et al. 2002). The most widely used of the quality of life scales is the SF-36 - Short
Form 36-item generic health-related quality-of-life questionnaire (Garratt et al. 1993;
Ware & Sherbourne 1992). A further advantage of SF-36 is that there are normative
data available for the UK (Jenkinson et al. 1993).
The SF-36 was devised to assess important generic health concepts as may be used in
a wide range ofoutcome studies and health surveys (Ware & Sherbourne 1992). It
comprises 36 items, 35 ofwhich are accumulated into 8 scale scores (Medical
Outcomes Trust 1994). SF-36 covers all aspects of health: general health and vitality,
physical and social functioning, physical and emotional role functioning, bodily pain
and mental health. It has been used successfully in menorrhagia outcome research
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(Coulter et al. 1994b). The remaining free-standing item is, on its own, a measure of
reported health transition (HT), asking for evaluation of current health compared to a
year ago. Five levels of response are possible: much better, better, about the same,
worse, much worse.
The validity and reliability of SF-36 are considered to be excellent (McHorney et al.
1993; McHorney et al. 1994). However, an internal reliability and face validity study
undertaken with menorrhagia patients revealed some problems (Jenkinson et al.
1996). These were attributed to conditions such as menstrual problems that are not
life-threatening, that the sufferer knows will not last for ever, and with intermittent
symptoms (Jenkinson et al. 1996). This supports the conclusion of a recent review of
quality of life instruments in studies of menorrhagia, that there is a need to develop a
disease specific quality-of-life instrument for menorrhagia, because the generic ones
do not have sufficient clinical face validity (Clark et al. 2002).
2.2.2.iii Overview
In order to develop a menorrhagia specific quality-of-life instrument with 'clinical
face validity' there is an urgent need to clarify exactly what the 'face' of
menorrhagia complaint is. It is clear from the diversity of three health status
measurements presented above, and from their item content, that there is confusion
about just what it is that should be assessed. This probably derives from a dissonance
between the narrow clinical definition ofmenorrhagia, and the complaint as
expressed by women in terms ofutilities (Shaw et al. 1998), and as enshrined in the
outcomes questionnaire (Lamping et al. 1998).
Chapter 2: Methodological Issues 41
2.3 RECONSIDERING MENORRHAGIA
Menorrhagia has been defined in terms ofvolume of blood loss, and is of clinical
concern both because of adverse effects of excessive loss on iron status and vigour,
but also because containment of excessive flow can have an adverse impact on
quality of life. This bi-partite nature has led to a lot of confusion in research and
clinical practice. There is one simple question (in two parts): if a woman's health is
severely affected by her periods, in particular the flow, how should her problem be
assessed to inform discussion between her and her doctor as to appropriate strategies
of management? Would it make any difference to these discussions to know that her
blood loss was 66mL, 86mL or 106mL?
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A brief review of physiological and epidemiological understandings of menstrual
problems has been presented in Chapter 1, and a critique ofexisting approaches to
assessment of menorrhagia has been set out in Chapter 2. Concerns regarding the
currently prevailing tendency for partitioned thinking about menstrual problems,
viewing dysmenorrhoea, menorrhagia and premenstrual syndrome as distinct
conditions, led to the key objective of this research - to develop a broad clinical
assessment for menstrual problems. In the first instance what was required was a
multi-faceted examination of the contemporary menorrhagia complaint.
3.2 DESIGN, AIMS AND OBJECTIVES
3.2.1 Aims and objectives
The study aims were:
I. To develop a clinical assessment for the contemporary menorrhagia complaint
that encompasses the spectrum of relevant symptoms and clinical parameters,
and also impact on quality of life and health.
II. To define and quantify menorrhagia, by relating objective measurement ofblood
and total fluid loss to health impact and quality of life.
III. To relate outpatient outcome (i.e. management up to 8 months later) to
menorrhagia assessment profile.
This determined the objectives of the study which were to:
I. Undertake a cross-sectional survey ofwomen referred to gynaecology clinics
with the menstrual complaints heavy periods, irregular periods, premenstrual
syndrome or period pain, addressing the nature of the complaint and background
details.
II. Identify the subgroup with 'complaint of excessive menstrual bleeding' and
request more detailed questionnaire assessment of their complaint, health,
quality of life, personality, psychological well-being and medical history. In
Chapter 3: Methods 45
addition, request each such woman that she undertakes menstrual charting and
menstrual collection of her next period to allow objective measurement of
menstrual loss volumes.
III. Undertake a case-note review follow-up at 8 months after recruitment to
ascertain clinic outcome.
3.2.2 Design Overview
The key element of the research design was the detailed menstrual loss study,
involving prospective data collection for one period and measurement of menstrual
loss. This was embedded within a cross-sectional survey of all referrals for menstrual
complaint. All women with any of a range of menstrual problems were invited to
participate in the cross-sectional study.
In addition there was a case note review 8 months after recruitment, to ascertain
management and outcome. However, because funding constrained the duration of
the study, this 8-month follow-up review was possible only for those women
recruited to the cross-sectional study eight months or more before the end of data
collection, i.e. all women recruited before the end ofFebruary 1998. The time-
course of the study is illustrated in Figure 3.1.
This means that the design is 'mixed', with a follow-up or cohort study of a subset of
the entire cross-sectional survey, and also a more detailed menstrual collection study
embedded within the wider cross-sectional survey, but overlapping both the cohort
and survey-only subgroups. In what follows the design and methods for each of these
sub-studies will be described:
the cross-sectional survey (3.3);
the menstrual collection study (3.4); and
the cohort (follow-up) study (3.5).
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TIME: at recruitment next period 8 months after
This is followed by details of funding and research support (3.6), consideration of
ethical issues (3.7) and an overview of the statistical methods used (3.8). The chapter
concludes with a summary of study design and rationale (3.9).
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3.3 CROSS-SECTIONAL SURVEY
3.3.1 Design
What was envisaged was a cross-sectional questionnaire survey ofpatients newly-
referred to gynaecology clinics with menstrual problems. The self-completed
questionnaires used are detailed below (3.3.2). They were a mixture ofestablished or
published questionnaires that have been used extensively in menstrual research, and
ofquestionnaires devised specifically for the study, albeit in part developments of
questionnaires used in earlier research. Areas addressed by the questionnaires were
current menstrual and general health, personality, psychiatric well-being, socio-
demographics, contraceptive and obstetric history, illness behaviour and quality-of-
life.
3.3.2 Study questionnaires
3.3.2.i Development of new questionnaires
MEQ -MENSTRUAL EVALUATION QUESTIONNAIRE.
This was devised as a prototype menorrhagia assessment, evaluating menstrual
complaint in breadth and detail. It built on earlier research work, and incorporated
findings from the literature (as described in (Bancroft et al. 1993; Warner 1995)) and
ideas developed from reflections on these findings (Warner 1992; Warner 1994). The
novel aspect of the MEQ is that it seeks to evaluate menstrual complaint broadly,
both in terms of a 'clinical menstrual history' (including accidents and use of sanitary
protection and pain-killers), and also in terms of impact on daily life and work,
practicalities and cost, and feelings about periods. (A copy of the MEQ questionnaire
is provided as Appendix 3.1)
It was intended that ultimately MEQ would be shortened, by deletion of items
established by analysis as redundant, but before this is attempted it would be better if
there could be a consensus agreement as to a menorrhagia definition that is relevant
to women's concerns underpinning the contemporary 'menorrhagia' complaint.
Consideration of this latter issue is the subject of this thesis.
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CQ - Clinic Questionnaire.
This very brief questionnaire 'audited' the referral population by asking minimal
details about the complaint, as well as some background and demographic data. It
was devised to ensure that at least some (key) data were obtained on a range of
issues, as a precaution, as it was anticipated there would be women who would be
reluctant to complete extensive questionnaires. There was therefore some
duplication of basic menstrual and demographic detail with the longer and more
detailed questionnaires described below. (A copy of the CQ questionnaire is
provided as Appendix 3.2.)
CQ is novel in that it asks not merely for, say, subjective judgements ofheaviness of
loss (elicited symptom), but for evaluations of a range of'aspects' ofmenstruation,
including aspects ofvolume of loss, with respect to their occurrence or not, and if
they do occur, the extent ofproblem. The distinction CQ makes between symptom
and problem circumvents the confusion that can arise, for example, when a woman
reports her periods as 'heavy'. (See also 1.3.1.ii) Such a judgement may not
constitute a complaint of excessive volume, or problem. 'Heavy' can be simply a
straightforward value-free account ofhow the woman classifies her period, most
probably in relation to her own previous experience, but possibly also from type and
quantity of sanitary protection required to contain the period, or possibly on the basis
ofdiscussions comparing experience with other women. This distinction as to extent
ofproblem, for all aspects, is ofpotential benefit for research and for clinical
communication with the patient.
Furthermore, the difficulties with assessment ofpremenstrual syndrome, (Wyatt &
O'Brien 2000), and the attitudes there are to that illness label, led to a decision to
side-step the medical definition ofPMS (or rather the lack of such a definition that
can feasibly be assessed by questionnaire). Instead respondents were asked about
problems with 'mood changes around the period', and with 'other bodily changes
before the period'. This was felt to have the further advantage that there may be
women who were experiencing such symptoms as problematic, and would affirm
this, but who would not define them as PMS.
Chapter 3: Methods. 49
Similarly for menstrual pain. For CQ, specification of intensity ofpain, duration of
pain of various intensities and use and effectiveness or not ofpainkillers was
replaced by a simple prompt 'Do you have period-type pain with your periods',
giving the respondent the responsibility of determining the extent ofproblem for her.
There were similar items for pain before the period, and for cycle-long pain.
The questionnaire was piloted with a number ofgynaecology patients, who were
very positive about the approach taken, and the opportunity provided to describe the
broad range of aspects of their periods (menstrual symptoms experienced) and the
extent of impact (problem) on their lives (Warner & Critchley 1995).
MBQ - MENSTRUAL BACKGROUND QUESTIONNAIRE.
MBQ assesses menstrual history and background, addressing contraceptive,
menstrual, and obstetric history, alcohol consumption and smoking, and previous
psychological problems. It was based partly on the Menstrual Health Questionnaire
that had been used extensively in earlier research (Warner et al. 1991). A number of
questions were added, in particular items on general health symptoms, and common
medical conditions, taken from another questionnaire used extensively in women's
health research (Morse et al. 1988). The novel aspect of MBQ was an attempt to
obtain life-course data regarding age at onset of menstrual problems, first
consultation for menstrual problems with general practitioner, first attendance at
hospital gynaecology clinic, and also of changes in severity of symptoms over time.
In addition, some questions on illness behaviour with regard to periods, adapted from
a previous study on menorrhagia, were included as MBQ multi-part question 23
(Hodges 1989). These items are not analysed for this thesis so will not be described
further. (A copy of the MBQ questionnaire is provided as Appendix 3.3.)
3.3.2.ii Selection of established questionnaires
In menstrual research the most widely used psychological/psychiatric questionnaires
have been the General Health Questionnaire (GHQ), which screens for psychiatric
morbidity (Goldberg 1972), and the short form of the revised Eysenck Personality
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Questionnaire (EPQ-R), which assesses personality dimensions (Eysenck & Eysenck
1964). It was therefore important that they were included in the present study.
SF-36, the most widely-used generic health-related quality-of life measure, was also
included in the study (Garratt et al. 1993; Ware & Sherbourne 1992). SF-36 was
included in order to be able to compare with other published research, in particular
some work in menorrhagia (Coulter et al. 1994b), and there were normative data
available for the UK (Jenkinson et al. 1993).
For this thesis only the data for SF-36 will be reported, therefore only this
questionnaire will be discussed below. Analyses of the remaining questionnaire data
will be reported in papers in due course.
SF-36 - Quality-of-life questionnaire
The SF-36 was devised to assess important generic health concepts and has been
discussed in 2.2.2.ii (Ware & Sherbourne 1992). (A copy of the SF-36 used is
provided as Appendix 3.4). Table 3.1 lists the conceptualisation for each of its 8
scales, the number of items in the scale, the range of possible scores (levels), and a
resume of the content of the items comprising the scale (Medical Outcomes Trust
1994). The single additional (non-scale) item is a measure ofhealth transition (HT).
It asks for evaluation of current health compared to a year ago. Five levels of
response are possible: much better, better, about the same, worse, much worse.
Usage in this study The SF-36 used was the 'developmental' version, prior to
making item 9j into a new separate question 10, with five possible responses instead
of six. The questionnaires were scored as per the manual with question 9j re-coded so
that the scale scores can be interpreted as equivalent to scores on the current standard
SF-36 (Medical Outcomes Trust 1994). To achieve this, the six possible responses
for item 9j, in order lfom 'all of the time' to 'none of the time', were re-coded to be
1, 1.8,2.6,3.4, 4.2 and 5.
As a first step a raw score was obtained for each multi-item scale. These scale raw
scores were then transformed into percent scale scores, by means of the formula:
Transformed = [Actual raw score - lowest possible raw score for that scale] x 100
score Range of scores possible for that scale
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It should be noted that because the denominators for the scaled scores (the possible
range of scores as presented in Table 3.1) range from 3 to 25, the scaled scores will
have discrete values. If the range of possible scores is 3, as for RE scale, then the
possible scaled scores are 0, 33.3, 66.7, and 100. On the other hand if the range of
possible scores is 25, as for MH, then the possible scaled scores are 0, 4, 8, 12, and
so on up in multiples of four to a maximum scaled score of 100.
The single-item Health Transition (HT) 'scale' was not transformed but is, as advised
in the SF-36 manual, reported as a simple frequency distribution, and analysed as an
ordinal variable (Medical Outcomes Trust 1994).
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BP: Bodily Pain 2 10 Intensity of pain and impact on work
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MH: Mental Health 5 25 Mental wellbeing and degree of
depression, anxiety and emotional
problems
3.3.3 Iron status
One of the reasons for concern about excessive menstrual blood loss is the risk of
depleted iron stores (Fraser & Inceboz 2000; Fraser 1994; Milman et al. 1993). It
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would therefore have been desirable to have iron status test results for every
participant. However, there were a number of concerns about such a design. Firstly,
it was not felt to be ethical to request a blood sample for this purpose from every
participant. Secondly, if such a test was imposed by us, and the results showed low
iron stores, this would be likely to affect subsequent management of the patient, and
hence bias our findings at the follow-up. Finally, it was thought that the fact of a
blood test may discourage some women from participation in the study. It was
therefore decided to take a pragmatic approach, and record iron status test results for
each woman for whom a test was requested by her managing clinician, which would
be when such a test was judged to be clinically indicated. Therefore the group
receiving blood iron tests would inevitably be a biased subgroup, those judged to
need the test by their clinicians and hence more likely to have low iron status.
However, they would be representative ofwomen who would be tested, and so their
management, and the management ofwomen not tested, would be representative of
usual clinical practice in the clinics surveyed.
The most widely used test of iron status is haemoglobin which indicates iron
circulating in the blood (Rees 1997). Physiologically this is protected, in that
depletion or loss of iron from the body will be followed by an attempt to remedy the
shortfall in iron in the blood as quickly as possible, so that very soon a 'normal'
haemoglobin level may be obtained. On the other hand, serum ferritin concentration
reflects iron reserves, and it is depletion in these that is the first indicator of a chronic
depletion or loss of iron. Therefore serum ferritin concentration is likely to be a
more sensitive indicator of threat to iron status.
At the Glasgow clinics measurement of serum ferritin levels was a standard test in
use, together with haemoglobin. In Edinburgh the test was initially available, and
could be requested whenever haemoglobin was indicated. However, some months
after the study started measurement of ferritin levels became non-routine at
Edinburgh. Therefore extra funds had to be sought so that the test could be
purchased in Edinburgh, as an additional test for every woman for whom a
haemoglobin test was indicated. The numbers ofwomen having the two tests at the
Edinburgh and Glasgow centres is presented in Chapter 4.
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A further difficulty experienced with the ferritin tests was the different methods of
laboratory measurement in use at the three clinics, and over the time course of the
study. Edinburgh used one system throughout the study, Abbot Axsym system
(normal range for premenopausal women 7-280). Glasgow Royal Infirmary used
IMX Technology (normal range for premenopausal women 6-81). At Western
Infirmary Glasgow Ciba Corning Magic Irma was used until June 1996, and from
then on Ciba Corning AC5180 (both systems had normal range for premenopausal
women as 12-300.) The systems differed in the ranges for results, but none of the
companies marketing the systems was able to provide a conversion formula from one
system to the other. However each did state a cut-off value, which delineated Tow
ferritin' values from the rest. For simplicity of combining the data from the four
systems this binary value was used for multivariate analyses.
3.3.4 Ascertaining socio-economic status
A number of approaches were taken. At the individual level the woman's job, or
most recent job, was elicited in the CQ questionnaire. Since we were able to ask
only the most cursory information this enabled very crude classification in terms of
Social Class by means of the Registrar General's Manual (OPCS 1992). A further
caveat is that the jobs undertaken by women in their child-rearing years may not be
indicative of their true social class, especially if bringing up children single-
handedly. We also ascertained years of formal education, a variable known to be
closely linked to socio-economic status.
All these methods ofascertaining individual socio-economic status depend on
obtaining specific details on employment or education. Since we could not obtain
from non-participants the data necessary for determining individual social class we
would have been unable to compare their socio-economic status with that of the
participant group. For this comparison we used instead an area level indicator of
socio-economic status, the deprivation score, derived from the postcode (Carstairs &
Morris 1990). The Carstairs postcode-based deprivation score categorises the
population into 7 ordinal categories in terms of relative affluence or deprivation.
Affluence/ deprivation is determined from the 1991 Census data and reflects the
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prevalence by postcode of various indicators of affluence, including car ownership.
Carstairs score 1 is assigned to those who live in postcodes that are among the 'most
affluent' areas in Scotland, whereas those living in postcodes corresponding to score
7 live in the 'most deprived' areas, with intermediate affluence/deprivation ranged
across the scores 2 to 6. For participants the deprivation score (Carstairs & Morris
1990) also provided an indicator of socio-economic status that could be used as an
alternative to social class and education described above.
3.3.5 Ascertaining referral reason
Reason for referral was ascertained from general practitioner letters by dedicated
study research nurses. As just over half the letters cited more than one reason it was
decided that the first two reasons should be recorded, to minimise the need for
subjective judgements, and to allow for the diffuse nature of menstrual complaint.
The letters tended to be very brief, so there was little loss of information. Coding of
referral reasons is described in 3.8.5.i.
3.3.6 Target population
Referral 'menstrual problems' eligible for recruitment to the study were defined as
any described in the referral letter as:
• Excessive periods - including menorrhagia (heavy menses), heavy periods,
periods going on too long, periods too much, periods increased, flooding, clots
• Period pain - dysmenorrhoea
• Premenstrual syndrome - premenstrual tension, perimenstrual problems
• Period problems (non-specific)
• Irregular periods.
Initially the target population was all such women aged 25 to 45 years referred for
'new' menstrual problems to collaborating consultants at gynaecology clinics at
Edinburgh and Glasgow Royal Infirmaries, and Glasgow Western. A problem was
defined as 'new' if the woman had not attended the gynaecology clinic in the past
year for the same problem. The rationale for the age range was to exclude at the
younger end the adolescent menstrual problems that are common until
gynaecological maturation is achieved (Fraser 2000; Widholm & Kantero 1971), and
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at the upper end to try to avoid complaints that are allegedly menstrual but where
menopausal problems are strongly implicated in the decision to consult or refer
(Fraser 2000). After a few months recruiting it was realised that a substantial number
ofwomen between 45 and 50 years of age, with main complaint of excessive
periods, were having to be excluded from the study because of the upper age limit, so
about 6 months into the study a decision was made to extend the upper age limit to
49 years.
For this study there was a need to be able to read and complete questionnaires, so
women unable to speak/read English, had to be excluded. In the clinics targeted this
was a very small proportion ofwomen. Questionnaire completion makes demands on
reading ability but the research nurses were present and able to help with any
difficulties. Women with poor reading ability could therefore be included in the
cross-sectional survey because 'minimal participation' was possible, involving
completion only of the very brief CQ (Clinic Questionnaire).
3.3.7 Recruitment procedure
The recruitment procedure adopted was to scan the referral letters for appointments
before a clinic, and note any patients who seemed eligible for the study.
The research nurses worked part-time, and had to undertake laboratory work
(measurement of menstrual blood loss) in addition to spending time in clinics
recruiting patients. Therefore they were not able to cover all gynaecology clinics.
They sought to maximise recruitment by, after a few months, focussing on the clinics
which from early experience of study recruitment had been found to have the greatest
numbers ofmenstrual problem referrals (and the greatest number ofcollaborating
consultants).
When the clinic took place, the research nurse would try to talk to each potential
participant, to explain the study to her and invite her to participate. Sometimes this
proved impossible because patients spent hardly any time in the waiting room before
being called in to see the gynaecologist, or because appointments of two potential
recruits were too close together and while one was having the study explained the
other potential recruit was missed.
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3.3.7.i Referral log
A log was kept of all potential recruits identified from the referral letters, including
age, referral reason(s) ascertained from letter (up to two -see 3.3.5), and post-code. If
a woman was subsequently recruited she would be given a study number and this
would be entered on the log. The rationale for the log was to enable those
successfully recruited to be compared to the remainder in terms ofage, deprivation
code and referral condition(s).
3.3.7.ii Balancing recruitment against questionnaire completion
The number of questionnaires to be completed posed an organisational challenge for
the nurses, and there was concern also that the questionnaire load may have a
detrimental effect on recruitment to the study. It might restrict participation to those
who were more compliant or altruistic, and very probably also to those with better
reading ability. To maximise recruitment it was decided to conduct the survey at
three levels:
> Minimal - completing the briefClinic Questionnaire (CQ) only;
> Basic - completing also the Menstrual Evaluation Questionnaire (MEQ);
> Research 1- completing, in addition to Basic, the questionnaire providing
background data, the Menstrual Background Questionnaire (MBQ), and also the
General Health Questionnaire (GHQ), the Eysenck Personality Questionnaire
(EPQ-Revised) and the quality-of-life questionnaire SF-36.
The aim was to have as many participants supply as much detail as possible about
themselves, but it was accepted that not all women would complete all
questionnaires. To ensure maximal recruitment the design allowed for some women
completing only to the 'Minimal' or 'Basic' levels. The research nurses tried to
ensure that the brief CQ (Minimal) was completed at the clinic, but if the woman was
short of time any uncompleted questionnaires were given to her to take away, with a
reply paid envelope for posting back to us. If these were not returned then the nurse
would make one phone-call requesting return of the questionnaires (even if
uncompleted), or if no phone contact number was available, write one letter.
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Since the 'Research 1' questionnaires were mainly for the purposes ofelaborating
understanding of relationships between measured menstrual loss and other
questionnaire variables (MEQ and CQ), it was felt to be unethical to impose them on
women who were not eligible for menstrual blood loss collection (see 3.4.4.i).
Therefore detailed instructions addressing recruitment eligibility for the various
levels, including menstrual blood loss collection, were devised for the study nurses,
together with a diagrammatic representation. These are provided as Appendices
3.7and 3.8 respectively.
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3.4 MENSTRUAL COLLECTION STUDY
3.4.1 Design
To explore fully the nature of the menorrhagia complaint, and practicable but
meaningful ways to assess it, it was determined that in addition to the traditional
menstrual blood loss assessment both total fluid volume measurement and also a
development of menstrual charting should be employed. These will be described in
more detail in the methods section ofChapter 6, so a very brief outline only will be
provided here.
3.4.2 Estimation of menstrual loss by prospective menstrual charting
A menstrual chart was developed specifically for this study based on the published
chart ofHigham (Higham et al. 1990). This presents pictograms representing used
sanitary pads or tampons for a range of degrees of soaking, and the respondent must
match the product she has just changed to one of the pictograms. A copy of the
Menstrual Chart (MC) is provided as Appendix 3.5. The rationale for adaptations to
the Higham chart, and the approach taken, are described in detail in the Methods
section of Chapter 6. This stage also involved completion of a Weekly Well-being
Diary up to six weeks, until the end of the menstrual collection. These data also are
not reported in this thesis.
3.4.3 Objective 'measurement' of menstrual loss
3.4.3.i Determining menstrual blood volume
Blood loss measurement was undertaken by the alkaline haematin method described
by Hallberg (Hallberg & Nilsson 1964) which involves collection ofall used
sanitary products for one period, and the taking of a blood sample around the time of
the period, for comparative purposes. In this study only one period was to be
collected, as it was felt this was all it was reasonable to ask ofwomen participating
out ofaltruism, and not as part of their care. To explore to some extent within-
woman variability in menstrual loss, women were asked in their Menstrual Chart (see
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3.4.2 above) how the period collected compared with periods over the previous 6
months (the time period on which questionnaire responses were to have been based).
A detailed description of the method used is given in the Methods section ofChapter
6 and there is further extensive elaboration of methodological issues in Chapter 7.
3.4.3.ii Total menstrual fluid volume measurement
As an alternative method of objective measurement, Fraser (Fraser et al. 1985) has
explored use of total menstrual fluid measurement. This measurement is far simpler
to undertake than blood volume measurement since it involves simply pre- and post-
weighing ofall sanitary products used. Clearly evaporation must be avoided before
weighing of the used products. The difference in total weight converts directly to
millilitres of total menstrual loss. Total fluid volume can be used to estimate
menstrual blood volume, which is typically about 45 to 50% of the total menstrual
fluid volume (Fraser et al. 2001). However, since the total menstrual fluid volume is
what the woman has to contain with menstrual protection, it may be a menstrual
parameter of utility in its own right.
A detailed description of the method used is given in the Methods section of Chapter
6 and there is some further elaboration of methodological issues in Chapter 7.
3.4.3.iii Checks on measurement
The research nurses undertook initial training and checks by their trainers. They then
started measuring blood volumes of menstrual collections. Total fluid volume was
also ascertained by weighing (see below). The early data were examined
descriptively separately for the two centres. While the tendency to higher blood
volumes that was found in Glasgow could have been a reflection of a true difference,
the disparity observed in the proportion ofblood to total fluid would be unexpected
even if Glasgow women tended to have heavier blood losses. It was therefore
decided part way through the study to undertake some validation laboratory studies
to test the basis for the observed differences between the two centres. These are
described in Chapter 7.
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3.4.4 Identification and recruitment of women prepared to undertake
menstrual blood loss collection
3.4.4.1 Inclusion criteria
There were two inclusion criteria for undertaking menstrual collection. The first was
that all the study questionnaires had been completed (3.3.2i). The second was that at
least one of three menstrual complaint conditions needed to be satisfied:
• the woman was referred by her general practitioner for 'excessive bleeding' -
including terms such as menorrhagia, heavy periods, periods going on too long,
periods too much, periods increased, flooding, clots; or
• on the Clinic Questionnaire (CQ) she subjectively rated her menstrual loss as
'heavy' or 'very heavy'; or
• on CQ she gave her (free text) reason for clinic attendance as excessive bleeding
- including terms as above.
The rationale for this was to be as inclusive as possible regarding the participants
who were eligible to be invited to collect. There have been reports of
misunderstandings, between women and the doctors they consult, about the specific
nature of the menstrual problem leading to consultation (Bancroft et al. 1993; Coulter
et al. 1989). Furthermore, we found that in some referral letters doctors cited not the
(presumed) menstrual complaint, but the suspected cause - fibroids, say.
('Presumed' here is in the sense that the presentation is much more likely to have
been a menstrual symptom - for example, heavy periods- than an organic pathology
such as fibroids.) A referral reason such as fibroids could not be taken as equivalent
to the occurrence of excessive bleeding as fibroids do not necessarily cause heavier
bleeding. For women referred for this reason the original consultation may have been
for other reasons, such as problems due to pressure by a large fibroid. We reasoned
that in cases where the doctor had referred the patient with 'fibroid', and excessive
bleeding was the complaint, it would be likely that the woman would either state her
reason for attendance as excessive bleeding, or would rate her menstrual loss as
heavy or very heavy. She would therefore be deemed eligible for the study by one of
these other routes.
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Conversely, there have also been numerous reports, albeit often anecdotal, that some
women believing their periods to be 'normal' in fact have excessive blood loss. (Of
course, the periods may indeed be 'normal' for the woman concerned, if similar to
what she has always experienced.) It is possible that in some of these cases
questioning by an experienced general practitioner, prompted perhaps by presenting
symptoms of tiredness, would elicit the fact of excessive bleeding. This may lead to
referral for this excessive bleeding, even though the woman may not even rate her
menstrual loss as 'heavy' or 'very heavy'.
Finally, in discussions ofmenorrhagia, and in some research questionnaires, there is
often failure to distinguish degrees of subjective heaviness. In the RCOG guidelines
(Royal College of Obstetrics & Gynaecologists 1998) and in other guidance as to
management of menorrhagia or excessive bleeding (American College of
Obstetricians and Gynecologists 2000; Prentice 1999b) there is no requirement for
objective assessment of menstrual loss, nor is there a detailing of the specific features
of the menstrual history suggestive of excessive bleeding. 'Heavy periods' is used as
a synonym for menorrhagia, and management is outlined without any further
elucidation as to what is meant by the term. It is however possible that many women
in their late reproductive years, who do not believe they have a problem of excessive
bleeding, would nevertheless label their periods as 'heavy', reflecting the fact that
they have become 'heavier' in recent years. The question is whether subjective rating
as 'heavy' necessarily denotes a problem with the volume of menstrual loss.
The wish was to invite to collect all women where either they or their doctors
indicated that bleeding was deemed to be excessive, or where the subjective rating of
menstrual loss was at least 'heavy'.
3.4.4.ii Exclusion criteria
If a woman satisfied the two inclusion criteria then before she was asked to collect,
two exclusion criteria were applied:
(a) There was a decision to confine collection requests to women with usual
menstrual cycle length of 54 days or less, to avoid long time-lags until the collection
could be accomplished. Unwarranted approaches to potential collectors could be
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avoided as it was possible for usual cycle length to be checked first by the research
nurse, since the relevant information was requested and hence would have been
supplied in the Menstrual Evaluation Questionnaire already completed by each
woman.
(b) For safety reasons it was decided to exclude from the collection study women
who were intravenous drug-users or who were recorded in their notes as HIV
positive. The diagram and instructions provided for the nurses to guide recruitment
to the survey and for the menstrual collection study are shown in Appendices 3.7 to
3.8.
3.4.4.iii Recruitment of collectors
In the event that a woman satisfied the inclusion criteria, and did not have reason to
be excluded (see above), then the research nurse would ask her if she would be
prepared to undertake a menstrual collection for the purpose of research into
women's menstrual problems.
3.4.5 Procedure for collection
A key aim for us was to make the collection procedure as easy and acceptable as
possible for the women agreeing to help our research, and to ensure that
measurements made were as accurate as possible.
3.4.5.1 Provision of sanitary protection
Women were provided with free menstrual products, Regular and Super Tampax
tampons as required, and Bodyform Ultra sanitary pads in Super and Super plus
sizes, as required. This was mainly to standardise products used so as to avoid as far
as possible the need to pre-weigh each product individually, as will be described
(6.2.1). It was also hoped that free sanitary protection would encourage some
women to participate.
3.4.5.ii Bags for storing each used product
Given the prevailing menstrual etiquette, it was judged very likely that used and
blood-stained tampons or pads in clear polythene bags, needing to be conveyed home
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to the 'collection' point, would be difficult for many women. This may lead either to
defaulting, or use of toilet paper to wrap used products, thus affecting data
completeness, weight measurements and/or calculations. We therefore sought to
obtain opaque bags suitable for the research. Opaque polythene bags were not
available in laboratory suppliers catalogue, but it was realised that infant 'nappy
sacks', for transporting used disposable nappies, and available from supermarkets
and high street chemists, were ideal for our purpose. The nappy sacks used (Safeway
own brand) were an opaque pale apricot colour, an ideal size, pleasantly perfumed,
and shaped to enable a water-tight seal by tying.
3.4.5.iii Container for accumulating collection of bagged used products
The most simple and practical way to collect and then transport the bagged used
products would be in a copious plastic bag. However this was felt to be unseemly,
given that the collection would either be brought back to the clinic by the woman, or
collected by the nurse from the woman's home. We therefore obtained sturdy green
plastic mail courier bags, with the capacity of a largish briefcase. They had a strong
zip closing, and the added advantage that the bag could ifwished be fastened closed,
proof only against tampering, with small plastic fasteners that could be provided to
the women. For added safety the bag was lined with a large and robust yellow plastic
hospital waste sack. The courier bags could be sterilised after use and re-cycled for
the next collector.
3.4.5.iv The procedure
Women consenting to 'Full' participation, i.e. to collect use menstrual products for
one period, were carefully instructed on the menstrual collection, and advised on
how to avoid accidents, or loss of blood in the toilet or shower. The instruction sheet
is provided as Appendix 3.9. It should be noted that some of the requirements result
from our wish also to ascertain total fluid volume (described above). The instruction
sheet also gave the names and telephone numbers of the research nurses, in case any
further help was needed.
Each collector was also provided with a Menstrual Chart (MC - see above 3.4.2), a
green courier bag lined with a strong yellow hospital plastic bag, and with sufficient
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nappy sacks for sealing each product after use. The approximate date ofnext period
was noted. About 10 days after the due date for the next period the nurse would
telephone the collector to ask if the period was finished, and if so arrangements were
made for hand-over of the collection once completed. Either the research nurse
would uplift the collection from the woman's home, or the woman may prefer to
bring it to the clinic. In the latter case travel costs would be reimbursed. At the time
of hand-over a venous blood sample would be taken. In some cases the woman had
decided for personal reasons not to collect the first period, but did do so for a
subsequent period. However, in some cases no collection was ever made, despite the
agreement to do so.
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3.5 CASE NOTE REVIEW FOLLOW-UP
3.5.1 Design
Patients referred to gynaecology clinics have varied symptom profiles, often with
combinations of menstrual problems (Bancroft et al. 1993). For the majority ofthose
with complaint of heavy periods it is unlikely measurement of loss would confirm
menorrhagia (Cameron et al. 1990), but regardless of this there may be associated
pathology such as fibroids. It was therefore decided that the detailed cross-sectional
survey and embedded menstrual collection should be complemented with a follow-
up study of diagnosis, management and outcome. This would enable examination of
the relevance to clinic outcome of subjective reports ofperiods, actual volume of
menstrual loss, and other patient characteristics.
The overall time-span of the study was constrained by funding, and recruitment was
expected to extend for almost all of this, so the longer the duration of follow-up the
smaller the proportion ofparticipants who could be followed up before the end of the
study. Discussions with clinical collaborators led to a decision to set the follow-up at
8 months, as it was judged that the majority ofgynaecology clinic patients referred
for menstrual problems would within this time have been discharged or had decisions
as to management. The shortest reasonable time-span was sought so as to maximise
the proportion of recruits who could be followed up within the fixed time-frame of
study funding.
3.5.2 Membership of cohort
To allow time for data entry and reporting, it was decided that case note review could
continue only until the end of October 1998, three months before the end of the
study. Counting back 8 months from this date identified the end ofFebruary 1998 as
the latest possible recruitment for which follow-up could be accommodated.
3.5.3 Methods
Case notes were drawn 8 months or more after recruitment and reviewed by research
nurses, for the 8 month period following recruitment. Data to be extracted were set
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out on a Follow-up Form - Appendix 3.6. The main information sought was on tests
and investigations performed, diagnoses and treatments, and outcome at 8 months -
discharged, referral elsewhere, or still under care. Background medical information
was also sought, including obstetric history, medication being taken at the time of
referral, and any chronic medical conditions. The data-manager coded the data
entered on the follow-up form, according to coding schemes discussed and agreed
with the investigators.
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3.6 FUNDING AND RESEARCH SUPPORT
Funding for the study was provided by the Chief Scientist Office for Scotland (CSO)
(K/MRS/50/C2472, Principal investigator PW). Clinical collaborators for the grant
application, and subsequently for the study, were Professor Hilary Critchley,
Obstetrics and Gynaecology, University ofEdinburgh, and Professor Mary Ann
Lumsden, Department of Obstetrics and Gynaecology, University of Glasgow.
Another key collaborator was Dr Mary Campbell Brown, who at that time supervised
a menstrual problems clinic at Glasgow Royal Infirmary. She provided helpful
advice at the design stage, and was very much involved in the clinical conduct of the
study, and also in the laboratory assessment of menstrual loss.
Initially the grant awarded covered salaries for two years for two half-time research
nurses, one each in Edinburgh (Elaine Kacser) and Glasgow (Dorothy Lyons), and
for a half-time data manager in Edinburgh (Anne Douglas). It also provided funds to
pay for data entry. The nurses were to recruit patients, administer questionnaires,
chase up non-returns, undertake laboratory measurement of menstrual blood loss,
and review notes for follow-up. The data manager designed a study management
database, assisted with design and layout of in-house questionnaires, and organised
their printing. Once the study was up and running she liaised with nurses regarding
recruitment and follow up, maintained the study management database, checked and
coded questionnaires, oversaw data entry, checked entered data, and accumulated the
study data set. She also undertook descriptive summary analyses.
The research was overseen by means of regular study meetings ofPW, the three
clinical collaborators, the two research nurses and the data manager. Recruitment
was monitored, and any potential problems discussed. After about 6 months it was
realised that number ofeligible potential recruits had been overestimated. The
problem with ferritin tests in Edinburgh had also arisen. In the first year report to the
CSO an application was made to extend the funding for the study for a further year,
and included in this was extra resource to fund ferritin tests in Edinburgh. The
application was successful, so ultimately the study ran for three years.
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3.7 ETHICAL APPROVAL AND INFORMED CONSENT
Ethical approval for the study was obtained from the Lothian Research Ethics
Committee (Reproductive Medicine and Paediatrics Sub-Committee, application
made by PW), and shortly after funding was obtained, ethical approval was obtained
from the West Research Ethics Committee, to cover the Glasgow clinics (application
made by Professor Mary Ann Lumsden).
In addition to the verbal explanation of the study, women received written
information sheets about the survey and menstrual collection stages of the study, and
they signed consent forms for the stages to which they agreed participation.
Appendices 3.10 - 3.12 show the three information sheets, for (i) cross sectional
survey; (ii) prospective charting of next period; and (iii) menstrual collection.
Consent forms for Edinburgh are given in Appendices 3.13 - 3.15. Information
sheets for Glasgow were the same and consent forms very similar.
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3.8 STATISTICAL METHODS
3.8.1 Overview of statistical methods used
A range of statistical methods have been employed, encompassing descriptive
statistics, hypothesis testing and statistical modelling. All analyses have been
undertaken using the Statistical Package for the Social Sciences (SPSS) software,
version 11. Specialised statistical methods used will be detailed in the relevant
chapters. Association in rxc tables was tested by chi-square (y2). For ordinal data
association has been summarised and tested by means of the non-parametric
Spearman's rank correlation rho (see below 3.8.3), or for 2xc tables by means of chi-
square test for trend. For 2x2 tables chi square or Fisher Exact test was used.
Continuous data have been compared by means of t-test, or analysis of variance.
Where skewness of the data requires it the data have been subjected to log
transformation. Linear regression has also been undertaken, where there is a need to
be able to predict one variable from another (see methods 6.2.3.i). For binary
outcome data, logistic regression modelling has been undertaken, with the regression
coefficients presented as odds ratios (see 9.2.4). Principal components analysis has
been undertaken in order to reduce the number of variables and elicit the underlying
components ofvariation in the data (see 5.2.3). Confidence intervals (95%) are
presented wherever informative. However, in some tables, where a number of
percentages are presented for proportions of almost the same large n (about 900 say),
a footnote indicates the approximate width of the confidence intervals for values in
the table (or a subset of them). This is felt to provide a more readable table, with
minimal loss of relevant information about the summary statistics.
3.8.2 Graphical methods
Graphical methods have been used extensively, and have been produced using either
SPSS or Microsoft Office Excel software. One graph that needs to be defined is the
box-plot, or box-and-whisker plot. This was originally devised as a simple succinct
depiction of the entire distribution of the data (Tukey 1977). The whiskers denote the
range, minimum to maximum, and the central box shows the location of the middle
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50% of the data, delineated by the quartiles, as well as the location of the median,
which is indicated by a solid bar across the central box. The graph has subsequently
been elaborated to indicate also potential outliers and extreme values, and it is this
version that has been used in the chapters that follow, as it is the version that is
provided by the SPSS computer package. In the form used in this thesis the whiskers
do not necessarily denote the range, but may do so, if the data are compact. At each
end of the box the whiskers extend from the box to the closer of two points, either
the maximum (or minimum), or a point that is a distance 1.5 times the box length
away from the end of the box. Any data values that are further than this distance
from the end of the box are defined as 'outliers' and represented as open circles, and
any that are more than 3 times the box length away are defined as 'extreme values'
and represented by stars. Despite the terms 'outlier' and 'extreme value', in certain
types ofdata, for example highly skewed menstrual loss measurements,
distributional outliers and extreme values are commonplace, and generally denote
perfectly valid values.
3.8.3 Summarising association
Spearman rank order (non-parametric) correlation has been widely used to
summarise the strength of association between pairs of variables. If continuous data
have a skewed distribution, or if data are ordinal, then if correlation is to be
calculated it must be non-parametric. However, the method can validly be applied to
continuous data that are not skewed. Therefore if associations between a mix of
variables are to be calculated it is felt to be preferable for the sake of consistency to
use Spearman for all correlations, even if data for some pairs were suitable for
calculation of (parametric) linear correlation. In such circumstances there is very
little loss ofpower due to use of the non-parametric method (9% loss) (Daniel 1978).
Spearman differs from other nonparametric correlation methods in that, if both
variables of the pair would have been suitable for application of the parametric linear
correlation (Pearson), then the non-parametric Spearman correlation applied to those
data would also yield a very similar numerical value to the linear correlation. For
example, Spearman rho of 0.48 in place of a linear correlation of 0.5, and 0.69 in
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place of linear correlations of0.71 (Kirkwood & Sterne 2003). (For null and perfect
correlations values of zero and ±1 would be obtained, as for linear correlation.)
The strength of Spearman lies in the fact that it can be applied to any ordinal or
continuous data. As used here, in most situations with a large n (600 to 952), what
appear on the face of it to be quite modest correlations (in the region of 0.1) may
nevertheless be statistically significantly different from zero. It should be noted that
the purpose of applying this analysis method in this thesis is to summarise the ordinal
associations pertaining, for comparison between them as to relative strength, not to
imply that a particular size of correlation has a particular import. In general only
correlations above a specified absolute size will be reported, with confidence
intervals where space permits.
3.8.4 Power calculation from grant application
The multi-faceted research design meant that different sample size judgements were
required for the disparate parts, and the novel nature of the research being planned
meant there had to be an element ofguesswork in some of the decisions as to sample
size. In the first instance a target figure was chosen for the menstrual collection study
based on knowledge of the sizes of studies that had been published in the past, the
informativeness of their findings, and prior experience of this type of research. The
target for this 'Full' participation was then factored up to adjust for the number of
explanatory variables being assessed in this study, arriving at a figure of 300.
Initial (recruitment) sample size would have to be large enough to ensure adequate
numbers with 'Full' participation, despite the various degrees ofnon-compliance
anticipated. Experience of this type of research suggested 40% compliance with
collection, within the context of treatment studies (Cameron et al. 1990), but in the
context of this observational study it was expected that recruitment would be more
difficult. Judgements were then made as to the attrition there would be moving
through the various levels ofparticipation, so as to be able to work back to a required
figure for initial recruitment to 'Minimal' level. That is, if the number completing
menstrual collections was to be ±300, the required n for the first level, 'Minimal',
was judged to be ±1100, with ±900 and ±800 respectively projected as completing
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the next two levels, 'Basic' and 'Research 1'. Over the recruitment period, originally
envisaged as 18 months of a two-year study, this would necessitate ±14 new referrals
per week, 4 ofwhom proceed to menstrual collection. From clinical judgements of
throughput of such patients it was believed that this rate could be achieved by
involving the two centres, Glasgow and Edinburgh.
For the purposes of calculating power, the aims presented in 3.2 were where possible
formulated as a number of research hypotheses. However, it should be noted that
these proposed hypothesis tests were not the sole purpose ofthe study which was
essentially descriptive and hypothesis generating. The hypotheses formulated were as
follows:
Hypothesis 1. Menstrual charting (of sanitary products used, degree of soaking, and
accidents, impact on daily life) provides a clinically-adequate assessment of
menstrual loss in the majority of cases.
Hypothesis 2. Total fluid loss reflects subjective evaluation ofmenstrual loss better
than blood volume.
Hypothesis 3. Patients rating periods 'very heavy' but with menstrual blood loss less
than 80 mLs will have one or more of:
heavy fluid loss; very variable periods; flooding and/or many accidents;
excessive concern about health; blood loss exceeding 60mls.; or one or
more of the factors in (4) below.
Hypothesis 4. Patients referred for menorrhagia who do not rate their periods as very
heavy will have one or more of:
severe pain; prolonged bleeding; low well-being/ energy (that they
attribute to their periods); a recent change in their periods; perimenstrual
fluctuations in physical/ emotional health; generally poor physical or
emotional health; circumstances making moderately heavy periods
problematic.
Assuming the recruitment profile outlined above, culminating in 300 with 'Full'
participation, the achieved sample sizes with adequate data, for the main hypotheses
outlined above, would then be: Hypothesis (1) 300 for relating charting to measured
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loss; Hypothesis (2) 300 with loss measured by both total fluid and blood volumes;
Hypothesis (3) ±200 with loss subjectively rated as 'very heavy', and measured;
Hypothesis (4) ± 700 referred for menorrhagia. In addition a survey of clinic
presentation would be possible for all 1100 patients.
Hypotheses 1 and 2 both involved modelling, and explicit power calculations were
not made. Hypotheses 3 and 4 were not unitary hypotheses, but rather each implied a
set of comparisons in terms of the variables listed. For these the subgroups being
compared were expected to be approximately 100 v 100 for hypothesis set 3, and 330
v 370 for hypothesis set 4. An example power calculation was made, as follows. If a
feature occurs with a prevalence of20% in one subgroup, these sample sizes give
90% power (at 1% significance one-sided) of detecting an increased prevalence in
the comparison subgroup, provided the increase is by at least 14 percentage points
(to 34% or more) for hypothesis 4, or by at least 24 percentage points (to 44% or
more) for hypothesis 3.
3.8.5 Coding, and construction of new variables
3.8.5.i Coding referral reason
The two main reasons extracted from the referral letter and recorded in the referral
log were considered to be equally important, with no cognisance being taken of order
recorded. They were subsequently coded, and in addition four new binary variables
were created indicating, respectively, referral (or not) for:
• excessive bleeding - encompassing referral reasons such as menorrhagia,
excessive periods, 'metromenorrhagia', periods going on too long, frequent
periods, flooding, continuous bleeding, clots, dysfunctional uterine bleeding
• period pain - encompassing all the variants ofpain around periods but excluding
dyspareunia and pelvic pain.
• cycle-related changes - mood changes around periods or physical symptoms
around periods (other than period pain).
• 'other' reason -for example fibroids, endometriosis, irregular periods, non¬
specific 'menstrual complaint' or 'period problems'.
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These reflect the main menstrual problem groupings, and each woman could have a
positive value (indicating referred for this reason) for up to two of the four reason-
groupings. In a number of cases two reasons were extracted from the GP referral
letter but both were categorised into the same referral-reason-grouping. For example
referral reasons of flooding and clots would lead to a positive value only for the
'excessive bleeding' referral reason grouping, whereas GP referral reasons ofheavy
periods and fibroids would convert to positive values for both the 'excessive
bleeding' and 'other' referral reason groupings.
For a patient subsequently recruited, the referral codes (and the four binary referral
variables derived from the codes) were entered into the database as part ofher data
record.
3.8.5.ii Patient's stated reason for clinic attendance
The patient's understanding of the reason for her clinic attendance, the first (free
text) item on the Clinic Questionnaire (CQ), was converted into four indicators as for
referral reason.
3.8.5.iii Classification of participants with 'putatively heavy periods'
We created a classification of'putatively heavy periods' which included any
women who:
• were referred by their general practitioner for 'excessive bleeding' (see 3.8.5.i
above); or
• subjectively rated their menstrual loss as 'heavy' or 'very heavy' (on the Clinic
Questionnaire CQ); or
• stated their reason for clinic attendance as excessive bleeding (also on CQ - see
3.8.5.ii above).
This definition is the same as the menstrual inclusion criteria for the menstrual
collection part of the study (given in 3.4.4.i). Therefore only women with 'putatively
heavy periods' were invited to take part in this stage of the study.
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3.8.5.iv Age grouping
For presentation of data and use as a stratification variable, age was categorised into
five 5-year age bands from 25 to 49 years. For some analyses, this categorisation was
further collapsed to increase subgroup sizes, to three age bands or to just two. The
rationale for choice of adjacent categories to be combined was to make subgroup
sizes as even as possible. The number of age bands, and the age ranges for the bands
are shown in Table 3.2.
Table 3.2 Categorisation of ages into bands for the various age category
variables used.











Age Group (5) 1st 2nd 3rd 4th 5th
Age Group (3) 1st 2nd 3rd
Age Group (binary) 1st 2nd
3.8.5.v Deprivation code
For the purpose of analysis 'adjacent' deprivation subgroups were combined as
necessary to obtain fewer larger strata (1&2, 3&4, 5, and 6&7), using the same
rationale as for age above. For the various forms of the variable used the number of
deprivation bands, and the code ranges for the bands are shown in Table 3.3.
Table 3.3 Categorisation of deprivation codes into bands for the two
deprivation category variables used.




5 6 & 7
Deprivation group (4) 1st 2nd 3rd 4th
Deprivation group (3) 1st 2nd 3rd
Deprivation group (binary) 1st 2"d
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3.8.5.vi Body moss index
Body mass index is a ratio ofweight to height (squared) and provides an indication
ofobesity. For women a BMI over 24 is regarded as overweight, and over 30 as
obese. The formula used to calculate body mass index (BMI) was:
BMI = weight(kg) / [height(m)]2
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3.9 SUMMARY OF STUDY DESIGN AND RATIONALE
3.9.1 Summary of design
As has been noted, the study design was mixed, comprising a cross-sectional survey
with an embedded detailed menstrual blood loss collection study, and also a follow-
up (cohort) study of the (70%) earliest recruits to the survey group, so that the cohort
includes both collectors and non-collectors. This is illustrated in Figure 3.2 below.
Figure 3.2 Schematic diagram of study design
Taking into account the one-year extension to funding the research took three years,
with recruitment continuing for 30 months. Numbers of women in the various






3.9.2 Rationale for aspects of design
3.9.2.i Cross-sectional survey
Referral log. This enabled recording of age, deprivation and referral reason ofall
eligible patients in the clinics targeted.
Participants are those referredfor any menstrualproblems, not just menorrhagia.
This was to address discordance between referral reason and subjective report of
periods.
Identifying survey participants with 'putatively heavy periods'. Given the vagueness
of'menorrhagia complaint' it was necessary to identify those women where there
was suggestive evidence of troublesome heavy periods on any one or more grounds.
Participants are confined to patients newly-referred to gynaecology clinics. If all
patients attending the clinic had been surveyed it would have biased the study sample
towards women with intractable period problems.
Use ofmultiple questionnaires. Reasons for this were: the many and varied causal
attributions that have been advanced in the literature for women's menstrual
complaints (see Chapter 1); the wish to assess the impact of menstrual problems on
daily life; and the aim to develop a broad-based assessment of the contemporary
menorrhagia complaint by cross-referencing the MEQ to other measures. There was
also a need to be able to compare findings with research already published.
Allowing levels ofparticipation. The aim was to maximise recruitment to the clinic
survey by having an option of minimal participation (CQ only), but to obtain more
detailed data wherever possible. A subsidiary aim was to be able to judge the
representativeness of the sample participating fully.
Observational approach to iron status tests. This was to ensure usual clinical
practice was unaffected, minimising bias in management and outcome data. It also
avoided ethical and recruitment difficulties with imposing tests on all patients.
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3.9.2.ii Menstrual collection study
Embedding the menstrual blood loss collection within a survey. Reasons were:
• This would involve a broad range ofwomen with putatively heavy periods, who
could then be asked to undertake menstrual blood loss collection.
• It would avoid dependence on the GP referral letter to identify women with
heavy periods.
• We wanted to be able to compare the characteristics of those who agreed to
collect with those who were eligible but declined.
• We would be able to make projections as to volume of loss from the detailed sub-
study to the larger body ofwomen participating in the survey.
Measuring totalfluid We wished to explore the utility oftotal fluid measurement
for the following reasons:
• It constitutes the containment challenge experienced by the woman.
• Total fluid volume measurement is far easier to undertake.
Menstrual chart The aim was to ascertain if the performance of charts could be
improved, both in terms of quantification of menstrual loss, and also whether it
provided a clinically useful broad assessment of the menstrual experience.
3.9.2.iii Follow-up study
Follow up ofparticipants. The aim was to enhance insights provided by the cross-
sectional survey, and by measurement of menstrual loss, with an examination of
clinic outcome.
Follow up period set to 8 months. This was judged to be the best balance between
maximising the number ofparticipants who could be followed up within the time
constraints of the study, and a time period within which the majority of referrals to
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4.1 INTRODUCTION
The aim was to undertake a study of menorrhagia that collected data on a wide-range
of variables, including both subjective assessment ofheaviness ofperiods and
objective measurement of menstrual blood loss. However, as has been explained in
Chapter 3, for reasons of space data on personality, psychological well-being,
alcohol consumption and smoking are not reported in this thesis.
Study results will be presented in Chapters 4 to 9. Given the separate but inter¬
linking facets of the study there will be discussion of results, sometimes fairly
extensive, within each chapter. In addition, in a number of the results chapters extra
more detailed/specialised explanation of methods specific to the chapter is provided.
In an effort improve the flow of the thesis, and to constrain length, some of the
specialised analyses, additional tables, and similar have been removed from the main
text but are provided in the Appendices, in case there is a wish to refer to the
material. (The Appendix numbering matches the associated chapter in each case).
Some of the study results have already been published, and copies ofthe papers are
provided in the Appendix (Warner et al. 2001; Warner et al. 2004a; Warner et al.
2004b).
Material to be found in the following results chapters is:
• Description of current menstrual problem and clinic outcome - Chapter 5;
• Menstrual collection and charting results - Chapter 6;
• Measurement issues for quantification ofmenstrual loss - Chapter 7;
• Comparing Glasgow and Edinburgh participants, and addressing
representativeness ofparticipants, compared to the local general populations,
and across the various levels ofparticipation, in particular menstrual
collection - Chapter 8; and
• Detailed examination of factors associated with subjective assessment of
problem and measured menstrual loss - Chapter 9.
Finally, Chapter 10 will present an integrating discussion, and conclusions.
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The present chapter begins by reporting recruitment success rate and participation,
with a comparison of the study sample against those not recruited. Numbers of
participants receiving iron status tests and undergoing case-note review are also
reported. The background characteristics of the study sample are then summarised
and there is some examination of the reliability of responses for questions replicated
in more than one questionnaire.
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4.2 METHODS FOR THIS CHAPTER
4.2.1 Referral log
As described in 3.3.7.i, the Referral Log was used to record, for each woman
attending any of the targeted clinics, her age and up to two referral reasons, extracted
from the GP referral letter. Postcode was also recorded. Inclusion criteria were
described in 3.3.6,
4.2.2 Cross-sectional study questionnaires
Study questionnaires have been described in 3.3.2 (and copies for all but EPI and
GHQ are provided in Appendix 3). The various questionnaires ascertained specific
domains of data, except for the brief CQ, which was completed by all participants,
and which sought to capture key data on a broad range of data domains. Table 4.1
shows the data coverage of the six cross-sectional questionnaires used.
Table 4.1 Coverage of data derived from the study questionnaires
Questionnaire *
Data Domain CQ MEQ MBQ SF-36 EPI GHQ
Menstrual complaint SS ✓✓✓✓
Demographics SSY
Impact of complaint
Menstrual history V SS ✓✓✓✓
Obstetric history V W







* CQ ~ Clinic Questionnaire; MEQ ~ Menstrual Evaluation Questionnaire; MBQ ~
Menstrual Background Questionnaire; EPI ~ Eysenck Personality Inventory; SF36 -
Quality-of-Life questionnaire; GHQ ~ General Health Questionnaire
Extent of coverage: ^-minimal, ss= moderate, airly detailed, SSSS=extensive
Data reported in thesis: •<.. ✓VWC =yes, <... ✓wv: = no
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As has been indicated, data on smoking, alcohol consumption, personality and
psychological well-being are not reported in this thesis. Preliminary analyses found
considerable inter-correlations between SF-36, GHQ and EPI scores, and similar
associations between some of their scores and other study variables, suggesting that
as potential explanatory or elaborative variables the three measures offer overlapping
conceptual coverage. SF-36 was chosen for reporting in this thesis because of its
established reputation as a health outcome variable, and because the prototype
Menorrhagia Evaluation Question (MEQ) has the aim, essentially, to assess
menorrhagia complaint in terms of disease specific health impact and quality-of-life.
4.2.3 Participation level
As has been explained in 3.3.7ii, it was envisaged that different women would
participate to varying degrees. Level of participation was judged to be the
cumulative extent of completion of study measures. Table 4.2 shows the measures
needing to be completed for the five participation levels in this study.








Basic CQ + MEQ
Research 1 CQ + MEQ + (MBQ, EPI, SF-36, GHQ)
Research 2 CQ + MEQ + (MBQ, EPI, SF-36, GHQ) Menstrual Chart
Fuii CQ + MEQ + (MBQ, EPI, SF-36, GHQ) Menstrual Chart + Collection
* See footnote to Table 4.1 above
This shows that completion of the brief CQ only was labelled as 'Minimal'
participation, whereas if all cross-sectional questionnaires were completed,
participation was to level 'Research 1'. To be eligible for menstrual collection
women must have been classified as having putatively heavy periods (see 3.8.5.iii),
and must have completed questionnaires to level 'Research 1'. However in a few
cases, where only one of the five extra 'Basic/Research 1' questionnaires was not
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returned, then given the extent of the measures that had been completed the patient
was deemed to be nominally 'Research 1'.
4.2.4 Iron status
As described in 3.3.3, if an iron status test was requested by the managing clinician
then test results were recorded for the study, but the tests were not imposed on all
participants. The number of tests undertaken is reported here, and results in Chapter
5 (5.3.2.U).
4.2.5 Menstrual chart and collection
Numbers completing the Menstrual Chart, and undertaking menstrual collection, are
reported here, but the data from these are held over to Chapter 6.
4.2.6 Case-note review for 8-month follow-up
As has been explained in 3.5.2, case note review was undertaken only for those
women recruited before March 1998. The numbers ofwomen reviewed will be
reported here, descriptive findings in Chapter 5 and comparative analyses in Chapter
9.
4.2.7 Epidemiological/statistical issues for this chapter
4.2.7.i Statistical methods for this chapter
The main aim of this chapter is to describe the study population. Therefore, statistical
testing will to a large extent will be eschewed in favour of graphical or tabular
display of distributions to allow visual comparison, or summary statistics with
confidence intervals. There will be some exploration of the associations of patient
characteristics with the key socio-demographic variables. Statistical methods have
been described in 3.8.
4.2,7.ii Representativeness
The patients recruited are compared to those not recruited, in terms of age,
deprivation code and referral reason.
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4.2.7.iii Reliability
Where the same or similar information was obtained from the patient using more
than one questionnaire item, the consistency of responses has been examined. Where
the same information was obtained from more than one source (patient or referring
doctor), concordance of some of these responses has been examined.
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4.3 RESULTS
4.3.1 Recruitment and representativeness
Recruitment is summarised in Figure 4.1. To maximise recruitment within resource
constraints, those clinics with greatest likelihood of suitable patients were targeted.
Potential recruits (n=1926) were identified by scanning of new referral letters, and
efforts were made to speak to all of them. Further investigation revealed that some
potential recruits could not be included because of study exclusion criteria (n=420,
22%). The categories of 'unsuitability' were wrong age (38% of 420), other
exclusion criteria (not new referral, language: 35%), non-participating consultant
(22%), and other e.g. involved in another study (5%).
Figure 4.1 Recruitment
For a further proportion of potential recruits (n=136, 7%) there was in the event no
opportunity for discussing the study with the eligible patient, the predominant reason
being shortage of time in the clinic (93%). Of suitable patients approached, only 4%
(n=50) refused, whereas 1320 consented. Of these, 368 (28%) took the
questionnaires home but failed to complete and return them, despite a reminder
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phone-call or letter. The 952 who ultimately participated to some degree in the study
comprised 63% of the 1506 eligible patients.
Table 4.3 presents for the study group, and the 554 eligible referrals who did not
participate, the data that were ascertainable for the entire target population - age,
deprivation code and referral reasons. Participants were very similar to non-
participants, in terms of age and deprivation code. The main reasons for referral
were also very similar in the two groups.












Carstairs Deprivation Code (n=934, 544) % distribution % distribution
Least deprived: 1 & 2 19 16
3 & 4 35 33
5 20 25
Most deprived: 6 & 7 26 26
Referral by GP for: (n=952, 554) independent % s independent % s
Excessive bleeding 76 79
Pain 23 21
Cyclic changes 7 5
Other 35 36
*
up to two referral reasons per participant, so independent %s are reported, and add to
more than 100%
90 Menorrhagia Reconsidered
4.3.2 Participation and data collected
4.3.2.i Participation level
Level of participation was defined as the cumulative extent of completion of study
measures (see 4.2.3 and Table 4.2). Figure 4.2 shows for each participation level the
numbers ofwomen completing up to that level but no further (signified by n's), and
also the cumulative numbers completing the various levels (N's).














MEQ Menstrual Evaluation Q
MBQ Menstrual Background Q
SF-36 SF-36 Quality of Life Q
GHQ General Health Q




MBL Measured Blood Loss
TFV Total Fluid Volume
(n= no. completing this far only)














Survey of Menstrual Complaint Referrals
(n=952)
or H = measures to be completed for this level ofparticipation
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The N for a particular level therefore includes those stopping at that level (the
corresponding n) and all those going on to higher levels of participation. It can be
seen that 952 women participated to at least some extent in the cross-sectional survey
of menstrual complaint referrals, and that 226 women (24% of 952) participated
fully, completing all questionnaires and undertaking menstrual collection. Therefore,
although total number participating fell somewhat below target (see target sample
size in 3.8.4), since only 952 participated whereas approximately 1100 had been
estimated as required, the proportion participating fully was close to the predicted
rate (24% v 25%).
Not all women were eligible for menstrual collection, as the inclusion criteria for this
were to have putatively heavy periods (see 3.8.5.iii) and to have completed the
questionnaires up to Research Level 1 (see 3.4.4.i), Altogether 865 (91%) women
had putatively heavy periods, and of these 691 had also completed the necessary
questionnaires. Therefore the women participating fully comprised 26% of those
having putatively heavy periods, 33% of the subset also eligible for collection, in
having completed questionnaires up to Research level 1.
4.3.2.ii Iron status tests
Overall 458 (48%) women were given haemoglobin tests and 288 (30%) ferritin
tests. The percentage of study participants receiving haemoglobin tests and ferritin
tests at the two centres, and overall, is shown in Table 4.4.
Table 4.4 Number of iron status tests undertaken, overall and by centre,
and percentage of all participants tested
Test
Edinburgh (n=530)





Haemoglobin 197 37% 261 62% 458 48%
Ferritin 67 13% 221 52% 288 30%
There was generally more testing of iron status at the Glasgow clinics than in
Edinburgh. As explained in 3.3.3, further disparities in testing rate between the two
centres arose because there was also a period of some months when ferritin tests
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were not possible at all in Edinburgh, as the test had been declared 'non-routine'.
The test results are reported in 5.3.2.ii, and the characteristics of participants
receiving these tests are described in Chapter 8.
4.3.2.iii Follow-up case note review
Of all 952 women recruited to the study, 748 were recruited before the end of
February 1998 (see 3.5.2), Notes for 665 (89% of 748) women were retrieved and
reviewed.
4.3.2.iv Data provided
All 952 participants completed the minimal CQ. The numbers ofwomen providing
data in addition to this, by completing further questionnaires, having iron status tests,
or having their case notes reviewed, is summarised in Table 4.5.
Table 4.5 Data provided by participants, in addition to CQ questionnaire,
by participation levels
Data available for analysis, in addition to CQ *









MEQ MBQ SF36 MC Case
note
review
(No. of variables per
'measure')
(1) (1) (142) (126) (36) (< 241) (120)
Level n
Minimal 99 14 4 - - - - 80
Basic 139 41 14 139 - - - 125
Res. 1 402 172 76 398 396 402 - 221
Res. 2 86 49 26 85 85 85 84 55
Full 226 182 168 224 226 224 211 184
Total 952 458 288 846 707 711 295 665
KEY: CQ ~ Clinic Questionnaire; MEQ ~ Menstrual Evaluation Questionnaire; MBQ ~ Menstrual
Background Questionnaire; SF36 ~ Quality-of-Life questionnaire; MC ~ Menstrual Chart
* Since data for the personality and psychological well-being measures (EPI and GHQ respectively)
are not to be reported in this thesis, as explained above, the measures have been excluded from
Table 4.5 and will not be mentioned further.
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This shows that if the analysis involves CQ data only, the n will be 952, or slightly
less where there is missing response for the specific item. However, if, say, the
analysis includes data from SF-36, then the effective 'n' can be no higher than 711.
This will be made clear when analyses are reported. For each measure or data
extraction the typical number of variables per individual is also given, in the bottom
row of the header section. While this shows that there were very many variables, in
some questionnaires there is typically substantial data reduction, because the
questionnaire is analysed as accumulated scale scores (SF-36) or because principal
component analysis of items was undertaken (some of the MEQ data).
4.3.3 Description ofstudy sample
4.3.3.i Demographic and socio-economic data
The age distribution for the study sample was presented in Table 4.3 and the
remaining demographic data are presented in Table 4.6. The modal age group for
patients was 40 to 44 years old, modal family size was two children and modal
employment status was 'working'. Modal values for the two domestic status
variables were 'married or cohabiting' and still having two children living at home.
Table 4.7 presents socio-economic data for the study sample. The patients were
living predominantly in areas with deprivation codes 3 to 6, and the majority left
school at 16 years of age. Of those who worked, and provided job descriptions that
could be classified, the majority were social classes II and III non-manual.
The interrelationships amongst the socio-demographic variables were summarised.
Number of babies was correlated with age (rho=0.24, n=950, 95% CI 0.18 to 0.30)
and negatively correlated with extent ofworking (rho=0.24, n=941, 95% CI 0.18 to
0.30), but no association was detected with deprivation. Living with husband or
partner (as opposed to being single) was linearly associated with age, going from
59% in youngest age band to 81% in highest and even more strongly with parity,
going from 52% in nulliparous women to 84% in para 3+. There was a negative
linear association with deprivation, with 85% of the least deprived women living
with a partner but the proportion dropping to 68% in the most deprived subgroup.
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Table 4.6 Demographic characteristics
Variable n %
Age (n=952)
25 - 29 years 90 10
30 - 34 years 164 17
35 - 39 years 224 23
40 - 44 years 257 27
45 - 49 years 217 23
Relationship (n=950)
Married/cohabiting 703 74
Single - Separated/divorced 127 13
Single - Widowed 10 1
Single - never married 98 10
Single - subgroup unspecified 12 1
Working (n=942)
No job 241 25
Part-time work 280 30
Full-time work 421 45
Parity (n=951)
No births 211 22
1 baby 150 16
2 babies 351 37
3 babies 188 20
4 to 6 babies 51 5
Number of own children living at home (n=949)
Not applicable - no births 211 22
None 68 7
1 child 220 23
2 children 313 33
3 children 112 12
4 or 5 children 25 3
Number of other children living at home (n=949)
None 934 98
1 child 10 1
2-3 children 5 1
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Table 4.7 Socio-economic characteristics
Variable n %
Deprivation score (n=952)






Most deprived - 7 112 12
Highest level of education reached (n=947)
Left school at 16 years 554 59
Studied A-levels or Highers 124 13




III (non-manual) 294 34





Report ofgeneral health compared to most other women the same age was 'worse'
20%, 'about the same' 64%, and 'better' 16% (CQ item, n=944). Ratings of'worse'
health were more common in younger patients, in more deprived patients, those of
higher parity and those not working. This will be explored further in the comparison
of Edinburgh and Glasgow recruits (Chapter 8).
Body Mass Index
Table 4.8 gives the participants' height and weight, as reported in the MBQ, and the
body mass index (BMI) calculated from these two variables (see 3.8.5.vi). It can be
seen that half the participants had BMI exceeding 24, and so were 'overweight',
while just under a quarter had BMI exceeding 29, and were therefore 'obese'.
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Height (cm) 690 162 157 167 142 186
Weight (kg) 673 65.3 58 76 38 146
BMI (kg/m2) 672 24.6 22 29 15 47
BMI increased with parity (rho=0.133, n=666, 95%CI 0.06 to 0.21), age (rho=0.104,
n=666, 95%CI 0.03 to 0.18) and deprivation code (rho=0.094, n=660, 95%CI 0.02 to
0.17) and with self-assessed comparatively worse health (rho= 0.119, n=659, 95%CI
0.04 to 0.19).
Long term illnesses
Of the 702 women answering the question on the MBQ addressing long-term health
problems, 41% did not affirm any of the conditions, whereas 36% affirmed just one,
14% two, 6% three, and 3% three to six conditions. Table 4.9 gives the proportions
reporting the long-term health problems specified, together with the difference in
prevalence for these conditions between those rating their general health worse than
others, and the remainder (i.e. those with self-reported general health the same or
better than others). The most prevalent conditions were migraine, allergies, arthritis
and asthma. The large category of'other' health problems comprised predominantly
gastro-intestinal conditions (4% of 580), central nervous system conditions (3%),
musculoskeletal conditions (3%), uro-gynaecological conditions (2%),
haematological/nutritional conditions (2%), endocrinological conditions (1%) and
cardio-vascular conditions (1%). The six women reporting past cancer specified the
site of their cancer as breast (3 cases), head/neck (2 cases) and skin (1 case).
Inspection of the table shows that there was, for high blood pressure, arthritis and
'other conditions', an absolute difference in prevalence between those rating their
health 'worse than others' and the remainder rating their health same or better, that
was substantial (over 16 percentage points). There was a smaller but statistically
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significant difference (over 3 percentage points) for ulcer, migraine, asthma and heart
disease.
For those women who were followed up (n=665), up to three chronic conditions
were also ascertained from the case notes. The prevalences of the condition groups
most frequently recorded were: central nervous system 11%, respiratory 7%,
cardiovascular 6%, gastrointestinal 6%, endocrine 4%, gynaecological 3%,
nutrition/blood 3%, musculoskeletal 3%, skin 2% and endometriosis 2%. Therefore
the prevalences of chronic conditions recorded in the case notes are generally lower
than self-report.
Table 4.9 Long-term health problems and association with comparative
health








Difference in % prevalence (95% CI)
'Worse' health - 'Same'/Better'
Migraine 692 21 8 (2, 16)
Allergies/eczema 692 18 3 (-4, 10)
Arthritis 694 12 18 (12, 24)
Asthma 696 12 8 (2, 13)
High blood pressure 696 8 17 (12, 22)
Ulcer (stomach or bowel) 696 6 9 (4,13)
Thyroid 624 4 2 (-2, 6)
Diabetes 695 1 1 (-1.3)
Cancer 686 1 1 (-6, 3)
Heart disease 690 1 4 (2, 5)
Other 580 18 32 (24, 40)
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Current medication
Overall 53% ofwomen (367/690) reported on MBQ that they were taking regular
'drugs, pills or medicines' and 359 women specified the drug being taken and the
condition for which it was being taken. In order ofprevalence these were 18%
central nervous system drugs, 15% endocrine, 11% nutritional/ haematological, 8%
cardiovascular, 8% respiratory, 8% rheumatic drugs but for menorrhagia, 5%
gastrointestinal, 5% musculoskeletal and 4% cardiovascular drugs but for
menorrhagia. Where drugs were specified as being taken for menstrual reasons
(n=108), these were subjected to a finer classification. In order of prevalence
menstrual treatments being taken were 38% prostaglandin synthetase inhibitors, 25%
progestogens, 23% antifibrinolytic agents, 10% oral contraceptive and 1% each
clomiphene, danazol and HRT. Appendix 4.1 considers data reliability for health
problems and medications, by comparison with self-report and case-note data. There
was fairly low concordance between the two data sources, with case-notes less likely
to have cardio-vascular medications recorded.
Common minor symptoms
MBQ (question 1) also presented a list of 24 common minor symptoms, and asked
the participant if she had been bothered by any of them in the last two weeks. A
yes/no response was offered for each symptom and the numbers completing these
items ranged lfom 703 for headaches to 693 for craving for particular foods. The
prevalence of 'yes' responses ranged from 88% for lack ofenergy, then 69% feeling
sad, 67% headaches, 65% backache, 65% swelling ofparts of the body, 55% trouble
sleeping and 54% difficulty concentrating, through to 19% migraine, 14% persistent
cough, 14% cold sweats and, least prevalent, 6% bladder infection problems. For
each patient the total number of these symptoms reported as experienced in the last
fortnight was counted up. The number ofpatients who answered either yes or no for
every symptom was 630, and for these respondents the total number of symptoms
reported ranged from 0 to 22 (median 9 and inter-quartile range 6 to 12).
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4.3.3.iii Quality-of-life
Out of 703 participants completing the Health Transition item, 10% reported their
health in general better than a year ago, 54% about the same, 32% somewhat worse,
and 4% much worse. The distributions of eight scaled scores for the SF-36 are shown
in Figure 4.3. The scaling is such that the possible range of scores is 0 to 100, and a
higher score means better health status or functioning. It can be seen that participants
have least favourable scores for Bodily Pain and Vitality, and over a quarter of
participants have worst possible score (zero) for Role-Emotional. However, it is also
the case that over a quarter have best possible score for Role-Emotional, that is, no
limitation of role for emotional factors. In addition over a quarter have maximum
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The number of long term conditions affirmed (as reported in Table 4.9, section
4.3.3.H) was also correlated with SF-36 scale scores, negatively, such that long-term
illnesses were reflected in poorer status/functioning scale scores (all p<0.012). The
strongest correlations were with General Health, Physical Functioning, Role-
Physical, Bodily Pain and Social Functioning (rho= -0.325, -0.310, -0.237 and
-0.231 respectively, all p<0.001, n= 674 to 682).







SF-36 scale scores were markedly less favourable for the 122 participants with
'worse' self-reported comparative health (as described in 4.3.3.ii), than for the 551
with 'same' or 'better' health (Mann-Whitney, p<0.001), and this effect was
strongest for, in order, General Health, Physical Functioning, Vitality and Role-
Physical.
4.3.3.iv Contraceptive and obstetric history
All participants completed the brief Clinic Questionnaire (CQ), which ascertained
number ofbirths (reported in 4.3.3.i), years since last pregnancy ended, current
contraception (broadly categorised), years since operation if female sterilisation, and,
ifever used, years since stopping oral contraceptive pill. The MBQ ascertained
current contraception in more detail, and explored menstrual, contraceptive and
obstetric history further.
Current method of contraception
The current method ofcontraception is presented in Table 4.10, both as ascertained
by CQ and also as ascertained by MBQ (the relevant items being completed by 947
and 700 participants respectively). The wording on the CQ item was ofnecessity
very succinct, allowing only 5 choices, as shown in the last column ofTable 4.10.
The most common method in use was sterilisation (46%), then 'other' (20%), while a
relatively high proportion was using no contraception (26%). The distribution of
responses to this 5-option CQ item was very similar for the subset of 700 who also
went on to complete MBQ (second to last column). For this subset the more detailed
responses regarding current contraception that were obtained via MBQ can be used
to further elucidate contraceptive use (first column ofpercentages in table). For
example, those answering 'none' can be subdivided into 3% trying for pregnancy,
8% with no sexual relationship, and 15% with no explanation, and so perhaps risking
unplanned pregnancy. Similarly, sterilisation breaks down to 20% male and 28%
female, and 'other' is revealed as predominantly condom (18%).
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Table 4.10 Current Method of Contraception
Ascertained from MBQ Ascertained from CQ





None 26 25 26
No sexual relationship 8
Wanting pregnancy 3
No explanation 15
IUD/ Coil 2 2 2 2
Sterilisation 48 48 46
Vasectomy of male 20
Female sterilisation 28
Hormonal 5 5 5 6
Other 20 20 20
Condom/sheath 18
Rhythm, cap, other 2
The succinct wording of the CQ contraception item ran the risk of
misunderstandings. Appendix 4.2 reports checks that could be made by cross-
referencing to MBQ responses, where these were available. Where such data were
available CQ responses were if necessary altered to concur with the more detailed
responses of MBQ. If the errors found applied commensurately to the 252 women
who completed only CQ, for whom MBQ checks were therefore not possible, it
would mean that the proportions responding 'Sterilisation' and 'Other' on the CQ
variable may be an underestimate (by approximately 8 and 2 individuals
respectively), and the proportion responding 'None' may be overestimated (by about
10 individuals). This would make a difference of up tol percentage point to the
figures presented in the last column of Table 4.10.
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Pastoral contraceptive use
Although relatively few women referred for menstrual problems were currently using
hormonal contraception (n=58, 6% of 947), the vast majority had used it at some
time (n=815, 86% of 952). This was calculated by accumulating as 'ever-pill-users'
all respondents to items addressing current or past oral contraceptive use on CQ or
MBQ. Appendix 4.2 reports checks that could be made by cross-referencing to
MBQ responses. Applying the proportions in Appendix 4.2, it would be estimated
that of the 55 who did not answer the relevant item on CQ, and did not go on to
complete MBQ, a further 21 (39%) are likely also to have been past pill users. If so,
the overall estimate of 'ever-pill-users' is an underestimate, and it should be 88%.
Among those who had ever used oral contraception, 69% ofwomen (out ofn=610
who responded to this item) started the pill for contraception only, 29% for menstrual
or 'other' reasons only, and 2% for a combination of contraception and
menstrual/other reasons. The 'menstrual/other only' reasons were 11% period pain,
6% irregularity only; 4% heaviness; 2% premenstrual syndrome or 'other', and 6%
some combination of these. Recalled effect oforal contraception on periods will be
reported in 4.3.3.vi.
The patterns ofpast oral contraceptive use were examined in relation to the main
demographic variables. Never having used the oral contraceptive pill was unrelated
to deprivation and weakly related to self-rated comparative health, with those with
worse health being more likely never to have used the pill (19% compared to 14%
overall, x2=6.3, 2df, n=944, p<0.042). Figure 4.4 shows the proportions ofwomen
who had never used the pill by parity (x-axis) and age (separate lines). In general
never having used the pill was less likely the younger the age group. In each age
band the para 2 women were least likely to have never used the pill (that is, most
likely to have used the pill). However, within age bands the subgroups most likely
never to have used the pill differed by age band, being the least parous women (para
0/1) within the two younger age bands, but the most parous (para 3+) in the oldest
age group.
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Figure 4.4 Proportions who have never used the oral contraceptive pill, by
age group and parity
PARITY SUBGROUP
)( 40 to 49 yrs
(n=139,194,141)




Overall 239 women gave affirmative responses to the MBQ item asking 'Have you
been troubled by side-effects while on the pill?'. This comprises 38% of the 625
ever-users of oral contraception who completed MBQ. This is a substantial
proportion, considering that it was not just experience of symptoms but troubling
side-effects that was being ascertained. Furthermore, in an effort to avoid suggestion,
there was no explanation as to what the term 'side-effects' meant. This may have
prevented some who should have done so from answering. Those reporting troubling
side-effects cited bloating/weight problems (29% of 239), headache/migraine (26%),
mood changes (12%), nausea (9%), inter-menstrual bleeding (6%) and other assorted
effects (18%).
Obstetric history
Whereas the parity information used so far has been derived from the CQ completed
by all participants, it was ascertained by asking how many babies the respondent had
had. On MBQ there was an explicit question as to the number ofpregnancies. For
each of the 701 women who completed both items the number of babies (CQ) was
subtracted from the number of pregnancies recorded (MBQ). Figure 4.5 shows this
difference by parity. For 233 women (33%) there had been one to five more
pregnancies than babies, and for 7 (1%) there had been one fewer, presumably
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because of a twin birth. Of the 149 recording no babies born, 22 (15%) had
nevertheless experienced one or more pregnancies.
Figure 4.5 Distributions of numbers of babies born, showing within each
parity column the relative number of pregnancies experienced
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If she had had any pregnancy at all the woman was also asked to record the outcome
of the pregnancies, by providing counts for number of pregnancies resulting in each
of miscarriage, abortion, still birth and live birth. Of the 573 who recorded having
experienced one or more pregnancies, and who were therefore eligible to complete
this item, 569 did so (99%). Overall only 16 (2.8% of 569) women who had been
pregnant had experienced still births (nobody had experienced more than one), so
still births were combined with miscarriages for presentation and analysis. Altogether
30.2% (172/569) of the women had experienced miscarriage or still birth, the
majority of these had experienced only one (79% of 172), 13% two and 8% three to
five. With regard to abortion, 17.2% (98/569) of the women had had abortions, the
majority only one (88% of 98), 10% two, 2% three to four. It should be noted that it
is possible that for this item there could have been mistakes in completion in the case
of multiple pregnancies. This is considered further in Appendix 4.3. For presentation
and analysis of the data for abortion and miscarriage/stillbirth, the variables have
been re-coded into binary form, signifying for each respondent the occurrence or not
of at least one pregnancy with such an outcome. By cross-referencing it was
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established that 23 women had had multiple pregnancies (4% of 569). Consideration
of the reliability ofobstetric and contraceptive data was also undertaken by
comparison ofquestionnaire self-report and case note data, as described in Appendix
4.4.
Timings of contraceptive and reproductive milestones
Table 4.11 presents the data summaries of ages for various reproductive events, and
time-spans. Both the actual number responding to each item (n) and the potential
number are presented. In some cases the potential n has had to be estimated and
annotations to the table explain the way this has been done. The large amount of
missing responses (17%) for duration of current contraception is explored in
Appendix 4.2, while the fact ofmore than expected responses regarding time since
last pregnancy ended is explored in Appendix 4.3. For the remaining items the
missing response rate was 2 to 7%.
The median age at starting oral contraception was 19 years old. In study women the
contraceptive method in use was fairly stable, with median time on current method
being 8 years. However 25% ofwomen had used their current method for 3 years or
less. The median total time taking the oral contraceptive pill was 7 years and the
median time since stopping the pill was 10 years. The median time since female
sterilisation operation was also 10 years and the median time since last pregnancy
ended was 11 years.
4.3.3.v Health history
On MBQ women reported on past treatments for depression and anxiety. Table 4.12
reports the prevalence ofpast treatment for these conditions, 20% for anxiety and
28% for depression. Statistics for the duration of longest treatment received are also
presented. Over half of the women treated for depression had courses of treatment
exceeding 6 months, and over halfof those treated for anxiety had courses of
treatment exceeding 3 months.
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Table 4.11 Age at starting oral contraception, duration of use of current
method of contraception and of oral contraception, time since










6251 609 19 17 to 21 11 to 46
Duration of current
contraception
7072 590 8 3 to 13 Oto 28
Total time on oral
contraception
Q251 582 7 3 to 11 Oto 26
How long ago stopped
oral contraception
7573 707 10 5 to 16 Oto 28
How long ago sterilised 2764 259 10 6 to 15 Oto 24
How long since last
pregnancy ended
740s 750 11 6 to 17 Oto 28
* Potential n is the number of respondents to whom the item applies (for example items addressing
oral contraception can only be answered by those who have used it). The way in which potential n
has been calculated/estimated is described in the notes below:
1 Calculated as the number completing MBQ who answered any item on oral contraception on MBQ
or on CQ
2 Number completing MBQ
3 Calculated as the number completing CQ who answered any item on oral contraception on MBQ
or on CQ (but given that some did not go on to complete MBQ, and there was therefore less
opportunity to identify them as past pill users, this may be an underestimate by 20 to 30 patients)
minus the 58 still using oral contraception
4 Calculated as the 299 completing CQ who were taken to have indicated that they themselves had
been sterilised (by answering that consideration of their future fertility was 'not applicable -
already sterilised'), plus the 2 who did not answer thus but on MBQ indicated female sterilisation,
minus the 25 who on MBQ revealed that it was partner (male) sterilisation to which they were
referring. /As 79 of the 299 did not go on to complete MBQ, and so this potential for correction was
not possible, the calculated denominator may be a slight overestimate (by about 8 individuals).
5 On CQ responding one or more to 'how many babies have you had altogether', and which may be
fewer than those who have pregnancies.
Table 4.12 Past treatments for depression and anxiety
n Ever treated Duration of longest treatment (months)






Anxiety 689 20.3 129 3 1 to 6 <1 to 60
Depression 686 27.7 174 6 2 to12 <1 to 84
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There was a tendency for the same women to have been treated for both these
conditions. Of the 681 women completing both items, 35% reported past treatment
by GP for one or both of these conditions: 7% for anxiety only, 15% for depression
only and 13% for both. The combination of treatments experienced was associated
with deprivation (three bands), going from 26% of least deprived having had some
treatment to 46% of most deprived (%2=20.8, 6df, n=674, p=0.002), and with relative
frequency of treatment for depression increasing more with deprivation. The
combination was strongly associated with comparative health, going from 20% of
those reporting 'better' health having had some treatment compared to 59% of
'worse' (x2=66, 6df, n=674, p<0.001). Again, the gradient was more marked for
depression.
4.3.3.vi Menstrual History
AGE AT MENARCHE, RECENT CHANGE IN PERIODS AND PREVIOUS EXPERIENCE OF PERIOD
PROBLEMS
These data were obtained via MBQ. Age at menarche had median 13 years (IQR 12
to 14, minimum 9, maximum 18, n=692 out of 707 who completed MBQ). Women
were asked if they had noticed any change in their periods recently. Up to two
changes could be noted (as free text), and for each the respondent was asked to
record how long ago the change had happened. In total 513 women reported at least
one recent change. In order of prevalence changes were period heavier (32%),
duration changed (22%), more irregular (10%), clots (8%), colour of blood (6%) and
more frequent, increased pain and inter-menstrual bleeding (all 3%). The time since
noticing the change was recorded as 9 months (IQR 6 to 18, maximum 96, n=487).
The order ofprevalence was virtually unchanged if both changes recorded were
taken into account, so for simplicity only the first has been reported.
Table 4.13 shows the percentages reporting past history of any of four menstrual
problems, firstly 'at all' and then 'severe'. While pain and heaviness were the most
common past problems (about 90%), heaviness was the most common past severe
problem (75%).
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Table 4.13 History of menstrual problems, at all, and the subsets









Period pain 89 692 58 689
PMS 77 691 50 685
Irregularity 62 698 41 691
Heavy periods 90 699 75 691
The generally high percentages, even for severe problems, indicate that many women
had experience of more than one severe problem. The percentages reporting all/ 3/ 2/
1 or none of these problems as severe in the past were 14%, 18%, 19%, 13% and 8%
respectively. So a third ofwomen had in the past had three or more of the menstrual
problems, severely. Figure 4.6 shows, for women subdivided into those aged less
than 40 years of age, and those aged 40 or over, the distributions of ages at which the
problems started and became severe. For each problem there are two box-plots, one
for the age that problem started, the second for the age that problem became severe,
if it did.
Only period pain (not necessarily severe) had onset predominantly in the teenage
years, but there were also many women with onset later in life. Severe pain had a
broader range of ages for onset. In general the younger group ofwomen would be
expected to have constrained age at onset or age at problem becoming severe, since
the age specified has to be less than the current age, which is between 25 and 40
years. However, the plots for the older group of women show a wide mid-range of
ages of onset (lower to upper quartile, the extent of the box) indicating that despite
their older age at recruitment to the study, their problems are not generally new
problems. Many have had the problems since they were much younger. Broadly
speaking, the relative timing of onset of the menstrual problems in the group was
pain at the youngest age, then PMS, then irregularity, and lastly heaviness.
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Figure 4.6 Box-plots of ages at which problems started and at which
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Figure 4.7 shows the distribution of times elapsed since onset of the most recent
severe episode of menstrual problem, and this attendance at the clinic. Where women
have reported more than one severe problem then it should be noted that it may be
that only one of them is the referral reason, and/or the woman's self-stated reason.
Assessed visually it appears that the shortest elapsed time is for women stating
heaviness as (a) reason, with increasing elapsed times in order for women stating
irregularity, PMS and pain.
Experience of past severe problems was strongly associated with self-reported poorer
health. In terms of the number of the four period problems experienced as severe in
the past, 65% of those with 'better' health had two or fewer past problems, whereas
58% of those with 'worse' health had three or all four. Considering the problems
separately, the increase in reporting with worsening self-rated health was 11
percentage points for pain, 13 for heaviness, 21 for PMS and 27 for irregularity, the
latter representing a two-fold increase. Irregularity was also associated with
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deprivation, increasing 18 percentage points across three deprivation subgroups
(1&2; 3&4; 5, 6 & 7). Reporting of problems with heaviness increased with parity
(13 percentage points across three parity subgroups (0, 1, 2+)), whereas reporting of
pain decreased with increasing parity, by 16 percentage points. There were no
associations with age or work status.
Figure 4.7 Box-plots of years to clinic attendance, since severe problem
started, separately for two age bands
N= 204 147 132 223 181 170 135 269
< 40 years 40 plus
AGE GROUP
Previous health-care consultations for period problems
A third ofwomen (301/952, 32%) stated on CQ that they had previously attended a
hospital clinic for period problems, the majority of these (75%) for the 'same
problem' as now. Of the 301 who had attended such a clinic before, 278 reported the
time elapsed since that attendance, which had median 3 .2 years (IQR 2 to 7 years,
maximum 27 years). Ofthose who reported time elapsed (23 did not do so), 25 had
attended such a clinic in the past year, this despite attendance in the past year being
an exclusion criterion for this study (see Chapter 3). Only 19 had attended within the
last 10 months (2% of the 952 participants).
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From MBQ it was ascertained that the number ofprevious visits to GP for period
problems was median 3 (IQR 1 to 6, minimum 0, maximum 70, n= 618 completing
the item). Women were asked on MBQ if they had been seen before by a hospital
doctor for period problems, and 41% responded that they had seen a hospital doctor
(of657 completing the item). The number ofprevious visits to a hospital doctor was
median 2 (IQR 1 to 3, maximum 30, n=269 who had visited hospital doctor). The
number of the four problems consulted for (pain, heaviness, PMS, irregularity) was
predominantly one or two (70%), but 19% stated three of the problems and 11% all
four (n=269). Overall the median age for first visit to hospital doctor was 31 years of
age (IQR 24 to 39, n=244). Separately for the two age bands, less than 40 years and
40 years or more, the ages for first visit were 27 years (20 to 31, n=120) and 39 years
(31 to 43, n=124). The proportion ofwomen reporting past dilation and curettage
was 31% (n=650 responding), with 4% having had three or more, the maximum
number being 8. Current medications have already been reported (4.3.3.ii), with 16%
ofwomen (108/690) taking drugs for menstrual reasons.
Attendance before at a hospital clinic was associated with poorer self-rated health
(increase of 9 percentage points from 'better' to 'poorer' health) but not with other
demographic variables. The numbers of past appointments with GP and at hospital
clinics were also associated with poorer health (Spearman rho =0.16, 95% CI 0.11 to
0.20 for GP and 0.10, 95%CI 0.09 to 0.14). The only other demographic variable
associated with appointments was age which was inversely correlated with the
number of GP appointments (Spearman rho= -0.13, 95%CI -0.17 to -0.09), which
means that the younger women had had most GP consultations for periods.
Effect of past oral contraceptive use on periods
Respondents who had ever used oral contraception were asked in MBQ to comment
on whether it had had an effect on their periods, in terms of pain, regularity,
heaviness of loss and premenstrual symptoms. The judgements are presented in
Table 4.14. For each aspect ofperiods there was a potential of625 respondents (the
number of ever-users of the pill completing MBQ), but one possible response was
that the woman could not remember if there had been an effect. For all 4 aspects the
number responding at all was fewer than 625 (n=585 to 548, i.e. 6 to 12% missing
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responses), and the number able to make a judgement was even fewer (n=440 to 318,
70 to 50% of the potential 625 respondents). Period pain had the best response rate,
but regularity had the best judgement rate, both within responders and overall. PMS
had the lowest response rate and the lowest judgement rate both overall and within
responders. The effects reported are presented as a percentage of those making
judgements.
Table 4.14 Recalled effect of oral contraception on regularity and
heaviness of periods, and on period pain and premenstrual
symptoms (PMS)
Regularity Heaviness Period Pain PMS
n responding to item 573 567 585 548
nr able to recall if effect 440 418 413 318
EFFECT OF PILL % of nr % of nr % of nr % of nr
Made better 72 68 55 38
Had no effect 26 31 43 50
Made worse 2 1 2 12
It is noteworthy that although the effect of oral contraception on regularity and
heaviness, as observed by patients making judgements, was good (improved in 72%
and 68% of cases), oral contraception had not been generally effective in terms of
period pain (no effect or detrimental for 45% of cases). This is surprising given that
the most common period-related reason for commencing the pill was pain (11%
started for pain alone, and for a further 7% pain was a contributory reason, as
reported in 4.3.3.iv), If it is assumed that among those failing to respond, or unable to
make judgements, there was very likely no discernible effect, then the proportions
for which the pill had a noticeably beneficial effect on periods can be recalculated,
using 625 as denominator. This gives 51% noticing the pill improved regularity,
45% for heaviness, 36% for period pain and 19% for PMS.
4.3.3.vii Referral
For 45% of the study sample only one referral reason was cited, and for the rest the
first two were recorded. In a number of cases the two reasons cited were
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subsequently coded into the same category (e.g. both bleeding or both 'other') so
ultimately the percentage ofwomen with only one coding for referral reason was
58%. Overall 725 of study participants (76% of 952) had menstrual bleeding
problem mentioned as one of the first two referral reasons. With regard to other
menstrual problems, 216 (23%) of all referral letters cited period pain as a reason,
and 68 (7%) cited cycle-related symptoms or PMS. There were also 8 women (1%)
with reasons for referral given as 'menstrual problem' (unspecified), 5 as the only
reason, and one each in addition to pain, PMS and bleeding. Unspecified menstrual
problem, and all remaining reasons not classified as bleeding, pain or cycle-related
symptoms, were classified as 'other' reasons (e.g. intermenstrual bleeding/ discharge,
fibroids, irregular periods, endometriosis, varied bleeding pattern, ovarian cysts).
Altogether 342 women (36%) had 'other' as one or the only reason for referral.
There was considerable overlap between the referral reasons, and this is illustrated in
Figure 4.8, with the participants divided into two subgroups (columns), those
referred for bleeding and those not (n=725 & 227 respectively).
Figure 4.8 Numbers of women referred for bleeding (or not) and within each
category the subsets referred (also) for the remaining referral




















Bleeding (n=725) Not bleeding (n=227)
Referral or not for bleeding
In the 'referral for bleeding' column over half the women were referred for bleeding
only (52%), and the majority of the remainder were referred for bleeding with 'other'
or with pain. By comparing thickness of slices between the two columns it can be
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seen that women with pain or 'other' as referral reason were predominantly in the
'referred for bleeding column', that is, they were more likely than not also to have
had bleeding as a referral reason. This is perhaps to be expected, given the
prevalence of bleeding as a referral reason. It is all the more striking then that in the
case of referral for PMS, it was more likely that bleeding would not be an adjunctive
reason (53 without bleeding as reason v 15 with bleeding).
The association of four coded referral reasons with demographic variables were
examined. Figure 4.9 shows referral by age.
Figure 4.9 Prevalence by age of each referral reason separately (n=952)
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There were significant trends for bleeding and, more strongly, pain. Bleeding referral
increased with age, pain referral decreased (xVendldf =9.7 and 31.4 respectively,
p<0.005 & p<0.001). PMS was also associated with age, but rather than a step-wise
trend with age, 'PMS' referral was most common in women aged 30 to 44 years
(X2=14.9, 4df, p<0.005). There were no detectable associations of referral for 'other'
reason with age or the other demographic variables - parity, deprivation, extent of
working, comparative health or single/cohabiting status.
For bleeding and pain referral reasons the only other associations detected were with
parity, which were similar to those for age, shown in Figure 4.9. Referral for
bleeding increased with parity, from 70% in nulliparous women to 80% in para 3+
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(X trend=5.9, ldf, n=951, p=0.014). Referral for pain decreased with parity, from 34%
in nulliparous women to 18% in para 3+ (x trend=13.4, ldf, n=951, p<0.001).
The association of referral reason with sterilisation was also examined and it was
found that referral for bleeding was more common if sterilisation was the
contraceptive method (as ascertained on CQ, meaning that either the woman herself
or her male partner had been sterilised). Of those 'using' sterilisation 82% were
• • • 2referred for bleeding versus 71% among those not using sterilisation (x =13.6, ldf,
n=947, p<0.001). If association was examined in the subset who completed MBQ,
enabling male and female sterilisations to be distinguished, then it appears that the
effect was due mainly to female sterilisations, with 81% referred for bleeding among
those not using sterilisation, 82% among women where it was the male partner who
was sterilised, and 89% where it was the woman herself who was sterilised (n=365,
141 and 194 respectively). Referral for PMS seemed unrelated to sterilisation, but
referral for pain and for 'other' reasons were slightly less common if there was
sterilisation (respectively 21% v 25%, p=0.18 and 32% v 39%, p=0.25).
If referral for two reasons rather than one was examined there were no detectable
associations with the demographic variables. The largest combination subgroup with
clear definition was referral for both bleeding and pain (13.7% of 952). Given the
trend for referral for bleeding to increase with age and parity, and the reverse trend
for referral for pain, it is of interest to examine the demographic associations for the
subgroup referred for bleeding and pain together. Referral for this combination
decreased with age, from 17% to 9% (x2trend=6.6, ldf, n=952, p=0.01), but no
associations were detected with any other demographic variables, nor with
sterilisation.
Referral reasons were also examined in relation to the SF36 quality-of-life scale
scores. Those referred for cycle-related symptoms did not differ from those not
referred in respect of any of the scales. With respect to referral for bleeding, pain and
other reasons, the only scores for which differences were found, between those
referred or not for one ofthese reasons, were for Bodily Pain and Physical
Functioning. Physical Functioning was worse for those referred for bleeding
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compared with those not referred, and similarly with respect to referral for pain.
Effects were also seen for Bodily Pain by referral for pain or for 'other'. To ascertain
the associations for the four combinations of referral reasons a new combined
categorisation was computed (referral for neither, bleeding only, pain only and both
reasons) and the scale scores were compared across these four subgroups. Figure
4.10 shows the subgroup mean ranks calculated by the Kruskal-Wallis test (K-W) for
these two scales.
Figure 4.10 Mean rank summaries of Kruskal-Wallis (K-W) tests comparing
SF-36 Bodily Pain and Physical Functioning scores across the
four subgroups determined by referral or not for bleeding and/or
pain (lower score = worse functioning/status).
Neither (n=72) Bleeding only Pain only Both(n=107)
(n=469) (n=48)
Referral for Bleeding and/or Pain
Bodily Pain (p=0.001) o Physical Functioning (p=0.005)
Bodily Pain scores were ranked lower, indicating worse pain, if there was referral at
all for these reasons, even more so if it was for pain, and worst of all if there was
referral for both pain and bleeding (K-W x2=16.0, 3df, n=696, p=0.001). However,
Physical Functioning scores were ranked lower, indicating worse functioning, if
there was referral for bleeding alone (K-W x2=13.0, 3df, n=696, p=0.006). This
suggests Physical Functioning as a 'selecting in' factor for referral for bleeding, most
notably in the subset who do not have pain.
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4.4 DISCUSSION
4.4.1 Study design, recruitment and completion of measures
This research study, of measured menstrual loss in women with menstrual complaint,
was designed to accommodate a low rate ofagreement to menstrual collection. In the
event the rate of agreement among women eligible for collection (in terms of having
putatively heavy periods) was 26%. This rate is very close to what was anticipated
based on the approximately 40% that had been achieved in the past in the context of
clinical trials (Cameron et al. 1990). Patients invited to participate in treatment trials
for heavy bleeding are probably more highly selected for severity ofbleeding
symptoms, than our unselected gynaecology clinic referrals with putatively heavy
periods. Furthermore, the prospect ofperhaps obtaining a new and effective
treatment for their heavy bleeding, if consenting to menstrual loss measurement,
would probably result in more highly motivated participants.
Many and varied theories have been advanced, as to aetiology of subjective
menorrhagia complaint, especially of complaint that is not confirmed by menstrual
blood loss measurement. Variables that have been implicated include demographic
factors, personality, psychological health, general health, domestic and employment
status, quality-of-life, health behaviours and obstetric, contraceptive and health
history. This means that a wide range of data are required to allow elaboration of the
contributions that the various factors make to the explanation of the association
between subjective complaint of menorrhagia and measured menstrual loss. The
present study has been the first to undertake this. However, questionnaire surveys
can deter those with poor literacy who might find difficult, or impossible, the amount
of reading involved in completion of all the questionnaires. This in turn runs the risk
of a decrease in the proportion of women participating in the survey, or an increase
in defaulting with respect to completion of questionnaires. Our study had a very high
rate ofagreement to participation (96%) but also a high default rate, with 28% of
those recruited failing to return any questionnaires at all.
There was therefore concern that the design should maximise participation across the
range ofwomen referred for menstrual complaint. In order to achieve these aims it
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was decided that the design should allow minimal participation, providing the basic
demographic and menstrual complaint data. An extent of defaulting was anticipated,
not least because of the relatively poor literacy skills of a substantial proportion of
our population, so the aim of the very briefCQ was to ensure that at least that
questionnaire could be completed at the clinic, prior to leaving. The nurses did try
hard to ensure this was done. In reality though, a crowded and busy gynaecology
outpatient clinic is a very difficult environment in which to undertake survey
research of this type. No room was available for study use, so there was scant privacy
to talk with prospective recruits about the study, and even if there had been there
would probably have been anxiety on the patient's part that she may miss her earliest
possible slot with a doctor. The patient may at any unpredictable point be called for
her consultation with the doctor, interrupting any ongoing discussion or
questionnaire completion. Many of the patients were stressed by the nature of the
examinations they anticipated, by the need to take time out lfom work or family
commitments to attend the clinic (for a problem that is felt by many in our society to
be 'unmentionable'), and often by time pressures and transport or parking concerns.
In the circumstances recruitment and completion rates achieved by the nurses were
impressive.
The nurses would invite women to participate on the basis that minimal participation
(CQ) was better than none, but that the more questionnaires that could be completed
the better for the research study. The success of this strategy is shown by the
numbers completing CQ compared to the number completing all questionnaires, 952
versus 714. It can be estimated that a further 25% of recruits would have defaulted,
effectively, if participation had involved completion ofall questionnaires.
Furthermore, the brevity ofthe questionnaire used, together with research nurse
support, ensured broad participation. The participants to the cross sectional survey
were very similar to potential recruits who did not participate, in terms of age,
deprivation code and referral reason.
Despite the number ofquestionnaires requiring to be completed, 75% ofparticipants
completed all the questionnaires required up to Research level 1, providing a wealth
of data about themselves and their menstrual complaint. As intended these data have
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enabled a very thorough evaluation of the characteristics of those agreeing to
menstrual collection, compared to all referrals with menstrual complaint, and this is
reported in Chapter 8.
4.4.2 Study sample
4.4.2.i Referral reasons
Referral reasons were extracted from general practitioner letters, ensuring naturalistic
data. A disadvantage of this aspect of the study is that these data extractions and
their coding into categories are with respect to free-text communications and hence
subject to higher levels ofunreliability than pre-specified responses. However, to
have contacted each GP about the basis for referral of his/her patient would have
escalated the workload, resources needed and logistic complications of the study
beyond feasibility. The recording of two reasons when given, and the general brevity
of the letters, minimised the need for subjective judgement, but these data should be
interpreted with caution.
The study inclusion criteria were referral for any of the period problems heavy
bleeding, pain, premenstrual symptoms or irregularity, or non-specific referral for
'menstrual problem'. The very high proportion of referrals where the GP gave
bleeding as a reason for referral (76%) is therefore striking. It should be remembered
though that the study focus was menorrhagia, and so gynaecology clinics targeted for
attention by the part-time research nurses were those where more menorrhagia (than
say cycle-related) referrals were to be found.
More than one referral reason was common, with 42% of women having two reasons
coded to different categories (out of the four, bleeding, pain, cycle-related symptoms,
other). The most common combinations were bleeding and 'other' (for example
irregularity, or fibroids), bleeding and pain (14%), pain and other. Bleeding as reason
increased with age while pain as reason decreased. A similar pattern was observed
within parity subgroups. PMS as reason was most common in the middle age range,
while 'other' reason was unrelated to age. Referral for bleeding was also more
common if the woman had been sterilised. Referral for bleeding and pain combined
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declined with age. These associations could with benefit be explored in terms of the
more detailed nature of the complaints that are age-related, parity-related, or related
to sterilisation.
4.4.2.ii Background data, health and quality-of-life
The majority of study participants were aged 35 to 49 years of age (83%) and were
parous (78%), with 25% having had 3 or more babies. With regard to socio¬
economic status, years ofeducation was ascertained and despite the fact that the
detail required for rigorous determination of social class can not be gleaned by brief
questionnaire, especially not for women, an attempt was made to classify social class
from the woman's very brief description of her current or most recent employment.
Deprivation codes derived from post-code of area of residence, and based on 1991
census data, were also utilised as a proxy for individual socio-economic status
(Carstairs & Morris 1990). This was particularly valuable for comparison of those
who were and were not recruited, among all eligible referrals, because social class or
years ofeducation could not be ascertained for those who did not complete CQ. As it
turned out, deprivation proved to be the most useful socio-economic explanatory
variable for all the study analyses, as reported in this and subsequent chapters.
Women in the study were well-dispersed across the range ofdeprivation codes. In
Chapter 8 the deprivation distribution for study women will be compared to local
populations, and between centres. The majority of women were working (75%),
which may make menstrual symptoms less tolerable. While self-rating ofgeneral
health as being 'about the same' as others the same age was common (64%), this was
somewhat contradicted by what on the face of it seems a high rate of
overweight/obesity (50%), chronic illnesses (59%) and experience of minor
symptoms (half the women experienced 9 or more ofthe symptoms in the past two
weeks). The proportions who had received treatment for depression and/or anxiety
were 28% and 20% respectively, with 13% having been treated for both conditions.
In terms of SF-36 quality-of-life scores, 36% rated their health as worse or much
worse than a year ago. For the eight scaled scores, poorest quality of life (in terms of
these scores being standardised on a 0-100 scale) was reported for Bodily Pain and
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Vitality (median scores of about 50 or lower). In Chapter 8 we report comparisons
with population data for SF-36, and between centres. Referral for bleeding was
related to poorer scores on the Physical Functioning scale, albeit the scores were not
necessarily low in an absolute sense. Referral for pain was associated with poorer
scores for Bodily Pain and Physical Functioning. Therefore it would appear that SF-
36 scores may reflect impact of menstrual problem on quality-of life, but that the
heavy bleeding and pain are indistinguishable in their impact on physical functioning
(Jenkinson et al. 1993). This will be examined further in Chapter 9.
4.4.2.iii Contraceptive history
In this group contraceptive method was fairly stable, with half the women having
'used' their current method (or no contraception) for 8 years or more. Nearly half the
women were not actively using contraception because they or their partner had been
sterilised, and a further quarter because they were not in a sexual relationship, were
wishing to get pregnant, or with no explanation. Only 6% were using hormonal
contraception of some sort, but the vast majority had used oral contraception in the
past (86%). More than half the women had used the pill for 7 or more years and had
stopped using the pill 10 or more years ago. It would be to interest to examine both
these time-spans with regard to aetiology of complaint. Do women with recent
prolonged use of the pill develop an unrealistic idea of 'normal' periods? Does
prolonged uninterrupted menstruation lead to an 'ageing' effect on the
endometrial/physiological process of menstruation, with problematic periods the
consequence?
Among past pill users, 31% stated that they first started the pill for menstrual rather
than contraceptive reasons, and the majority ofpast pill users felt the pill to have had
a beneficial effect on period problems other than PMS. However, a high proportion
of past pill users affirmed having had 'side-effects' while using oral contraception
(38%). Furthermore, many study women would be precluded from taking it, because
ofobesity, smoking, or health history. Therefore many women referred to
gynaecology clinics for period problems may be unsuitable for or unenthusiastic
about the use of the pill to ameliorate menstrual symptoms.
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4.4.2.iv Menstrual history
Although study patients were 'new' referrals for period problems there was evidence
in the menstrual history data of considerable and diverse past menstrual morbidity,
with 92% having had one or more of the four period problems (heaviness, pain,
premenstrual symptoms (PMS) or irregularity) severely in past. Considering the
problems separately, 75% ofwomen had had severe problem with heavy periods
before, 58% with pain, 50% with PMS and 40% with severe irregularity. Indeed,
32% had had three or more of these severe problems in the past. Another striking
thing about the menstrual history data is the long duration ofproblems for many of
these women, particularly so for pain. Ages of onset for the four problems showed a
wide-spread but nevertheless consistent pattern, whether considering 'any problem',
or the subset with severe problem. Pain had earliest onset, then premenstrual
symptoms, then irregularity and slightly later heaviness. Therefore many women had
long experience, often of more than one severe menstrual problem, with 'heavy
periods' typically being the last to develop. This may partly explain the shorter time,
compared to the other period problems, from onset of'severely' problematic heavy
periods, to referral to gynaecology clinic. However, it should be remembered that in
this study group the strongest associations of past severe period problems with poor
self-rated comparative health were for PMS and irregularity. So health impact and
indication for referral may reflect differing rationales.
The history of severe period problems meant that a third of all study participants had
attended gynaecology clinic before. Despite the picture of serial menstrual morbidity
presented above (with respect to the four 'partitioned' period problems listed on
MBQ), among those whose current clinic attendance was not their first, 75% had
previously attended for 'the same problem as now'. This raises questions about the
extent to which women conceptualise/recall their menstrual problems in the neatly
partitioned way ofgynaecology textbooks, GP referral letters, the majority of
menstrual research, and the MBQ questionnaire.
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4.5 CHAPTER SUMMARY
4.5.1 Recruitment and participation
• The 1320 women who consented to participate comprised 88% of the 1506 referrals
logged who satisfied the inclusion criteria, but 28% of them did not complete and return
the questionnaires. The remaining 952 women who participated comprised 63% of the
eligible referrals.
• Those recruited to the first level were very similar to those not recruited, in terms of age,
deprivation and referral reason.
• The study was designed to allow participation to varying levels, and 226 (24%)
participated fully, by undertaking menstrual collection. Overall 48% of participants were
given haemoglobin tests and 30% ferritin tests.
• With regard to case-note review, 665 women (70%) were followed up, comprising 89%
of those recruited early enough to be eligible for follow-up.
4.5.2 Description ofsample
• Up to two referral reasons were coded for each participant. Considering coded reasons
separately, 76% of participants were referred for bleeding problem, 23% for pain, 7% for
cycle-related symptoms and 36% for 'other' problems/conditions (with 42% having
reasons mentioned which coded into two of these categories).
• Referral for bleeding increased with age and parity, and was greater if the contraceptive
method was female sterilisation. Referral for bleeding and pain combined decreased with
age.
• Participants tended towards the older end of the 25 to 49 age range, and the more
deprived end of the deprivation scale, with modal age band was 40 to 44 years of age
(27%), modal number of births was 2 (37%), and the modal deprivation codes were 4
and 5 (21 % and 20% respectively).
• The most common 'methods' of contraception were sterilisation (46%) or none (26%),
and while only 6% of participants were currently using hormonal contraception the vast
majority had used oral contraception at some time (86%).
• Half the women were overweight or obese (BMI >24 kg/m2). BMI increased with age,
parity, deprivation and with worse self-rated health.
• Only 20% judged their health to be 'worse than other women the same age' but there
was a fairly high level of chronic health problems, experience of minor symptoms,
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overweight, past treatment for anxiety/depression and generally poor health status/
functioning on the SF-36 scales:
In total 59% reported one or more long-term health problems (such as migraine,
allergies, arthritis, asthma) and 53% were taking regular medication and 75%
reported six or more minor symptoms (such as lack of energy, feeling sad,
backache and bodily swelling).
Past treatment by GP for depression was reported by 28% of women, and past
treatment for anxiety by 20%, with 13% of women having been treated for both
conditions.
On the SF-36 quality-of-life scale, 54% of the sample judged their health much the
same as a year ago, 36% as worse. Judged from the scale scores, the study sample
recorded worst health status/functioning on the Vitality and Pain scales.
• Menstrual History
- A third of women (32%) had previously attended hospital clinic for period
problems, the majority (75%) for the same problem as this visit.
The majority of women completing MBQ had in the past had a severe problem
with PMS (50%), period pain (58%), heavy periods (75%) and/or with irregularity
(41%).
Recent changes noted in periods were heavier periods (32%), changed duration of
period (22%), more irregular (10%), clots (8%) and colour of the blood (6%).









As has been explained in 1.4.2, the four most common period problems (excessive
periods, period pain, PMS and irregular bleeding) are on the whole similar to each
other, in that:
• the characteristic symptoms are signs ofpotential clinical importance;
• the 'severity' of symptoms may warrant management in the absence of
pathology; and
• there is often associated worry in the patient.
Each facet may impact on clinician behaviour (referral/ investigation/ therapeutic
strategy) and on patient help-seeking behaviour. With regard to 'severity' of
symptoms, the question is how this is judged, objectively in terms ofpain intensity or
measured volume of menstrual loss, or holistically and contextually, in terms of
overall menstrual experience and impact of symptoms ofdaily-life and broader
health. Clinicians and patients may be conceptualising 'severity' differently.
This bipartite (clinician/patient) and multifaceted (sign/severity/worry) model means
that even where symptoms are not of themselves intolerable, referral to the
gynaecology clinic may be necessary solely for exclusion of serious disease, for
clinical reassurance on this score. For some women then, once pathology is excluded
for her GP, nothing more needs to be done for her. In contrast, for many other
referrals to gynaecology clinic, the symptoms, unexplained or not, are intolerable to
the patient, and seriously diminish quality of life. Therefore even if serious pathology
is excluded, such a woman will be hoping for some therapeutic intervention to
relieve her suffering. This has been shown in Table 1.1.
It also means that a general practitioner's decision to refer may not be based
primarily on severity of symptoms or concern about symptom-signs, but more
because the patient is very anxious, and investigation and reassurance are judged to
be potentially helpful to her. Therefore, anxiety is more likely to be apparent in the
subgroup ofpatients referred with less severe symptoms, since they are more likely
to have been 'selected' for referral on the basis of their anxiety. They are similarly
more likely to be patients with new or recently exacerbated symptoms.
Chapter 5: Menstrual Problem and Outcome. 129
Therefore the themes for the menstrual data collection have been mainly 'severity' of
symptoms (both objectively and holistically/subjectively), associated worry, and to a
lesser extent the potential clinical meaning of symptoms (as may be reflected in
referral by general practitioner and investigation by the gynaecologist.).
This chapter begins by reporting women's self-stated reasons for clinic attendance
and a summary of data obtained on current menstrual symptoms, and ofwomen's
reports of how much of a problem they find various aspects of their periods. This is
followed by a thematic analysis of responses regarding dealing with periods and
feelings about this. Finally, there is a brief description ofclinic outcome as
ascertained from the case-note review follow-up i.e. the main findings for diagnosis,
management (including results of iron status tests where undertaken) and outcome.
The results for the menstrual collection are held over until Chapter 6, with
measurement issues being considered in more detail in Chapter 7. Chapter 8
examines the interplay of socio-demographic factors in the study groups, while in
Chapter 9 integrative analyses and modelling will be presented to draw together the
data reported in the preceding chapters.
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5.2 METHODS FOR THIS CHAPTER
5.2.1 Patient's self-stated reason for clinic referral/attendance
In previous research some discordance had been found between reasons given for
referral in the GP's letter to the gynaecology clinic, and the woman's reports of
menstrual problem (Bancroft et al. 1993). Therefore in this study participants were
also asked (on CQ) their (perceived) reason for clinic attendance: 'What problem,
mainly, has brought you to this clinic?'. The free text responses were classified as for
GP referral reasons (that is, as excessive bleeding, period pain, cycle-related changes
or 'other': see Methods 3.8.5). Also as for referral reasons, a maximum of two
reasons were coded, the first two mentioned if more than two reasons were given. In
Chapter 4 the categorisation of GP referral reasons was reported (4.3.3.vii),
5.2.2 'Aspects ofperiods' and 'causes of clinic attendance'
5.2.2.i 'Aspects of periods' as problems
On CQ question 5 the woman was presented with 16 aspects ofperiods and asked to
respond to each so as to indicate if this aspect occurred in her case, and if so, how
much of a problem it was - not a problem or slight, marked or severe problem. The
items were chosen to describe the range of aspects of menstrual experience, or
attributions of impact ofperiods, rather than to partition pre-emptively into
'menorrhagia', 'dysmenorrhoea' and 'PMS', or lay versions of these terms. A count
was made for each participant to ascertain how many aspects she had reported as a
severe problem, and also how many aspects she had rated a marked or severe
problem.
A further summary variable was derived, indicating whether a woman had noted as a
severe problem any of the three aspects ofvolume of loss (lose too much blood,
difficulty preventing accidents and periods going on too long, the latter being
included because that is often part of the menorrhagia definition, particularly in the
USA.). Similar summary variables were derived for pain (3 aspects, pain with and
before periods, and pain all the time) and cycle-related changed (two aspects, mood
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changes and other physical changes around periods). Another aspect which suggests
a cyclic change in health/vigour attributed to periods is 'feeling unwell because of
periods', so a fourth summary variable was derived, cycle/unwell (three aspects,
cycle-related mood changes and other physical changes and feeling unwell).
5.2.2.ii Citing aspects of periods as 'cause' of clinic attendance
After indicating for each aspect how much of a problem it was for her, the woman
was asked to note in order of importance up to three aspects that had been the main
cause ofher coming to the clinic. It was decided in advance that, ifmore than one
cause had been cited, all should be taken into account, up to a maximum of three as
specified on CQ. The rationale was that from the woman's point of view there might
be little difference in importance between, for example, first and second causes cited.
The causes cited were used to derive new variables, indicating separately for each
aspect listed on CQ whether that respondent had cited it as a cause of coming to the
clinic, regardless ofwhether first, second or third in order. For these variables, no
cause cited at all (18 respondents) was taken as 'not cited', not as missing. The
additional (non CQ-listed) causes cited, as reported above, could not be mapped
reliably onto the CQ aspects, and so were ignored (135 citations out of a total of
2253).
As for 'aspects as problems', summary variables were also derived for volume, pain,
cycle and cycle/unwell with respect to citations of'cause' of help-seeking. (For the
cycle groupings, 6 free-text citations of'PMT' as cause could also be mapped and
hence counted.)
5.2.3 Principal components analysis for data reduction
5.2.3.1 Introduction
The way in which a woman experiences her periods, and finds them distressing, is
likely to reflect a number of underlying processes. For example, some of these may
be: the nature of her menstrual symptoms; the context of her daily life; her personal
and practical resources for dealing with the symptoms; her tendency to be concerned
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about her health; her past experience; and her emotional resilience. The various
processes at work are likely to be reflected by differing degrees ofaffirmative
responses to the broad range of items, describing adverse consequences of periods,
presented in the Menstrual Evaluation Questionnaire (MEQ). Variables reflecting the
same process should be highly correlated, and in the interests of parsimony it would
therefore be helpful if they could be summarised into one score. In practice, specific
variables might reflect more than one of the underlying processes. Nevertheless,
there would be considerable advantage in being able to express the original variables
in terms of a smaller number of dimensions ofvariability.
5.2.3.ii Aim of principal components/factor analysis
Principal components and factor analysis are multivariate methods which can be
employed to reduce a large number of variables to a smaller number of factor scores
that reproduce, to a sufficient extent, the correlations among the observed variables.
Over and above data reduction there are two further advantages of these methods:
• the nature of the factors obtained provides insight to the underlying processes
that may be operating to generate the observed data;
• when the factor scores are estimated for each subject, from the entire set of
variables, they tend to be more reliable estimates of the underlying dimensions of
variability, than any one ofthe original observed variables is ofwhatever it is that
it measures (Tabachnick BG & Fidell 1996b).
Therefore these methods can offer both parsimony and precision. Important
methodological issues are the number of factors to be retained in the solution, and
whether or not the factor solution should be rotated.
5.2.3.iii Theoretical issues
There are a number of theoretical limitations to principal components analysis, and
factor analysis. If there is much missing data its impact needs to be assessed. It is
important that variables take a spread of values, and the solution is enhanced if the
variables are normally distributed, which also implies linear relationships between
pairs of variables. However, in the case ofexploratory data analysis these
assumptions are less constraining, and decisions can be made on a pragmatic basis
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(Tabachnick BG & Fidell 1996b). It is also important correlations are reliably
estimated, so a correspondingly large sample size is important. Three hundred cases
is regarded as a practical minimum (Tabachnick BG & Fidell 1996b). In the present
study the MEQ data have a sample size ofover 700.
A number of reservations have been expressed about these methods, in particular that
there is no criterion against which to test the solution (Tabachnick BG & Fidell
1996b). Also, there is an 'indeterminacy' due to the infinite number of rotations
possible to achieve a final solution, all with differing interpretations, to a greater or
lesser degree. However, neither of these is a serious concern when the aim is
exploratory data reduction, as here.
5.2.3.iv Method used
As it is so specialised the detailed method is given in an appendix (Appendix 5.2)
which will be referenced at the time results are reported, in section 5.3.1.iv, The
method steps covered are:
• Choice ofextraction method -principal components was chosen;
• Extraction of components- the approach taken by the SPSS software is
described;
• Deciding number of components- a combination ofscree plot, eigenvalue, and
meaning ofcomponents was used;
• Rotating the solution- varimax rotation was used;
• Estimating factor scores- the approach taken by the SPSS software is described;




5.3.1 Current menstrual problem
5.3.l.i Patient's self-stated reason for clinic attendance and duration of
problem
For the 15 who did not respond at all to this free-text question, the classification for
both reasons was set to 'missing'. For the remainder text responses were classified as
per 5.2.1 and 3.8.5.ii, Overall 56% ofparticipants mentioned two (or more)
problems, but in many cases both problems were coded to the same reason, so in
terms of codes assigned only 31% ofparticipants had two distinct reasons. (For
example, 'periods going on too long' and 'heavy periods' would both code to
'excessive bleeding' reason.).
The breakdown of reasons stated by participants was 568 (60%) excessive bleeding,
283 (30%) period pain, 67 (7%) cycle-related changes, and 323 (34%) 'other'. The
distribution of reasons coded to 'bleeding reason' was:
- heavy periods (72%),
- periods going on too long (12%),
- periods too frequent (7%),
- clots (6%) and
- continuous bleeding (3%).
Intermenstrual bleeding, varied bleeding pattern and changed bleeding pattern were
coded as 'other' (59, 6%), as was unspecified 'menstrual problem' (48, 5%). The
most prevalent reason coded as 'other' was irregular periods (144, 45% of the 323
participants coded with 'other' reason).
The concordance between patients' self-stated reasons for clinic attendance and GP
referral reason, and the association of self-stated reason with the various
demographic, health and menstrual variables will be reported in Chapter 9.
The duration of the self-stated problem was ascertained via CQ: median 24 months
(IQR 11 to 54 months, n=923). The question asked was 'How long has this been
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bothering you?', referring to the 'problem, mainly, that brought you to the clinic'.
Therefore, if more than one problem was cited it is not certain that the duration given
applies to both problems cited. If pain was cited, either as the single reason or as one
of two reasons, the median duration of'problem' was 36 months (n=283), as it was if
cycle-related changes was cited as reason (n=67). If bleeding was cited, median
duration of'problem' was shorter, at 24 months ^=568), and if'other' was cited it
was shortest of all, 16 months (n=323). Figure 5.1 shows box-plots of duration of
problem for the various combinations of self-stated reason for attending clinic.
Figure 5.1 Box-plots of duration of problem by the various combinations of
self-stated reasons (cycle, bleeding, pain), sub-classified by
whether 'other1 has been stated as a reason.




COMBINATION OF SELF-STATED REASONS - Cycle (C), Bleeding (B) & Pain (P)
This shows that the distributions are typically positively skewed, with durations of 10
years or more not uncommon, some being more than 25 years. Figure 5.1 also shows
that in all the reason-combination subgroups where there can be subdivision by
'other', durations tend to be shorter in the subgroup where 'other' was one of the
reasons (or the only reason, 2nd box) .
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5.3.1.ii Sub jective assessment of menstrual loss, pain and cyclic changes
Detailed data were obtained describing periods, both in CQ, and MEQ. These data
are summarised in Appendix 5.1 Tables A5.1.1 to A5.1.7, and the main features are
described here in a number of sub-sections addressing in turn: description of
heaviness of loss; anticipation and planning for period; containment of period; pain
associated with periods; and other cycle-related symptoms.
Description of heaviness of loss
Appendix Tables A5.1.1 and A5.1.2 report variables describing heaviness of
menstrual loss. Figure 5.2 shows the distribution of subjective ratings of heaviness
ofperiods in the last 6 months. The vast majority ofwomen reported 'heavy' (45%)
or 'very heavy' loss (36%). While these percentages are for almost the entire study
sample completing CQ (except for 7 women who failed to complete this item,
n=945), the subset of 818 who also completed MEQ had very similar distribution of
ratings for 'heaviness' of loss, that is, 45% heavy and 38% very heavy.






E Very heavy loss
While almost all women were able to respond when asked to provide subjective
ratings of 'heaviness' of their periods, as reported above, this was not the case when
asked to respond in terms ofvolume of menstrual loss. As shown at the bottom of
Appendix Table A5.1.1, when a woman was asked to select one of three options
indicating how much she thought her whole menstrual loss would measure, she was
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more likely than not to tick 'no idea' (55%) rather than one of the volumes offered. A
teacup holds about 150mL and a mug about 270mL. Taking into account the blood
and non-blood components of the menstrual loss, a period comprising 80mL blood
would be expected to have a total fluid volume of about 180mL (Fraser et al. 2001).
Therefore periods measuring 'mug' or 'much more' would be likely to exceed 80mL
blood volume. These responses were given by only 30% of those completing MEQ.
Figure 5.3 shows the distributions of responses to this item for women subdivided
into three groups on the basis of their subjective ratings of the heaviness of their
periods. The heaviest group are most likely to hazard a guess as to the measurement
of their period, but nevertheless 46% report they have 'no idea' as to volume.
Figure 5.3 Estimated 'measurement' of whole period, within subgroups









Subjective rating of heaviness of period
Moderate/light Heavy Very heavy
(n=140) (n=370) (n=302)






Nearly half of all respondents reported spotting between periods (46%), and a similar
percentage bleeding 'between periods' (48%). 'In between periods' was defined as
days separate from the woman's proper periods. The distinction between 'bleeding',
as opposed to 'spotting', was defined in terms of whether the break-through bleeding
was sufficient for sanitary protection to be required. When bleeding and spotting
were considered in combination it was found that 59% of respondents reported
bleeding and/or spotting either some, or nearly all, cycles.
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Appendix Table A5.1.2 summarises count data for periods (duration of period, days
full flow, days breakthrough bleeding/spotting or number of clots). The median
number of days occurrence for each type of break-through bleeding was 3 days
(n=307 & 272 respectively for break-through bleeding and spotting respectively).
Roughly two-thirds of these women (n=198) reported both types ofbreak-through
bleeding/spotting.
On CQ the respondent was asked to report on duration of longest and shortest
periods, if the duration of period varied from cycle to cycle. Approximately four
fifths of the 906 women reporting on duration also reported duration of longest and
shortest periods and for them the difference between the two durations was
calculated. Figure 5.4 plots the median and IQR for the usual and longest periods,












Although 819 women completed this item, for 8 their responses exceeded the usual
duration quoted for the entire period, so their values for this item were set to missing.
The median days 'full flow' was 3 days (IQR 2 to 4 days).
Days duration of usual period, longest period and 'full flow', and
difference between longest and shortest periods (median & IQR)
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CQ data show that, for the entire study group, passing of clots was very common
(90%), but large clots, that is, greater than the size of a 50p coin, were relatively
uncommon (15%) (Appendix Table A5.1.1), In MEQ women were asked to state
the usual number of clots of each of three sizes (up to 20p, 50p, or greater than 50p)
that were passed per period. Combining counts for all three sizes of clots, 725
women had responded for all three sizes, and for them the median total number of
clots per period was 6 (IQR 3 to 12). Figure 5.5 presents box-plots of the three
separate clot-size variables (counts of clots per period), as well as for a further
variable, derived by adding together the number of clots recorded of size 50p or
greater. This shows that the two larger sizes of clots were relatively uncommon.
Figure 5.5 Numbers of clots of the stated size, usually, in one period
(MEQ data)
U.
N = 762 770 793 725
CLOT SIZE: Up to 20p size About 50p size Bigger than 50p Size 50p or bigger
J
Anticipation and planning for period
Appendix Table A5.1.3 summarises data from MEQ pertaining to timing and
anticipation of bleeding. Success in containment of the period may depend on the
suddenness of onset of flow. In this sample, 26% ofwomen reported that their period
started 'in a gush'. If a woman has a regular cycle she may anticipate the onset of her
period by counting days from the previous one, and 65% (of those completing MEQ)
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reported this was possible for them, although for only 42% was this the case 'most
cycles'. However, 90% (n=741) responded that they knew by 'other signs' that a
period was due to start in a few days. In total 714 women recorded the 'other signs'
that alerted them to the imminence of a period, with 303 recording two signs. The
signs were coded as physical signs (e.g. pain, bloating), mood signs (e.g. tense,
irritable etc.), and 'PMS/PMT' (symptoms unspecified). Women were categorised
according to the combination of signs recorded. Figure 5.6 shows the distribution of
responses to this MEQ item.
Figure 5.6 Distribution of responses regarding signs alerting to imminence
of period (MEQ data, n=820)
No signs noticed
Containment of menstrual bleeding
Appendix Table A5.1.4 reports on the women's description of containment of
menstrual loss. On CQ, 946 women reported on the type of sanitary protection used.
The most common type used was pads only (48%), but a further substantial
proportion used tampons as well as pads to contain their periods (40%), whereas 12%
used tampons only. The proportions using high-absorbency protection (at that time
typically labelled 'super plus') was 26% for pads only and 22% where pads and
tampons were both used.
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Nearly half ofall women (46%) reported accidental leakage onto underclothes or
bedding 'most periods' and a further 40% 'some periods'. Getting up at night to
change sanitary protection was marginally less common: 42% 'most periods', 37%
some periods. Use of double protection (two products at the same time) is indicative
of concern about accidental leakage: 60% ofCQ respondents reported having to use
double protection at times. There was strong evidence of a positive association
between use of double protection and reporting accidental leaks and getting up at
night to change. Nevertheless, a quarter of the 441 who had leakage most periods did
not use double protection, and nearly a quarter of the 131 who very seldom had leaks
did use double protection. There was a very similar pattern for getting up at night to
change.
When women were asked on MEQ 'how often do you have to change your pad/
tampon when you period is full flow?', 22% said every hour and 11% more often
than every hour (819 responded). The subset of 821 women completing the CQ item
on double protection, and also completing MEQ, were very similar to the entire study
sample in terms of their prevalence of use ofdouble protection as reported on CQ,
62% compared to 60%.
Use ofdouble protection was also reported on MEQ, but this item offered three
options for describing recourse to double protection - 'no/ some periods/ most
periods'. There was strong evidence of a positive association of MEQ-reported
frequency of use of double protection with frequency ofaccidental leakages and also
with frequency of having to get up at night to change protection, as for the CQ item.
However, only just over halfof the 392 reporting leakages 'most periods' also
reported use ofdouble protection most periods, and one sixth of the 114 reporting
leakages 'seldom', nevertheless reported using double protection most periods.
Appendix Table A5.1.5 reports count data with respect to containment. For the
women completing the item on CQ (n=927) the median duration of use of double
protection was 2 days (IQR 0 to 4 days). Only 3% ofwomen reported more than 7
days use ofdouble protection, and 41 % reported zero days of double protection. As
reported on MEQ, leakages onto underclothes were relatively common, with 75% of
781 women reporting 2 or more per period (median 3). Leakages onto outer-clothes
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or bedding were less common, with the proportions reporting no such leakages being
61% and 32% respectively (medians 0 and 1 respectively, n= 796, 785).
In MEQ women quantified their usual usage of sanitary protection. The median was
30 products per period (IQR 20 to 40). For high absorbency products specifically the
median was 10 products (IQR 0 to 24). For both these variables the maximum value
was 164, a very high usage, but only 3% and 1% respectively used more than 85
products.
Pain around periods
Appendix Table A5.1.6 presents data on women's reports regarding pain around
periods. The majority ofwomen completing MEQ (72% of 827) reported pain
around 'most' periods and 59% of 829 used pain-killers for pain most periods. The
pain-killers used were predominantly NSAIDs (98% of 710 giving a name for the
pain-killer used), and of those using them only just under a half reported that the
pain-killer used was effective most times (47% of 740).
Women were asked to record the numbers of days of period pain experienced, both
before periods and with periods. Pain before periods was common, being reported by
70% of 812 women responding, but pain with periods was more common (86% of
803). To ascertain pain of an intensity that was likely to have adverse impact on daily
life, women were also asked to record for each time phase the numbers of days that
the pain experienced was severe. The corresponding percentages ofwomen
experiencing severe pain were 40% before periods, and 72% with periods (n=811 in
each case). Therefore severe pain was proportionally less common before periods.
This is illustrated in Figure 5.7. The relative heights of the columns shows that for
vast majority ofwomen who experience pain some of it was severe.
For days duration ofpain there was greater separation between any pain and severe
pain. The total number ofdays pain usually experienced around periods was obtained
by adding the two together counts for before and during periods. This was done
separately for (any) pain, and for severe pain. Appendix Table A5.1.6 presents the
distributions ofnumber ofdays reported for total days of (any) pain, for total days of
severe pain, and for number of days severe pain with periods. The median total
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number of days of (any) pain was 5 days (IQR 2 to 8), whereas the median total
number of days severe pain was 2 days (IQR 0 to 5).
Figure 5.7 Percentages of women reporting the various combinations of
timings of pain around periods, separately for 'any pain', and for
'severe pain'.
Any pain (n=799) Severe pain (n=806)
Intensity of pain
Occurrence of pain as specified
□ Only before periods
□ Only with periods
□ Before + with periods
Cycle-related symptoms around periods
Appendix Table A5.1.7 reports women's responses with respect to other cycle-
related symptoms. In these questionnaire items the questions were all phrased in
terms of cycle-related symptoms, and there was no requirement to affirm
'premenstrual syndrome'. Out of 797 women who completed the main item, 86% did
experience cycle-related symptoms from time to time, 71% 'most periods'. Of those
who experienced symptoms, 741 responded to the item ascertaining how
troublesome the cycle-related symptoms were, and 76% reported they found the
symptoms troublesome, with about a third of these rating the symptoms very
troublesome. Women specified when their cycle-related symptoms were most
troublesome, with nearly half (46% of 720) saying equally-troublesome before and
during the period, and the remainder roughly evenly divided between 'before' and
'during' the period.
Women were asked to detail the cycle-related symptoms that were worst for them,
separately for before and during the period. Backache/pain and tiredness were
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commonly-noted troublesome symptoms both before and during the period, with
backache/pain the predominant symptom during the period. The symptoms most
often noted tended to differ by timing: before the period a greater range of symptoms
was noted, including more emotional symptoms, with 'bloating/weight gain/breast
tenderness' being most commonly reported as troublesome.
5.3.1.iii Aspects of periods, their occurrence and how problematic they are
Description ofaspects, occurrence and severity
The rationale for the aspects part of CQ has been explained in 5.2.2, Table 5.1
shows, sorted in order of prevalence, the percentages judging each aspect a 'severe
problem' and the effective (non-missing) n for each percentage.









Cyclic mood changes 943 33.2 1
Pain with periods 933 32.6 2
Amount of period more than used to be 924 26.8 3
Impact on daily life 943 23.6 4
Periods go on too long 930 23.3 5
Feel unwell because of periods 946 23.3 6
Other cyclic changes 937 22.9 7
Lose too much blood 935 22.5 8
Worry something wrong 929 18.5 9
Difficulty preventing accidents 944 18.4 10
Pain before periods 930 16.8 11
Irregular periods 927 16.5 12
Extra washing 946 15.3 13
Pain all the time 937 15.2 14
Money spent on pads/tampons 911 11.6 15
Bleeding in between periods 937 8.8 16
f 95% confidence intervals are, forprevalences > 22%, within 3 percentage points either side
ofthefigure reported, andfor those < 22%, within 2 percentage points either side.
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Although 952 women completed CQ, each of these items had some missing
responses, but for all except one item this was less than 3% (that is, 6 to 28 missing
responses). For 'money spent on pads/tampons' there were 41 missing responses
(4%). It can be seen that excessive volume of menstrual blood loss (23%) is only
eighth in order of prevalence. The most prevalent 'severe problems' were cyclic
mood changes, pain with periods, increased period and impact of periods on daily
life (33%, 33%, 27% and 24%).
Given the 5-point response scale for the items, consideration just ofsevere problems
(as in Table 5.1) loses some of the information in these data. Figure 5.8 presents the
full data as stacked bar charts. The response 'does not happen' is not plotted, but for
each item would make the column up to 100%. The overall length of the bar as
plotted therefore shows the total prevalence of occurrence of the aspect.
Figure 5.8 Distribution of degree of problem for aspects of periods (CQ
data)
Irregular periods n =927)
Bleeding in between periods n =937)
Money spent on periods n =911)
Extra washing n =946)
Impact on daily life n =943)
Difficulty preventing accidents n =944)
Periods go on too long n =930)
Lose too much blood n =935)
Worry som ething wrong n =929)
Amount of period increased n =924)
Feel unwell because of periods n =946)
Cyclic mood changes n =943)
Other cyclic changes n =937)
Pain with periods n =933)
Pain before periods n =930)









Aspect occurs and is: ■ Severe problem □ Marked problem □ Slight problem □ Not a problem
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The bars have been organised into sets of related aspects (separated by dashed lines)
- irregularity, impact, volume, concern, cyclic changes, and pain. The green-shaded
slices represent degrees ofproblem - severe to slight - and the white slice 'happens
but not a problem'. All women have to spend money on periods, so that bar (3rd)
totals 100%, but it can be seen that relatively few find cost a severe or marked
problem. Although far fewer women experience irregular periods (1st bar), relatively
more, and indeed more in absolute terms, find this aspect a severe or marked
problem (compared to 'money spent'). Even if severe and marked problem are
considered together the relative ordering in terms ofprevalence (of'severe/marked
problem') is little different to that for 'severe problem', with excess volume of
periods remaining low in the ranking (7th). On the whole the binary variable of
'severe problem' (or not) gave a similar ordering in terms ofprevalence of the
various aspects.
The median number of severe problems was 2 (IQR 0 to 5), with 285 women (30%)
reporting no aspect severe and four (0.4%) reporting all 16 severe. The
corresponding count for severe or marked problem, had median 7 (IQR 4 to 10), with
18 women (2%) reporting all 16 aspects severe. It was therefore decided that 'severe'
was a more discriminating cut-off for creation ofbinary variables for 'problem'.
Categorising aspects into three groupings: volume, pain and cyclic changes
Summary variables were derived as described in 5.2.2.i, indicating whether a woman
had noted as a severe problem any of the three aspects ofvolume of loss (3rd
grouping on Figure 5.8), and similarly for pain (last grouping on the same figure)
and cycle-related changed (5th grouping). Analysing these variables it was found that
roughly equal proportions ofwomen reported a 'severe' problem with some aspect of
excessive volume, ofpain, or of cycle-related changes (38%, 37% and 40%
respectively for the three groupings), with considerable overlap between these. In
total 62% ofwomen reported at least one of these groupings of problems, 37% more
than one, 16% all three (Figure 5.9). Of the 361 women who reported none of these
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three aspect groupings a severe problem, 79% reported none ofall the 16 aspects
listed on CQ a severe problem.
Figure 5.9 Percentages of women experiencing as a 'severe problem'
volume of period, pain around periods or cycle-related changes,
and combinations of these














□ pain & cyclic
□ volume & cyclic
□ volume & pain
□ volume & both others
Aspect groupings reported as 'severe'
Identifying one or more aspects as cause of clinic attendance
After indicating for each aspect how much of a problem it was for her, the woman
was asked to note in order of importance up to three aspects that had been the main
cause ofher coming to the clinic. The number citing no cause at all was 18, while
150 cited only one cause, 249 only two and 535 three causes. In some cases, causes
other than the aspects listed were cited: overall 38 women cited clotting, 21 frequent
periods, 5 discharge, 6 'PMT', 2 dyspareunia, 2 low haemoglobin, 3 endometriosis, 3
changed bleeding pattern and 55 cited reasons coded as 'other (non-menstrual)'.
Therefore the total number of causes cited by the 952 participants was 2253, but the
total number of causes cited that were also aspects listed on CQ was 2118, an
average of 2.2 per woman.
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Calculating for each aspect howoften it was cited as a cause
As explained in 5.2.2.ii, the causes cited were used to derive new variables,
indicating separately for each aspect listed on CQ whether or not that respondent had
cited it as a cause of coming to the clinic, regardless of whether first, second or third
in order. The prevalences of citation of each listed aspect as a cause of help-seeking,
as any of 1st, 2nd or 3rd most important cause for respondents, are shown in Figure
5.10, arranged in order of decreasing prevalence.
Figure 5.10 Prevalences of (i) citation of aspects as cause of coming to
clinic (n=952 for all bars), and (ii) reporting aspects as 'severe
problem' (n=911 to 946)
Feel unw ell because of periods
Amount of period more than before
Lose too much bbod
Cyclic mood changes
Pain w ith periods
Irregular periods
Ffcin all the time
Periods go on too long
Worry something w rong
Other cyclic changes
Impact on dailylrfe




Money spent on perbds
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□ % severe problem □ % cause of coming to clinic
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As on average the women cited 2.2 aspect-causes each the total of these prevalences
is 222%, and women tending to respond expansively will have contributed more to
the pattern ofprevalences than women citing just one (main) cause. The prevalences
of reporting the aspects as severe problem (as reported in Table 5.1) are also plotted
in Figure 5.10, for comparison.
It can also be seen that for some aspects their prevalence as severe problems is not
reflected in a corresponding prevalence as cause of coming to the clinic. This is
indicated by disparity in length ofpale and dark bars for the same aspect. This is the
case particularly for pain (with and before periods), cyclic changes (mood and other)
and the various impact variables (daily life, accidents, washing and cost).
Categorising 'causes'into three groupings: volume, pain and cyclic changes
It is therefore of interest to examine the overlap in citation ofgroupings of causes
(volume ofbleeding, pain and cycle-related, described in 5.2.2.ii), as has been done
for severe problems in Figure 5.9 above. On this basis, at least one of the 'pain'
grouping (with periods/ before/ all the time) was cited by 360 women (38%) and at
least one of the cycle-related aspects (mood/ other) was cited by 293 women (31%).
Therefore, in terms ofcitation as cause, volume and pain are equal (38% each), but
there are slightly fewer citations of cycle-related aspects as cause (31%).
Figure 5.11 shows that in total 77% reported at least one of these groupings of
problems, 28% more than one, 2% all three.Compared to Figure 5.9 for severe
problems, this figure for 'causes' shows a flatter distribution across the categories,
with relatively fewer women citing more than one of these causes, and fewer women
citing none. Examining the 'none (ofbleeding, pain or cycle-related)' subgroup, the
first causes cited by these 221 women were predominantly: increased period (19%),
irregular periods (17%), worry something wrong (15%), bleeding in between periods
(15%), feeling unwell (10%) and 'non-menstrual reasons' (9%).
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Figure 5.11 Percentages of women citing as a 'cause of help-seeking'
excessive volume of period, pain around periods or cycle-related
changes, and combinations of these











□ pain & cyclic
□ volume & cyclic
□ volume & pain
□ volume & both others
Combination
(n=266)
Groupings reported as 'cause' of help-seeking
Other possible groupings for aspects
These relative percentages for the groupings, and the various combinations, do to a
certain extent depend on the aspects grouped. It may seem that citation of 'amount
of period more than it used to be' should have been counted in with volume, but it
has not been, because strictly it is a relative judgement, and does not necessarily
denote an excessive absolute volume (this can be related to ideas summarised in 5.1
and Table 1.1). Similarly, citation of clotting as cause was not counted in with
'volume', because clots are not necessarily an issue of absolute volume. (Checks
revealed that of 38 citing clotting as a cause, 13 gave other cause(s) that meant that
they were anyway classified as having cited volume of loss as a cause. Of the
remaining 25 who did not cite any of volume aspects as cause, 14 reported at least
one severe problem, this being predominantly pain with periods and/or cyclic
changes. Therefore they do not appear to have been using clotting as shorthand for
excessive loss. For the remaining 11, who did not cite volume causes and who
reported no severe problems, if reporting of marked problems was examined it was
found this was mainly increased period, mood changes and feeling unwell, so there is
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no evidence even of'restrained' reporting of excessive loss. Therefore it does not
appear volume has been missed as a cause in women where clotting but not volume
has been cited as a cause.)
As explained in 5.2.2.i, 'feeling unwell because of periods' this does suggest a cyclic
change in health/vigour attributed to periods, so a further cyclic summary variable
was derived including this aspect/cause. Figure 5.12 shows the difference in
distributions for severe problems and causes when 'feeling unwell' is included in the
cyclic grouping ofaspects. That is, relatively more severe problems fall into the
'none' and combination categories.
Figure 5.12 Distributions of reports of 'severe problem' and 'cause of help-
seeking' by the three aspect groupings: excessive volume of









A similar difference between distributions for severe problems and causes was seen
when the cyclic grouping did not include 'feeling unwell'. (This can be ascertained
by comparing Figure 5.9 with Figure 5.11.)
Furthermore, by comparing Figure 5.12 with Figures 5.9 and 5.11 respectively, it is
also possible to see how the patterns change when the cyclic grouping includes
feeling unwell. When 'unwell' is included there are, for both severe problems and
None of the three Uhw ell/cyclic only Pain only Volume only
'Severe problem* / 'Cause of attending clinic'
Combination
□ Severe problem (n=948) □ Cause ofattending clinic (n=952)
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causes, fewer in the 'none' category, and in 'pain only' and 'volume only', but more
in the 'unwell/cyclic' grouping, and more with combinations of the three groupings.
5.3.1.iv Managing periods
In CQ assessment had been constrained to 16 aspects ofperiods, this being dictated
by the need to have a very brief questionnaire for all participants. Not all respondents
are happy to affirm something as a 'problem' because this has a connotation of
failure to cope. To develop an assessment of menorrhagia it would be preferable to
present women with a large pool of statements, and on the basis of responses and
associations select from among these the ones that best encompass the scope of
menstrual distress reported. Therefore in MEQ questions were asked addressing
facilities at home for dealing with periods (question 20 (11 sub-items)) and facilities
at work (question 21(17)), if the woman was in paid or voluntary employment.
Question 22 addressed general experience of and strategies for dealing with periods
(21 sub-items), and question 23 the woman'sfeelings about her periods and her
managing of them (41 sub-items).
FACILITIES AT HOME
For the items on home facilities the prevalence of responses indicating adverse
features are shown in Table 5.2. A score was calculated for facilities at home, by
adding one point for each adverse feature reported, and in the case of the six items
where two response options were offered ('very much so' or 'a little'), an extra point
if the response was the stronger of the two. Using this rule the maximum score
possible was 17. For the 807 respondents to MEQ who had completed all the sub-
items ofthe score, the maximum score obtained was 15, and the median was 3 (IQR
2 to 5). The score was correlated with deprivation category, such that more deprived
women were more likely to have more adverse scores for home facilities (Spearman
rho= 0.21, n=792, 95% CI 0.14 to 0.27).
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Table 5.2 Dealing with periods at home: adverse features reported
n %
Adverse features of home facilities for dealing with responding
periods
Others in home realise when having period 798 84
Nowhere suitable for soaking bloodstains 829 81
No toilet separate from bathroom 830 75
Periods inconvenience others in home * 822 32
Others in home complain about periods * 826 26
More than 4 people in home but only 1 toilet 832 23
Storage for supplies is not private enough * 830 22
Difficult to dispose of soiled pads/tampons * 832 20
Not enough space to store supplies of pads/tampons * 833 14
Difficult to get privacy to change * 829 14
No washing machine 830 1
* two degrees ofaffirmative response possible
Facilities at work
For the items on work facilities the prevalence of responses indicating adverse
features are shown in Table 5.3. The number of days per period off work for heavy
periods had median 0 (IQR 0 to 2, n=593). A workplace score for managing periods
was calculated for facilities and attitudes at work. Scoring for this was the same as
for the home score. The maximum score possible was thus 22. For 585 respondents
to MEQ who had completed all the sub-items, the maximum score obtained was 21,
and the median was 5 (IQR 3 to 9). The workplace score for period-management
was weakly correlated with deprivation category, such that more deprived women
were more likely to have more adverse scores for work facilities (Spearman
rho=0.09, n=575, 95% CI 0.01 to 0.17).
154 Menorrhagia Reconsidered
Table 5.3 Dealing with periods at work: adverse features reported





Job involves standing for a lot of the time 633 59
Frequent trips to the toilet are noticeable 627 57
Job involves lifting/carrying 631 52
Absence from work because of periods is disapproved of * 610 50
Nowhere to store supplies of pads/tampons 630 39
Storage place is not private enough for you 577 38
Hard to get away from post to change * 626 35
Can not always get access to toilet if urgently needed * 628 35
Difficult to get at your supplies of pads/tampons * 627 29
Can not go to toilet whenever need to 633 25
Someone has to take place if going to toilet 628 24
Difficult to dispose of soiled pads/tampons at work * 629 22
Job requires white or pale uniform 631 20
Not enough toilets available at work 631 19
Frequent trips to the toilet are disapproved of * 625 18
Job is impossible to do during full flow' 628 7
* two degrees of affirmative response possible
Dealing with periods
This section comprised 21 items all to the same format - 'How well do the
following statements describe your periods...?' with 5 response options ranging
from 'not at all' to 'very much'. The main focus of the entire set of statements was
dealing with bleeding, which included issues ofpredictability (regularity), but a
number of statements could have been responded to in terms of severe period pain,
for women who were suffering pain but not heavy periods. Examples of such
statements are 'I feel unwell during my period' and 'If my period comes
unexpectedly I have to cancel outings'. Therefore, interpretation of factor scores for
components involving statements not specific to volume will need to take this into
account.
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The entire set of data was subjected to factor analysis, for which method an overview
was given in 5.2.3, and for which more detailed methods are described in Appendix
5.2. The initial principal component solution comprised 6 factors accounting for 68%
of the variance, and this was subjected to varimax rotation to improve interpretability
of factors. One of the items, 'My partner complains about interruption to our sex life'
loaded on its own as the 6th factor. This item could be completed only by the subset
ofwomen with partners, and was therefore 'missing' for the remainder, so it was
decided to drop it lfom the factor analysis, and report separately. The five factors
remaining, accounting for 66% of the variance in the remaining items, comprised the
following variables, mainly:
a) Avoidance of menstrual accidents by planning activities, cancelling
arrangements, limiting what one does
b) Unpredictable/changed pattern of flow, uncertain when finished, going on too
long, change from normal
c) Resource consequences such as cost, laundry, ensuring supplies ofprotection
d) Being unwell/irritable during period
e) Unpredictable onset, wearing protection before period starts.
A number ofvariables loaded to more than one component. Oblique rotation slightly
improved this situation, but with the resulting components remaining very much as
above, with respect to the main variables loading on them. Given that the
interpretation is little changed, the varimax solution has the advantage oforthogonal
components. Further analyses are required to refine the set of statements to provide
purer components. The five factors could be interpreted as:
a) impact ofvolume on life
b) variable/unpredictable flow
c) resource consequences ofheavy periods
d) loss ofwell-being
e) unpredictable onset/need for containment.
The varimax component scores for factors were saved for use in subsequent analyses
(Chapter 9). The factor loadings are presented in Appendix 5.2 Table A5.2.1,
together with box-plot graph of the distribution of component scores (Appendix
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Figure A5.2.1), In response to the statement 'My partner complains about
interruption to our sex life', 35% of the 694 women answering this item reported
that this was the case, but only 11.5% responded 'a lot' or 'very much'.
Feelings about periods
This section comprised 35 items all to the same format - 'How true are the following
ofHow you feel about your periods nowadays ...?' with 5 response options
ranging from 'not at all' to 'very much'. The main focus ofthe statements was
feelings about dealing with bleeding, and about consequences ofbleeding, but a
number of statements could have been interpreted in terms ofother menstrual
symptoms, for example severe period pain. Statements of this more general type
were 'I think my periods make me feel low/depressed' and 'No more periods would
be a great relief.
As for 'dealing with periods' (above), data reduction was achieved by means of
factor analysis (for methods see 5.2.3 and Appendix 5.2). The initial principal
component solution comprised 6 factors accounting for 71% of the variance, and this
was subjected to varimax rotation to improve interpretability of factors. One of the
items, 'I resent the interruption to my sex life caused by my periods' loaded on its
own as the 7th rotated factor. This item could be completed only by the subset of
women with partners, and was therefore 'missing' for the remainder, so it was
decided to drop it from the factor analysis, and report separately. Furthermore, the
third rotated factor comprised solely the two items regarding feelings about impact
on work, and these also were completed only by the subset ofwomen in
employment. Therefore it was decided to remove them from the factor analysis and
report separately. The analysis was rerun, and five factors accounted for 66% of the
variance. After rotation the five components comprised the following variables,
mainly:
a) emotional consequences of flow - embarrassment, annoyance, nuisance re
accidents or having to change plans/limit activities, upset at failure to prevent
accidents, feel overwhelmed by flow, always having to worry about changing,
dread start ofperiod
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b) feeling bad re burden ofperiods (generally) on family/friends, feel upset by
period and/or low/depressed, find periods intolerable
c) worry about change in periods and whether something wrong, wish periods
back how they were
d) resent cost ofprotection and waste ofmoney, feel embarrassed and/or
abnormal buying so many supplies
e) no more periods would be a great relief, wish an end to them.
The majority ofvariables loaded onto more than one component. Oblique rotation
improved this situation, but with the resulting components remaining very much as
above, with respect to the main variables loading on them. Given that the
interpretation is little changed, the varimax solution has the advantage oforthogonal
components. Further analyses are required to refine the set of statement to provide
more succinct components. The five components could be interpreted as:
a) Containment distress
b) Periods a burden, in particular for family/friends
c) Worry about change in periods
d) Resent resources used on periods
e) Had enough of periods.
The varimax component scores for factors were saved for use in subsequent analyses
(Chapter 9). The factor loadings are presented in Appendix Table A5.2.2, together
with graphs of the distribution of component scores (Appendix Figure A5.2.2).
In response to the statement 'I resent the interruption to my sex life caused by my
periods, 60% of the 675 women answering this item reported that this was the case,
but only 22% responded 'a lot' or 'very much'. In response to the two statements
about work - 'I feel bad I have to miss work because of flooding' and 'It
embarrasses me to have to miss work because of flooding' - the responses affirming
these feelings were 34% for feeling bad, 30% for embarrassment, with 19% and 17%
respectively responding 'a lot' or 'very much' (n=625, 626 respectively). There was




5.3.2.i Time-course of clinical encounter
Of the 665 patients followed up at 8 months after initial appointment, outcome was
established for 663: 5% had been referred on to another specialty, 53% had been
discharged, 15% had not been discharged but had failed to return for a further
appointment, and 27% were still under care. Failure to return was strongly related to
deprivation code, being more likely in disadvantaged groups. The median for number
ofclinic appointments up to 8 months after initial appointment and entry to study
was 2 (IQR 1 to 3, maximum 9). The median time to discharge or referring on was
13 weeks (IQR 3 to 22 weeks, n=388).
5.3.2.ii Iron status
Results of iron status tests were obtained not just for patients followed up but for all
patients who had these tests. 'Low' ferritin results, as defined for clinic and assay
system used, were obtained for 6% (4/67) ofEdinburgh women tested and 25%
(56/221) of Glasgow women tested. Haemoglobin levels were correlated with ferritin
levels (Spearman rho=0.51, 95% CI= 0.41 to 0.60, n=273). Figure 5.13 presents
haemoglobin results as box-plots separately by centre, with patients sub-grouped by
ferritin status. Although haemoglobin levels look fairly similar across the two centres
the proportions of low haemoglobin values (<120 g/L) were 17% (45/261) for
Glasgow and 25% (49/197) for Edinburgh.
5.3.2.iii Other investigations
Apart from iron status, the most common test undertaken was biopsy, in 43% of
patients (n=284), the vast majority of these being endometrial biopsy. The biopsy
findings ofpotential interest were: irregular cyclical activity in 39 women, polyps 10,
hyperplasia 5, perimenopausal endometrium 4, endometriosis/adenomyosis 3 and
dyskaryosis 1, with no findings of malignancy. The other tests undertaken were
ultrasound 33%, thyroid test 20%, hysteroscopy (theatre) 12%, hysteroscopy
(outpatient) 11%, dilation and curettage 10%, laparoscopy 10%, colposcopy 1%, clot
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screen 1% and suction curettage <1%. In addition 26% of patients had other assorted
tests, for example hormone assay, smear, etc.



















Up to two 'final' diagnoses (at 8 months) were to be extracted from the case-notes.
(For some patients these may in fact have been interim diagnoses, given that they had
not yet been discharged.) For 39 cases (6% of 665) no diagnosis could be found in
the notes, and of the remainder, 626 had at least one diagnosis recorded, and 138 of
these a second final co-diagnosis as well. There were only two malignancies, one
ovarian cancer and one cancer unspecified. The distribution of diagnoses made is
presented in Table 5.4 after re-coding as 'other' the many and varied but very
infrequent diagnoses (such as urinary, infertility, gastrointestinal, cancer and so on).
Three patients had both first and second diagnosis recoded as 'other' (their first
diagnoses being hypothyroidism, pelvic inflammatory disease and iatrogenic -
IUCD), but have been included only once each in the table, under 'other'. This table
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therefore presents percentages obtained by combining 626 first and 135 second
diagnoses.
Table 5.4 Diagnosis made for patients followed up by case-note review
Diagnosis
n % of 626*
Dysfunctional uterine bleeding (DUB) - regular cycle 180 29
DUB - irregular cycle 160 26
Fibroids 111 18
Endometriosis 48 8
Premenstrual syndrome (PMS) 46 7
Dysmenorrhoea 41 7
Polycystic ovary syndrome (PCOS) 25 4
Polyps 17 3
Peri-menopausal or menopausal 16 3
Anovulatory bleeding without evidence of PCOS 13 2
Other 90 14
No abnormality diagnosed 8 1
Symptoms settled by clinic visit 6 1
* percentages total 122% since 135 women contribute 2 diagnoses each
Overall 54% of study women received a diagnosis ofDUB (a diagnosis of exclusion,
that no pathology, such as fibroids, has been found that may account for reported
abnormal bleeding (Fraser 1994)). This diagnosis was common even if no volume
aspect had been reported as a severe problem (50% of 399), if the women did not
given bleeding as self-stated reason for clinic attendance (39% of 259), if the woman
rated her menstrual loss as moderate or light (34% of 118), rather than heavy or very
heavy, and if the GP had not referred her for bleeding (33%). Of the 340 women
diagnosed with DUB, 97 had another diagnosis as well. The distribution of co-
diagnoses (with DUB) was fibroids 24% (of 97), dysmenorrhoea 24%, PMS 12%,
endometriosis 6%, peri-/menopausal 4%, PCOS 3%, polyps 3%, anovular bleeding
without PCOS 1% and 'other' 23%.
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If the percentages in Table 5.4 were calculated just on the basis of the first final
diagnosis extracted (626 diagnoses) then the percentage for each diagnosis was as
would be expected slightly lower (for example 51% for DUB), but giving a pattern of
percentages very similar to what has been shown. However there was relatively more
reduction in the percentage for endometriosis, fibroids, dysmenorrhoea, PMS and
'other', reflecting the fact that these were more likely to be extracted as second
'final' diagnosis.
5.3.2.V Treatments
Previously tried by GP
In the case note review it was recorded if the GP referral letter or notes mentioned
treatments already tried for menorrhagia. Out of 665 notes reviewed, treatments
already tried could be extracted for 343 women (52%). The main treatments that had
been tried were progestogens (52% of 343), prostaglandin synthetase inhibitors
(35%), anti-fibrinolytics (22%), oral contraceptive (17%), danazol/HRT (3% each).
(Note that up to three treatments could be recorded per patient so the total of all the
percentages (including those not presented here) add up to more than 100%.)
Treatments tried/recommended at clinic
The follow-up data extraction form comprised a list of 11 types ofdrug treatment,
plus hormone releasing IUCD and 'other drugs', 4 surgical treatments plus removal
of IUCD, 'cancer treatment' and 'other'. The nurses were to record treatment given
or suggested (to GP). Ofthe 665 notes reviewed, treatments given were recorded for
71%, and treatments given or recommended for 79%. The distribution ofnumbers of
treatments given per patient in the 8 months was one (39%), two (22%) or three to
five different treatments (10%). The corresponding percentages for treatments given
or recommended were 43%, 25% and 11% respectively. The most recent treatment
was also extracted (up to two). Table 5.5 presents for each treatment type the
percentages of women for whom this was the 'most recent treatment' and hence, for
many, the final treatment. This information was missing for 4 women, and 91 of the
remaining 665 had two recent treatments recorded.
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Table 5.5 Most recent treatments provided or recommended as
ascertained from case-note review at 8 months after first clinic
visit
Treatment




Hormone replacement therapy 81 12
Oral contraceptive pill 67 10
Progestogens 58 9
Hormone-releasing IUCD 47 7
Prostaglandin synthetase inhibitors 36 5
LHRH analogue 18 3
Other drugs 55 8
Surgical
Hysterectomy 81 12
Dilation & Curettage 7 1
Endometrial ablation (3) & myomectomy (2) 5 <1
Removal of IUCD 9 1
Other 10 2
*
percentages total 114% since 91 women contribute 2 treatments each
As the case note review was undertaken towards the end of the study, for some of the
early recruits more than 8 months had elapsed. In addition to review of the first 8
months, as described above, treatments since the 8 month cut-off were also recorded.
A further 30 women (5%) had undergone hysterectomy by the time of actual case-
note review and a further 11 (2%) had had a hormone releasing coil fitted, while a
further 6(1%) had had removal of coil. Dysfunctional uterine bleeding or fibroids
were the most common indication for hysterectomy.
5.3.3 Reliability of data
In Appendix 5.3 there is some consideration of issues of reliability in the
questionnaire data on periods. The concordance of data obtained from more than one
questionnaire was found to be satisfactory. There are concerns about some of the
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high values, for days bleeding, days use ofdouble protection, and for number of
clots, all data intended to describe the usual count, per period, over the last 6 months.
It is possible some women instead reported the total over 6 months, but the positively
skewed data, some ofwhich it is possible to corroborate, means that it can not be
automatically assumed that all very high values must errors.
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5.4 DISCUSSION
5.4.1 Presenting menstrual problem
Given the study focus on heavy bleeding, and the recruitment strategy, the 81% of
women rating periods as at least heavy was perhaps to be expected. However, given
the clinical definition of menorrhagia as excessively heavy bleeding, it is surprising
that only 36% of referrals rated their menstrual periods as 'very heavy'. Furthermore,
it appears that responses regarding heaviness were not based on judgements of
volume, as 55% ofwomen responded 'no idea' to an item offering various volumes
of menstrual loss as response-options. Cycle-related changes were commonly-
reported, with 71% reporting this occurring most periods, and 25% of the 741
women who ever experienced cyclic changes reporting them as very troublesome.
Pain with periods, at the intensity ofsevere, was very common, with 40% ofwomen
reporting it before periods, and 72% with periods. Considering total days severe pain
reported before and with the period, a quarter ofwomen reported 5 or more days
(25%) and fewer than halfof the women who reported using painkiller found that
they worked most of the time (47%). Yet when in questionnaire CQ women were
asked their reason for attending the clinic, women were nearly twice as likely to state
bleeding (60%) as pain or other reasons (30% and 34% respectively).
With regard to aspects ofperiods, it was striking that 'lose too much blood' was only
the 8th most prevalent severe problem. The top two were cyclic mood changes and
pain with periods, and fourth was impact on daily life. The most prevalent loss
volume item (third overall) was 'amount ofperiod more than it used to be', which
strictly addresses the issue of change in periods rather than absolute volume.
Considering the partitioned view of menstrual problems, it was notable that when
aspects were considered in groups corresponding to the main menstrual problems
(bleeding, pain, cyclic), then the two biggest subgroups ofwomen either had no
severe problem with any of the three, or had severe problems with two or more. Very
few had a clear-cut severe problem with just bleeding or cycle or pain (10%, 8% and
6% respectively). However, when aspects were considered as cause of help-seeking
then the prevalence of'lose too much blood' as cause was higher than expected on
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the basis of reports of severe problems. The question arises as to whether women's
indication of'cause ofclinic attendance' reflects more what they know of the basis
and destination for their referral, rather than the severe problems they experience
(and report on CQ). This is supported by the fact that GPs were more likely, than the
women themselves, to attribute their clinic referral (attendance) to bleeding problems
(76% (reported in chapter 4), compared to 60% for self-stated reason), and clinic
gynaecologists were likely to diagnose DUB in the absence even of referral by GP
for bleeding (33% nevertheless diagnosed with DUB), rating periods heavy (34%
diagnosed with DUB), reporting a volume aspect of bleeding a severe problem (50%
diagnosed with DUB).
To what extent then does volume emerge as a key problem for women in this study?
Increase in amount ofperiod has been top or next to top in the three rankings
discussed so far, but as noted it does not indicate volume per se, and certainly should
not be expected to be indicative of volume of blood loss in excess of 80mL. Women
were asked (on MBQ) about any recent changes they had noticed in their periods.
Examples given on the questionnaire were 'number of days, colour, flow' so this
could have been suggestive. In order ofprevalence changes noted were: heavier
period, duration changed, more irregular, clots, colour of blood, more frequent, more
pain, inter-menstrual bleeding. Perhaps for many it is the recent changes in their
periods that are the key to presentation at the clinic. It may be that these two
constructs - change from normal pattern ofbleeding, and absolute volume - have
become blurred in clinical practice. As suggested in 5.1, the former may be important
mainly as a potential clinical sign ofpathology, and/or as a cause of anxiety in the
patient, whereas the latter reflects intolerable symptoms for which the woman wishes
help, regardless of the issue ofpathology. Recognition of the distinction between the
two, in terms of need for intervention if serious disease is excluded, may improve the
clinical management ofpatients presenting with problems around menstrual
bleeding.
Women were also asked the age at onset for the current/most recent severe episode(s)
of menstrual problem, if any were reported, so it was possible to calculate time
elapsed from then to this clinic visit. Generally time elapsed was shortest for
166 Menorrhagia Reconsidered
excessive bleeding, and longest for PMS, and pain, particularly. This suggests that
women have shorter-lasting tolerance of severe bleeding problems compared to pain
and cycle-related symptoms, or that abnormal bleeding is viewed as a symptom that
can or should be more swiftly referred to gynaecology clinic. If the latter, and if this
tendency had become apparent to a woman suffering multiple menstrual problems, it
is clear which problem she should present to her GP or gynaecologist. Many of the
women (41%) had visited such a clinic before, so they were very likely to know the
focus of interest. Clots were a very common occurrence, with 90% of women
reporting some, the number per period being 3 to 12 (IQR), mostly up to 20p size.
The significance ofclots to women has not been researched, and the significance to
doctors is not explicit in text books, guide-lines nor published papers. In this study
group, 6% self-stated clots as reason for clinic attendance, and 4% cited clots rather
than one of the listed aspects as cause ofhelp-seeking. Perhaps clots are
misinterpreted by women experiencing them. If so, this would suggest that clots
could with benefit be addressed in clinical consultation.
5.4.2 Components of variation in menstrual experience
Women responded to two sets of items about their menstrual experience. The one set
of items was about dealing with periods, a set matter-of-fact statements about what
happens in their periods and what actions they take to deal with their periods. The
other set of items covered similar territory, but in the sense of how the woman feels
about her periods and about the efforts she has to make to contain with them. The
components ofvariation that emerged from the factor analyses of these data sets
were very interesting. The largest component ofvariation for dealing with periods
was labelled, on the basis of the items involved, 'impact ofvolume' (21% of
variation in the data accounted for), the next 'variable flow' (17%), then 'resource
consequences' (13%), 'being unwell/irritable during period' (9%) and 'unpredictable
onset' (6%). The items were devised with menorrhagia in mind, so focussed on
volume, containment and similar issues. However, some items loading on 'impact'
could reflect pain or cyclic symptoms, and so could the 'unwell/irritable' component.
In this factor solution 'variability of flow' and 'unpredictability of onset' ofperiod
have loomed large.
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For the items phrased to ascertainfeelings about periods, a set of components was
obtained that partly addressed similar facets to the first set, but from the point of
view of emotional reaction to them. The largest component of variation was labelled
'containment distress' (23% ofvariation), the next was 'periods a burden' (17%),
then 'worry' (10%), 'resent resources' (10%) and 'had enough ofperiods' (7%).
'Containment distress' and 'resent resources' would appear to be thefeelings
versions of two components in the 'dealing with periods' set - 'impact ofvolume'
and 'resource consequences'. It is interesting to note that a 'worry' component is
evident in the feelings set, as this lends weight to the hypothetical structuring of
period problems in 5.1 and Tablel.l.
Therefore, while 'heavy bleeding' is a common reason for referral and attendance at
the clinic, the key issues for women are change from usual, containment of flow
(often in the face ofunpredictability), the practical consequences and the emotional
burden of this challenge (and sometimes failure), and the impact on their lives and
health. The question is whether these components will prove useful in understanding
and modelling of menstrual complaint. This will be pursued in Chapter 9.
5.4.3 Containment ofperiod
Duration of'full flow' was 2 to 6 days (IQR), although there were many durations
considerably longer than this. Women reported quite striking cycle-to-cycle variation
in the total duration of their periods (IQR 2 to 8 days difference between shortest and
longest reported periods), and this does seem to present a problem to many. Perhaps
this explains the emergence of a dealing with periods component 'variable flow'.
Furthermore, in items addressing feelings about periods there was also a 'worry'
component capturing the anxieties arising from such a change in pattern. An
important factor in successful containment of periods is knowing when the period
will start, and when it does, that the onset should be staged, so appropriate action can
be taken in time. Only about a quarter ofwomen reported their periods starting 'in a
gush' (26%) and overall 90% ofwomen stated that they had signs warning as to
imminence ofperiod. Nevertheless, one component ofvariation for management of
period was 'unpredictable onset' ofperiod. Perhaps the period is anticipated in some
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vague way, but not sufficiently precisely to allow timing of commencement of
protection. Further analyses of these component scores, against signs indicating
onset, will be informative (Chapter 9).
Protection used was compatible with heavy flow - nearly half ofall women used
only pads (48%) and a further 40% both pads and tampons. Approximately a quarter
of these women were using the top (super plus) grade ofabsorbency. It is however
intriguing that there were a number ofwomen who never used double protection
despite frequent accidents (about 110). The vast majority ofwomen had to get up at
night to change (79%), used double protection (69%), and experienced accidents
(86%). A third ofwomen reported having to change every hour or more often during
full flow. The supplies and attention that need to be devoted to containment ofperiod
appears to be a burden for many women. A dealing with periods component of
variation addressed the 'resource consequences' ofheavy periods - maintaining
adequate supplies, their cost, and the workload ofdealing with laundry. In addition a
feelings component ofvariation 'periods a burden' addressed the emotional
consequences ofproblematic periods, and another, 'containment distress' addressed a
sense of the relentless battle against accidents.
The difficulties expressed by women in the data discussed above, about frequency of
changing, and dealing with accidents, is emphasised by the data pertaining to
facilities at home for coping with periods: 75% of women have no toilet separate
from the bathroom, and 81% have nowhere suitable to soak bloodstains. The home
facilities deficit score is associated with deprivation, so further analyses of this
against components and against severe problems with aspects ofperiods will be of
interest. On the whole facilities at work seemed rather better, but a fairly high
proportion ofwomen had jobs that were unsuitable for women with problem periods:
59% involved standing, 52% lifting/carrying. It has been argued that when
menstruation interferes with functioning at work, then either the menstruation must
be 'abnormal' or the problem needs to be redefined as one ofoccupational health
(Harlow 1986). In addition, 57% ofwomen reported that frequent trips to the toilet
were noticeable. As has been discussed, many women are embarrassed, or feel
abnormal because of their periods, as in thefeelings about periods component 'resent
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resources'. It will be of interest to analyse this work facilities score against 'resent
resources'. Further analyses in Chapter 9 will clarify these issues.
5.4.4 Clinic outcome
Although the median time to discharge or referring on was 13 weeks, over half the
women had only two or fewer clinic appointments in total. Although nearly halfof
all study subjects reviewed had endometrial biopsy (n=284) there was no finding of
malignancy from these biopsies.
The low rate ofdiagnoses ofdysmenorrhoea and PMS (7% each) contrasts strongly
with the high rate of self-report of severe problems with these aspects ofperiods
(37% and 40% respectively) and with the high rate ofciting of these aspects as cause
ofhelp-seeking (38% and 31%). Neglect of these conditions was commented nearly
40 years ago (Dalton 1969), and it seems little has changed. It is not straightforward
to compare complaint of excessive bleeding with corresponding diagnoses. Both
fibroids (diagnosis for 18%) and polyps (3%) are considered to be potential causes of
heavy bleeding, but making such a diagnosis does not constitute confirmation of the
bleeding complaint. Similarly, diagnoses ofperi-menopausal/menopausal (3%) and
anovulatory bleeding without PCOS (2%) may be intended as an explanation for
reported heavy bleeding, or may simply be a physiological observation. Apart from
these diagnoses, 55% ofwomen received a diagnosis of dysfunctional uterine
bleeding, on its own far more than the 38% ofwomen who found volume of bleeding
a severe problems or the 38% who cited bleeding volume as cause for help-seeking.
This diagnosis should be a diagnosis of exclusion, when no physiological
explanation can be found for excessive bleeding (Fraser & Inceboz 2000). There are
therefore two concerns about the prevalence of this diagnosis. Given that many
women receiving this diagnosis did not seem to be complaining of bleeding, it seems
it does not necessarily indicate the doctor's judgement that there is excessive
bleeding (albeit unexplained). Secondly, the fact that this diagnosis is given in
conjunction with fibroids or PCOS, for example, raises questions about what if
anything this diagnosis means, when written in the notes. For remaining analyses the
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diagnosis ofDUB will be taken to apply only if it is thefirst 'final diagnosis'
recorded (n=326, 51%).
5.4.5 Overview
There is substantial overlap in menstrual morbidity and, as we learned in 4.3.3.vi
many women have long histories ofproblems, in many cases of multiple menstrual
problems. This questions the partitioned nature of menstrual problems as currently
conceptualised. An integrated life-course view may be more helpful to women trying
to maximise their 'lived health', and to come to terms with unexpected and
sometimes frightening or very inconvenient and discomfiting changes in their private
bodily rhythms and function.
The symptom, problem and component reporting of these patients, referred
predominantly for menorrhagia, raises doubts about the clinical definition of
menorrhagia, focussed as it is entirely on the volume of blood loss. It is therefore of
considerable concern that the predominant clinic diagnosis is dysfunctional uterine
bleeding, this diagnosis being common even where the woman's menstrual
complaint and help-seeking does not seem to be focussed on volume of loss.
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5.5 SUMMARY OF CHAPTER
5.5.1 Presenting menstrual problem
• Despite the predominant referral reason of excessive bleeding (76%), relatively few
women report 'very heavy' periods (36%).
• Problems with severe pain and cyclic symptoms were common. Cycle-related
changes were reported by 71 % as occurring most periods, a quarter of these women
reporting them as very troublesome. Severe period pain was reported by 40% of
women before periods, and 72% with periods. A quarter of women reported 5 or
more days severe pain per period and fewer than half of the women who reported
using painkiller found that they worked most of the time.
• Nevertheless the focus of the gynaecology clinic appears to be perceived as
abnormal bleeding, by both referring clinicians and the women themselves. Women
were more likely to state bleeding (60%) as reason for clinic attendance, compared
to pain or other reasons (30% and 34% respectively).
• Reports of severe problems with aspects of periods were most commonly cyclic
mood changes, pain with periods, 'amount of period more than it used to be' and
impact on daily life. It was striking that the aspect of periods 'lose too much blood'
was only the 8th most prevalent severe problem. So, where abnormal bleeding is a
problem the issue is not specifically volume but instead appears to be based on
concerns about change from normal and the strain of containment.
• Women's citations of which aspects had been the cause of help-seeking were in
order of prevalence: feeling unwell, increased period, lose too much blood, cyclic
mood changes, period pain and irregular periods.
• Clots were a very common occurrence, with 90% of women reporting some, the
number per period being 3 to 12 (IQR), mostly up to 20p size, and 6% self-stated
clots as reason for clinic attendance, and 4% cited clots rather than one of the listed
aspects as cause of help-seeking.
• Time elapsed between onset of severe symptoms and clinic visit was shortest for
excessive bleeding, and longest for PMS, and pain, particularly.
5.5.2 Components of variation in menstrual experience
• For dealing with periods the components of variation that emerged were: 'impact of
volume' (21 % of variation in the data accounted for), 'variable flow' (17%),
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'resource consequences' (13%), 'being unwell/irritable during period' (9%) and
'unpredictable onset' (6%)..
• Forfeelings about periods the components that emerged were: 'containment
distress' (23% of variation), 'periods a burden' (17%), 'worry about change' (10%),
'resent resources' (10%) and 'had enough of periods' (7%).
5.5.3 Containment ofperiod
• Women reported cycle-to-cycle variation in the total duration of their periods (IQR 2
to 8 days difference between shortest and longest reported periods)
• A quarter of women reported their periods starting ' in a gush' (26%).
• Duration of 'full flow' was 2 to 6 days (IQR), although there were many durations
considerably longer than this. A third of women reported having to change every
hour or more often during full flow.
• Protection used was compatible with heavy flow - nearly half of all women used
only pads (48%) and a further 40% both pads and tampons. About a quarter of these
women were using the top (super plus) grade of absorbency.
• The vast majority ofwomen had to get up at night to change (79%), used double
protection (69%), and experienced accidents (86%).
• With respect to facilities at home for coping with periods: 75% of women have no
toilet separate from the bathroom, and 81% have nowhere suitable to soak
bloodstains. This score is associated with deprivation.
5.5.4 Clinic outcome
• Median time to discharge or referring on was 13 weeks, and half the women had
only two or fewer clinic appointments in total.
• The low rate of diagnoses of dysmenorrhoea and PMS (7% each) contrasts strongly
with the high rate of self-report of severe problems with these aspects of periods
(37% and 40% respectively).
• Diagnoses that might be associated with heavy bleeding were fibroids (18%), polyps
(3%), peri-menopausal/menopausal (3%) and anovulatory bleeding without PCOS
(2%).
• Apart from these diagnoses, 55% of women received a diagnosis (first or second
mentioned) of dysfunctional uterine bleeding. Diagnosis of DUB was made in the
absence even of referral by GP for bleeding (33% nevertheless diagnosed with
Chapter 5: Menstrual Problem and Outcome. 173
DUB), rating periods heavy (34%), or reporting a volume aspect of bleeding a severe
problem (50%).
• For remaining analyses the diagnosis of DUB will be taken to apply only if it is the







For many decades menorrhagia has been the clinical descriptor for complaint of
excessive heaviness of menstrual blood loss. In this chapter the data for the three
methods ofquantification ofmenstrual loss will be reported. These are:
• Measurement of menstrual blood volume from collected used sanitary
products.
• Measurement of total menstrual fluid volume by weighing used sanitary
products, which have been protected from evaporation as far as possible, and
subtracting dry weight ofproducts used to obtain directly from change in
weight in grams the total volume of menstrual loss contained by the products.
This total fluid volume can in turn be used to estimate menstrual blood loss
volume.
• Prospective charting of menstrual period detailing experience and also
number ofproducts used and degree of soaking, with the aim ofestimating
menstrual loss volumes from product usage/soaking data
The relationships between the methods will be evaluated and methodological
concerns will be noted, but description of theoretical investigations and experiments
undertaken to elucidate measurement issues, will be held over to Chapter 7.
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6.2 METHODS FOR THIS CHAPTER
6.2.1 Objective measurement of volumes
6.2.1.i Principle
Total fluid volume.
As explained in Chapter 3, the principle used for measurement of total volume of
menstrual loss is that each millilitre of loss weighs one gram (Fraser et al. 1985). If
all the menstrual protection used is collected in air-tight storage (to avoid
evaporation), and if the dry weight of menstrual protection used is known, then all
that is required is to weigh the used products, and subtract their dry weight prior to
use. The difference in weight in grams can then be converted directly into millilitres
for an estimate of total menstrual fluid loss.
This part of the study was essentially a feasibility trial of the use of the much more
easily-measured total fluid volume, rather than menstrual blood loss, as an objective
measure of'heavy periods'. We particularly wished to develop a method that would
be acceptable to women. Anecdotally, one of the aspects of menstrual collection (for
measurement ofblood volume) that women express distaste for is the idea of some
laboratory worker handling their used sanitary products. Therefore it was believed a
proposed method would be more acceptable ifwomen could be reassured that the
assessment of menstrual loss does not require handling of individual used products in
the laboratory.
In the present study all used and collected products had to be handled for
measurement ofblood volume (see below), but we nevertheless wanted the total fluid
measurement procedure to have the potential in the future to be a 'stand alone'
method, if it proved a sufficient and clinically-useful quantification. In a future
application of only the total fluid volume measurement procedure, women could be
asked to collect used products sealed in opaque polythene bags, and record a count of
the number and types ofproducts used, on the basis of an undertaking that the
collection would be weighed unopened.
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With regard to the dry weights of the products used, we wished to avoid prior
weighing of individual products, as had been used in other menstrual collection
studies (Fraser et al. 2001; Fraser et al. 1985). Prior weighing would mean products
had to be unwrapped, and then repackaged. In addition, it would have meant each
product being supplied to the woman in a polythene bag labelled with the product's
dry weight, and her being requested to track products by replacing each product once
used into its original polythene bag, the one in which it had been supplied. Therefore
individual pre-weighing ofproducts would mean excessive demands on collectors,
and may lead to defaulting or errors. The need to match wet to dry weights would
also have made the goal of 'weighing unopened' very difficult to achieve. In the
interests ofacceptability therefore it was decided that individual products would not
be pre-weighed, but instead the total dry weight of the products used would be
estimated by means ofpreviously established average weights for the various
products used, by brand and absorbency grade.
This allowed the sanitary products to be provided to women still in their packaging
as taken from retailer's shelf, thus avoiding any concern that their sanitary protection
might have been 'contaminated' prior to use through handling by laboratory staff.
The intention was the woman would seal each individual used product in one of the
airtight bags provided, without any wrappings or toilet paper, and all used products
thus bagged were to be collected into an outer (strong) plastic bag. It would then be
possible to weigh the entire collection in the outer bag, without opening any of the
sealed bags. The menstrual chart would provide a count ofproducts in the collection,
and known average dry weights of these products, and of the plastic bags provided
and used, would be used to calculate the expected dry weight ofthe collection. The
method would have the further advantage of retaining, in the overall (wet) weight of
the collection, the weight of any moisture that has evaporated from the products and
condensed on the insides of the bags. The question is whether total fluid volume
measurement would be accurate and informative enough for clinical purposes.
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Menstrual Blood loss.
The method to be used for measurement of menstrual blood loss was that initially
described by Hallberg (Hallberg & Nilsson 1964). Our study pre-dated the trend
towards making adjustments for spillages and clots, so such a potential was not
allowed for in the design. However, a concern about the quality of life impact of
menstrual accidents did ensure that the menstrual diary each collector completed for
the period collected, asked about clots by size and about leakages (but without asking
that 'size' of spillage be estimated). Therefore some examination of the potential bias
due to under-measurement is possible.
The principle invoked is that if used sanitary products are soaked in sodium
hydroxide (NaOH) then even dried blood will be dissolved, and the haemoglobin in
the blood, and indeed most products resulting from degradation ofhaemoglobin, will
be converted to alkaline hematine (Hallberg & Nilsson 1964). Spectrophotometric
assessment of the soaking solution will determine the optical density (or
'absorbance') of the solution, that is the amount of light transmitted through the
sample relative to a reference cell of pure NaOH (the reference cell being arbitrarily
set at 100% transmittance). A particular compound in solution will produce a
spectral-transmittance curve across the entire light spectrum that is characteristic for
that compound. This feature can be used for identification ofunknown compounds.
However, in this application the part of the spectrum that is of interest is known; the
absorbance range for heme chromogens is centred on 546 mp, in the 'blue-green'
range of the spectrum. For a particular band of the spectrum, the 'absorbance' is
proportional to the concentration in the solution being assessed, of the compound of
interest. This is generally the case for a range ofconcentrations, but the relationship
may break down at extremes of concentration.
Provided proportionality holds, then the concentration of the compound in the
solution can be obtained by relating the optical density of the solution with unknown
concentration to that for a solution with standard concentration. In this application
however it is not concentration as such that is of interest, but volume ofblood in the
menstrual collection. Furthermore, alkaline haematin is derived from haemoglobin,
180 Menorrhagia Reconsidered
and women differ from each other in terms of the concentration ofhaemoglobin
circulating in their blood streams, and therefore also in terms of the concentration of
haemoglobin in the menstrual blood collected. Therefore a 'standard' concentration
of heme chromogens can not be used for spectrophotometric comparison. Instead, the
comparator is a known dilution, in NaOH, of the woman's own blood, the venous
sample taken around the time ofmenstruation. It is then possible to estimate for each
collector the volume of her blood there must have been in her menstrual collection.
This is done by taking the ratio of the optical densities (absorbances) of the two
solutions in NaOH of her blood (venous and menstrual collection), each factored up
by the dilution volumes ofNaOH added.
6.2.1.ii Procedure for measurement.
Total fluid volume.
The procedure used for ascertaining total fluid was:
• The woman was provided with standard brand products, still in their own
packaging.
• Once used each product was to be sealed in an opaque nappy sack, and
returned to the yellow liner bag, with no wrappings or toilet paper included.
• The woman was to record prospectively on the menstrual chart (MC) each
new item of sanitary protection applied, and note any non-standard products
used, including brand and type.
• At the laboratory the collection was to be weighed, still in the nappy sacks
and yellow liner sack, giving the Total Weight for the Collection (TWC).
• The Total Product and Bag Weight (TPBW) was obtained by accumulating
average dry weights of the products used, the average weight of the nappy
sacks, and the weight of the yellow liner sack.
• Total weight of menstrual fluid collected was calculated by subtracting, from
the total weight for the collection, the accumulated product and bag (dry)
weight (TWC - TPBW).
• Total Fluid volume was obtained by a direct conversion from grams to
millilitres: Total Fluid (mL) = [TWC - TPBW]g
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Menstrual Blood loss.
The procedure described by Hallberg for ascertaining blood volume is detailed below
(Hallberg & Nilsson 1964). (Some of the adaptations made for this study, or
comments on Hallberg's method, are described in square brackets.)
• After weighing ofentire collection for Total Fluid loss determination (as
described above), and after cutting open the nappy sacks in which the
products had been stored, the products were counted into a plastic liner bag
within a container (bucket). (Any blood remaining on the inside of the bags
was wiped offwith a spare pad, which was added to the others, for
extraction.)
• Sodium hydroxide solution (NaOH) was mixed at a strength of 160 NaOH
pellets to 4 litres ofwater (5%).
• A measured amount of the NaOH solution was used to cover collected pads
and tampons in the container Hallberg recommended 1 to 2 litres for up to 15
towels, and if there were too many to undertake the extraction in two halves
(Hallberg & Nilsson 1964). (The solution was added in multiples of2 litres
until the products were covered).
• A measured amount of the venous blood sample was made up to a volume of
lOOmL with the prepared NaOH. Hallberg used a dilution of 1 in 100
(Hallberg & Nilsson 1964). ( In Edinburgh the same dilution was used, for
example, lmL venous blood + 99 mL NaOH gives a 1 in 100 dilution. In
Glasgow, according to their established practice, 0.5ml blood was made up to
lOOmL, giving 1 in 200 dilution.)
• The products soaking in the container, and the diluted venous blood, were left
to soak/stand in the laboratory. Hallberg recommended a duration of soaking
of at least 20 hours (Hallberg & Nilsson 1964). (In this study the duration of
soaking was 48 hours or sometimes longer.)
• After soaking Hallberg recommended thorough squeezing and rubbing of
each product to ensure all dried blood stains have disappeared, with rubber
gloves for protection of hands. (This is not a pleasant activity, and would now
also be considered an excessively hazardous task to request of laboratory
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staff. This probably accounts for the introduction in recent years of
stomachers, which undertake the mashing in an automated way, within the
'safety' of a heavy duty polythene bag.)
• A sample of the supernatant was then taken by dipping in a glass beaker. This
fluid was filtered into a clean beaker. Hallberg recommends alkali-resistant
filter paper (Hallberg & Nilsson 1964).
• The dilute venous blood and the filtered supernatant were each measured for
haemoglobin by means of a spectrophotometer, measuring at the 546 mp.
absorbency spectrum ('blue/yellow'), in the haematin range. (The optical
density (OD, absorbance) was measured, without a conversion to
haemoglobin.)
Hallberg does not in fact provide a formula for the calculation of blood loss volume,
but comments only: "The amount of haemoglobin lost during menstruation was
easily calculated from the extinction and the volume of the extract (Hallberg &
Nilsson 1964). The menstrual blood loss was then calculated from the haemoglobin
concentration of the subject." 'Extinction' (of light) is clearly an older term for
'absorbance' (Evenson 1994). (Most papers on this topic do not give the detail of
the calculation/formula (Cole et al. 1971; Fraser et al. 2001; Hallberg et al. 1966;
Higham et al. 1990; Rees 1991; Reid et al. 2000; Wyatt et al. 2001).) The formulae
available at Edinburgh and Glasgow as 'the Hallberg method', undertake the
calculation without an explicit need to specify haemoglobin concentration of venous
blood. The formula applied in this study to calculate blood volume of menstrual loss
collected was:
Blood (mL) = Optical Densitv(products) x Soaking Volume ofNaOH
Optical Density(venous blood) x 'Dilution' of venous blood
where 'dilution' is the volume to which 1ml venous blood is diluted. The advantage
of this formula is that the same spectrophotometer is used to obtain haematin
concentration (implicitly the haemoglobin concentration) for both the soaking
solution and the venous blood solution. Therefore, where 4L ofNaOH is used for
soaking, and a 1 in 100 dilution ofvenous blood is used, the formula is:
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Blood volume (mL) = OD (products solution) x 4000
OD (venous blood) x 100
There will be further discussion of the formula in the following chapter.
Although the optimum would have been to take the venous blood sample just prior to
menses the timing for this would have been difficult to predict, and in all cases
obtaining the sample would have been logistically very difficult, and an
inconvenience for the women involved. Therefore it was decided that the blood
sample would be taken when the menstrual collection was handed over, usually very
soon after the end of the period. In a few cases (n=8) the woman and the research
nurse did not meet up, and so no sample could be taken. In these cases the most
recent clinic blood sample was used instead.
6.2.1.iii Preparatory work for measurement
Total fluid volume.
For the calculation of total fluid volume, estimates were required of the average dry
weight of the standard sanitary products to be used, of the nappy sacks for sealing
each product, and for the yellow liner sacks. We undertook test-weighings of
samples ofproducts from a number ofdifferent packs of the brands/grades provided
to the collectors. By calculating the means and standard deviations we would be able
to estimate the error likely to be introduced into our measurement of total fluid loss
by use of our 'overall' method.
Table 6.1 shows the average weights ascertained. In the case of sanitary protection
these weights were free ofwrapping and in the case of tampons free also of
applicator. For nappy sacks the individual sack weights were very low, and in
practice the majority ofwomen would use 20 or more for one menstrual collection.
These were therefore weighed in bundles of 25 sacks. There was highest variability
in weights for the bundles of nappy sacks (coefficient of variation 9.7%). Our
impression was that this was a production issue, resulting in an entire roll of nappy
sacks tending to be heavier, or lighter, than the average given in the table, perhaps
due to the temperature of the plastic fluid at the time ofextruding into bags. For the
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purposes of accumulating 'dry weight' of the collection, each nappy sack used was
counted as weighing 46.79g divided by 25, that is 1.87g.





Heavy duty yellow liner bag (each) 70.82 0.77
Nappy sacks (bundle of 25) 46.79 4.53
Bodyform superplus pads (each) 6.43 0.23
Tampax tampons (super, each) 3.30 0.08
Tampax tampons (super plus, each) 3.70 0.20
Although methodologically it would have been preferable to provide women with
single bags randomly selected from different rolls, to average out the errors, it was
decided that it would be easier and hence preferable for the women collecting, and
the research nurses, if they could be given a single run (bundle) of 30 nappy sacks.
The purpose of this aspect of the study was simple provision of a clinically 'good
enough' estimate of total fluid loss, which could form the basis for discussion
between patient and doctor about the menstrual complaint, and strategies to manage
it. For 68% of collectors the error introduced by the variability in weight of nappy
sacks would be expected to be less than 4.6mL either side of the true value (which
for a woman with menorrhagia as clinically defined, blood loss of 80mL or more
would be anticipated to be, on the basis of past research, 180mL or more (Fraser et
al. 2001)).
When the weighings ofproducts were undertaken the opportunity was taken to check
the scales at the two laboratories, and also to compare measurement reliability for the
two research nurses. The weighings were undertaken by the study co-ordinator using
both Edinburgh and Glasgow scales, and also in each centre by the local research
nurse. At each centre there was good agreement between the two weighers (0.0 lg
mean difference in Edinburgh between weighers for bundles of 25 nappy sacks,
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0.06g difference in Glasgow for the same weighings, so less than 0.5% for the
Edinburgh research nurse, less than 1.5% for the Glasgow research nurse). A small
difference in weights between centres (scales) was observed across the range of
weighings, with the Glasgow scale weighing, for example, bundles of25 nappy sacks
lighter by 0.42g, a discrepancy of less than 1% of the goods being weighed.
Where non-standard sanitary products had to be used, because of some emergency, it
was requested that the brand and absorbency be recorded on the Menstrual Chart
(MC). Once the data collection was underway, there was surveillance ofMenstrual
Charts returned, for any recording ofuse of non-standard sanitary protection. If this
occurred a pack of equivalent products was purchased and weighings undertaken by
the study co-ordinator to ascertain the appropriate average weight per product to be
used for each recorded use of such a product, in summations ofdry weight.
MENSTRUAL BLOOD LOSS.
The study design had specified that the established method of blood volume
measurement would be used (Hallberg & Nilsson 1964). At the Glasgow centre
blood loss determinations were already being used for assessment of some patients,
so a measurement protocol was in use. Dr Mary Campbell Brown, the gynaecologist
running the menstrual problem clinic, oversaw the service. She undertook to train the
Glasgow research nurse, who would work in that laboratory for the purposes of the
menstrual blood loss measurements. At the Edinburgh centre such determinations
had been undertaken in the past, for research studies, and there was a technician who
had been involved in the studies and could thus train the Edinburgh research nurse.
At Edinburgh it had been the practice to use a 'stomacher' to mash the soaked
products, sealed in a strong plastic bag designed for the equipment, to ensure speedy
and efficient extraction ofhaematin into the NaOH solution. Elowever, Glasgow
revealed that they did not use a stomacher, but soaked only, for 48 hours, and that
this worked well. Given that there was an established protocol in operation in
Glasgow, and a wish to have homogeneity of methodologies across the centres in the
study, it was decided that the stomacher would not be used Edinburgh, but instead
the 'soaking only' method of Glasgow would be adopted. A further factor in making
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this decision was that the research nurses were both part-time, and in the time
budgeted also had to attend clinics to recruit patients, and undertake paperwork and
administration to do with the study. So it seemed that the 'soaking only' approach
would fit in better with their time schedules, since the collection could be set to soak
at the end of one shift, and then left, needing only about 10 minutes attention two
mornings later, for filtering and spectro-photometric analysis.
6.2.1.iv Objective measurement data
For measured menstrual blood loss the variables recorded were: date ofanalysis,
volume NaOH used for soaking, secondary dilution factor (1 if no secondary
dilution), optical density for soaking solution aliquot, venous sample dilution,
optical density for venous sample aliquot, calculated menstrual blood volume.
For total menstrual fluid loss the variables recorded were: total wet weight of
collection in yellow bag, weight of yellow sack given, number of nappy sacks used,
numbers of study (super plus) pads, regular tampons and super tampons, numbers
and weights of other non-study pads/tampons, calculated total dry weight of
collection (including bags/sacks), calculated total fluid volume, numbers ofpads and
tampons stated as lost.
Blood as percentage of total fluid volume was calculated from menstrual blood
volume and total fluid volume estimates.
6.2.2 Menstrual charting
Two charts were published when we designed the study, (Higham et al. 1990;
Janssen et al. 1995) but Higham's was chosen as the model. The two charts were
actually almost identical. The chart requesting recording for each product used the
extent of soaking/soiling of it, by matching to one of the pictograms ofused
menstrual protection provided (three each for pads and tampons) (Higham et al.
1990). The menstrual chart data in Higham's study enabled estimation of the volume
of menstrual blood loss (Higham et al. 1990). Routine use of such a method of
estimation would have the advantage ofavoiding the need to collect used products,
thereby preventing much of the discomfit ofmenstrual loss assessment. In the study
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published, however, the products were collected, since as a methodological research
study it was necessary to have objective measurement ofblood loss alongside the
charting, to enable development of the estimation formula.
6.2.2.i Rationale for adaptations to menstrual chart
For each type of protection, pad and tampon, Higham's menstrual chart (Higham et
al. 1990) offered only three pictograms for recording extent of soaking/soiling, and
none of them was suited to that stage of the period where the pad or tampon is used
for reassurance mainly, when generally virtually no soiling occurs. It was felt that
this over-simplification may have made it more difficult for women to complete the
chart accurately, and certainly must have made it more difficult to estimate blood
volume precisely. In addition, the pictograms for tampons were rather short and
squat. Therefore, for the chart used in this study two pictograms were added to the
sets for each of pads and tampons, one for very light soiling, and an extra one in the
range of moderately heavy soiling. The tampon pictograms were also drawn to have
a more realistic shape. The pictograms used are shown in Figure 6.1. The added
pictograms are the first and fourth in each set.
Figure 6.1 Excerpt of menstrual chart showing pictograms for reporting of





IF you also changed a
TAMPON now;
HOW MUCH PERIOD WAS
SOAKED INTO THE TAMPON?
Please tick once to describe each
PAD changed now
Please tick one
0 0111 MM ii
i : : :
The Higham chart (Higham et al. 1990) accumulated by day the numbers of products
used with each of the three degrees of soiling, and the number of clots of various
188 Menorrhagia Reconsidered
sizes (compared to coins), with no indication of timing ofproduct use. In the present
study it was felt it would be helpful to understanding of the nature ofcomplaint if the
time-frame of changes could be captured. The chart was therefore adapted to become
a log of changes ofproducts (and degree of soaking of these) by time ofday, as well
as by day. This adaptation of the menstrual chart could give some insight to pattern
of flow (and occurrence ofclots) across the period (see Appendix 3.5). (When a
research nurse analysed a menstrual collection in the laboratory she counted the
products 'collected'. It was thus possible to check this number ofproducts against
product changes recorded in the chart.)
Thirdly, from discussions with women complaining of heavy periods (Warner &
Critchley 1995), readings of the qualitative literature (Hodges 1989; Marshall 1998;
O'Flynn & Britten 2000), and earlier research (Bancroft et al. 1993; Fraser et al.
1984), a picture was emerging that the main cause of complaining was not the
volume of menstrual loss, but the impact on daily life, perhaps exacerbated by
associated symptoms such as period pain. It was therefore decided that the menstrual
chart should also capture the impact of periods. The log was elaborated to include
use ofdouble protection, accidents, and intensity ofpain, by time of day, and to ask
on a once per day basis about activities cancelled, use ofpain-killers and use ofother
medication (see Appendix 3.5).
Finally, to be able to relate the period charted (and collected) to the reports ofperiods
as already given in the questionnaires (CQ, MEQ), the woman was asked at the end
of her period to compare it to periods over the last 6 months. The five aspects to be
compared were: amount of loss, effect on daily activities, leakages, period pain,
tiredness. For each the response had to be chosen from a five-point scale - much
less, a bit less, much the same, a bit more, much more (than usual). This period
review question can be found on the inside cover of the Menstrual Chart (see
Appendix 3.5).
6.2.2.ii Development of the Menstrual Chart
To offset the quantity of information sought, great care was taken with the design
and formatting of the chart to make it as user-friendly as possible. (See Appendix
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3.5). The chart was laid out as an A5 landscape booklet, as it was expected women
would have to carry it around with them if away from home. Both outside covers
were blank, for discretion. Careful instructions were provided within the chart,
together with the names and telephone numbers of the research nurses, in case any
help was needed.
In previously published analyses, based on menstrual chart data (Higham et al.
1990), a score was assigned in advance to each of the possible pictograms, conveying
degree of soaking (1,5 and 10 were used for her tampon pictograms, and 1, 5 and 20
for pads). (For each of pads and tampons Higham's lightest and heaviest pictograms
were almost identical to the 2nd and 5th pictograms used in the present study, while
her middle pictogram was about half-way between the 3rd and 4th pictograms in the
present study.) Higham's assigned scores were subsequently converted into total
menstrual blood score (PBAC) by accumulating for each woman's period the
relevant scores for each used product (pictogram) recorded (Higham et al. 1990). (In
addition, the score was incremented for each clot reported - by 1 for clots size lp, by
5 for clots sized 50p - but this would have been an adjustment for loss not collected.)
If the final score was >100 this was deemed to be equivalent to a blood loss of >
80mL. In contrast, the intention for this present study was to find by multiple
regression the best score to apply for each pictogram, so as to achieve optimum
estimation of menstrual blood volume and total menstrual fluid volume using a chart.
In order to be able to describe pattern of flow it was also requested that the time of
changing be recorded. However, for the purposes of this initial analysis only the
overall product use and soaking will be analysed, and related to the fluid volumes of
interest.
6.2.2.iii Chart data
Menstrual chart variables recorded for analysis were: date and time of commencing
protection; whether or not used tampons at all; total days charted; and, at end of
period, comparison ofperiod charted to periods in last 6 months, by means of a 5-
point scale (much less/ less, about the same/ a bit more/ much more), in terms of five
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features - amount of loss, having to stop activities, leakage onto clothes (and so on),
severity ofperiod pain and tiredness.
For each day the following summary variables were recorded: total number of
changing times recorded; number of items changed; how many pads charted for each
of 5 degrees-of-soaking pictograms; how many tampons charted for each of 5
degrees-of-soaking pictograms; whether pain was at any change in that day recorded
as moderate; and whether at any change recorded as severe; how many clots were
charted in that day of sizes 20p, 50p and 'bigger'; how many times in that day the
respondent charted leakages onto underclothes, outer clothes and bedding/ furniture;
whether any activities had had to be cancelled that day; how many pain-killers taken
that day; and whether any other medication had been taken that day.
Further variables were calculated summarising the entire period: total pads, tampons
and products (any) charted as used; total days where severe pain was charted and
total days at least moderate pain; total numbers of clots of each size; total numbers of
leakages of each degree; total pain-killers used; total days pain-killers used;
maximum painkillers used any one day; maximum changes in any one day; and
maximum items used in any one day.
6.2.3 Statistical methods
6.2.3.i Regression modelling of volumes
The menstrual blood and total fluid volumes have positively skewed distributions so
for parametric analyses log transformation was used. For counts ofproducts recorded
in the menstrual chart, log transformation was also necessary for regression
modelling. In this case, as some counts were zero, for which there is no Tog' value, 1
was added to every count prior to log transformation. For the estimation of blood
volume lfom total fluid volume multiple regression was employed. For this
regression the analysis was confined to women for whom there was a total fluid loss
of 85mL or more. This was to avoid the excessive noise that was likely to pertain at
lower total fluid losses, but would have been expected to retain in the analysis most
women with menstrual blood losses of42mL or more. The dependent variable was
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blood volume, and the independent variable total fluid volume. This analysis was
undertaken adjusting for centre (Edinburgh, Glasgow), and there was also
examination of the effect of various other dependent variables, such as sanitary
products used, and missing or extra products. Initially it had been intended to use
two-thirds of the data as a training data set, and then to evaluate the prediction on the
remaining data. However, this plan was changed because of a finding of between-
centre differences in blood loss measurement, which will be reported in 6.3.1.iii (and
further examined and discussed in Chapter 7). It was felt it would be better to use all
the data for modelling, in an effort to better understand the measurement differences
between centres, and to have better scope to derive informative models adjusted for
centre.
Multiple regression was also used to model menstrual blood loss and total menstrual
fluid loss volumes in terms ofdiary data. As explained already, this had to be
undertaken adjusting for centre. There was no prior specification that analysis would
be confined to women with total fluid loss over a specific threshold, as had been
done for the analyses for Fraser's study (Fraser et al. 2001), but it was anticipated
this may be necessary for pragmatic reasons.
6.2.3.ii Confidence intervals for regression modelling
For regression estimates two confidence intervals can be calculated for the predicted
value. For example, if estimating blood volume from total menstrual fluid volume,
the first confidence interval is analogous with the commonly understood confidence
interval for a mean or other summary statistic. It is the confidence interval for the
true mean value for blood volume for collectors with that total fluid volume. Since
there is greater confidence in prediction near the 'centre' of the data the intervals will
be narrowest near the mean for the x-values (total fluid volumes), and widest towards
the extremes of the x-values. The tendency for closer limits at the centre will be more
noticeable for sparse data sets with a wide range of x-values. The line formed by
joining the upper end points ofall possible confidence intervals across the range of
x-values therefore forms a diagonal arc, closer to the regression line in the 'centre' of
the data. Similarly, but in reverse, for the lower limits. This is essentially the
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confidence interval for the regression line predicting blood volume from total fluid
volume.
The second form of confidence interval is that which applies to an individual
prediction. That is, for an individual collector with a certain measured total menstrual
fluid volume, the 95% confidence interval for her blood volume as predicted
(estimated) by the regression model. For a specific measured total menstrual fluid
volume, the 'predicted' blood volume will be the same regardless ofwhether it is an
individual prediction being made, or an estimation (prediction) of the true mean
value for collectors with that total menstrual fluid volume. However, the confidence
interval for an individual determination, has to allow for the substantial between
individual variability that bedevils clinical measurement, and so will always be
considerably wider than the confidence interval described first, for the true mean
blood volume. The confidence interval for an individual prediction is sometimes
called the prediction interval, to distinguish it from the confidence interval for the
true mean value.
In fact the regression analyses ofblood volume on total fluid volume were
undertaken with both variables log transformed, to deal with skewed distributions. In
such a situation the definitions above for the two forms of confidence interval apply
to the data and predictions on the logged scale. However the predictions and
prediction intervals obtained by regression modelling on the logged scale can be
back-transformed to the original scale, and can then be plotted with the original data.
The process ofback-transformation will however change the shape of the lines. For
example, the regression line will be curved rather than straight after back-
transformation, although this may be imperceptible.
6.2.4 Reporting results for log transformed menstrual volume
variables
Menstrual loss volumes were log-transformed prior to parametric analysis by means
of the t-test for independent groups. Group means (and confidence intervals)
calculated for these logged data can be back-transformed and reported on the original
scale as geometric means, with confidence intervals. (A geometric mean of n values
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is the 11th root of the product ofall values multiplied together.) However, in such
comparisons the preference would be to report the difference between groups, with
confidence interval for the difference. This is not possible given analysis on the
logged scale. A back-transformed difference between group means of logged data is
effectively a ratio ofgeometric means. Fortunately this ratio has a meaningful
interpretation, as 'how many times bigger one geometric mean is than the other'. For
example, a ratio of 1.8 would imply the one group's geometric mean is 1.8 times the
other, or 80% bigger. If the ratio is 1 or very close to it then the means are
(approximately) equal. Since the analysis of the logged data provides a difference
with confidence interval for the difference, all three quantities (mean, lower limit and
upper limit) can be back-transformed to give on the original scale a ratio of means




6.3.1 Findings for measured menstrual loss
6.3.1.i Measured blood volume
The distribution of measured blood losses for the 226 women who collected is shown
in Figure 6.2; the median loss was 53mL (inter-quartile range 27 to lOlmL) and
34% had losses of 80ml or more. Blood volumes in Glasgow were generally higher
than in Edinburgh. The median, inter-quartile range (IQR) and maximum for blood
volume in Edinburgh were 41.4 mL (IQR 22 to 77mL, maximum 351mL), and in
Glasgow these were 64.7mL (IQR 31 to 119, maximum 668mL).
Figure 6.2 Histogram of measured blood losses, with superimposed box-
plot (total n=226)
The positively skewed distributions for blood loss volume mean that log
transformation is appropriate prior to use of parametric analysis methods, and so the
natural logarithm transformation (Ln) was applied. Figure 6.3 shows box-plots of
Ln(blood volume) by centre. It can be seen that after transformation the distributions
Chapter 6: Quantifying Menstrual Loss 195









0 100 200 300 400 500 600 700 800 900
50 150 250 350 450 550 650 750 850
Total Fluid Volume (mL)
Figure 6.5 shows box-plots of Ln(total fluid volume) by centre. It can be seen that
the resulting distributions are fairly symmetrical and the central location is almost
equal. That is, Edinburgh total menstrual fluid volumes are very similar to those in
Glasgow (medians 102.6mL and 103.4mL respectively).
The blood component of the menstrual loss can be calculated as a percentage of the
total volume of menstrual loss. The median and inter-quartile range (IQR) for
percentage blood by volume in Edinburgh were 44.3% (IQR 33 to 55%,), and in
Glasgow these were 68.8% (IQR 53 to 86%). This difference in percentage blood
loss was unexpected, based on earlier research work, so led to the various
experiments and theoretical work to try to explain the differences (for example, to try
to ascertain whether blood measurements in Glasgow were biased upwards, and/or
total fluid volume measurements biased downwards, or vice versa in Edinburgh).
These will be described in Chapter 7.
Std. Dev = 141.77
Mean = 138
N = 225.00
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loss. This strategy also eliminates from analysis women with low menstrual volumes,
where there are proportionately greater errors in total fluid measurement. The results
of the analysis are shown in row 2 of Table 6.2. The residual error mean square was
lower for the second analysis, and this allowed identification of an extreme outlier,
with a standardised residual of -4.18.
Table 6.2 Linear regression analyses of logged menstrual blood volume
on logged total menstrual fluid volume: data inclusion criteria
and analysis of variance statistics
Analysis
Collectors included





1 All with data for x,y 225 0.742 0.276 319.7 2, 222 <0.001
2* Total fluid > 80mL 140 0.665 0.154 135.8 2, 137 <0.001
3 ~ Total fluid > 80mL &
case is not the
extreme outlier*
139 0.704 0.134 165.3 2, 136 <0.001
4(E) Edinburgh collector &
total fluid > 80mL
56 0.647 0.142 98.0 1,54 <0.001
5 (G) Glasgow collector &
total fluid > 80ml_ &
case is not the
extreme outlier*
83 0.678 0.130 170.8 1, 81 <0.001
+ 2
R is the proportion of the variance of (log) blood volume that is explained by the
regression on log total menstrual fluid volume and, for analyses 1,2, and 3 only, centre.
Residual Error Mean Square from the analysis of variance table for the regression
model
* One extreme outlier A was noted in analysis 2, with standardised residual -A. 18.
(Details of this and subsequent outliers are given in Appendix 6.1 Table A6.1.1.)
Examination of this case found very high fluid:blood ratio, and that the woman had used all
non-study (and heavy) pads. This case was excluded for subsequent analyses involving
Glasgow collectors, that is, 3 and 5.
One new outlier B was noted in analysis 3, with standardised residual -3.08.
Examination of this case found high fluid:blood ratio, but that the woman had used all
standard pads. This case was retained.
Two outliers were noted in analysis 5, B again, and a new case C, with standardised
residuals -3.16 and -3.03. C had high fluid:blood ratio and had used a large amount of
sanitary protection, about a third of which were non-study pads. These were retained.
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Given the size of the standardised residual, and the fact that the woman had used for
her menstrual collection all non-study pads (for which a very heavy dry weight was
assigned in the calculation), it was decided that the analysis should be re-run
excluding this data point. The results for the analysis excluding this extreme outlier
are shown in the third row of the table. This model also was a very good statistical
fit, but the R2 of 70% was not quite as good as that for the first analysis (74%). This
is a result of the reduction in range ofx-values in the model, due to excluding those
with total fluid volume <= 80mL, since this allows the model less scope (range) to
display it fit. However, it can be seen that by focussing on the upper range of total
fluid volumes, and excluding the one extreme outlier, the Residual Error Mean
Square, the residual error used to calculate confidence intervals for estimates, has
been halved compared to the first analysis.
A further analysis was undertaken to explore the interaction between centre and
slope, but there was no improvement in the model. The implication of this is that the
best (parsimonious) model for these data has parallel regression lines for Edinburgh
and Glasgow (on the log scale). For interest, analyses were also undertaken
separately within centre, and these are presented in rows four and five of the table
(Edinburgh and Glasgow respectively). The regression coefficients for all five
analyses are presented in Table 6.3.
Table 6.3 Linear regression analyses of logged menstrual blood volume







b|n(total fluid) (95% CI)
1 0.44 .05 to 0.82 -0.451 -.59 to -.31 0.907 .84 to 0.98
2 0.54 -.11 to 1.19 -0.439 -.57 to -.31 0.900 .78 to 1.00
3 0.34 -.27 to 0.95 -0.457 -.58 to -.33 0.946 .83 to 1.10
4(E) -0.42 -1.3 to 0.5 n.a. 0.916 .73 to 1.10
5(G) -0.23 -0.9 to 0.5 n.a. 0.967 .82 to 1.11
* See Table 6.2 for details of data cases used, n and regression ANOVA results.
A scatter plot of all the menstrual fluid by blood volume measurements (logged) is
presented in Figure 6.6, together with the parallel regression lines obtained for
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Edinburgh and Glasgow from analysis 3 (see Tables 6.2 & 6.3). For each centre the
regression line represents the predicted (logged) blood volume across the range of
(logged) total menstrual fluid volumes.
Figure 6.6 Scatter plot of blood volume by total fluid volume (both logged)
by centre, with superimposed lines for blood volume regressed
on fluid volume.
Ln(Fluid volume mL)
o Glasgow o Edinburgh Edinburgh predictions Glasgow predictions
To ease interpretability the logged values on the y-axis (blood component of
menstrual loss) have been annotated with corresponding volumes on the original
scale. Points plotted to the left of the solid black line on the x-axis (total fluid volume
<80mL) were excluded from the regression modelling (analysis 3 in Table 6.2). All
but one of these points had logged value for blood volume less than 4.2 (that is,
measured blood volumes between 2 and 63mL). However, one Edinburgh point thus
excluded had blood volume of 107mL, despite an 'impossible' total fluid volume of
only 57mL - presumably the result of procedure (evaporation) and/or measurement
errors giving a lower than true total fluid volume and/or a higher than true blood
volume. As explained for analysis 3 (Table 6.2), one point initially included in the
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analysis was subsequently excluded as an extreme outlier: this point, on the right of
the line, is circled. All remaining points to the right of the line were included in the
analysis. It can be seen that predicted menstrual blood volumes were higher for
Glasgow collectors compared to Edinburgh collectors, across the range of total fluid
volumes.
The regression equation was
In{blood volume mL) = 0.34 - 0.457 x centre + 0.946 x In{total menstrualfluid mL)
where centre =1 for Glasgow or 2 for Edinburgh.
Considering solely the data used in the analysis, Figure 6.7 shows the logged data
points and the regression lines and individual prediction intervals separately for each
centre (second type of confidence intervals described in 6.2.3.ii).
Figure 6.7 Scatter plot of blood volume by total fluid volume (both logged),
with superimposed regression lines (and 95% individual prediction intervals),
separately by centre.
(a) Glasgow (n=83) (b) Edinburgh (n=57)
5 6
Ln(Total fluid volume mL)
7 4 5 6
Ln(Total fluid volume mL)
This shows that in Edinburgh prediction is fairly reliable for logged fluid volumes
greater than 5 (that is, volumes > 148mL). For Glasgow there are 7 noticeably low
estimates, plus the excluded outlier (not plotted here but shown in Figure 6.6), but
otherwise estimation appears reliable. However, with the two plots being on the same
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scale it is very clear how much higher the blood volume estimates are in Glasgow
compared to Edinburgh.
The log transformation of the data was a mathematical contrivance to allow linear
regression analyses of these data, but is not otherwise helpful to assessment of the
clinical utility of the model. The real clinical interest lies in the predicted blood
volumes converted to the original scale. The original data points have therefore been
plotted in Figure 6.8, together with the regression lines for each centre and the
confidence intervals for the regression lines (means), all anti-logged to the original
scale.
Figure 6.8 Scatter plot of blood volume by total fluid volume by centre, with
superimposed regression lines (and 95% confidence intervals) for mean blood
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These graphs show only the data included in analysis 3. The (thicker) regression
lines are identical with those shown in Figure 6.7, except back-transformed. The
(lighter) confidence intervals however are those pertaining to the regression lines
(means) and are not back-transformations of the individual prediction limits shown in
Figure 6.7. The confidence intervals plotted in Figure 6.8 are the first type of
confidence interval defined in Statistical methods (62.3.i), those for the true mean
blood volume the hypothetical group of collectors with that total fluid volume.
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It can be seen that once anti-logged the regression lines of Figure 6.7 (on the logged
scale) are no longer 'parallel'. (They will also be slightly curved, but this is hardly
perceptible.) The interpretation of this plot is that on the original scale the amount by
which a predicted blood volume in Glasgow exceeded that in Edinburgh, for the
same total fluid volume, was greater for greater total fluid volumes. The regression
equation can be re-written in the original scale as:
Blood volume (mL) = 0.890 x Total Menstrual Fluid(mL)° 946 for Glasgow
or = 0.563 x Total Menstrual Fluid(mL)° 946 for Edinburgh.
Therefore across the range of total menstrual fluid volumes the estimated blood
volumes for Edinburgh were smaller than the Glasgow volumes by a factor of
0.563/0.890, that is 0.63. This means blood volume estimates in Edinburgh were
lower by 37%, and confirms the visual impression from Figure 6.8.
The clinical utility of using total menstrual fluid volume to estimate blood volume
depends on the width of the prediction interval expressed on the original scale. The
width, once back-transformed, of the (narrower) confidence intervals for the means
(regression lines) in Figure 6.8 gives some idea of the width that would be expected
for the much wider 95% prediction intervals, once back-transformed. However, in
place of no estimation ofblood volume at all, the usual clinical scenario, some
prediction may be preferable, even if less than 95% confident. Figure 6.9 shows the
80% prediction intervals for blood volume estimates derived using the model of
analysis 3 (Tabie 6.2) for a range of total menstrual fluid volumes from 20 to
600mL. (It should be noted that the first three total fluid volumes (20, 40 and 60mL)
are out-with the range of total fluid volumes used to derive the model (>80mL), that
is, are extrapolated.)
On the log scale the prediction interval is plus/minus approximately 0.5 either side of
the estimated log blood volume, across the whole range of (logged) total fluid
volumes. The marked widening of the prediction intervals with increasing total fluid
volumes, seen in Figure 6.9, is almost entirely due to the arithmetic process ofback-
transforming from the log scale. However, in the range where the widest prediction
204 Menorrhagia Reconsidered
intervals are found, total fluid volumes of more than 400mL, for each x-value the
entire interval of blood volume estimates is on the whole 'extreme' (>100mL, say),
regardless of whether at the top, middle or bottom of the prediction intervals.
Figure 6.9 Blood volume estimates and 80% prediction intervals for a range
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For easier reference Table 6.4 presents prediction intervals in tabular form for the
same range of total menstrual fluid volumes. In Glasgow the blood volumes are high
relative to total fluid volumes, so the upper limits of the 80% prediction intervals for
estimated blood volume exceed the total fluid volume in every case. Since the blood
volume is a sub-part of the total fluid volume it is a physical impossibility for the
blood volume to exceed the fluid volume. However in these data both the fluid
volume and blood volume are measured with error. The width of the prediction
interval reflects that fact and does not imply that the true blood volume could be
greater than the true total fluid volume.
The predicted blood volumes are demarcated with a solid line denoting the
separation between fitted values (with total fluid volume >80mL) and extrapolated
(where total fluid volume <80mL). The blood volume estimates have been classified
tentatively as light, moderate, heavy, very heavy and extreme.
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Table 6.4 Linear regression predictions of blood volume separately by














20 15 10, 25 L 10 6,16 L
40 29 18, 47 L 18 11, 30 L
60 43 26, 69 M 27 17, 44 L
80 56 35, 90 H 36 22, 57 M
100 70 43, 112 H 44 27, 71 M
120 83 51, 133 VH 52 32, 84 H
140 95 59, 153 VH 60 37, 97 H
160 109 68, 175 VH 69 43,111 H
180 121 79, 174 E 76 47,123 VH
200 134 83, 215 E 85 53,136 VH
250 165 102,265 E 104 65,168 VH
300 195 121, 315 E 124 77, 200 E
400 257 159, 415 E 163 101,263 E
500 317 196, 513 E 200 124,325 E
600 379 234, 615 E 240 148,390 E
* KEY: Possible classification of blood volume- L = light (<35mL), M = moderate (35-50mL),
H = heavy (50-75mL), VH = very heavy (75-115mL), E = extreme (>115mL)
6.3.2 Description ofperiods by prospective charting
6.3.2.i Completion of charts and description of prospectively charted periods
In total 295 women completed menstrual charts. Of the 226 women undertaking
menstrual collection 19 did not provide completed menstrual charts. Table 6.5
summarises the prospective record on the period collected for the 207 women who
completed a chart. The number of changes of protection will in some cases be fewer
than the number of products used because some women use double protection and
hence may use one 'change' to replace two or more products. The timing of'onset'
of periods (defined as the time of day when use of sanitary protection commenced)
was relatively unlikely to be overnight, that is between 7pm and 6.59am, with only
2% ofwomen per hour on average commencing their periods during this time. The
206 Menorrhagia Reconsidered
most common time to start wearing protection was 7am to 9.59am (average 11% of
women per hour), whereas the rate of commencing protection for the remainder of
the day was a fairly even 5% per hour.
Table 6.5 Description of collected period in terms of prospectively
collected menstrual chart data (n=207 women, missing data
n=19).
Prospective record of period Mean Median (IQR) Maximum
Duration of period (days) 5.6 5 (4,6) 27
Changes of sanitary protection:
Total no. 22.6 21 (16,27) 68
Most in a day 6.4 6 (5,8) 13
Number of products used:
Total no. 25.1 23 (17,31) 78
Most used in a day 7.7 7 (5,9) 23
Clots:
Total no. size 20p 6.1 4 (1,8) 71
Total no. size 50p 2.2 0 (0,3) 35
Total no. bigger than 50p 0.6 0 (0,0) 15
Leakages:
Total no. onto outer clothes 0.6 0 (0,1) 6
Total no. onto bedding, furniture 1.1 1 (0,2) 6
Cancelled activities:
Total no. of days 0.7 0 (0,1) 4
Days with period pain:
Total days moderate/severe pain 2.6 2 (1,4) 12
Total days severe pain 1.2 1 (0,2) 6
Use of pain-killers:
Total no. of days 2.3 2 (1,4) 9
Most no. taken in a day 3.6 4 (1,6) 12
The 19 women who collected but did not complete charts, despite agreeing to do so,
were compared with the remainder of collectors. The collectors who did not
complete charts were predominantly of lowest socio-economic status (Carstairs
deprivation categories 5,6 &7, 84% v 43%) (Carstairs & Morris 1990). These women
were more likely to have rated their periods as less than 'very heavy' (68% v 46%),
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so it may seem that their menstrual loss was not extreme, which is supported by the
fact that they were slightly more likely to have measured blood loss less than 50mL
(53% v 45%). However, they were also more likely to have given bleeding problem
as their self-stated reason for clinic attendance (79%v 70%), to have responded that
'losing too much blood' was a marked/severe problem for them (84% v 64%), and to
have identified one or more aspects of excessive bleeding as the reason for coming to
the clinic (58% v 41% cited as reason one or more of losing too much blood,
difficulty in preventing accidents and periods going on for too many days).
The periods of the subgroup collecting (already shown in Table 6.5) were for some
variables different to the periods described by the women who agreed to complete
charts but who did not collect (n=88). This latter subgroup comprised some women
who agreed to collect but in the event did not manage to achieve this, although they
nevertheless completed the menstrual chart. Other women were clear from the outset
that they would not or could not collect, but offered to complete the chart to describe
their experience of an actual period. The charted periods ofwomen who did not
collect tended to last about a day longer, with mean 6.8 days and median (IQR) of 6
(5,8) days, and they were more likely to use tampons (63% v 43%, using tampons
solely or in addition to pads). The other variables that seemed to differ between the
two subgroups have been presented in Figure 6.10 as separate box-plots for the two
subgroups.
It can be seen that the charting women who did not collect reported more of the
larger two sizes of clots, and also considerably more changes of sanitary protection,
and a greater total number ofproducts used. For all the other variables in Table 6.5
the two subgroups were very similar, in particular for the maximum number in any
day ofproducts used and changes required. They were also similar in terms of timing
of 'onset' ofperiods.
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Figure 6.10 Amongst all women completing menstrual chart, comparison of
those undertaking menstrual collection with those who did not




6.3.2.ii Comparison of period collected to 'usual' periods
At the end of the period the woman was asked to complete a summary page on her
chart, indicating how the period charted compared with her periods over the last 6
months (the time frame for reporting on periods in CQ and MEQ). Comparisons
were requested for amount of period, leakage, impact of period on activities, pain
and tiredness. Responses offered were the same, a bit less, much less, a bit more and
much more. Figure 6.11 plots the percentages of collectors responding 'the same' or
either degree of'less'. Those responding more and much more are not plotted but
would make the total bar length up to 100%.
It can be seen that nearly 80% of collectors (who completed charts) felt the period
charted (and collected) was less or much less in volume than their usual periods, and
over 50% experienced less leakage. For the other three items (tiredness, pain and
impact of period on activities) over 50% of collectors felt the period charted was the
same as usual periods. Women finding their periods not 'the same as usual' in these
respects, were relatively more likely to experience less (rather than greater)
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curtailment of activities, but relatively less likely to experience less tiredness rather
than more.
Figure 6.11 Comparison of period charted (and collected) with periods over
the previous 6 months
Amount of loss (n=198)
Leakage onto clothes (n=198)
Preventing usual activities (n=195)
Severity of period pain (n=195)
Tiredness (n=198)
0 20 40 60 80 100
%
□ Much less DA bit less □ About the same
The equivalent summary for the 82 women who charted periods but did not collect
showed a very similar distribution of responses, except for amount of loss. Only just
under 50% reported the period charted as less than usual in amount (compared to
80% for collectors) and more reported the period as more than usual (19% v 5%).
6.3.2.iii Product use by degree of soaking
Women were asked to categorise for each product changed its extent of soaking by
rating it against pictograms showing degrees of soaking (there were two separate sets
of 5 pictograms, one set each for pads and tampons). For each woman, for each day
of her period, counts were accumulated against each of the 'soaking' pictograms, of
number of products used in this way. The daily counts of each type were then
totalled over the whole period. The summarised counts of product use/soaking are





Figure 6.12 Separately for (a) tampons and (b) pads: number of products
used by degree of soaking, separately by combinations of products used
('degree of soaking' is as represented by pictograms, with the 5 columns left to right
representing in order none/minimal to completely soaked)
a) SOAKING OF TAMPONS
PRODUCT USE
b) SOAKING OF PADS
PRODUCT USE
Women were categorised in terms of combination of sanitary protection used, as
users of tampons only, pads only, or both types of product. For the 23 women who
used only tampons, all their product use is reported in graph (a), and for the 152
using pads only, all their product use is reported in graph (b). However for the 120
women using both types, their total product use is reported partly (that is, with
respect to tampons) in graph (a) and the rest, pads, in graph (b). It can be seen that
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women using tampons tend to report a relatively high number of completely soaked
tampons, even more so if they use pads as well. In contrast, in the case of pads,
completely soaked pads are relatively seldom reported.
The counts summarised in Figure 6.12 give an idea of the numbers of products with
each degree of soaking, over the study group, but do not give an insight to individual
profiles of soaking of products used. To achieve this each woman's reported
product/soaking counts were expressed as percentages of the total number of
products she used.
Figure 6.13 is a box-plot summary of these percentages, for women who used both
pads and tampons. It can be seen that in most individual profiles completely soaked
pads were relatively uncommon (median 0%) but completely soaked tampons were
the most common (median percentage of total products used, 20%). However, there
were women with different profiles, for example the woman with over 70% of all her
products categorised as heavily soaked pads.
Figure 6.13 For women using both pads and tampons, box-plot summary of
individual profiles of product type/soaking: individual percentages of each













Figure 6.14 shows the corresponding product-use profiles separately for women
using pads only or tampons only. It can be seen that among women using pads only
there are also relatively few pads that are completely soaked (Figure 6.14a) - median
0% for those using fewer than 25 pads, and median 7% among those using more.





DEGREE OF SOAKING OF PADS & TAMPONS
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Figure 6.14 For women using (a) pads only or (b) tampons only: box-plot
summary of individual percentages by degree of soaking, out of total number
of products used, plotted separately for those with total number of products
25 or less, and more than 25. (For each cluster of five 'boxes' the degree of
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There were a number ofwomen with profiles differing from the group average, in
particular a number with very high percentages of completely soaked pads (including
two over 60% and one over 80%). There was also one woman who reported every
pad she used as corresponding to the middle pictogram (moderately soaked), giving a
percentage of 100%. For women using tampons only, the most common degree of
soaking recorded was 'completely' - median 28% for those using 25 or fewer
tampons, 34% among those using more than 25 tampons.
Comparison of Figures 6.13, 6.14a & 6.14b shows that the profiles ofproduct
soaking differ according the combination ofproduct types used - pads only, tampons
only or both product types. For pad only and tampon only users, Figure 6.14 shows
that the median profiles were very similar between the subgroups of women using
fewer or more products. The same was observed for women using a combination of
pads and tampons (not shown). The profiles of product use/soaking were also similar
between the two centres (not shown).
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6.3.3 Estimating menstrual volumes from chart data
6.3.3-i Predicting total menstrual fluid volume from chart data
Linear regression analysis was undertaken to examine the potential for prediction
(estimation) of total menstrual fluid volume (logged) from chart data on products
used. In the first instance all 206 women with values for total fluid volume and the
menstrual chart were included in the analysis, and numbers ofproducts of each of the
various degrees of soaking, as summarised in Figure 6.12, were entered into the
analysis as they were. For this analysis there was no improvement in the model due
to including centre in the model. The only product-usage data required in the model
to predict total fluid volume were the counts for the three 'most soaked' pad
categories (out of the five offered) and the counts for the two most soaked tampon
categories. Subsequent analyses revealed what the box-plots suggested, that it would
be better to log transform the counts to deal with skewness in the data. When the
regression analysis was rerun using the logged product data the same variables were
needed for the model, but the F statistic increased from 35.7 to 40.2 (df 5,200 and
p<0.001 for both). The analysis results for this are shown as the first analysis column
of Table 6.6. The model was a good statistical fit, but only just over 50% of the
variance in logged menstrual fluid volume was explained by the regression on
product use/soaking data from the menstrual chart.
Since it was possible that the pictograms for pads used as secondary protection (in
addition to a tampon) may denote a different absorbed volume of fluid/blood than for
a pad used as the sole protection, further analysis was undertaken to explore the
relevance of tampon use to the modelling. This found that the value to the model of
some product use did differ by whether the woman was a tampon-user or not, in
particular that use of the second-most soaked category of pads contributed
additionally to the model if the woman was not a tampon user. (In effect there was an
interaction between use of pads only and the 'value' of the count ofproducts with
this degree of soaking in predicting total fluid volume of menstrual loss.) Using this
model 57% of the variance in logged menstrual fluid volume was explained by the
regression on product use/soaking data from the menstrual chart. In this model the
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significance of regression coefficient bpads3 was p=0.18, but for consistency across
models it has been retained in the model.
Table 6.6 Linear regression analyses of logged total menstrual fluid
volume on logged product use data from the menstrual chart
Analysis 1# Analysis 2*
n (included in analysis) 206 (all with data) 204 (all except 2 outliers*)
r2+ 0.502 0.566
Residual Error MS ** 0.479 0.365
F 40.2 42.7
df 5, 200 6, 197
P <0.001 <0.001
Regression coefficients Coeff. (95% CI) Coeff. (95% CI)
a 3.203 2.94, 3.46 3.169 2.92, 3.42
bpads3 0.149 0.01, 0.28 0.097 -0.03, 0.22
bpads4 0.332 0.20, 0.46 0.211 0.06, 0.35
bpads5 0.385 0.20, 0.47 0.326 0.20, 0.45
btampons4 0.252 0.03, 0.47 0.261 0.07, 0.46
btampons5 0.550 0.29, 0.60 0.534 0.38, 0.68
bpads4 * non-tampon-user 17. a. 0.227 0.08, 0.38
+ 2
R is the proportion of the variance of (log) total menstrual fluid volume that is explained
by the regression.
++
Residual Error Mean Square from the analysis of variance table for the regression
model.
#
There were three outliers in this analysis, A, D and E (standardised residuals -3.7, -5.5,
and -3.6. It was decided to exclude A (as previously excluded, see Table 6.2) and D (as
standardised residual so extreme). (Details of all outliers are in Appendix 6.1 Table
A6.1.1.)
* Three outliers were noted in analysis 2, but retained: E again (standardised residual for
this analysis= -4.2) and two new outliers F (-3.6) and G (+3.1). G had very high fluid
and blood volume (total fluid 593mL), but contained on only24 products, whereas F had
very low volumes (18mL fluid) contained on 17 products.
The regression equation for estimating total menstrual fluid volume (TMF) using
analysis 2 is, after back-transformation:
TMF(mL) = 23.8 x(pads3)0097 x(pads4)0A3S y(pads5)0326 if using pads only
= 23.8 x(tamp4)0261 x(tamp5)°534 ifusing tampons only
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or, ifuser of both pads and tampons
= 23.8 y(pads3fmi x(pads4f2X6 y{pads5f326 x(tamp4)0261 x(tamp5)0 534
where pads 3 — 'count' ofpads rated as third pictogram of soaking degree, pads 4 =
'count' of pads rated fourth pictogram of soaking degree, and so on, and tamp4 and
tamp5 similarly correspond to the fourth and fifth pictogram ratings for tampon
soaking.
'Count' is in fact the recorded count ofproducts plus 1, to allow log transformation
(see methods 6.2.3.i). However, since the back-transformed equation is
multiplicative rather than additive, if for a particular pictogram there is no usage
recorded, the zero count plus 1 is just 1, and so regardless of the power indicated in
the equation the multiplier due to that term in the equation is just one. Hence in
estimation for such a period there is no change to the predicted volume due to
products of that type and that degree of soaking, despite the zero count having been
increased to 1. This arithmetic fact also explains the simplification of the equation in
the case ofwomen using pads only or tampons only. Note that the power to which
pads4 is raised differs depending on whether tampons are used or not.
Examination of the formulae shows that for women using pads only the key
determinant of the estimated volume is the number ofpads almost soaked, and to a
slightly lesser extent the number ofcompletely soaked pads. For women using
tampons only by far the most important predictor ofvolume is completely soaked
tampons. For women using both types ofproducts the key predictor is the number of
soaked tampons and to a lesser extent the number of completely soaked pads.
Figure 6.15 shows for analysis 2 ofTable 6.6 a scatter-plot of the total fluid
volumes as estimated from chart data, plotted against the volumes as measured.
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Figure 6.15 Scatter plot of fluid volumes estimated from chart data, against
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6.3.3.M Estimating menstrual blood volume from chart data
Linear regression analysis was also undertaken to examine the potential for
prediction (estimation) of menstrual blood volume (logged) from the chart data on
logged counts ofproducts used for each of the various degrees of soaking, as
summarised in Figure 6.12. In the first instance all 207 women with values for blood
volume and the menstrual chart were included in the analysis. For this analysis it was
necessary to include centre in the model to improve fit. The product-usage variables
required in the model to predict blood volume were the same as those required for
the prediction of total fluid volume (Table 6.6 analysis 2), plus pcids3 (which in the
total fluid prediction was not statistically significant at conventional levels of
significance, but was retained in the model). The interaction term was also required.
The regression statistics and coefficients are presented in the first analysis column of
Table 6.7.
Chapter 6: Quantifying Menstrual Loss 217
Table 6.7 Linear regression analyses predicting logged blood volume
Independent variables for regression analysis
Chart data only # Including Total Fluid volume ~
n (included in analysis) 207 (all with data) 204 (all except 1 with missing
fluid volume & 2 outliers*)
R2t 0.577 0.821




Regression coefficients Coeff. (95% CI) Coeff. (95% CI)
a 2.892 2.5, 3.3 0.217 -0.17,0.61
bcentre -0.415 -0.61,-0.22 -0.403 -0.53, -0.28
bpads3 0.143 0.004,0.28
bpads4 0.198 0.03,0.36
bpads5 0.359 0.22, 0.50 0.085 -0.004, 0.17
btampons4 0.316 0.09, 0.54
btampons5 0.600 0.43, 0.77 0.205 0.104,0.304
bpads4 x non-tampon-user 0.314 0.14, 0.48 0.158 0.071,0.245
b|n(total fluid volume) n.a. 0.860 0.768, 0.951
+ R2 is the proportion of the variance of (log) total menstrual fluid volume that is explained
by the regression.
++
Residual Error Mean Square from the analysis of variance table for the regression
model
There was one outlier in this analysis, G again (see Table 6.6). It had standardised
residual 3.37 and was retained. (Details of all outliers are given in Appendix 6.1 Table
A6.1.1.)
* Two outliers were excluded and the analysis re-run - D (again, see Table 6.6), with std.
residual here of 5.6, and H (std. residual -3.7) which had an extremely low blood: fluid ratio,
possibly because the very low optical density for menstrual solution was an error.
There was one outlier in this analysis, K (standardised residual 3.19). It was retained.
It can be seen that the model was a good statistical fit, and 58% of the variance in
logged menstrual blood volume was explained by the regression on centre and
product use/soaking data from the menstrual chart. The regression equation for
estimating menstrual blood volume for Glasgow is, after back-transformation:
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Bloodo(mL) = 11.9 x(pads3)0143 x(pads4)0 502 *(pads5)0 359 if using pads only
11.9 x(tamp4)0316 x(tamp5f600
or, ifuser of both pads and tampons
if using tampons only
11,9x(pads3)0143 x(pads4)0 l9g x(pads5)0 359 x(tamp4)0 316 x(tam/?5)° 600
where pads 3 etc. are logged counts as explained above.
The term in the regression equation for centre, additive on the logged scale, back-
transforms to a multiplicative term in the original scale. So the corresponding
equations for Edinburgh, for all three product-type-usage groups, can be obtained
directly from the Glasgow formulae above, by multiplying by the (back-transformed)
factor indicated by the regression model. That is,
BloodE(mL) = 0.66 x BloodG(mL)
That is, for the same product use/soaking, an Edinburgh estimate of blood volume is
66% of the corresponding Glasgow estimate.
Figure 6.16 shows for the first analysis of Table 6.7 a scatter-plot of the blood loss
volumes as estimated from chart data, plotted against the measured blood volumes.
Figure 6.16 Scatter plot of blood volumes estimated from chart data, against
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6.3.3.iii Estimating menstrual blood volume from chart data and total fluid
volume
Since both the total menstrual fluid volume and the menstrual chart record are easier
to obtain than the measured blood volume, further linear regression analysis was
undertaken to explore the possibility of using these in combination to predict
(estimate) menstrual blood volume.
Initially all 206 women with values for blood volume, the menstrual chart and total
fluid volume were included in the analysis. For this analysis also it was necessary to
include centre in the model to improve fit, but with total fluid volume included in the
model the only product-usage variables required were the counts ofcompletely
'soaked' pads and tampons, and the interaction term that had been included before,
pads4 for women using pads only. The regression statistics and coefficients are
presented in the second analysis column ofTable 6.7. The model was a very good
statistical fit, with 82% of the variance in logged menstrual blood volume explained
by the regression on centre, logged total menstrual fluid volume and product
use/soaking data from the menstrual chart. The regression coefficient for completely
soaked pads (pads5) just missed statistical significance at the conventional level
(p=0.06) but has been retained in the model.
Using the second analysis model ofTable 6.7, the regression equation for estimating
menstrual blood volume for Glasgow is, after back-transformation:
BloodG (mL) = 0.8 y{pads4f 1 38x(pacfc5)° u85 x(totalfluid)0 i6v if using pads only
= 0.8 x-(tamp5)0 205 x(totalfluid)°860 if using tampons only
= 0.8 x (pads5)0 <m x (tamp5)0 205 x(totalfluid)°860 ifusing both
where pads 3 etc. are logged counts as explained above.
As before, the corresponding equations for Edinburgh, for all three product-type-
usage groups, can be obtained by multiplying by a factor derived by back-
transformation, for this model 0.668 (rather than 0.660 in the preceding model):
Bloode (mL) = 0.668 x BloodG
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Therefore, for periods with the same measured total fluid volume and the same
profile of use/soaking of sanitary protection, Edinburgh estimates ofblood volume
are 67% of Glasgow estimates.
Figure 6.17 shows, for the second analysis of Table 6.7, a scatter-plot of the blood
loss volumes as estimated from chart data and total fluid data, plotted against the
blood volumes as measured.
Figure 6.17 Scatter plot of blood volumes estimated from chart and total fluid




























6.3.4 Comparison of models estimating menstrual blood volume
For the three models for estimating blood volume, from total fluid alone (Table 6.2),
chart data alone (Table 6.7 column 1) and from both (Table 6.7 column 2) can be
compared in terms of R , the proportion of the variance in logged blood volume
explained by the regression. For the three models R2 was 74%, 58% and 82%
respectively. The interpretation of this is that total fluid volume is the best predictor
of the volume of the blood component of the period, but prediction can be improved
by including prospective menstrual chart data. Considering use of predictive models
in the case of individual patient, the models can also be compared in terms of the
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residuals of the observed values minus the fitted (estimated values). Figure 6.18
presents the residual by predicted value plot, overlaid for the three models. The
residuals for the model predicting blood from fluid only were derived from the model
using only data points with total fluid volume greater than 80mL. The residuals for
the model using only chart data are most dispersed about the zero line. It can be seen
that when both chart data and total fluid data (including data points with total fluid
<80mL) are used the residuals are closer to the zero line, and fairly evenly dispersed
on either side for the line for the range of predicted values.
Figure 6.18 Plot of residuals versus predicted values (both on the log scale)
for three regression models for predicting ln(menstrual blood
volume): (i) Total fluid >80mL (n=139), (ii) chart data (n=207)
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Figure 6.19 presents separately for the three models, the median and inter-quartile
range for the estimated blood volumes for periods with measured blood volumes
categorised into four subgroups: <50mL, 50 to 79mL, 80 to 119mL, >120mL. The
blood volume bands are demarcated for estimated volumes by the horizontal lines. In
each case the unshaded area is the region within which all estimates would fall, for a
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perfect model. For the fluid only model, no median (1QR) estimate is plotted for the
lowest blood loss grouping, as the relevant total fluid loss volumes were on the
whole excluded from that model. If estimates were made they would be unlikely to
be unbiased or precise. However, the two models using chart data provide accurate
estimates in this grouping. For the next blood band up the 'chart data only' estimate
is fairly good, but the estimates are even better when total fluid volume data is used.
For the 80mL to 120mL band the estimates are on the low side for all models, but
considerably better for the fluid only model. For the highest losses estimation is best
by models involving total fluid. These judgements are possibly over-optimistic as the
estimates pertain to the same data as was used to derive the models.
Figure 6.19 Median (IQR) for estimated blood volumes, for periods grouped
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MODEL FOR ESTIMATING BLOOD VOLUME
Considering the 80mL criterion for menorrhagia, the total fluid model correctly
estimates 97% and 79% respectively of the first two blood loss groups as being less
than 80mL, and 67% and 91% of the second two groups as being over 80mL. For the
combined model the corresponding percentages are 99%, 79%, 44%, 92%. The same
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6.4 DISCUSSION
6.4.1 Quantification of menstrual loss
Our study is the first to measure menstrual loss in routine patients referred to a clinic
with heavy periods, rather than women selected for clinical trials. Collectors' periods
have been quantified in three ways. Firstly, total menstrual fluid volume was
measured by weighing of menstrual collection (and subtracting dry weight of
menstrual products used). Secondly, the volume of the blood component of the
period was obtained by laboratory assay, involving soaking of the collection in
sodium hydroxide (NaOH), spectro-photometric assessment of the optical densities
of the soaking solution and a solution of venous blood, and calculation of blood
volume from the optical densities and the volumes ofNaOH used. Finally,
prospective reporting, in a menstrual chart, of products used and their degree of
soaking, against 5 pictograms each for pads and tampons, offered a third approach to
quantification of menstrual loss. Chart data are easiest to obtain, total menstrual fluid
volume is next easiest to obtain, and blood loss determination is a resource intensive
laboratory procedure. Since the clinical definition of menorrhagia involves the
volume of the blood component of the menstrual loss (>80mL), the gold standard for
assessment of menorrhagia is laboratory blood volume assessment, typically by the
method of Hallberg (Hallberg & Nilsson 1964). It was intended to evaluate the total
fluid and the chart data as alternatives to determination of blood loss volume.
6.4.2 Blood loss determinations
It was therefore of considerable concern that the blood volumes obtained in Glasgow
were substantially higher than in Edinburgh (medians 65mL and 41mL respectively),
when both laboratories were evaluating blood loss by the Hallberg method (Hallberg
& Nilsson 1964). While the difference in average blood volumes could have been a
true difference in the patient populations, this was thought to be unlikely, because of
the similarity in total fluid volume distributions between the two centres, and in
product use/soaking profiles. Experimental and theoretical research was undertaken
to seek a methodological explanation of the difference in blood loss volumes, and
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this work will be reported and discussed in Chapter 7, together with a general
consideration of measurement issues for all three methods. For the purposes of the
present chapter all regressions were undertaken in the first instance with centre as an
independent variable in the model, to allow for adjustment for between-centre effects
in the relationship between the dependent variable (blood volume say) and the
independent variable(s). Centre proved to be necessary in all models involving blood
volume.
6.4.3 Estimating blood volumes from other measures
6.4.3.i Using total fluid volume
The model for predicting blood volume from totalfluid volume was a good fit,
although the percent of the variation explained by the regression (70%) was less than
in Fraser's analysis (86%) (Fraser et al. 2001). However, that study involved
weighing ofevery product prior to use, whereas the present study sought to use
methods that could feasibly be employed in routine clinical assessment.
6.4.3.ii Using chart data
The model for predicting blood volume from the chart data did not capture as much
of the variation in blood volume (58%). Interestingly, to enable prediction ofblood
volumes the counts ofproducts used by degree of soaking needed to be log
transformed. This means that a simple summation of scores for each product
recorded, as has been used in other published research, would be sub-optimal
(Higham et al. 1990; Hurskainen et al. 1998; Janssen et al. 1995; Wyatt et al. 2001).
This is possibly why Higham's chart does not in fact claim to estimate blood volume
itself, but simply provides a PBAC score which is increasingly biased/unreliable at
higher volumes (Higham et al. 1990). The utility claimed for the method is that if the
PBAC score is > 100 this 'predicts' a blood volume greater than 80mL, but if the
volume is greater than 80mL the PBAC does not inform in any interpretable way as
to the whether the volume is, say, around 90mL, over 160 mL, or over 240mL. A
validation study was undertaken with Higham's chart and it was found to perform
poorly compared to the founding study, with generally high chart scores which did
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not agree with the measured blood volume (Reid et al. 2000). Higham's original
study involved patients referred to a gynaecology clinic being assessed with a view
to participation in a treatment trial, whereas the validation study involved volunteers
recruited by advertising, and patients referred by GPs who had been informed about
the study (Higham et al. 1990; Reid et al. 2000).
There were two further features of interest in the analysis. The first feature was that
the model presented here took no account of the first two pictograms. One was an
extra pictogram relative to the Higham chart (Higham et al. 1990), denoting minimal
spotting, so its irrelevance to prediction was expected. However, products
categorised thus remain 'products used', so this finding does confirm the difficulty
for clinicians in trying to estimate menstrual blood loss by enquiring as to total
number of sanitary products used in a period. The second pictogram not required in
the model was one that would have scored 1 per product in PBAC (Higham et al.
1990). As some women recorded many such products these could have made a big
difference to the total score ifPBAC was being implemented. However the present
analysis found they make no useful contribution to volume estimation. The second
feature of interest was the need for an interaction term in the regression model. That
is, the relevance of'heavily soaked' pads differed depending on whether the woman
used pads only, or pads with tampons, with the contribution being more if she did not
use tampons. A possible explanation for this is to do with the relationship between
the surface area of the blood stain, and the volume ofblood. When blood leaks out
around a tampon it may spread more across the surface of the pad, rather than soak
down, and so may represent a smaller volume of blood for the same (size) pictogram,
than if it was a pad worn as the only protection. That is, it would not be as 'heavily
soaked' as it appeared from the surface staining. This, the size of the 'stain' (as
represented by the pictogram) relative to the volume of blood involved, raises a
broader measurement issue. Even a fully-soaked pad may vary hugely in the volume
ofblood it contains, depending on whether it is a regular absorbency pad or, say, a
special 'night-time' pad. This will be discussed further in the next chapter.
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6.4.4 Estimating total fluid volume from chart data
This leads to a further reflection, on the ability of the chart data to predict the total
menstrualfluid volume. There may be no logical need to estimate in this way, since
blood is the key volume and that can be obtained directly from the menstrual chart.
However, in a future re-consideration ofmenorrhagia complaint it could be that there
is realisation that total menstrual fluid volume itself might be the menstrual volume
of importance, representing as it does the woman's containment challenge. If that
was the case though, total fluid volume is relatively easy to obtain by weighing, so it
would be preferable to assess it directly.
A further issue is that the pictograms of the chart denote the extent of blood staining,
if viewed two-dimensionally, so it is unclear how women would categorise products
which were soaked but not with dark blood. However, the prediction of total fluid
volume by chart was attempted for interest, mainly to see if this could throw some
light on the differing distributions of blood volume at the two centres. In the event,
the best model for predicting total menstrual fluid volume accounted for 57% of the
variation in total fluid volume, so this was almost as successful as the prediction of
blood volume. The relative sizes of the coefficients for the pictograms were very
similar to those for the blood volume model, with slightly more weight given (than in
the blood volume model) to heavily and completely soaked tampons. However, a
striking difference was that there was no need for a coefficient for centre, since total
fluid volume could be predicted from product use/soaking by exactly the same
formula in both centres. This gives support for the growing impression that in this
study the implementation of the Hallberg (Hallberg & Nilsson 1964) method at the
two centres yielded centre-specific bias or biases in the blood loss determinations.
This will be addressed further in the following chapter.
6.4.5 Reflection on utility of menstrual charts
In the present study ifboth chart data and total fluid volume were used to predict
blood volume then the model was considerably improved, with 82% of the variation
in blood volume accounted for by the regression model. The major contributor to the
prediction is however the total fluid volume, with the only chart data required for the
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model being completely soaked tampons or, for women using pads only, heavily
soaked pads. This raises the question ofwhether the menstrual chart is worth the
resources and the additional albeit modest imposition on the patient? However, the
menstrual chart has the potential to do more than quantify the menstrual loss as it
collects, in addition to numbers, types and degree of soaking ofproducts used,
information on other aspects of the period - time-course, leakages, clots, curtailment
ofnormal activities, pain and use ofpain-killers. This could provide useful
prospective description of the period for the clinical encounter. However it should be
remembered that menstrual charting requires a high level ofcommitment from the
woman, and to do it conscientiously is a challenging task. We found that the women
least likely to produce charts to go with their menstrual collections were the more
deprived women.
Some ofthe experiences described are extreme - for example a quarter ofwomen
who collected changed 8 or more times on their worst day, one woman 13 times.
Halfof all collectors used 23 or more products for their period, representing a
considerable financial outlay, especially if using higher absorbency products, and
one woman used 78 products. Product usage was even higher for the 88 women who
charted their periods but did not collect, with a quarter of them using over 50
products, five over 80 products, and the maximum being over 120. Leakages and
cancellations ofactivities were not as prevalent as might have been expected, but
perhaps women planned their lives in anticipation of periods, and avoided accidents
by frequent changing. Absence of accidents does not necessarily denote absence of
containment challenge (nor absence of adverse impact on daily life).
6.4.6 Cycle-to-cycle variation in menstrual loss
The comparison for the collected period against usual periods in the last 6 months,
unique to this study, was very helpful to interpretation of the research data, but this
information would possibly be useful also clinically. For 80% ofcollectors the period
collected was less or much less than usual, and it is statistically very unlikely that by
random variation period-to-period one would observe such a high percentage of
women with periods less or much less than usual on the period that happened to be
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collected. One obvious explanation is regression to the mean, since symptoms may
have been at their peak at the time of consulting their GP, but by the time they
attended the gynaecology clinic, symptoms may have been subject to spontaneous
improvement. However, for periods that were charted but not collected (n=82) the
proportion experiencing periods less than usual in amount was under 50%, and these
periods should have been equally subject to this phenomenon. Another explanation
may be commencement of medication, since we could not ethically require women to
delay commencing medication prescribed by the clinician at the first appointment,
for the sake of the menstrual assessment for our research purposes. In the case of
menorrhagia, if therapeutic effect or regression to the mean was at work then it was
more evident for collectors than women charting their periods but not collecting, and
this difference was confined to amount ofperiod, and was not seen for leakage,
curtailment ofactivities, and so on. This does therefore raise the issue of reliability of
reporting. Are women more circumspect in their judgements of the amount of their
menstrual loss when they know there is to be objective validation of the volume (the
purpose of the collection)? If so, then this does not augur well for the validity of
menstrual chart estimations in the absence of menstrual collection, the purpose for
which they have been developed.
A further possible explanation is the effect of the process of charting on the woman's
experience ofher period. It was observed in PMS research that when women kept
menstrual diaries to assess their premenstrual symptoms they often reported at the
next clinic appointment that in the cycle just recorded their symptoms had not
troubled them nearly so much as before. A commonly accepted interpretation of this
phenomenon was that the process ofdiary-keeping was therapeutic for some women,
by giving them some semblance of'control' over their symptoms. It is possible that
some similar mechanism may operate in menorrhagia, especially with respect to the
emotional response to the menstrual flow. If this is the case then there may be
potential to capitalise on this psychological effect in clinical management of the
complaint. The question would remain as to why the effect was not so apparent in
non-collecting women who charted their periods. Many did wish to be helpful but
had a strong aversion to undertaking collection, and they are undoubtedly a self-
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selected subgroup. They may differ psychologically in a way that gives a different
outcome (periods judged as heavy as usual) despite the process ofcharting. Future
analyses in combination with the psychological questionnaire data may elucidate this
point.
6.4.7 Menorrhagia and blood loss volume
Higham added scores to the total PBAC score for each clot recorded, although there
has been no empirical assessment of the true blood volume equivalent to clots
(Higham et al. 1990). There have recently been attempts to further improve the
measurement ofblood volume by adjusting for blood lost to the collection, because
of clots or blood leaking into the toilet, or onto clothes or bedding (Hurskainen et al.
1998). Among 154 women recruited into a menorrhagia treatment trial the average
adjustment to volume judged necessary, based on diary recording of uncollected
menstrual loss, was an increase of 20mL. For many women the adjustment made was
a surprisingly high proportion of the blood successfully collected, 57% in one case.
The validity of the adjustments made was not demonstrated, so reassurance is
required as to the rigour of this approach (Hurskainen et al. 1998). It is difficult to
imagine a scenario whereby a woman with moderately light menstrual blood loss
could manage to lose over halfof it into the toilet or onto her clothes.
However, there is a further fundamental flaw to this activity. That is that the clinical
definition of menorrhagia is statistically-derived, based on a population distribution
of menstrual blood volumes measured without any adjustmentsfor clots or leakage
(Hallberg et al. 1966). Taking as given the conceptual validity of the original clinical
definition, it defined menorrhagia as the cut-off for the extreme 4% of the population
distribution of menstrual blood volume as measuredfrom that successfully collected
on sanitary protection. Therefore the only valid way to implement that definition is
to continue to apply it to measurements made in the same way. If in that seminal
study the measured blood volumes been adjusted up in accordance with reported
clots (and possibly also leakages) then the distribution ofblood volumes they would
have obtained would have been shifted to the right, and the resulting menorrhagia
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definition, using the same reasoning, may have been 1 OOmL, or more. Calibrating
adjusted blood volumes against the wnadjusted threshold (80mL) is meaningless.
6.4.8 Overview
In this chapter there has been examination ofestimation of blood volume by three
regression models, using total menstrual fluid volume or chart product use/soaking
data separately, and in combination. In-depth consideration of the relative merits and
demerits of these models must wait until the measurement issues have been
considered, in Chapter 7. However, one issue could be addressed now. That is the
disparity in prediction precision possible for the overall model for the data, and the
prediction possible for an individual patient. Very little of the published work
confronts the unreliability inherent in individual estimations (Higham et al. 1990;
Hurskainen et al. 1998; Reid et al. 2000; Wijma et al. 1982; Wyatt et al. 2001),
although there is one exception (Fraser et al. 2001). Generally, well-fitting regression
• ?
models can be obtained, as has been the case in the present study (R 74% or 82%).
This summarises the entire model, and reflects the fact that the model is successful at
estimating the 330mL menstrual blood volume to somewhere in that region (give or
take lOOmL), and the 20ml blood volume as somewhere in that region (give or take
15mL). However, the high degree ofbetween women variability means that
generally the individual prediction limits for a specific patient with a particular
product use/soaking profile, or a particular total menstrual fluid volume, are very
wide. Therefore, in the region where it matters clinically, by tradition around 80mL,
imprecision can render such estimation for the individual as almost pointless. Is it
clinically helpful to know that a patient's menstrual blood volume is with 95%
confidence between 40 and 120mL? Yet this is the reality behind chart-estimated
blood volume. This matter will be further addressed in Chapter 10.
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6.5 CHAPTER SUMMARY
6.5.1 Measured menstrual loss volumes
• Total fluid loss estimations were similar in Edinburgh and Glasgow (median (IQR)
l03mL (55 to 156),n=225).
• Overall 226 women had blood loss volume determinations: 91 Edinburgh collections
had median 41mL (IQR 22 to 77) and 135 Glasgow collections had median 65mL
(31 to 119).
• The between-centre difference in blood volumes but not total fluid volumes was of
concern, and led to a series of experiments/theoretical reflections which will be
reported and discussed in Chapter 7.
6.5.2 Menstrual chart completion
• Overall 295 women completed menstrual charts but 8% of collectors failed to
complete the menstrual chart.
• Collectors who did not chart were of lower socio-economic status (85% deprivation
category < 5 compared to 43% for collectors completing chart).
• Women who declined to collect their used sanitary protection, but completed charts
(n=88), used almost twice as many products as those who charted and also collected.
6.5.3 Menstrual chart description ofperiod
• Chart data provided details of products used and degree of soaking, number and size
of clots, number and degree of leakages, prevention of usual activities, associated
pain and use of pain-killers, and provided a comparison of the period charted to
periods in the last 6 months, in terms of amount of loss and other features.
• Women were most likely to commence use of sanitary protection between 7am and
10am.
• Overall 8% of women charting their periods used tampons only, 52% used pads only
and 40% used both types of products.
• Over 50% of women reported that pain, curtailment of activities and tiredness were
'the same as usual'.
• Nearly 80% of collectors reported the charted period as less or much less than usual
in amount, and over 50% experienced less leakage.
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• In contrast, fewer than 50% of those who did not collect, but charted periods,
reported the charted period as less than usual in amount
6.5.4 Prediction of blood volume from total menstrual fluid volume
• Blood volume could be predicted within centre using total fluid volumes (both
volumes logged, R2= 70%, F=165, df 2,136, p<0.001).
• However, the between-individual variability meant that the individual prediction
limits were wide. This was exacerbated, at higher losses especially, by the need for
back-transformation from the log scale. Total menstrual fluid volume of lOOmL
gave an estimated blood volume in Glasgow of 70mL (80% PI 43 to 112mL) and a
total fluid volume of 200mL gave an estimated blood volume of 134mL (80%PI 83
to 215mL).
• The estimation formulae obtained for the two centres were, after back-
transformation:
Glasgow Blood volume (mL) = 0.890 x (Total fluid volume mL)0 946
Edinburgh blood volume (mL) = 0.563 x (Total fluid volume mL)0 946
• For the same total fluid volume, blood volume estimates were therefore 37% lower
in Edinburgh than in Glasgow.
6.5.5 Prediction of menstrual loss volumes from chart data
• Both total menstrual fluid volume and blood volume could be predicted by chart data
after applying log transformation to volumes and product counts.
• The product-use information needed in the model for totalfluid volume (R2 = 57%,
Table 6.6) was only for pads and tampons matching the two most soaked
pictograms. No coefficient for centre was required, so estimates of fluid volume
would be the same in both centres for the same profile of product use/soaking.
• The model for blood volume (R2 =58%, Table 6.7 col. 1) required the same
variables as the total fluid model but also needed the count for pads corresponding to
the third-most soaked pictogram. A coefficient for centre was required, so for the
same profile of product use/soaking estimates of blood volume would be 34% lower
in Edinburgh estimates than Glasgow.
• Prediction of blood loss volume from a combination of chart data and total fluid
volume resulted in a much better fitting model (R2 =82%, Table 6.7 col. 2). The
product-use information required was reduced to only counts for completely soaked
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pads and tampons and, for women using pads only, counts for pads corresponding to
the second-most soaked pictogram. A coefficient for centre was required, giving
Edinburgh estimates of blood volume 33% lower than Glasgow estimates.
• The residuals (observed - predicted) were best behaved for heavy losses (over 80mL
blood volume), for predictions using just total fluid, and for lighter losses, for









An important issue is the reliability and validity of the available methods for
quantification ofmenstrual loss. Some errors are inevitable, but the scale oferrors
(precision) determines their utility for clinical assessment of menstrual loss volumes,
particularly with regard to management of individual patients. Furthermore, if
implementations of the same method at different clinics can lead to disparate results,
then this undermines the entire notion ofa universal clinical criterion for
menorrhagia in terms of absolute volume, such as the 80mL. Such a situation would
also make very difficult the synthesis of research findings across studies, and hence
ofconsolidation of the evidence base. In the first instance there is a need to explore
the extent to which there may be errors or biases affecting the fluid volume
determinations in the present study. If there are systematic biases then efforts must
be made to try to establish whether they could be a result of factors operating at the
collection stage or in the laboratory. In addition there is a need to extrapolate from
findings in this study to consider menstrual loss measurement generally.
Care was taken to avoid errors at the collection stage by the nurses providing women
with explanation of the requirements of the collection, with written instructions, and
with a contact telephone number in case extra guidance was needed. In an effort to
obtain a broad description of the woman's experience ofher period and its
containment, the menstrual chart requested a detailed record ofboth usage and
changing of menstrual protection, and of associated symptoms. Cross-referencing the
menstrual chart to the collection would enable some check of individual success in
collecting and recording the collection. Findings for these checks will be reported in
this chapter. Efforts were also made to minimise errors arising at the laboratory
measurement stage. Glasgow had a blood loss measurement protocol in operation,
and a protocol also following the Hallberg method (Hallberg & Nilsson 1964) was
set up in Edinburgh. The study nurses were appropriately trained to comply with
these protocols. Quality checks were undertaken to assess the measurement of tests
collections. The findings for these will be reported in this chapter.
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In 6.3.1.iii it was reported that Glasgow collectors tended to have higher blood
volumes than Edinburgh collectors. This may not have been a result of measurement
bias, as it could have been due to the referral case mix of the main Glasgow clinics
involved in the study, which may have comprised more women with excessive
menstrual blood loss. However, the regression model fitted Edinburgh blood
volumes at 37% lower than Glasgow, across a range of observed total menstrual fluid
volumes (see 6.3.1.iii). The percentage that blood comprised of the total menstrual
fluid volume of each collection was higher in Glasgow than had been found in
previous research, whereas in Edinburgh it was lower, with mean percentages blood
by volume of69% and 46% respectively. Previous research had found that the mean
percent blood loss varied only marginally, from 48% to 50%, over the range of
menstrual losses from moderately light to very, very heavy, (at the upper limit, with
blood volumes greater than 600mL) (Fraser et al. 2001). Taking the constancy of
average percentage blood in menstrual loss as a given, there was thus a need for
investigation as to the possible causes of the difference in percentage blood loss
estimates at the Edinburgh and Glasgow centres. The blood percentage could be
biased upwards ifeither the total fluid measurement was biased downwards, or the
blood volume measurement was biased upwards. It was felt that the latter (more
complex) measurement process was more likely to have resulted in between-
laboratory differences. A further indication that the problem lay with blood loss
determinations was that the regression model estimating total menstrual fluid volume
from chart data required no coefficient for centre, whereas the model for estimating
blood volume form the same chart data did require a centre coefficient, (see 6.3.3.i &
ii).
Discussion established that there were a number ofways in which the methodology
used in this study differed from that detailed by Hallberg (Hallberg & Nilsson 1964),
and in addition that there were a number of differences between the two centres in
the interpretation/adoption of the Hallberg method. There were two methodological
concerns:
■ To what extent might methodological variants explain the disparity between the
two centres in percent blood determinations?
238 Menorrhagia Reconsidered
■ To what extent does the method actually used at either centre qualify as blood
loss measurement 'by the Hallberg method' (Hallberg & Nilsson 1964)?
This chapter will report a number of investigations and experiments that were
undertaken to try to elucidate the between centre differences in percentage blood
loss.
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7.2 METHODS FOR THIS CHAPTER
7.2.1 Procedure for measurement.
7.2.l.i Menstrual Blood loss.
The procedure described by Hallberg for ascertaining blood volume has been
described in 6.2.1.ii. Hallberg's paper (Hallberg & Nilsson 1964) recommended
calculating menstrual blood volume via circulating haemoglobin and haemoglobin in
the collection. However the formula used in the two centres undertaking blood loss
determinations for this study is the much more widely-used one, calculating directly
from optical densities (Newton 1977). For each collector the volume ofher blood
there must have been in her menstrual collection is calculated by taking the ratio of
the optical densities (absorbances) of the two solutions in NaOH of her blood
(venous and menstrual collection), each factored up by the dilution volumes of
NaOH added. The formula most usually applied to calculate blood volume of
menstrual loss collected is:
Blood (mL) = Optical Density!products) x Soaking Vol. NaOH x Dilution factor
Optical Density(venous blood) x 'Dilution' of venous blood
where 'dilution' is the volume to which 1ml venous blood is diluted, and 'dilution
factor' is the factor by which 1 ml of supernatant solution is (secondarily) diluted up
with NaOH. For example, if the factor is 10, then ImL of supernatant is diluted to
lOrnL with additional NaOH. This addition to the standard formula involves a simple
proportioning up of the calculated volume to compensate for the dilution of
supernatant prior to spectro-photometry. In Glasgow, there was in most cases
secondary dilution of the soaking supernatant, prior to spectro-photometric
assessment.
Reflection and detailed discussion of the blood loss measurement protocols in the
two centres identified the following differences in method between the centres:
a) Different tubes were used to collect the venous blood sample - orange cap
(standard) or purple cap (heparinised tube).
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b) Different dilutions of venous blood were used prior to measurement ofoptical
density (absorbance) of venous blood - Edinburgh used 1 in 100 (as per
Hallberg) whereas Glasgow used 1 in 200.
c) Collections waiting to be measured were stored in a freezer in Edinburgh but in a
refrigerator in Glasgow.
d) Different methods of filtration were used for the supernatant soaking solution -
in Edinburgh two standard filter papers and in Glasgow one stiffened filter paper.
e) Glasgow further diluted the supernatant prior to measuring optical density
(absorbance), but this was only relatively seldom the case in Edinburgh. The
rationale for secondary dilution is that provided no bias or random error is
introduced in the dilution stage, estimation via photometric measurements will be
more accurate if the two samples being tested are of similar concentration. (There
was at the time no explanation for this, but as has since been established (and will
be described in Appendix 7.6) this would avoid distortion due to any non-
proportionality in the relationship between concentration and optical density).
Other factors pertinent to the need to dilute the supernatant would be the volume
ofblood in the collection, and the initial volume ofNaOH used to soak the
collection.
In addition it was established that on occasion pressure ofworkload meant that
products were left soaking longer than 48 hours. This may have been more the case
in Glasgow than Edinburgh.
7.2.1.ii Total Fluid loss.
The procedure for measurement of total fluid loss has been described in 6.2.1.ii.
Total fluid volume is obtained by subtraction ofdry weight of sanitary products from
the wet weight. Where non-standard pads were used their type was ascertained, and
individual products weighed to obtain a dry weight per product to use in calculations.
Menstrual blood volume and total fluid volume were two independent measurements,
and total fluid volume was known to be potentially error-prone. Possible contributors
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to measurement error and/or bias for total fluid volume could be envisaged as
follows:
■ Unpredictable errors - variability in dry weight of products as manufactured;
failure in calibration ofweighing scale used; transcription error when recording
the weight displayed on the scale used; error in recording count ofproducts used
on the menstrual chart; and use ofunknown non-standard products.
■ Biasing fluid measurements upwards - accidental wetting ofproducts (for
example by showering); and incorporation into collection bag of any wrappings
or toilet paper.
■ Biasing fluid measurements downwards - evaporation due to imperfectly sealed
bags.
■ Bias in unknown direction - change over the time course of the study in
manufacturing specification for standard products.
7.2.1.iii Menstrual Chart.
The menstrual chart provides a prospective record of the woman's experience of her
period, including the number of sanitary products used and the degree of soaking of
each. The number of sanitary products in the collection was checked against the
number ofproducts recorded in the chart.
7.2.2 Laboratory and theoretical exploration of methodological issues
in measurement of blood and total fluid volumes
7Z.Z.'\ Quality check on measurement of blood and total fluid
Quality checks on the volume measurements were undertaken at the two centres.
This was a considerable organisational and laboratory exercise. 'Test' collections
were initially created using out-of-date stored blood from the Blood Transfusion
Service. However, this simulation failed because the haematocrit of stored 'blood' is
typically 50 to 60%, relative to a standard haematocrit of 35 to 40% for women of
reproductive age. Further discussions with the Blood Transfusion Services
established that there was the possibility ofobtaining sufficient fresh 'whole blood'
to run a quality check. There were patients who attended regularly because they
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needed therapeutic venesection, and some of these had consented for their blood to
be used for research purposes. This enabled the first Quality Check to be made; this
described in Appendix 7.1.
7.2.2.H Experimental evaluation of factors related to blood volume
measurement differences by centre
Two factorial experiments were designed to try to evaluate the relevance to blood
loss determinations of the method variants identified above (except
refrigerator/freezer storage). Experiment 1 evaluated the effects ofvenous sample
tube and dilution, and soaking time, and Experiment 2 evaluated the impact of actual
menstrual blood loss volume, volume ofNaOH used for soaking, filtration method,
and subsequent dilution of filtrate on determination of menstrual blood volume.
These are described in Appendices 7.2 and 7.3 respectively.
7.2.2.iii Repeated quality check on blood and total fluid volume measurement
The second Quality Check is described in Appendix 7.4.
7.2.2.iv Reflection on impact of menstrual loss volume on accuracy of
estimation of menstrual blood loss
A further methodological error was detected by my examination of the formula for
calculating blood volume. The method as described by Hallberg (Hallberg & Nilsson
1964) assumes that the used sanitary products have been allowed to dry out. The
formula derived from Hallberg's work (Hallberg & Nilsson 1964), and widely-used
in menstrual collection studies, makes no correction for the volume of the menstrual
blood loss contained by the sanitary products. This may have minimal effect if the
collection has dried out, although this has probably not always been the case in past
research studies, as the best way to avoid odour is to keep the collection in a tightly
sealed container or bag, right up until covering with NaOH, ifpossible in a fume
cupboard. Where there was an intention to avoid evaporation altogether, as in the
present study, the conservation of the full menstrual loss volume has the potential to
render the estimation formula inaccurate for purpose ofcalculating menstrual blood
loss, giving a bias towards underestimation ofblood volume.
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Appendix 7.5 shows that if the menstrual collection has been stored so as to prevent
evaporation, then to allow for the volume ofmenstrual blood loss added to soaking
solution, the formula used to calculate blood volume should be (formula (v)):
Blood Vol. adj. for bid. vol. (ClL) QDmenstrual solution X V'ni x s
[ODyenous X Vv] — [ODmenstrual X s]
where Vm = initial soaking volume ofNaOH, Vv - volume to which lmL of venous
blood is diluted with NaOH, s = secondary dilution factor (the volume to which lmL
of soaking supernatant is further diluted with NaOH), and the ODs are the optical
densities of the venous and menstrual solutions. The term printed in bold in the
denominator is the elaboration of the standard formula to adjust for the menstrual
blood volume in the collection.
The fact of underestimation due to wet blood volume has since been confirmed by
reading Eijkeren, who noted the effect when undertaking methodological studies on
pads directly after adding known amounts of blood (that is, while still wet) (van
Eijkeren et al. 1986). However the adjustment formula provided can be used only
for known amounts ofblood added to products, and not for wet menstrual collections
ofunknown blood volume (van Eijkeren et al. 1986). Furthermore, with wet
menstrual collections blood is not the only liquid volume added, since the menstrual
blood volume comprises on average only half the total fluid loss volume for the
period, as has been shown by Fraser (Fraser et al. 2001). The formula taking total
period into account would be, as shown in Appendix 7.5 (formula (vi)):
Blood Vol. adj. for total vol. (mL) — ODmenstrual solution X Vm X S
[ODyenous Vv] [2x ODmenstrual X S]
Since the adjustments to the denominator are not included in the standard formula,
blood loss measurement of'unevaporated' menstrual collections using the standard
formula will underestimate the blood loss volume. Appendix 7.5 derives formulae
for the extent of underestimation of the blood volume, and the formula expressed in
terms of total menstrual fluid volume (formula (ix)) is:
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Underestimation ofblood (%) = TMF mL x 100%
[TMF + Vm] mL
It can be seen that this formula has no term involving the secondary dilution factor s,
and that only the initial soaking volume ofNaOH (Vm) and the liquid volume of the
entire period (TMF) are pertinent to the extent ofunderestimation.
7.2.2.v Importance of proportionality to accuracy of menstrual blood loss
estimation formula
The formula for calculation of blood loss volume depends for its accuracy on the
assumption ofproportionality of optical density against concentration of haematin.
This is a more stringent condition than simple linearity. Figure 7.1 plots optical
densities for a range ofdilutions of the same blood, undertaken on the Glasgow
spectro-photometer. Regression ofoptical density on concentration shows that the
points are best modelled by a regression line with a non-zero intercept. This is the
case even if the modelling is confined to concentrations 0.005 to 0.010. The fact of
this non-proportionality has been noted before, in Experiment 1 (Appendix 7.2). The
two dilutions (1 in 100 and 1 in 200) tested for each of the blood samples in
Experiment 1 should have yielded optical densities that were in proportion, that is in
a ratio of2:1. Yet as was shown the mean ratio at 48 hours standing was 2.07. For
the data plotted in Figure 7.1, different regressions were obtained for different
ranges ofconcentration. The concentration used for venous blood in Glasgow was
0.005, and in Edinburgh 0.010. Modelling ODs for the lower range of concentrations
(0.005 to 0.01), as used at Glasgow, the regression model had intercept a=0.012 and
slope 6=49.3. However, if a higher range was used, 0.007 to 0.017, as common in
Edinburgh, the regression model had a=0.022 and 6=48.5. We needed to establish
what impact these non-proportional linear relationships would have had on blood
volume estimation.
Chapter 7: Measurement Issues in Menstmal Loss 245
Figure 7.1 Optical density (OD) by blood concentrations, for a range of
dilutions (double-headed arrows have been added as annotation to
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Concentration: 1mL blood / diluted volume
Appendix 7.6 derives a formula for the error in estimation of blood loss volume,
when the relationship between optical density and concentration is non-proportional,
but the standard formula (that does not make allowance for non-proportionality) is
used.
Estimation Errorstandard-allowing for non-proportionality(HlL) 3 X (ODv ODm) X S V'ni
ODv x [ODv -a] Vv
This can also be written as (formula (v)):
Estimation Errorstd. -adj. for non-proportionality(nL) a x I sVm IVI|
ODv Vv
In Appendix 7.6 it has been shown the extent of estimation error, ignoring sign, will
be related to the size of a and to the amount by which the ratio of effective NaOH
solution volumes, sVm /Vv, differs from the true menstrual blood volume M. The
error will also be inversely related to ODvenous That is, the error will be bigger for
lower optical density. For situations where intercept a is positive, then where the
specific dilutions used lead to sVm /Vv being greater than M, there will tend to be
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over-estimation, and vice versa. If a is negative the pattern ofover- and under¬
estimation is reversed.
To demonstrate the joint effect of the differing dilutions a graphical simulation will
be plotted. Taking the OD by concentration data reported in Figure 7.1, a perfect line
was fitted between concentrations 0.005 and 0.02, beginning and ending on the same
ODs as had been found in that experiment. (The reason for doing this was to
eliminate, for the purposes of this explanatory graphing exercise, the perturbations to
calculations arising from the random error in the OD measurements of Figure 7.1.)
This line had a=0.026, b=47.
Next, using these fitted values for ODs, the standard formula could be used to
estimate blood loss volume for a range of simulated collection solutions. All
simulations had haematin corresponding to 80mL blood, but diluted in various
volumes ofNaOH. Therefore the true (correct) estimation in every case would be
80mL blood volume. For the venous blood ODs the appropriate fitted values for
these dilutions were used, 0.496 (for 1 in 100 as used in Edinburgh) and 0.261 (for 1
in 200 as used in Glasgow). Using the relevant volumes ofNaOH solutions and
corresponding fitted ODs, the blood loss volumes were estimated.
7.2.2.vi Reflection on impact of laboratory error on estimation of blood
volume
The measurement ofblood loss involves a number of steps of laboratory work that
are at risk of simple technical error. If such technical errors are random then they
would tend to cancel each other out at the group level, but would contribute to an
inflated experimental error. However, there is also the possibility of bias. The latter
may occur, for example, if the technician consistently dispenses aliquot volumes
wrongly, in the same direction, as might occur if there was a consistent misreading of
the meniscus. For example, the 0.5mL of venous blood, for the venous solution, may
be dispensed consistently at under the nominal volume, perhaps under by 0.02mL
(4%). The laboratory errors that would lead to a biasing upwards of the blood loss
estimate would be:
■ Adding less than the nominal volume of soaking NaOH.
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■ Dispensing less than the nominal aliquot of venous blood (0.5mL in Glasgow,
lmL in Edinburgh).
■ Diluting the venous blood up to more than the nominal venous dilution (lOOmL
in both centres).
■ If secondary dilution is used, dispensing more than the nominal aliquot of
supernatant and/or diluting it up to less than the nominal dilution volume. For
example if diluting 1 to 5 this could be, instead ofdispensing exactly 10 mL of
supernatant and diluting it up to 50mL with further NaOH, inadvertently
dispensing 10.2mL of supernatant and/or diluting it up to 49.8mL. If both these
occur the effective dilution is more concentrated than the nominal dilution by
almost 5%.
Ifall these errors occurred in the same blood loss determination in the directions
indicated, at the level of 5% error, the effect would be multiplicative, leading to an
overall error of22% over-estimation.
Simulation analyses will be undertaken of the effects of various hypothetical
laboratory errors on blood loss determinations.
7.2.2.vii Experimental evaluation of effect, on blood volume measurement, of
rubbinq/wrinqinq
Hallberg advocated rubbing and squeezing the products after 20 hours soaking
(Hallberg & Nilsson 1964). The main reason for physical 'work' on the products
was to extract dried blood, which would be common feature in fully dehydrated
collections. The requirement in the present study to store used products in air-tight
bags after use, in order to avoid evaporation before weighing, means that the used
products in this study would have been subject to less evaporation/drying. However
there would still have been some, because this tends to happen anyway during
wearing of pads, due to body heat. The method advised by the Glasgow laboratory
was that longer soaking (48 hours instead of 20) obviated the need for the use of a
stomacher to mash the products. It was therefore some surprise to be told, when
further deliberating the discrepant blood loss measurements for Edinburgh and
Glasgow, for Quality Check 1 (Appendix 7.4), that Glasgow used manual squeezing
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and rubbing ofproducts to ensure maximal extraction ofblood. Therefore
Experiment 3 (described in Appendix 7.8) was designed to enable the Edinburgh
nurse to ascertain the improved extraction that is possible with squeezing and
rubbing products.
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7.3 RESULTS
7.3.1 Measurement of menstrual blood volume
7.3.l.i Completeness of collection and compliance with procedure for
measurement
Altogether 246 women agreed to collect, but 20 (8%) failed to do so, or provided
collections that were too incomplete. There was a fairly high rate of use of non-study
pads and tampons, with 34% the 226 collectors having used non-study products in
the period collected, either pads, tampons or both (median 5 (IQR 1 to 18, maximum
47, n=77)). Overall for 14% of Glasgow collectors and 21% ofEdinburgh collectors
more than a quarter of the products used were non-study products. In addition, 11
(5%) reported pads lost (and therefore incomplete collections): the number ofpads
lost ranged from 1 to 9, with median 4 (IQR 2 to 9). Out of 95 collectors who used
tampons, 3 women (3%) reported tampons lost to the collection: two women lost 4
each, and one lost 6. With regard to the requirements for calculation of blood loss
volume, for 8 women no blood sample was obtained, so a standard value had to be
used for calculation of blood volume. For one woman the blood sample was taken
later i.e. not at the time of collection. We have already reported (6.3.2.ii) that 80% of
women reported that the period collected was 'less or much less than usual'.
7.3.1.ii Treatments potentially affecting menstrual blood volume or iron
status
While not strictly speaking a measurement issue for the blood loss volume of the
period collected, use of medication is of concern with respect to quantifying the
presenting complaint. Some collectors were taking medication for their periods by
the time of the collection: 10 tranexamic acid, 5 mefenamic acid, 2 each
norethisterone, goserelin acetate and iron supplement, and 1 each oral contraceptive
pill and warfarin. The numbers were very small, and we do not know what their
blood loss volumes would have been if not medicated. Visual inspection ascertained
that the one patient taking Warfarin, one each of those taking tranexamic acid,
norethisterone and goserelin acetate, and two of those taking mefenamic acid, had
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measured blood volumes in the low range for their centre (less than 30mL). On the
section of the menstrual chart where women recorded the amount of the charted
period 'compared to usual', nearly all women taking these medications reported the
period collected, compared to 'usual', as less or much less in amount (17 out of 21,
excluding two women on mefenamic acid who did not complete this part of the
chart). However, as shown in Figure 6.10 this is very similar to the proportion of all
198 collectors (completing this part of the chart) who judged the collected period to
be less or much less than usual, (nearly 80%).
7.3.1.iii Evaluation of effects of deviation from procedure
The distributions of blood volume for subgroups of collections classified in respect
of compliance, or not, are presented in Figure 7.2.
Figure 7.2 Distribution of measured blood volume by centre and compliance






























Non-compliance was sub-classified in terms of various aspects of the procedure (2nd
to 5h columns) as problems with venous sample (not obtained, so standard value used
in calculation), taking of medication which may render volume non-representative of
complaint (albeit this was not 'non-compliance' as such), more than two products
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lost, or more than a quarter of products used being non-study products. Three
collectors from Glasgow who were both taking medication and using non-study
products have been classified into the latter category. They had blood volumes that
were higher than the overall average.
It can be seen that collectors classified as users of non-study products tended to have
high blood volumes, and this may be why they resorted to their own tried and tested
methods of containment, often very high absorbency 'night time' pads.
7.3.1.iv Exploration of methodological issues in measurement of blood and
total fluid volumes
Description of dilutions and optical density distributions in this study
As has been explained in Methods (7.2.2.iv & v) the NaOH dilutions used are
important to the accuracy and potential for bias in the determination ofblood
volume. The distributions for these are given in Table 7.1.
Table 7.1 Soaking volumes of NaOH for menstrual collection, secondary






Soaking volume NaOH (L) G 0.9 1.5 2.0 2.5 4.0
E 3.8 3.9 3.9 5.8 9.9
Secondary dilution factor G 1.0 3.5 10.0 11.0 40.0
E 1.0 1.0 1.0 1.0 2.0
Effective dilution volume # (L) G 1.0 6.0 15.0 25.0 140.0
E 3.8 3.9 3.9 5.9 19.8
* G= Glasgow, E = Edinburgh
*
Effective dilution volume = Initial soaking volume x Secondary dilution factor
Higher initial soaking volumes were used in Edinburgh, nearly twice the volumes
used in Glasgow. On the other hand, secondary dilution was rare in Edinburgh
compared to Glasgow (6% versus 91% of determinations). The strategy for
secondary dilution in Glasgow was to achieve a haematin concentration in the
menstrual solution that was very close to that of the venous solution. Therefore the
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majority ofcollections were subjected to secondary dilution, with more than half the
dilution factors being 10 or more. The high secondary dilution factors in Glasgow
meant that the effective dilutions were much greater than in Edinburgh (50% being
'effectively diluted' in 15L or more NaOH (up to a maximum of 140L), compared to
3.9L in Edinburgh (max. 19.8L)).
Secondary dilution was adopted in Edinburgh very late on in the study, and only for
collections where the optical density for the menstrual solution would otherwise be
greater than one (where there is a danger ofunreliability in optical density
measurements). There were 12 blood loss volume determinations with menstrual
optical densities greater than 1, these having been processed before this change. For a
further five soaking solutions, secondary dilution was undertaken, in each case by a
factor of2. The data recorded from four of these spectro-photometric measurements
plus two other test measurements of solutions, before and after secondary dilution,
gave six pairs of optical densities with one over 1 and the other a 50% dilution. The
regression fitted to these data (R2=0.68, F=T0.85, df=l,5, p=0.03) showed that the
undiluted optical density was on average 1.98 times the 50% dilution. This enabled
an estimate to be made of the impact ofoptical densities greater than 1 on blood
volume determination; the average effect would have been to underestimate the
blood volume by 1% (95% CI 'underestimate by 9%' to 'overestimate by 7%').
Figure 7.3 shows separately for the two centres the distributions optical densities for
venous blood dilutions and for 'effective' menstrual soaking solution (after
secondary dilution). The menstrual optical densities reflect the effective menstrual
dilutions, as shown in the bottom row ofTable 7.1.
The menstrual optical densities had a much narrower inter-quartile range in Glasgow
because of a deliberate policy to choose the secondary dilution to ensure the
menstrual optical density was as close as possible to the venous optical density. The
between-centre difference in the central locations of the distribution of venous optical
densities was due to the 1 in 200 dilution of venous blood in Glasgow, compared to 1
in 100 in Edinburgh. However, the Glasgow distribution of venous optical densities
was also more compact, despite the fact that the range of haemoglobin test results in
the two centres was similar. This is partly because ofgreater dilution. If the
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Edinburgh venous optical densities are halved, to what they would be expected to be
if a 1:200 dilution had been used in Edinburgh, then the Edinburgh and Glasgow
distributions are much more similar (Edinburgh median 0.25 IQR 0.22 to 0.28,
Glasgow 0.22 IQR 0.20 to 0.24). It can be seen that the Edinburgh venous optical
densities are marginally higher. Regression of optical densities on haemoglobin
results confirmed that the regression lines in the two centres are parallel, with
Edinburgh optical densities higher by 0.03 for the same haemoglobin.
Figure 7.3 Box-plots of optical density readings for venous and menstrual
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First quality check on measurementof blood and total fluid
The first Quality Check is described in Appendix 7.1. The fluid loss volume
measurement was satisfactory, but the blood volume measurements were anomalous.
A possible explanation was the settling of the blood in the pack, leading to
successively higher haematin concentrations in later drawn test samples. The check
would have to be re-run.
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Experimental evaluation of factors related to blood volume measurement
differences by centre
Experiment 1 (described in Appendix 7.2) showed that tube type had no bearing on
optical densities. Optical densities did differ markedly by centre and standing time to
measurement, but when the within-sample optical density ratios (lin 100 dilution : 1
in 200) were considered there was no detectable effect between centres nor across
time. There was a trend for decline in optical density ratio with time, albeit not
statistically significant in the small experiment undertaken. Optical density ratios
varied quite markedly between individual readings, such that an 80mL blood loss
collection requiring spectro-photometric assessment of two dilutions of blood
(equivalent to 1 in 100 and 1 in 200) would in 95% of such determinations estimate
the blood volume as between 65mL and 98mL. These results do not inform as to the
situation at solution concentrations outside the range of 1:100 to 1:200 dilution of
blood of normal haemoglobin content, nor in situations where very similar
concentrations for venous blood and soaking solution are compared spectro-
photometrically (say 1:150 to 1:150).
Experiment 2 (described in Appendix 7.3) showed that the double filter paper used
in Edinburgh resulted in slight underestimation of the blood volume. Since this
affected only the collection optical density, the extent of underestimation is
multiplied up if greater effective volumes ofNaOH are used, from lmL
underestimation at 4L ofNaOH to 5.2mL if the volume ofNaOH is increased by a
factor of 5. In Edinburgh, where the double filter paper was used, the majority of
determinations had 4L of NaOH, but for heavier losses the underestimation would
have been greater. This experiment also highlighted the importance ofNaOH
volumes for the menstrual soaking solution being sufficient to ensure low enough
concentrations of haematin for reliable spectrophotometer readings. For the purposes
of photometric readings the upper limit of acceptable blood concentration is 80mL
blood in 4L NaOH.
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Repeated quality check on blood and total fluid volume measurement
The second Quality Check is described in Appendix 7.4. The total fluid
measurements using standard pads and average weights were on the whole
satisfactory (within 4% of actual fluid volume). There was one aberrant estimation,
which was possibly due to a transcription error, the sort of error that could occur for
fluid or blood loss volume measurements. The blood loss measurements on the other
hand were anomalous. Blood volumes were underestimated in Edinburgh (by 5 to
16%) and overestimated in Glasgow (by 13 to 35%).
reflection on impact of menstrual loss volume on accuracy of estimation of
menstrual blood loss
The key formulae are presented in Methods (7.2.2.iv) based on the algebraic proof
presented in Appendix 7.5. The formulae show that the important volumes in
judging the extent of this bias are:
• the liquid volume of the menstrual loss contained in the products at the time of
commencing soaking, and
• the initial volume ofNaOH used for soaking.
The extent of secondary dilution has no bearing on this bias. The theoretical
underestimation is illustrated in Figure 7.4, for a range ofvolumes of total menstrual
period (blood and non-blood).
It can be seen that the greater the total volume of the period, the more marked the
underestimation (separate lines). For all lines underestimation is less marked the
greater the volume ofNaOH used for initial soaking. The thicker line represents a
total period volume that would, on Fraser's data (Fraser et al. 2001), comprise a
blood loss volume ofapproximately 80mL. For a menstrual period such as this,
underestimation of blood volume is less than 2% if a minimum of 8L ofNaOH is
used for initial soaking, and less than 4% if a minimum of4L is used. It should be
noted that if, despite air-tight storage, there has been some evaporation of the
menstrual loss from the products, then the underestimation will not be as much as
indicated by Figure 7.4.
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Figure 7.4 Percentage underestimation of menstrual blood loss volume
against volume of NaOH used for initial soaking, separately for a
range of total fluid volumes of the menstrual period.
Soaking Volume NaOH (Litres)
0 2 4 6 8 10 12 14 16
Even when there is no adjustment for total menstrual loss volume, if initial soaking
volumes are at least 20 times the total menstrual fluid volume then the estimation
error will not be substantial (that is, will be less than 5%). For example, calculating
the underestimation applying for Quality Check 2 (Appendix 7.4), the difference in
estimation in Edinburgh, if using the standard formula rather than one adjusting for
menstrual loss volume, would be to under-estimate the test collections of 70, 120 and
190mL blood volume, by only 2.8, 8.1 and 13.2mL respectively. However, for
Glasgow the under-estimation would be by 5.6, 12.4 and 26.4mL respectively. The
greater under-estimation in Glasgow is because the menstrual fluid volume has had
more impact given the generally lower initial soaking volumes ofNaOH. The
soaking volumes used in Edinburgh were 3.9, 3.9 and 6L respectively, compared to
2L, 2.5L and 3L respectively in Glasgow. The initial soaking volumes in Edinburgh
were 24, 15 and 14 times the total menstrual fluid volumes. In contrast, in Glasgow
the initial soaking volumes were approximately half the corresponding Edinburgh
volumes, so the soaking:blood volume ratios also were approximately half what they
were in Edinburgh.
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Importance of proportionality to accuracy of menstrual blood loss
estimation formula
The formula for calculation of blood loss volume depends for its accuracy on the
assumption of proportionality of optical density against concentration of haematin.
Using the relevant volumes ofNaOH solutions and corresponding fitted ODs, as
described in Methods (7.2.2.v), the corresponding blood loss volumes were
estimated. These are shown in Figure 7.5, plotted against the ratio of NaOH solution
volumes, Vm /Vv, since in this case no secondary dilution was involved.
Figure 7.5 Estimated blood loss volume when non-proportionality applies
(with positive intercept), using Edinburgh and Glasgow
approaches for venous blood sample (Vv = 100 and 200mL
respectively), for a range of simulated collections, all with
haematin corresponding to 80mL blood loss, but with differing
volumes of soaking NaOH (Vm)
Ratio (Vm / Vv)
-e—Edinburgh —•—Glasgow
-o—Glasgow (extrapolated) —Glasgow (hypothetical)
For the green and purple lines the ODs used are derived from the same model and so
have the same (positive) value for intercept a. For the Edinburgh data points, the
menstrual soaking volumes ofNaOH go from 4L to 16L, left to right, and for the
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Glasgow data, the soaking volumes for the 'solid diamond' data points are 4 to 16L,
and for the 'open circle' data points 19.2 to 32L.
As would expected from the formula for Estimation Error above, where the ratio of
NaOH solution volumes Vm /Vv is greater than the menstrual blood volume M (that
is, 80), there is over-estimation, and conversely where Vm /Vv is less than M there is
under-estimation. For both Edinburgh and Glasgow processes, assuming no random
error, the estimate is exactly correct, despite non-proportionality, if the dilutions are
such that the ratio ofNaOH solution volumes Vm /Vv is equal to M (dotted line). If
Vm /Vv is approximately equal to M then the blood concentration is approximately
the same in both solutions, so the optical densities also should be approximately
equal. This therefore confirms that approximately equal ODs should be advantageous
to estimation. It can also be seen that, for equal ratios Vm /Vv, estimates made using
the Edinburgh process are closer to the true value of 80mL (the solid black line), than
Glasgow estimates. Hence Edinburgh estimates would also be closer to the true
value for equal differences between this ratio and M (or, if using the OD formula,
between ODmenstruai and ODvenous)- This is because of the lower venous dilution used
in Edinburgh and the higher ODvenous as a consequence. Apart from this, the
estimates made by either the Edinburgh or Glasgow processes deviate more where
the ratio of dilutions Vm /Vv deviates most from the menstrual blood volume M, to
either end of the plotted green and purple lines.
Further reflections on Figure 7.5 and the methodological issues can be found in
Appendix 7.7. In practice the errors due to non-proportionality are unlikely to be
large. For the determinations in Quality Check 2 (Appendix 7.4), taking the intercept
a as 0.01, the under-estimation in Edinburgh would range from 0.8 to 1.5mL across
the three 'collections', and in Glasgow the mis-measurement would range from over-
estimation by 1.8mL to under-estimation by 2mL. If the intercept were instead 0.02
these biases would be doubled.
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Reflection on impact of laboratory error on estimation of blood volume
In Methods (7.2.2.vi) there has been reflection on the laboratory errors that could,
hypothetically, occur. The impact of errors on estimated blood volume is presented
in Figure 7.6, where the true blood loss volume of 160mL is shown by a black line.
The contribution of laboratory errors at the various stages of the blood loss
determination is shown by the extent of deviation of the estimates (coloured lines)
from the true value (black line).
The errors modelled along the x-axis are 0.2% for soaking volume (error of 4mL in
2000mL), 0.5% for venous dilution (erroneously diluting up to 100.5mL rather than
lOOmL), 5% for the venous blood aliquot (dispensing 0.48mL rather than 0.50mL),
and a combination of these. Two of the three lines model the effect of a 5% error for
the secondary dilution (using slightly more of the supernatant and/or slightly less of
the additional NaOH, similar to the example given in Methods (7.2.2.vi), so that the
effective blood concentration is 5% more than intended).
Figure 7.6 Impact of laboratory errors for hypothetical volume
determinations of blood loss of 160mL (initially diluted in 2L
NaOH, then second dilution by a factor of 16 or 32), measured
against a venous blood sample diluted 0.5mL to 100mL (1 in 200).
None Soak Venous Venous All 3
Volume dilution up 0.5ml
down 0.2% 0.5% aliquot
down 5%
Errors applying prior to secondary dilution
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Part of the rationale for this examination was to ascertain a mechanism for the higher
than expected blood volumes in Glasgow, so the figure models only errors in the
direction that would increase the blood volume estimate. A marked impact can be
seen due to under-sampling of blood in the venous dilution (last two columns of
points). These calculations use the optical density data ofFigure 7.5, derived from
the observed data ofFigure 7.1. For the blue line the (error-free) secondary dilution
is such that, provided there are no other laboratory errors, the venous and menstrual
ODs are identical, avoiding the problems ofnon-proportionality. For the other two
lines, where there is an error in the secondary dilution, the deviation from the true
value of 160ml is partly due to the error and its impact in the formula, but is also
partly due to non-proportionality. The combination of under-sampling of venous
blood in the venous blood dilution, a high secondary dilution factor (32), and an error
in secondary dilution that gives an effective concentration of menstrual blood that is
5% higher than intended, results in a blood volume estimate of 185mL. This is up by
16% from the true value of 160mL.
Experimental evaluation ofeffect, on blood volume measurement, of
squeezing products
Experiment 3 (Appendix 7.8) showed that failure to mash or squeeze the products
did lead to underestimation ofblood volume in Edinburgh, and it is possible this is
exacerbated for very heavy losses. This varied across the five tests but averaged out
at an under-estimation by 14%.
7.3.l.v Exploration of measurement effects on study collection data
In this section analyses will be undertaken to explore the potential effect on blood
loss determinations of the factors theoretically and experimentally explored in the
earlier part of the chapter. While the main concern is that blood loss volume appears
to have been subject to a centre bias, so that Edinburgh determinations were lower in
volume than those in Glasgow, there is also the question ofwhether within each
centre the blood loss measurements are correct in a relative sense. The true blood
loss volume is of course unknown, but two approaches will be taken to obtain insight
to the possibility and extent of any biases or errors that may have occurred. Firstly,
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findings will be presented within-centre by four groupings based on measured blood
loss volume: <50mL, 50 to 79mL, 80-119mL, > 120mL. Secondly, the percentage
blood will be used as an indicator of the relative accuracy of the blood volume
estimation. The underlying assumption is that the true percentage should be around
50%, as per Fraser's data (Fraser et al. 2001). However, it should be remembered
that perturbations of the percentage can arise from either of both of the numerator
(the measured blood volume) and the denominator (the total menstrual fluid volume,
which is also subject to measurement error). Figure 7.7 shows the percentage blood
loss by centre and blood loss volume. The aim of such a plot is to examine variation
in percentage blood across the subgroups. In fact, for 6% of Glasgow and 4% of
Edinburgh collectors the calculated percentage blood exceeds 100%, a logical
impossibility and thus clearly due to measurement error with respect to one or both
volumes. However, the absence of a centre effect in the regression model predicting
total fluid volume from chart data suggests that total fluid volume determinations are
subject only to random error and not centre-specific bias.
Figure 7.7 Percentage blood by volume of total menstrual loss, by centre
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One interpretation of the graph is that subgroups with higher average percentage
blood loss have relative over-estimation of blood volume, while those with lower
average percentage blood loss represent relative under-estimation. So in Figure 7.7
Glasgow collections with measured blood volume of 80mL or over appear to have
over-estimated blood volume relative to all other (Glasgow and Edinburgh)
subgroups, while Edinburgh collections with measured blood volume less than 80mL
appear to have under-estimated blood volume. If it can further be assumed that the 48
to 50% blood by volume established in Fraser's study is the true proportion, then an
absolute judgement can be made, that subgroups with average percentage notably
less than 50% indicate under-estimation ofblood volume, and subgroups with
average percentage >50% over-estimation. This would suggest Edinburgh collections
with measured blood volume <50mL may have been subject to under-estimation, and
Glasgow collections > 50mL to over-estimation, with the extent ofover-estimation
increasing with greater measured blood volume.
IMPACT OF WET VOLUME OF MENSTRUAL COLLECTION ON ESTIMATION OF BLOOD VOLUME
The potential underestimation in the study data, due to the fact that the blood volume
calculation formula takes no account of the volume of the menstrual loss added to the
soaking solution, was calculated, assuming no evaporation prior to soaking. To make
the correction, formula (ix) derived in Appendix 7.5 was used, adjusting in
accordance with the total menstrual fluid volume, ascertained by weighing. This is
shown in Figure 7.8. It can be seen that because of the lower initial soaking volumes
ofNaOH the extent of underestimation would be expected to be greater in Glasgow
than Edinburgh, and in both centres it would be greater for greater menstrual blood
volumes. This latter effect is because it is algebraically greater for greater total
menstrualfluid volumes (formula ix in Appendix 7.5), and there is a strong
association between the total menstrual fluid volume and the volume of the blood
component of the menstrual loss.
The underestimation shown in the figure would be the maximum that would apply.
Inevitably some evaporation would have occurred from the products into the airspace
in the sealed plastic bags containing them, so that once the bags were opened this
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'moisture volume' would have been lost. If after opening there had been the
opportunity for part or complete evaporation of the remaining moisture in the
sanitary products collected, the underestimation would have been less marked or nil.
However the menstrual loss determination protocols in both centres involved
weighing of sealed collection, opening, counting and initiation of soaking all
occurring within a short space of time, so evaporation should have been minimal.
Collections were sometimes stored prior to processing (still sealed, in a refrigerator
in Glasgow, in a conventional freezer in Edinburgh, so no marked difference in
evaporation anticipated).
Figure 7.8 Anticipated percentage underestimation in blood volume due to





























These calculations may help explain some of the apparent underestimation of the
higher blood volumes in Edinburgh, but are contrary to the observed between-centre
disparity. This pattern ofunderestimation would have led to Edinburgh blood volume
measurements being on the whole higher than in Glasgow, for similar total menstrual
fluid volumes.
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Impact of failures in proportionality
It has been shown that the difference in optical densities of the menstrual and venous
solutions has a bearing on estimation error when there is non-proportionality. There
was a deliberate aim to avoid substantial differences in Glasgow, which was largely
achieved, the overall median and inter-quartile range for the difference in ODs being
-0.02 (IQR -0.07 to 0.03, n=135). (See also Figure 7.3) In Edinburgh the
differences were more marked and, as would be expected from the statistics reported
above, varied by blood volume stratum. The median optical density differences, for
the lightest to heaviest blood volume strata, were -0.19, 0.25, 0.39 and 0.68 (IQRs -
0.3 to -0.1, 0.17 to 0.41, 0.2 to 0.7 and 0.4 to 0.9 respectively, n=51, 19, 12 and 9).
Since the combined effect of these various factors on estimation error is difficult to
envisage, formula (iii) presented in Appendix 7.6 has been used to estimate the
blood volume measurement error for each collection. The actual menstrual and
venous dilutions used, and the optical densities obtained for the menstrual and
venous solutions, have been substituted into the formula. The value for a used was
0.01, the value obtained by modelling the data from the dilution experiment on the
Glasgow spectrophotometer, as presented in Figure 7.1. The estimated errors in
measurement due to that degree ofnon-proportionality are shown in Figure 7.9,
separately by centre and blood volume strata.
As anticipated from the theoretical deliberations, if non-proportionality applied (with
positive intercept) Edinburgh would have tended to under-estimate the heavier blood
volumes (due to the menstrual optical densities being on the whole substantially
bigger than the venous). Also as anticipated, Glasgow would have had, on the whole,
larger errors (due to factoring up by the greater dilution ratio) in both directions,
which would have been most apparent in the heaviest losses, where greater dilution
factors were needed. Furthermore, assuming the positive intercept applied, these
errors would have tended to be over-estimations (due to the high proportion of
menstrual optical densities that were less than corresponding venous optical
densities).
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Figure 7.9 Estimated error in blood volume measurement, due to failure of
proportionality (using actual dilutions and optical densities, and non-


























In absolute terms these non-proportionality errors were on the whole within 5mL, but
if, for example, the non-proportionality applying was greater than that represented by
the a used (0.01), then the errors would be greater. So for example, if in Edinburgh
intercept a was actually 0.02, double the value used, then the errors pertaining would
be double those shown in Figure 7.9, Similarly, if the non-proportionality applying,
in the lowest range of the Glasgow spectrophotometer, was not the same as that
found in the higher range for which test successive dilution data were available, but
more marked, then the over-estimation for Glasgow would be more extreme than
shown in Figure 7.9. (This effect has been illustrated hypothetically in Figure 7.5.)
7.3.1.vi Overview of measurement of menstrual blood loss volumes in this
study
For the present study Table 7.2 summarises the features of the method, as specified
by Hallberg, and as applied in the Glasgow and Edinburgh centres. Some of the
errors and biases that have been considered are summarised in Table 7.3 in terms of
the likely effect on blood volume determination.
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Table 7.2 Detail of methods used for blood loss measurement:
comparison between Hallberg (Hallberg & Nilsson 1964) and the
two centres in the present study
Hallberg Procedure Edinburgh Glasgow
Evaporated collection Not usually Not usually
Add 2L 5% NaOH per 12/15
products
3.9L, or more as
needed, for entire
collection
2L to start, but more
added if necessary
Soak 20 hours 48 hours plus 48 hours plus
Rub, wring and squeeze products No, stirring and prodding
only
Yes






Read against 5% NaOH at 546mp Yes, but latterly dilute
further and re-test if first
OD>1*
Yes, but dilute further
first, judged visually to
an OD of ± 0.2
"From the OD reading of
haemoglobin lost at menstruation,
calculate menstrual blood loss













diluted 1 in 200.
* This secondary dilution was introduced only near the end of the study.
Table 7.3 Observed or hypothesised under-estimation/ over-estimation of
blood volume at Glasgow and Edinburgh
Edinburgh Glasgow
Unknown effect(s), as evidenced in Quality Check
2 (Appendix 7.4)
-5 to -16% +13 to 35%
Menstrual loss volume unaccounted for in formula
(Appendix 7.5)
- 4 to -7% -8 to-14%
Use of double ordinary filter paper (Appendix 7.3) - 2% approx. n.a.
Failure to squeeze/rub products (Appendix 6.3) - 14% n.a.
Hypothetical systematic dispensing errors (as in
section 7.3.1.vii)
not considered +16%
The undefined errors encompassed by the 2nd quality check (row 1) were very similar
in degree and direction to what might be expected from both use of double filter
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paper and failure to squeeze products in Edinburgh, and some systematic dispensing
error in Glasgow.
Effects due to failure ofproportionality are not included in Table 7.3 because if
proportionality fails the direction of the effect depends on the sign of the intercept.
The sign of the intercept may vary for different ranges of the optical density
(concentration) scale, from run to run, and certainly between centres (equipment).
7.3.2 Measurement of total menstrual fluid volume
7.3.2.i Compliance with procedure for total fluid collection
The percentage of those agreeing to collect who succeeded in providing a collection
has been reported above, as has completeness of collection (7.3.1.i), Use ofnon-
study pads and tampons is a particular issue since the accuracy of the estimation of
fluid volume depends on the accuracy of the calculation of the dry weight. Overall,
19% of the 95 users of tampons in the period collected (which use may be in addition
to sanitary pads) used non-study tampons (median 13.5 non-study tampons (IQR 2 to
24, maximum 43, n=l 8)). Ofthe 205 collectors who used sanitary pads at all in the
period collected, 32% used non-study pads (median 4 non-study pads in the period
collected (IQR 1 to 17 pads, maximum 43, n=65)). Where the non-study product type
was, as requested, identified by the collector, similar products were purchased so that
a weight could be ascertained for the product to use in the calculation of total fluid
volume. However, 25 women used one or more pads ofunknown type, and 7 used
one or more tampons of unknown type. Ofparticular relevance to the measurement
accuracy is the proportion ofnon-study products used.
In addition 16 women used one or more non-study plastic bags for the products. (The
research nurses weighed these.) Despite clear instruction to include only products in
the collection, 12 women included wrappers and 10 included some toilet paper.
Weights were obtained per sheet of toilet paper and included in the calculation. The
research nurses reported that in the case of 4 collections (all Glasgow) there was
urine evident on the products, and for these the percentages blood by volume were on
the low side, 21%, 31%, 33% and 58%, compared to median 68% (IQR 53% to 86%)
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for all 135 Glasgow collections. They also noted 7 collections where the bags were
not tightly sealed to prevent evaporation (5 Glasgow and 2 Edinburgh) but for these
the percentage ofblood in the collection was not high compared to the remainder of
the collections (being 27% to 71% for Glasgow, 47% to 48% for Edinburgh).
7.3.2.ii Evaluation of effects of deviations from procedure
The regression analysis of blood volume on total fluid volume (analysis 3 ofTables
6.2 and 6.3) was re-run excluding collections where there were potential
measurement issues for total fluid volume. That analysis had been confined to
collections where total fluid volume was > 80mL so this restriction was maintained
for the re-run analysis. The extreme outlier excluded from that analysis was no
longer an issue as that collection was now pre-excluded on the basis of 100% use of
non-study products. A further 39 collections were now excluded because they had a
high proportion ofnon-study products (>0.25), or used unknown products, either of
which could affect measurement of total fluid volume. This left 100 collections for
re-analysis. The regression analysis results were very similar to before, but with
■ • • 9 •
evidence of a better fit to the regression model - increased R , increased F, and
diminished mean square error. The exclusion criteria were further extended to
exclude collections for which the research nurses coded the collection as smelling of
urine or to have had unsealed bags (so subject to evaporation), or where the patient
had already commenced medication (which might have affected the proportion of
blood in the menstrual loss). A further 14 collections were excluded on this basis,
and the regression analysis rerun. The 'goodness of fit' to the model improved
further, marginally, in terms of R2 and mean square error (n=86, F= 173.6, df2,83,
p<0.001, Residual Error Mean Square = 0.112, R2 = 81% ). It was noteworthy that
for both these re-run analyses the coefficient for centre was increased, meaning that
the better-fitting model revealed a greater between-centre disparity in predicted
blood volume, for the same total fluid volume. The coefficients for the model were
such that the predicted blood volume was 70% oftotal fluid volume in Glasgow but
37% of total fluid volume in Edinburgh.
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7.3.3 Measurement issues in menstrual charts
7.3.3.i Compliance with procedure
In total 315 women agreed to complete a menstrual chart for their next period.
However, 20 (6%) did not manage to do so, or provided charts that were too
incomplete to use for analysis. The use ofnon-study products has been reported
above (7.3.2.i) and is clearly an issue for calculation of total fluid volume. This is
because the calculation involves subtraction, from wet weight ofcollection, of as
good an estimate as possible of the dry weight of products used and collected.
However, it may also be an issue for menstrual chart estimation of blood volume.
Categorisation of a used sanitary pad as 'completely soaked', by indicating it as
matching the most extreme pictogram for pad soaking, is likely to represent a rather
different volume of menstrual loss if that pad is a regular absorbency pad, compared
to if it is 'super plus' 'night time' absorbency, or even, as occurred, an incontinence
pad used for menstrual containment.
7.3.3.ii Evaluating effect on estimation of blood loss volume of use of non-
study products
Collections with more than 25% non-study products, or using special night-time or
incontinence pads (with more than double the capacity of study pads), were excluded
(n=40) and the analyses ofTable 6.7, predicting blood volume from chart data, and
from both chart data and total fluid volume, rerun. For the prediction from the chart
data only there was modest improvement in fit to the regression model, with R2
increasing from 58% to 64%. The change in coefficients showed that in the model
derived from collections not including night-time pads, greater value was given to
pads rated as corresponding to the two most soaked pictograms. If total fluid volume
was also included in the model (with the same two outliers excluded as was noted for
the corresponding analysis in Table 6.7) then again there was modest improvement
in the fit to the model (R2 increasing from 82% to 84%). There was little change in
the coefficients for product use, but a slight increase in the coefficient for total fluid
volume (presumably because the reliability of measurement of total fluid was also
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better in the subgroup selected for this analysis, with low use ofnon-study pads, and
no use ofvery absorbent, and hence heavy, products). Again it was noteworthy that
for both these re-run analyses the coefficient for centre was increased, so that the
'chart data only' and 'chart plus fluid data' models predicted blood volume for
Edinburgh at 63% and 61% ofthe prediction for Glasgow, for the same product
use/soaking and total fluid profiles. (This is indicative of less disparity between the
centres than was shown in the re-run model predicting blood from fluid data only
where predicted blood volumes in Edinburgh were 52% of volumes
predicted in Glasgow for the same total fluid volume. It should be remembered that
that analysis was confined to collections where total fluid volume exceeded 80mL, so
this is yet further confirmation that the between centre disparity is greater at greater
volumes.)
7.3.4 Exploration of effect of adjustment to blood volume
determinations
7.3.4.i Adjusting blood volume determinations for potential laboratory errors
and biases
The potential estimation errors summarised in Table 7.3 can be used to inform
potential adjustments to blood volume estimations. An adjustment was made on the
basis that Edinburgh had under-estimated blood volume by 15%, and that if there
was no secondary dilution, Glasgow had over-estimated by 6%, or if secondary
dilution had been undertaken, that Glasgow had overestimated by 15%. The
presumed scenario was that Edinburgh's underestimation had arisen mainly from
non-mashing of soaked products, and Glasgow's overestimation from some
unspecified technical process around venous dilution (6%), or from that and in
addition some unspecified error around secondary dilution (15% in total). The
adjusted blood volumes were as shown in Figure 7.10.
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It can be seen that as would be expected the central location for the Glasgow
distribution has become lower (median 56.2mL IQR 27 to 103mL) as have the
outlier volumes, whereas the distribution for Edinburgh volumes has shifted higher
(median 48.7mL IQR 25 to 90mL). The percentage blood is also more similar in
distribution across the two centres; 60.2% in Glasgow (IQR 47 to 75%) and 52.1% in
Edinburgh (IQR 39 to 65%), compared to medians of blood percentage of unadjusted
data of 69% and 44% respectively.
No adjustment was made for the failure of the formula to account for the wet volume
of the menstrual collection. The difference in initial soaking volume practices would
have meant an adjustment that increased Glasgow blood volumes relative to
Edinburgh. However, this effect would be included in the overall estimate of
measurement error provided by Quality check 2 (Table 7.3). If the true (relative and
absolute) over-estimation in Glasgow is as found in Quality check 2 (Appendix 7.4),
despite the greater under-estimation theoretically likely in Glasgow because of the
addition to the smaller soaking solutions of the wet volume of the collection, without
any allowance for this in the formula, then the implication must be that factors
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producing a systematic (relative and absolute) over-estimation in Glasgow must be
more extreme than the 6% or 15% modelled.
It has also been explained above (7.3.1.vi) that without knowledge of the intercepts
applying at the time of the photometric reading it is not possible to anticipate the
direction ofmis-estimation due to failures ofproportionality. Therefore it is not
possible to make informed adjustments for non-proportionality.
7.3.4.ii Effect on regression models of adjusting blood volume determinations
for potential errors
When the adjusted blood volumes were regressed on total fluid volume, on chart data
and on both chart data and total fluid volume (all variables logged), the regression
results were almost identical to what was reported in Chapter 6 (Tables 6.2, 6.3 &
6.7), except that the regression coefficient for centre was much reduced. Whereas use
ofactual measurements for the regression gave a model where the Edinburgh
volumes were 34% lower than Glasgow (for corresponding values for the other
dependent variables), the adjusted volumes give Edinburgh predictions only 14%
lower than Glasgow, if modelled only on total fluid volume, or 12% and 10% lower
ifusing chart data, or chart data and total fluid. In the latter two models the
coefficient for centre was no longer statistically different from zero. (The two models
involving chart data involved (almost) all collections whereas the model for
prediction ofblood volume from total fluid was confined to collections for which
total fluid volume exceeded 80mL. These would have been the collections with
generally higher blood loss volume, where the between centre disparity has been
observed to be more extreme.)
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7.4 DISCUSSION
7.4.1 Between-centre differences in blood loss volume
determinations
As has been explained in the Introduction (7.1), the main driver for this chapter
considering measurement issues in menstrual loss, was the finding reported in
Chapter 6, that the blood loss determinations in Glasgow were higher than in
Edinburgh. Concern was heightened because the percent by volume of blood in the
menstrual loss was also considerably higher, with mean percentages 69% versus
46%. This emerging concern was reinforced by regression modelling analyses after
the end of the study. Whereas the regression models to predict blood volume from
chart product-use data required a coefficient for centre (Table 6.7), the regression
model based on the same data, to predict total fluid volume from chart data (Table
6.6), did not need centre in the model. Unless some mechanism could be envisaged,
whereby Glasgow patients are more prone to menstrual loss with a higher proportion
ofblood by volume, then the unavoidable conclusion is that measurement biases
have reduced Edinburgh measured blood volumes and/or inflated Glasgow blood
volumes. Furthermore, measurements for test collections created for a quality check,
provided quite startling evidence of discrepancy. Three collections were made up
with 70, 120 and 190mL blood, to be processed at each of the two centres. The
Edinburgh volume determinations were under-estimated by 5 to 16%, while the
Glasgow volumes were over-estimated by 13 to 35%.
Examination of the blood volume measurement protocols revealed disparities in
method that might have contributed to the differences between centres in percentage
blood by volume. In particular, Glasgow used more dilute venous blood samples,
lower soaking volumes ofNaOH, and much more secondary dilution of supernatant,
while Edinburgh used different blood sample tubes and different filter paper.
Experiments were devised to test some of these factors. Use or not of heparinised
tube was found not to be important, and relative optical densities were robust to
dilution (1:100 or 1:200) and standing time of 'soaking', but type of filter paper used
was shown to lead to slight underestimation ofEdinburgh volumes. Some of the
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value of these experiments was forfeited by the use ofblood concentrations that were
too high for reliable photometric reading ofoptical densities. In particular the
possibility that secondary dilution introduced a between-centre bias could not be
fully explored.
7.4.1.1 Inappropriateness of formula for 'wet' collections
The quest for an explanation, and consideration and manipulation of the formula for
calculation of blood volume, led to some theoretical insights. One was that the
formula made no allowance for the wet volume of the collection. Application of the
formula derived to make allowance for the 'wet' collection volume showed that
underestimation would have been greater in Glasgow than Edinburgh, because in the
context of the higher initial soaking volumes in Edinburgh the added volume of
collection would have had proportionally less impact. This finding would produce a
disparity between centres that is counter to what was observed. So, while the finding
that the standard formula applies only to completely dehydrated collections is
theoretically interesting, it rather exacerbates the concern about some mechanism
producing a disparity in percentage blood between Edinburgh and Glasgow.
Nevertheless, the finding regarding the formula does raise concerns about
comparability of other research into measured menstrual blood loss.
7.4.1.ii Importance of proportionality
A further theoretical insight was obtained through examination and manipulation of
the formula describing the linear relationship between optical density and haematin
concentration. The size ofthe measurement error arising from non-proportionality
depends partly on the absolute size of the intercept (the degree of non-
proportionality), partly on how low the venous optical density is, and partly on the
difference between the blood volume and the ratio of the effective soaking volume of
the menstrual collection (taking into account secondary dilution if it is undertaken),
to the dilution volume of the venous sample. Glasgow tended to use a greater venous
dilution and therefore to have lower venous optical densities, but Glasgow also had a
strategy ofensuring the dilution ratio was as close as possible to the blood volume. If
successful and error-free, this does avoid problems of non-proportionality. However
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it also revealed that the Glasgow practice of more dilute venous blood samples
(1:200) will mean that any random error occurring in optical density readings will
have a far greater impact on the calculated blood volume. Furthermore, it is likely
that secondary dilution provides an extra opportunity for the introduction of
measurement/dispensing errors.
The problem with non-proportionality is that the direction of error depends on
whether the intercept is positive or negative, and it is not possible to know what
situation pertained at specific readings. Furthermore, the non-proportionality is
unlikely to be the same in both machines, and within machine is very unlikely to be
constant over the full range ofoptical density readings. The between-centre
difference in practice regarding venous dilution and secondary dilution of
supernatant meant that almost all Glasgow photometric readings were in the range
0.1 to 0.3, whereas Edinburgh readings were centred on 0.5, and about a quarter of
menstrual collection readings were over 0.75. Therefore, in Glasgow the secondary
dilution strategy would lead us to expect a tendency to errors in both directions,
depending on the sign of the intercept and on whether the ultimate dilution of the
menstrual solution was more or less than the venous sample. Where secondary
dilution was high or venous optical densities very low these errors would be more
marked. Therefore it would be better to use a 1 in 100 dilution for venous blood and
use sufficient soaking NaOH at the start to ensure a blood dilution in the supernatant
also of about 1 in 100. That would mean 8L NaOH for an 80mL blood loss.
Assuming the same positive intercept obtained in Glasgow as was found for test
serial dilution readings between optical densities 0.26 and 0.96, non-proportionality
might explain some underestimation in Edinburgh, but even in the highest losses
would be unlikely to account for underestimation exceeding about 5mL. In Glasgow
however, non-proportionality could not be the explanation for systematic over-
estimation.
Realisation of the importance ofproportionality, to the accuracy of the blood volume
determination, confirmed a theoretical basis for the practice in Glasgow of using
secondary dilution of the supernatant to achieve a menstrual optical density that was
very close to the venous optical density. However, the interesting feature of this story
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is that the practice of secondary dilution was implemented via a 'steps to be
undertaken' rule, without the theoretical basis being understood/known. Therefore
staff involved in the laboratory work would have been unlikely to be aware of the
potential dangers of the practice: that minute measurement errors could have
substantial impact once factored up; or that any advantages may be more than offset
if the achieved optical densities were below the optimum operating range. Similarly,
laboratory staff at the other centre had no sense of the need to ensure optical densities
were not above the optimum operating range. This situation may also pertain in other
laboratories where such measurements are undertaken, which again raises concerns
about comparability of menstrual blood loss measurements across different research
laboratories.
7.4.1.iii Maximising extraction of blood from products
The foregoing has given some theoretical explanation for modest underestimation in
Edinburgh, and for some instability in volumes in Glasgow where there were heavy
losses, but not for the extent ofdisparity between Edinburgh and Glasgow, nor for
the disparity in blood percentages, compared to Fraser's data (Fraser et al. 2001). A
potential explanation for the latter was the discovery that in Glasgow the soaked
products were rubbed, squeezed and wrung to ensure maximal extraction of blood.
Previous provision for blood volume determinations for research in Edinburgh had
involved the use of a stomacher to mash products safely while ensuring extraction of
blood into the supernatant. However, when resurrecting the laboratory service for
this study it was decided, for the sake ofhomogeneity of procedures, not to use of the
stomacher in Edinburgh, because that was not the practice for the established blood
loss measurement service in Glasgow. Unfortunately it was not realised until too late
that the Glasgow practice of'just soaking for 48 hours' also involved subsequent
manual rubbing/wringing ofproducts. So, a decision that was made with the express
purpose of increasing homogeneity in measurement across centres, had in all
likelihood contributed to some of the disparity. To gain some insight to the size of
the blood extraction deficit, the Edinburgh nurse was asked to undertake her
remaining five blood loss determinations by her usual method, and also by
subsequently rubbing/wring the products to ensure maximal extraction. It was found
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that the average underestimation, without rubbing/wringing, was 14%. Fortunately
this was likely to be a pro rata effect, so that within Edinburgh determinations would
be ordered correctly, in a relative sense.
7.4.1.iv Possible technical error in laboratory practice
In the present study the outcome of all the experiments and deliberations around
measurement issues in menstrual loss was that there were possible explanations for 4
to 20% underestimation in Edinburgh (filter paper, not mashing, and collection
volume unaccounted for in formula). For Glasgow there was some theoretical
expectation of 8 to 14% wrafer-estimation effect (collection volume unaccounted for
in formula) but no explanation for a systematic over-estimation effect. Yet as has
been summarised in Table 7.3, the simulated collections with known blood volumes
provided evidence ofover-estimation in Glasgow relative to Edinburgh of 35% to
45%, and ofover-estimation against a known blood volume of 13 to 35%.
The only mechanism that could be imagined to account for this was some technical
procedure error(s), say in dispensing/diluting venous blood, or in undertaking the
secondary dilution. It is conceivable that this could be a laboratory
(equipment/pipette) or operator specific (judging meniscus) characteristic, occurring
at only one site. Furthermore, this could be exacerbated by differences in procedure
at the two sites, since the same absolute error in dispensing the required amount of
venous blood (0.5mL in Glasgow, lmL in Edinburgh) for the venous solution, would
result in a doubled percentage error in Glasgow. Another difference in procedure
between centres was the frequency of use of secondary dilution, which was far
greater at Glasgow than Edinburgh (91% v 6%), so if a bias was introduced at this
stage it would have been essentially a Glasgow-specific effect.
Adjustments were made to the measured blood volumes at the two centres, based on
a supposed underestimation of 15% in Edinburgh, and over-estimation by 6 or 15%
in Glasgow, depending on whether there was not secondary dilution (9% of
collections), or was (the remaining collections). This caused no change to the
regression models predicting blood volume (adjusted) from total fluid volume and/or
chart data, other than in markedly reducing the coefficient for centre. This is what
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would be expected in modelling terms given that what has been imposed by the
adjustment is in effect a pre-emptive centre 'term'. Furthermore, for the adjusted
blood volume data there was no longer statistical need for a 'centre' term in the
model for prediction involving chart data (with or without total fluid). The results for
Quality check 2 (Table 7.3) showed over-estimation against a known true value of
up to 35% in Glasgow, which suggests that a more extreme adjustment, than the 6 or
15% used here, may be warranted for Glasgow data. If a more severe adjustment had
been applied to Glasgow data then the distributions ofadjusted blood volumes in the
two centres would have approached each other even more closely, even for the
higher reaches of the distributions.
7.4.1.V Overview and implications for menstrual research
For this study our intention had been to use the Hallberg method for blood loss
determination (Hallberg & Nilsson 1964), the established method applied in the vast
majority of past menstrual research involving quantification of blood volume. The
blood loss measurement service was to be provided for the study by laboratory
personnel experienced in applying the Hallberg method for clinical assessment and
for previously published research studies. However, subsequent examination of the
protocols in use in Edinburgh and Glasgow showed that the protocols differed from
each other in small but potentially important details and that they did not replicate
closely the method described by Hallberg (Hallberg & Nilsson 1964). It was also
noted that Hallberg did not in fact provide the formula used to calculate blood
volume. With the benefit ofhindsight, and of my own post hoc engagement with the
laboratory processes, which were initially left to laboratory personnel, it could be
argued that Hallberg used rather low NaOH volumes for soaking, so would have
tended to have high optical densities, with attendant unreliability. Hallberg does not
advise on dilution for venous sample nor on secondary dilution (Hallberg & Nilsson
1964).
The measurement problems that beset this study became apparent only because total
fluid volume was measured and disparities were observed between the centres with
respect to percentage blood in total fluid volume. It is very likely that in past research
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ostensibly using the Hallberg method (Hallberg & Nilsson 1964) similar
measurement problems have pertained, but they have been undetected. Furthermore,
it is unclear how Hallberg's method has been applied in other published studies,
since it is not usual for detail to be reported ofdilution strategies, formula, pre-
soaking drying, timing (Fraser et al. 2001; Higham et al. 1990; Wyatt et al. 2001).
Use of automated extraction methods (equivalent to the stomacher) have been
specified in some research reports (Fraser et al. 1985).
This lack of technical clarity as to exact procedure for measuring blood volume
makes it difficult to compare findings with other research studies and raises concerns
about the actual comparability across other studies. Adaptations of the procedure are
many and varied (Stomacher to mash products (van Eijkeren et al. 1986), direct
calculation from optical density (Fraser et al. 2001; Haynes et al. 1977; van Eijkeren
et al. 1986)). There have even been reinterpretations of the definition, perhaps only
implicitly, such as: menorrhagia being defined as average blood volume for more
than one period over 80mL (inclusion criteria for trial (Bonnar & Sheppard 1996));
and by addition to the measured blood volume ofan amount to compensate for lost
blood and clots ((Hurskainen et al. 1998; Wyatt et al. 2001)). All these issues give
cause for concern about comparability of findings across studies.
7.4.2 General measurement issues for blood loss volume
Considering further one aspect of random measurement error, the experiments also
revealed the unreliability of optical density readings. Experiment 1 (Appendix 7.2)
found that for an 80mL blood loss the individual prediction interval, taking into
account only the variability ofoptical density readings, was from 65 to 98mL. That
is, from under by 19% to over by 23%. Previous research reporting menstrual blood
loss volumes, including our own ((Fraser et al. 2001; Warner et al. 2004a; Warner et
al. 2004b)) tends to refer to 'measured blood loss'(Gannon et al. 1996; Haynes et al.
1977; Hurskainen et al. 1998; van Eijkeren et al. 1986; Wyatt et al. 2001). This term
should perhaps be abandoned as misleading. No direct measurement is made. The
volume is calculated using a formula where both the numerator and denominator
involve predicted haematin concentrations obtained from linear regressions of
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haematin on optical density. Such predictions are very likely to have wide prediction
intervals, and for the ratio of two such quantities even greater imprecision will
prevail.
No previous research provides precision limits for individual blood loss
determinations, but considering the multiple sources ofvariation that pertain the
intervals are likely to be considerably wider than ± 18%. While there may be some
value in before-and-after blood loss 'measurement', in clinical trials of therapies for
reducing menstrual blood loss, in order to be able to estimate group effects, it is
difficult to see how blood loss measurement can be useful for clinical management of
individual patients. If a patient's blood loss is 'measured' to be 61mL (with 95%
prediction interval 43 to lOlmL, say), is she deemed to have menorrhagia? All else
being equal, should the management of that patient differ from another with
measured blood volume of 91mL (95% prediction interval 57 to 134mL), given that
the prediction intervals for their likely true blood loss volumes overlap (57 to
101 mL) more than they discriminate?
This leads us on to reflect that in practice the clinical definition of menorrhagia
presumes a distinction between patients with measured blood volumes of 79 and
81mL! Yet in our study we have exposed methodological problems in blood loss
determinations, and the high risk ofaccumulating errors in these measurements. We
have also noted the general omission in published research of important
methodological detail about the blood loss estimation undertaken. Taken together
these raise strong doubts about the rationality in the 21st century ofpersisting with a
menorrhagia definition based on laboratory blood loss measurements made in 1966
on a Swedish population(Hallberg et al. 1966).
7.4.3 Measurement issues for alternatives to blood loss measurement
7.4.3.i Menstrual charts
There have been efforts to find simpler ways to quantify menstrual blood loss, using
pictorial charts (Higham et al. 1990; Janssen et al. 1995; Wyatt et al. 2001), or
measurement of total fluid volume ((Fraser et al. 2001)). On the whole this work has
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been undertaken in the context of basic science research and validation studies
(Higham et al. 1990; Wyatt et al. 2001), or ofclinical trials ofnew and promising
treatments ((Bonnar & Sheppard 1996; Irvine et al. 1998), etc). The participants are
therefore likely to be (self-)selected and/or highly motivated. Ours is the first study
to attempt to undertake quantification in a more pragmatic way, with routine
gynaecology clinic referrals whose clinical care is not linked to the collecting.
Compliance with procedure
We did provide study products, and indicated our wish that these be used as far as
possible, but this was not an absolute requirement. (It should be remembered that the
study was measuring blood volume, total fluid volume, and asking for charting of
periods, so the demands on the participants were fairly high.) It was noteworthy then
that over a third ofwomen used at least one non-study product, and for between 14
and 21% more than a quarter of the products used were 'non-study'. Given the
goodwill evidenced by these participants, in terms of their substantial efforts on
behalfof the study (extensive questionnaires completed and a menstrual collection
undertaken), it seems likely that some deviations from optimal procedure, such as
use ofnon-study products, were unavoidable. For a woman with intolerably heavy
periods it must be extremely difficult to superimpose the study procedure onto an
already challenged menstrual daily life. That is, to ensure one has menstrual chart,
spare products and nappy sacks to hand at all times, and to transport home in nappy
sacks any used products changed while out. Furthermore, the strategy a woman uses
to contain her periods will evolve over months and years. Successful containment,
and confidence that this will be achieved, depends on a sense of the body's usual
pattern of flow, and of the capacity of the sanitary products usually used. (Indeed this
may be part of the reason why many women find it disturbing to have a change in
their periods (5-3-l.iii and 5.3.1.iv).) In such circumstances, a request to use only
'study products' for an entire period is likely to have significant adverse impact on
the serenity and confidence with which the collector can go about her daily life
during her period.
It was noteworthy that exclusion of collections where the very substantial 'night¬
time' or even incontinence pads had been used not only improved model fit but also
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resulted in a change in the regression coefficients to be applied to products classified
in terms of the pictograms. This refinement was tried on the basis that use of such
products might make for unreliable measurement of total fluid volume, given their
substantial dry weight and the likely variability in this. Also, the pictogram
representation of a 'fully soaked' pad of this type would denote a very different
volume of menstrual blood compared to, say, a fully soaked study pad, albeit 'super
plus' absorbency. Therefore the chart development to include specification of the
type of study product in addition to the pictogram rating, should on the face of it
improve measurement (Wyatt et al. 2001). However, such an addition to the
menstrual charting task would make it much more laborious, and would only
improve measurement ifwomen complied with the requirement to use the study
brand and range of products, which as we have shown is not a trivial imposition, and
recorded fastidiously which pictogram related to what absorbency ofproduct.
Optimising prediction of blood from chart data
With respect to chart assessment, this is the only study where the 'score' per product
used is derived from the data for product use and soaking. The model obtained for
predicting blood from chart data required the log transformation of the counts of the
numbers ofproducts used by the various degrees of soaking. This means that the
optimal estimation of blood volume is not by means of a sum of scores per degree of
soaking. Yet this is the approach that has been taken (Higham et al. 1990; Janssen et
al. 1995; Wyatt et al. 2001). This may explain why all three charts produce scores
that deviate systematically from measured blood volume, to a greater extent for
greater volumes (or for greater numbers of products used).
Clinical utility
It has been remarked that one validation study of the original chart found very poor
performance (Reid et al. 2000). Possible explanations are less highly selected
complaint, than women referred to gynaecology clinics, and possibly also lower
motivation. However, even if charting performs relatively well against measurement,
where both methods are applied, we need to be cautious of the potential for different
responding patterns depending on whether the chart is the sole record of menstrual
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loss, or supported by objective measurement. In our study a sub-group of 88 women
who did not want to collect but nevertheless agreed to chart their periods, differed in
some intriguing ways from the remainder ofwomen who collected and charted their
periods (n=207). They recorded a far higher usage ofproducts, and more clots of size
50p or bigger, and many fewer noted the period charted to have been less or much
less than usual in amount (<50% v 80%) (6.3.2.H). It is known that women with
complaint of 'heavy periods' are less focussed than their doctors on the volume of
loss (Marshall 1998; O'Flynn & Britten 2000) and that women acknowledge that
heaviness is difficult to judge, given the societal constraint on discussion of
menstrual loss even among female family members. Furthermore, in the present
study we asked a specific question about volume of period, and over halfof
respondents chose 'no idea' over various specified volumes offered as alternatives.
In these circumstances there is a strong possibility that in the face ofaccompanying
objective measurement it would be only human nature to be cautious about declaring
on the menstrual chart that the current period is representative of the presenting
complaint of'heavy' or 'very heavy' periods. For the women who charted but did
not collect, and whose accounts could not therefore be evaluated in objective terms,
the finding that so many fewer rated the charted period as less than usual, suggests
that they may have felt less need to be cautious in their responding. The possibility of
such a mechanism would need to be borne in mind if moving to assessment of
menorrhagia by chart only.
7.4.3.II Total menstrual fluid
Restrictions on the data used in the modelling analyses, to exclude data where the
measurement quality was suspect, resulted in better fitting models, but still with total
fluid being the best predictor (7.3.2.ii & 7.3.3.ii), Of course in routine clinical use
less than optimal measurement conditions such as these may apply to the patient
being assessed, and if a measurement deficit is picked up, clinical judgement as to
loss will have to be made instead. In general terms the estimation ofblood volumes
would be more accurate if total fluid volume were more accurately measured. If
prediction ofblood volume from total fluid were to be used in the future then it
would probably be most acceptable ifwomen were allowed to use their usual
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products. The brands and absorbency grades would need to be specified at the
recruitment stage, and sufficient packs of the relevant products purchased and
weighed, before being given to the participant for the collection. If she were to
return the unused products (even if just temporarily) these could be weighed as well
as the collection ofused products. This would enhance the accuracy of the total fluid
loss determination, as the exact dry weight of the products actually used could be
obtained by subtraction (from the weight of the products originally provided). It
would have the further advantages that the imposition on the patient would be
reduced, leakages would be minimised, and compliance would be more likely,
because each women would be using her usual products.
The methodological issues discussed above do raise the question as to whether the
true percentage that blood comprises of the total fluid volume is as found by Fraser
(48 to 50%) (Fraser et al. 2001). This hinges on whether products were thoroughly
dried prior to soaking in NaOH, and on concentrations of solutions subjected to
spectrophotometry. (Mechanical extraction was used.) However, the finding of fairly
constant percentage blood over the range of loss volumes is probably secure.
Perhaps this methodological wake-up call could be the stimulus for a paradigm shift
in thinking about menorrhagia. If menorrhagia was to be conceptualised as the
volume of the period to be dealt with, rather than volume of blood loss, then total
fluid volume is all that would need to be measured, and the objective assessment of
'menorrhagia' would be vastly simplified. Furthermore, measurement would be
much more precise, since there would no longer be the need for the regression
estimation of blood from fluid. However, the same cautions apply to total fluid
volume measurements as for charts, that the validity of the measurement depends on
the compliance with collection protocol by the patient. If she adds tampons that have
become soaked during bathing (by bath water rather than menstrual fluid loss), or
wraps products in toilet paper, or uses an extra 'emergency' product and forgets to
notify that this has happened, then her measurement of total fluid volume will be
biased upwards.
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7.4.4 Overview
The observed disparity in blood volumes must arise from a centre-specific
mechanism. It is likely to be greater than is apparent on inspection of the data, as it
will have been masked, to an extent, by the wet volume/formula anomaly, which will
have reduced calculated blood volumes in Glasgow, relative to Edinburgh, for equal
total menstrual fluid volumes.
It is impressive how many women achieved collections, and charting, but a question
remains as to just how feasible any of these quantification methods are in routine
clinical care. It was noteworthy that although those who ultimately collected were
representative in socio-demographic terms of those eligible to collect, those
collectors who failed to also provide a completed chart were twice as likely to be
living in areas of most deprivation (6.3.2.i), It needs to be remembered that although
charting may seem less of an imposition on patients than menstrual collection, and
less distasteful (in not requiring collection of used products), it may be more
problematic for some women. In addition, many of these women were attending the
clinic because they were finding their periods unmanageable, so they may have some
difficulty with the extra demands imposed by menstrual loss measurement, to use
only standard products and/or to collect all used products. Menstrual collection and
menstrual charting both require a degree of conscientiousness that is undoubtedly
much harder to accommodate in some life-styles than others.
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7.5 CHAPTER SUMMARY
7.5.1 Compliance with collection and menstrual blood loss
measurement
• For 14% of Glasgow collectors and 21 % of Edinburgh collectors more than a quarter of
products used were non-study products.
• Glasgow used lower initial soaking volumes ofNaOH and higher secondary dilutions for
menstrual solution. Glasgow used higher dilution of venous blood samples. This meant
optical densities were lower in Glasgow than Edinburgh (about 0.22 versus 0.5).
• The consequences of the disparities in implementation of the method at the two centres
have been discovered to be:
- Under-extraction of blood into NaOH at Edinburgh due to non-squeezing of soaked
products.
- Potential underestimation of blood volume in both centres due to failure to correct
for menstrual volume in soaking solution.
- If there is non-proportionality of OD to haematin concentration for the relevant
spectro-photometer then there will be either under- or over-estimation of blood
volume, depending on the sign of the intercept (positive or negative) and on whether
the menstrual optical density is greater or less than the venous optical density.
- If the non-proportionality of OD to haematin concentration in the relevant range for
concentration has intercept greater than zero, then in Edinburgh there would tend to
be under-estimation of blood loss volume, whereas in Glasgow there would tend to
be over-estimation, but not by large amounts. Procedure in Glasgow would also
mean more marked errors in both directions
• The measurement check showed that Edinburgh underestimated blood volume by 5 to
16% and Glasgow over-estimated by 13 to 35%.
• Unknown laboratory error (bias), such as systematically under-dispensing the venous
aliquot, would be a possible explanation for some of the overestimation apparent in
Glasgow.
• The differences found in blood loss determinations between centres means that all
analyses involving blood volume need to be checked stratified for centre.
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7.5.2 Total menstrual fluid volume measurement
• Re-running of the regression analysis excluding cases with sub-optimal data resulted in
a better-fitting model for estimating blood from total fluid volume.
7.5.3 Measurement by menstrual chart
• Women who did not manage to complete a Menstrual Chart were more likely to be from
deprived areas.
• Re-running of the regression analysis excluding cases using more than 25% non-study
products (which were often 'night-time' pads), resulted in a slightly better-fitting model










There are well-known socio-economic, religious and general health disparities
between the two cities contributing participants to this study. Such factors may have
an important bearing on experience of menstrual symptoms, on the extent to which
such problems can be discussed in lay networks to obtain support and information
that may aid self care, on access to information from other sources such as books or
web-sites, and on the initiation and conduct of consultations with the general
practitioner. These factors can therefore have a profound albeit indirect influence on
the outcome of an individual's symptoms. Furthermore, there may be differences
between the two centres in local clinical practice with respect to menstrual problems,
possibly affecting the referral culture and management ofproblems. This in turn can
permeate back to the woman consulting her general practitioner, or referred to
gynaecology clinic, who builds up an understanding of how best to negotiate her
menstrual health care needs.
Therefore, before we move on to the modelling analyses of chapter 9, it is important
to examine the study data with respect to the interplay of socio-demographic factors,
and the differences in these factors between the two centres. In addition it would be
salutary to examine the study recruits in relation to the local health board
populations.
The study design outlined in Chapter 3 is characterised by nesting, with even the
cross-sectional survey involving nested levels ofparticipation, in terms ofextent of
questionnaires completed. Also nested within the questionnaire survey were:
• a survey of iron status (among those for whom the gynaecologist deemed an iron
status test necessary);
• a case-note review follow-up study (among all those recruited more than 8
months before the end of data collection); and
• a prospective menstrual charting and menstrual loss volume measurement study
(among those with 'putatively heavy' periods, all questionnaires completed, and
who consent to menstrual collection)
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It is therefore important, for interpretation of findings, to ascertain the comparability
ofparticipants across the various levels of the questionnaire survey, of those
receiving iron tests or not, undertaking menstrual collection or not, and being
subjected or not to case note review.
In the present chapter the analyses outlined above are reported, prior to the final
results chapter (chapter 9) which draws on the multi-faceted study data to undertake
modelling analyses.
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8.2 METHODS FOR THIS CHAPTER
8.2.1 Homogeneity of centres
The patients recruited in Edinburgh are compared to those recruited in Glasgow.
Where differences are found associations reported in Chapter 4 are reviewed after
stratification by centre.
8.2.2 Representativeness ofpopulations
For a clinic population there is not any expectation that they should be
epidemiologically representative of the background population. However, for each
centre patients are compared to the local general populations, in terms ofdeprivation
code and age. This gives some insight to the demographic characteristics ofpatients
referred with menstrual problems, and some indirect opportunity to assess whether
there appears to be similarity in the referral filters operating in the two centres.
8.2.3 Comparability across levels ofparticipation
Not all women recruited to the study were in fact eligible for Full participation
(collection of loss). As stated in methods (3.4.4), to be eligible to collect the woman
needed to have putatively heavy periods. That is, to have been referred by her doctor
for heavy bleeding or, on CQ, to have reported her periods as heavy or very heavy or
to have stated that she was attending the clinic for bleeding. Out of the 952 recruited
87 were not eligible for collection.
The questionnaires comprising participation to level Research 1 and beyond were
intended mainly for the purposes of making sense of the measured menstrual loss
(ascertained at Full participation), in relation to complaint ascertained at recruitment
via the questionnaire CQ. Therefore, the nurses were instructed not to pursue
completion of the Research level 1 and 2 questionnaires if it was already evident
from CQ and referral letter that the woman was ineligible for collection. In some
cases all the questionnaires including CQ were completed together, so it would not
be until after completion of these that the research nurse would know that the
participant was not eligible for menstrual collection, and therefore should not be
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asked. It follows then that some differences between those participating to various
levels may be expected merely because of imposed criteria for eligibility to collect.
These would be observed:
(a) between those recruited but stopping before Research 1 (i.e. completing Basic
only) and those proceeding to Research 1 (and/or beyond) - due to non-pursuance of
completion for Research 1 questionnaires; and
(b) between those completing up to levels Research 1/2 but not collecting and those
proceeding to collection - due to ineligibility.
The characteristics ofpatients participating to a greater or lesser extent in the study
are compared. In addition, patients having iron status tests are compared to those not
having tests, and participants having case-note review to those not reviewed.
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8.3 RESULTS
8.3.1 Comparisons between Edinburgh and Glasgow recruits
8.3.1.i Socio-demoqraphic variables
ageand relationship
The Edinburgh and Glasgow centres recruited patients that differed quite markedly in
demographic characteristics. The Edinburgh participants were older, as shown in
Figure 8.1. The proportions ofwomen who lived with a partner or husband were
similar across the two centres (72% Glasgow versus 79% Edinburgh) but of the
remainder, the Glasgow participants were more likely to be single (51% versus 33%)
and less likely to be separated or divorced (45% versus 64%). To some extent this is
likely to be because of the age differences.
Figure 8.1 Age distributions within centre.
25-29 yrs 30-34 yrs 35-39 yrs 40-44 yrs 45-49 yrs
AGEGROUP
Parity
Parity was similar across the two centres, with 25% of Glasgow and 20% of
Edinburgh participants being nulliparous, and 26% of Glasgow and 24% of
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children by age did differ somewhat between the two centres. Figure 8.2 shows for
each centre the percentage of parous women in each of three age bands (overall
height of columns) with the columns subdivided into slices to show actual parity.
Figure 8.2 Parity distribution by age group within centre
Glasgow centre Edinburgh centre
< 35 yrs 35 to 39 40 to 49
(n=144) (n=110) (n=168)
AGE GROUP (years)







Figure 8.3 shows that the centres differed markedly by deprivation code, with
Glasgow having a preponderance of participants living in areas designated
deprivation code 6 or 7 (53%). Overall deprivation was negatively correlated with
age, so that the most deprived women were the youngest (rho= -0.24, n=934, 95%
CI 0.18 to 0.30). However, if the data were stratified by centre then the correlation
was found to be confined to Glasgow (rho= -0.292, n=409, 95% CI 0.20 to 0.38).
There were moderate differences with respect to education, in that 24% of Glasgow
and 32% ofEdinburgh participants had college/university level education, while 64%
of Glasgow and 54% of Edinburgh participants left school at 16 years of age. Social
class could be classified for only 860 women (368 Glasgow and 492 Edinburgh). The
difference in social class between the two centres was also less marked than for
deprivation: 35% Glasgow compared to 41% Edinburgh participants in social classes
I and II, while 21% Glasgow compared to 19% Edinburgh participants were in social
classes IV and V.
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1 &2 'Least' 3 & 4 5 6 & 7 TVIost'
Deprivation Code Group
Employment
Those in part-time work were most likely to be living with husband or partner (86%),
and those in full-time work or unemployed least likely (71% and 74% respectively).
Extent ofworking was negatively correlated with deprivation, so that the most
deprived were working least (rho=-0.19, n=924, 95% CI 0.13 to 0.25). It was also
associated with age, such that full-time working was most common in the youngest
and oldest age-bands (55% and 52% respectively), and unemployment was most
common in women aged 30 to 34 years (39%) and least common in the oldest age
band (18%) (x2=33, 8df, n= 942, p<0.001). Therefore, as would be expected, the
centres also differed by employment (x2=23, 2df, n= 942, p<0.001), with more
Glasgow compared to Edinburgh participants not working (33% v 20%), and fewer
Glasgow participants reporting full-time working (39% v 49%). This pattern was
evident within both the nulliparous and even more strongly in the parous subgroups
(among nulliparous 21% v 11% not working, 69% v 81% working fulltime, n=208;
among parous, 37% v 22% not working, 29% v 41% working full time, n=733). The
nulliparous group was too small to explore further, but within the parous group the
relevance of deprivation and time since last pregnancy were examined. For parous
women, in the most affluent group (codes 1&2, n=140) there was no detectable
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difference in extent ofworking between Edinburgh and Glasgow (overall 15% not
working, 31% part-time and 54% full-time). The remaining parous women
(deprivation codes 3 to 7) were stratified by the time since last pregnancy (less than
10 years since pregnancy (n=261) or 10 or more years (n=327)). In those with more
recent pregnancies the Edinburgh women were less likely to be 'not working' (28% v
52%) and more likely to be working part-time (51% v 31%). In those whose last
pregnancy was over 10 years ago, the Edinburgh women were more likely to be
working full-time (53% v 38%).
8.3.1.ii General health
The height, weight and BMI were very similar across the two centres. However,
there were quite marked differences in general health, with Edinburgh women
judging their health comparatively more favourably than Glasgow women ('better
than others the same age'18% v 12%, n=526 v 418, 'worse' 15% v 26% ). This
difference arose partly because the association of self-reported worse health with
younger age was accentuated in Glasgow, and Glasgow had a younger group of
participants.
Given the differing age and working profiles in the two centres it is not unexpected
that the prevalence of long-term health problems tended to be higher in Glasgow than
Edinburgh participants, differing by more than 4 percentage points for 'other' (11%:
predominantly gastro-intestinal, nervous system, musculo-skeletal,
urogynaecological and haematological conditions), arthritis (7%), high blood
pressure (6%) and migraine (4%).
Glasgow participants tended to report having experienced more of the common
symptoms in the last two weeks than Edinburgh participants. The specific symptoms
which differed most in prevalence between the centres (Glasgow exceeded
Edinburgh by more than 4 percentage points) were: craving for particular foods
(14%), diarrhoea/constipation (13%), swelling of parts of the body (12%), difficulty
in concentrating, nervous tension and aches/stiff joints (all 11%), feeling sad (8%),
dizzy spells (7%), lack of energy and rapid heartbeat (6% each), and upset stomach,
headaches, shortness of breath, backaches and sore throat (all 5%).
298 Menorrhagia Reconsidered
8.3.1.iii Quality-of-life
There was no evidence of an association of SF-36 Health Transition item with
demographic variables, but the scale scores were on the whole associated with
demographic variables, as shown in Table 8.1. The strongest correlation was with
deprivation, in that more deprived participants had poorer scores on all scales, in
particular mental health. Better scale scores were related to greater extent of
working. Physical Functioning was less favourable with increasing age, but the other
scales showed better scores with increasing age.
Table 8.1 Non-parametric correlations of SF-36 scale scores with age,
deprivation and extent of working (none, part-time, full time)
n Age Deprivation Working
Scale rhop rhop rhop
Physical Functioning 689 to 696 ** -0.088 **-0.218 ** 0.227
Social Functioning 691 to 698 ** 0 .114 ** -0.244 **0.157
Role-Physical 682 to 689 0.012 **-0.140 **0.122
Role-Emotional 683 to 690 0.053 **-0.186 **0.140
Mental Health 690 to 697 ** 0.098 ** -0.295 **0.165
Vitality 690 to 697 * 0.080 ** -0.229 **0.150
Bodily Pain 689 to 696 ** 0.144 ** -0.251 **0.165
General Health 686 to 693 ** 0.120 ** -0.235 ** 0.249
p Spearman's rho - positive value means better health status/functioning with increase in
demographic variable.
** p<0.01, * p<0.05
Given the correlation of scale scores with deprivation, and the previously reported
associations in this sample of deprivation with age and working, there was a
possibility that the correlations of scale scores with age and working reported in
Table 8.1, may be a result of confounding by deprivation. The study sample was
stratified by deprivation and then the correlations of scale scores with age and
working were calculated separately within the three strata. For the most affluent
stratum (deprivation codes 1 and 2) the only correlation persisting was Bodily Pain
which had more favourable scores with increasing age (rho =0.193, n=141). Within
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the middle stratum (deprivation codes 3 and 4) also, few correlation persisted: these
indicated that in this group extent ofworking increased with favourable scores for
General Health, Physical Functioning and Role-Physical (rho= 0.177, 0.164 and
0.127 respectively, n= 245 to 248).
In contrast, within the most deprived stratum (deprivation codes 5,6 and 7), extent of
working remained correlated with all scale scores (rho= 0.279, 0.231, 0.160, 0.206,
0.240, 0.200, 0.217 and 0.289 for the scales in order listed in the table, n= 290 to
296). These correlations were stronger than for the group as a whole (as reported in
the Table 4.14) and showed that among deprived women reduced or non-working is
associated with poor quality-of-life scale scores. In addition in this group Physical
Functioning deteriorated with age, also more strongly than for the group as a whole
(rho= -0.195, n= 299).
Distributions of responses for the SF-36 Health Transition item were similar in the
two centres but for all the scales except Vitality Edinburgh participants had more
favourable scale scores than Glasgow participants. However, after stratifying by the
three-level deprivation variable, only a few differences remained. Within the middle
deprivation group, there were differences in Role-Physical and Social Functioning,
with Edinburgh participants having better scores. Within the most deprived group
there were differences in Bodily Pain and Social Functioning, again with Edinburgh
participants having better scores. The differences were not however large in absolute
terms, the biggest difference between the median scores for the two centres being 13.
8.3.1.iv Contraceptive and obstetric history
The prevalences of abortions, miscarriage/still birth and multiple births were similar
in the two centres. Differences between centres in contraceptive usage were to be
expected because of its strong association with age, which differs between centres.
As is shown in Table 8.2, the current method of contraception differed between the
centres, mainly due to excess sterilisation in Edinburgh, and excess 'None' and
'Other' in Glasgow. Controlling for age group all but eliminated the differences
between the centres, with only a borderline significant difference remaining in the
oldest age band (40 to 49 years, n=470, p=0.063), mainly due to excess sterilisation
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in Edinburgh (61% v 48%) and excess 'none' in Glasgow (27% v 19%). On the other
hand, controlling for parity revealed that there was a difference between centres only
in the para 0/1 stratum (n=358, p=0.011), due mainly to excess sterilisation in
Edinburgh (21% v 11%) and excess hormonal methods (13% v 5%) in Glasgow.
Table 8.2 also shows there were differences between Glasgow and Edinburgh in
rates of sterilisation (any) and female sterilisations.




% of n P






Sterilisation, male or female (n=420, 527)3 41 50 0.0042
Female Sterilisation (n=262, 439)b 20 32 0.0012
Years on oral contraception (n=215,367)b
Median (IQR)
6 (3 to 10)
Median (IQR)
8 (4 to 12) 0.0013
Statistics - 1: x 4df, 2: x 1df, 3: Mann-Whitney U
Data source - a: CQ data, b: MBQ data
Rates of male sterilisations did not differ between the centres (18% v 19%). For all
sterilisations, if age, parity or deprivation were controlled for, detectable differences
between centres, in terms of fewer sterilisations in Glasgow than Edinburgh,
remained only in subgroups age 40 to 49 years (48% v 61%, n=166, 304),
deprivation '5,6&7' (43% v 56%, n=237, 190) and para 0/1 (11% v 21%, n=167,
191).
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Ever having used the pill was similar in the two centres (84% Glasgow and 87%
Edinburgh), and remained so after controlling for parity and age. There were no
detectable differences between the centres in reason for starting the pill
(contraception only or menstrual-related reasons), nor in observed effect on pain,
heaviness, regularity and PMS. However, age starting oral contraception was
younger in Edinburgh, and age stopping older, so total number of years using oral
contraception was greater for Edinburgh participants.
8.3.1.V Health history
There was no detectable association ofpast treatment for anxiety with current age,
parity or domestic status (single/cohabiting). However there were trend associations
with comparative self-reported health (increasing from 14% in those with 'better'
health to 35% in those with 'worse', x2trend=16.8, ldf, n=682, p<0.001), deprivation
(increasing from 13% in the least deprived to 29% in the most deprived, x2trend=10.0,
ldf, n=682, p=0.002) and extent ofworking (increasing from 16% in those with full-
time work to 29% in those not working, x2trend=l 10, ldf, n=683, p=0.001).
There was no detectable association ofpast treatment for depression with domestic
status (single/cohabiting), and only a non-significant trend for past treatment for
depression to be slightly less prevalent in nulliparous women. However there were
trend associations with comparative self-reported health (increasing from 14% in
those with 'better' health to 54% in those with 'worse', X2trend=51.9, ldf, n=681,
p<0.001), deprivation (increasing from 19% in the least deprived to 46% in the most
deprived, x trend=23.0, ldf, n=679, p<0.001) and extent ofworking (increasing from
22% in those with full-time work to 44% in those not working, x2trend=22.7, ldf,
n=680, p<0.001).
As would therefore be expected then there were marked differences between patients
at the two centres in terms of past treatment by GP for depression or anxiety, with
more Glasgow participants having had some treatment (45% compared to 28%), this
increase being in all combinations - anxiety only, depression only and both. It would
be expected that in the population the prevalence ofpast treatment for depression
and/or anxiety would be higher in older women because of the longer time during
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which the woman may have succumbed to either of these conditions and sought help
from her GP.
Given the demographic differences between the centres it is necessary to make a
comparison between them in past treatment taking age, deprivation and parity into
account. Considering the simple binary variable of treatment (of either or both sorts)
or not, it was found that overall the prevalence of a past history of treatment was
30% in those aged 35 to 39 years (n=156) and 32% in those aged 40 to 49 years
(n=355) compared to 45% in the youngest women, those aged 25 to 34 years
(n=170). A similar age pattern was observed within both centres, but when
subdivided by parous state, only within the parous subgroup (n=534). The centres
were compared in terms of prevalence of past history of treatment, stratified as
subgroup sizes permitted by parous state, deprivation (codes 1 to 4 versus codes 5 to
7) and age (under 35 years or 35 years or older). The prevalences in the four resulting
strata are shown in Figure 8.4, separately by centre.
Figure 8.4 Comparison between Glasgow and Edinburgh of prevalences of
past treatment for depression and/or anxiety within subgroups
resulting from stratification by parity, age and deprivation
Parity: parous nulliparous
STRATIFICATION SUBGROUPS
-o- Edinburgh (n=57, 108, 171, 90) —e— Glasgow (n=53, 63, 79, 57)
It can be seen that past treatment was least common among nulliparous women, and
most common among younger parous women. Within the older parous women it was
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possible also to stratify by deprivation, and past treatment was more common among
women living in greater deprivation. In all three parous subgroups there was more
past treatment in Glasgow women compared to Edinburgh. There was no detectable
difference between the centres in duration of longest treatment for either depression
or anxiety.
8.3.1-vi Referral
More of the Edinburgh participants had been referred for bleeding (80% v 71%) and
fewer referred for PMS (3% v 12%). Even if age was controlled for (three strata) the
differences for bleeding persisted in the two older age bands, and even if deprivation
was controlled for (three strata), the differences for PMS persisted in the two more
deprived strata.
8.3.2 Comparisons with population data
8.3.2.i Socio-demoqraphic characteristics
The age and deprivation distributions ofEdinburgh and Glasgow participants
differed, so the question arose whether this reflected background populations. The
distribution of age and deprivation score as at the 1991 census was obtained for
women aged from 25 to 49, for the Glasgow and Lothian Health Boards. The age
distributions of the populations in the two areas were very similar. Figures 8.5a and
8.5b show for each health board the age distribution for the 1991 population,
compared to participants in the study (during 1996 to 1998).
It can be seen that the age distribution ofparticipants showed a different pattern to
the population, with a lower proportion ofwomen aged under 35, particularly women
under 30 years, and a higher proportion ofwomen aged 35 years or older. This is
likely to reflect the epidemiology of menstrual complaint. However, the extent of
discrepancy between population and participant distributions differed between the
two centres. It was less marked in Glasgow, with the modal age group for
participants being 35 to 40 years. The trend for participants to be towards the older
end of the age range was most marked in Edinburgh, with very few participants aged
under 30 years of age, and the majority aged 40 years or older.
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Figure 8.5a Age distributions of Glasgow Health Board 1991 female











Figure 8.5b Age distributions of Lothian Health Board 1991 female population










□ Lothian Health Board (n=136241) ■ Edinburgh participants (n=530)
Figures 8.6a and 8.6b show that in each health board the deprivation distribution for
participants was fairly similar to the background population. Comparison of the two
25-29 yrs 30-34 yrs 35-39 yrs 40-44 yrs 45-49 yrs
Age group
Glasgow Health Board (n=158886) □ Glasgow participants (n=422)
25-29 yrs 30-34 yrs 35-39 yrs 40-44 yrs 45-49 yrs
Age group
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figures shows that the deprivation distribution for Glasgow Health Board differed
markedly from Lothian, with the majority of Glasgow women living in areas with
marked deprivation (scores 6 or 7).
Figure 8.6a Distributions by deprivation score of Glasgow Health Board 1991
female population and Glasgow study participants
18.2'Least' 3 8.4 5 6 8.7'Most'
Deprivation Group
□ Glasgow Health Board (n=158886) □ Glasgow participants (n=409)
Figure 8.6b Distributions by deprivation score of Lothian Health Board 1991
female population and Edinburgh study participants
60 — .. 1
%
50
18.2'Least' 3 8.4 5 6 8.7'Most
Deprivation Group
□ Lothian Health Board (n=136241) ■ Edinburgh participants (n=525)
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In 4.3.3,i it was reported that in the study participants overall there was a correlation
between young age and deprivation. In 8.3.3.i it was established that this correlation
was confined to the Glasgow centre. To ascertain whether such a correlation exists in
the background populations the above data were plotted as stacked histograms of age
within deprivation. In neither the Glasgow nor Lothian Health Board data was there
evidence of a younger demographic within the more deprived areas.
8.3.2.ii Quality-of-life
Figure 8.7 presents the means and 95% CIs for participants in the present study, and
population means (weighted to reflect the age profile of study participants).
Figure 8.7 Comparison of population normative data* for SF-36 with mean
(and 95% CI) of scale scores for study participants
» This study (n=699) Population (n=2509)
100





* Jenkinson, Coulter and Wright BMJ1993
Normative data for the SF-36 in the UK was obtained using a sample of 13042
randomly selected subjects aged 18 to 64years, residing in Berkshire,
Buckinghamshire, Northamptonshire and Oxfordshire (Jenkinson et al. 1993). The
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response rate for females was 77%, providing 5103 respondents. Scale scores were
presented by age band, two ofwhich were 25 to 34 years and 35 to 54 years (n=1299
and 1210 respectively) (Jenkinson et al. 1993). The scale means for these age bands
have been combined into a weighted mean reflecting the relative sizes of the nearest
corresponding age bands in the present study - 25 to 34 years (n=176 completing SF-
36) and 35 to 49 years (n=523). Our outpatient sample had lower scores on all
scales, in particular Pain, Role-Physical and Role-Emotional.
8.3.3 Comparability of women participating to a greater or lesser
extent
8.3.3.i Socio-demoqraphic variables
Age distribution was very similar across levels of participation, albeit with very
slightly fewer young women proceeding to Full participation. If the analysis was
restricted to women eligible for menstrual collection by virtue of putatively heavy
periods then there was even less shift in age by level ofparticipation.
Distribution of deprivation was very similar across participation levels, overall and
within centre. Social class distribution was similar across levels within Glasgow.
Each ofparity, employment and living with a husband/partner was similar across
participation levels.
8.3.3.ii General health
Distribution of self-reported comparative general health was very similar across
levels ofparticipation, as shown in Figure 8.8, albeit with slightly more women with
worse health proceeding to Full participation. If the analysis was restricted to women
eligible for menstrual collection by virtue ofputatively heavy periods then there was
slightly less shift in health by level ofparticipation.
BMI were very similar across the levels ofparticipation and for long-term illnesses
there were no differences in prevalence exceeding 4 percentage points. For minor
symptoms the differences exceeding 8 percentage points were all in the direction of
those proceeding to Full participation being more likely to have reported symptoms
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in the last two weeks. The differences were backaches (11%), diarrhoea (10%) and
feeling sad (9%).














□ Research 1 (n=721)
■ Full (n=223)
8.3.3.iii Quality of life
Women completing the SF-36 may have stopped at Research 1 (n=473) or proceeded
to Full participation (menstrual collection, n=225). There were very similar Health
Transition and scale scores in the two subgroups, except for Bodily Pain and Social
Functioning. For both these scales those proceeding to menstrual collection had
better scores, with the medians differing between the participation subgroups by 10
scale points in each case.
8.3.3.iv Contraceptive and obstetric history
There was a significant difference in the prevalence of sterilisation between Basic
only and 'Research 1 or more' participants (39% v 48%, n=235 v 712, p=0.018).
However, if analysis was confined to participants eligible for Full participation then
the difference in prevalence of sterilisation between Basic and Research 1
disappeared (44% v 49%; n=172, 689; p=0.26).
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There were no differences detected for (any) sterilisation nor current contraceptive
method from Basic to Full nor from Research 1 to Full. However, with respect to
female sterilisation there were significantly fewer sterilised women proceeding from
Research 1 to Full participation (31% v 22%, n=476 v 225, p=0.033) and this was
essentially unchanged if analysis was confined to women with putatively heavy
periods and therefore eligible for collection.
There was a significant difference in the prevalence of current or past use of the oral
contraceptive pill, between Basic only and 'Research 1 or more' participants (78% v
88%, n=238 v 714, p<0.001) and this difference persisted even if only women
eligible for full participation were considered. However, the fact that there were no
differences detected between Basic and Full, nor Research 1 and Full suggest the
above finding may be partly artefactual, due to the greater likelihood of ascertaining
pill use via the Research 1 questionnaire MBQ. Fortunately, the observed difference
between those who completed Basic only (n=238) and those who completed more
does not translate into marked differences when comparing all who have completed
Basic (n=947) versus the sub-groupings who have completed more.
8.3.3.V Health history
There was no detectable difference in prevalence of past treatments for depression or
anxiety between women completing MBQ only and those proceeding to full
participation (menstrual collection).
8.3.3.vi Referral reason
Given the criteria for eligibility for 'full' participation a higher proportion of full
participation would be expected in the 'bleeding' referral categories. This was indeed
the case, as 76% ofwomen overall were referred for bleeding, whereas 81% of those
who completed Research 1 were referred for bleeding, and 86% of those
participating fully. Referral for pain was very similar regardless of level of
participation, but referral for bleeding and pain together was slightly more common
among those participating fully (14% overall, 13% of those completing Research 1
and 19% of those participating fully). Referral for PMS and 'other' reasons was less
common among those participating to a greater extent.
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8.3.4 Among women eligible for menstrual collection, comparability
of those collecting or not collecting
Table 8.3 shows the socio-demographics of collectors, and of those who were
eligible but did not collect.
Table 8.3 Description of women who undertook menstrual collection (and
of non-collectors)












Deprivation Code (n=222) (n=630)
Least deprived: 1 & 2 19 19
3 & 4 35 35
5 16 21
Most deprived: 6 & 7 31 25
Parity
no births 20 21
1-6 births 80 79
Employment status (n=632)
no job 28 24
part-time work 31 30
full-time work 41 46
Factors used to determine invitation to collect
Referral for excessive bleeding 87 83
Patient believes referral is for excessive 71 64
bleeding
Subjective Heaviness of Periods (n=225) (n=634)
moderate 3 14
heavy 49 49
very heavy 48 37
Total 'heavy' 97 86
declined to complete further questionnaires, or completed questionnaires but then
declined to undertake menstrual collection
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The 226 women who collected their used sanitary protection comprised 26% ofall
865 eligible women (with putatively heavy periods), 32% of the 691 who had also
completed the necessary questionnaires. The two subgroups are well-matched,
except for a slight deficit of collectors aged 45 to 49 years. The remainder of the
table gives the prevalence of the criteria for eligibility to 'collect', and shows
collectors were somewhat more likely to judge their periods very heavy. Among
women eligible to collect (n=865), those collecting or not were compared in terms of
the prevalence of reporting the various aspects ofmenstruation as a severe problem.
Pain with periods, mood changes, and increased amount ofperiod were consistently
most problematic. (This was the case even if all women in the study were considered
(n=952), or the subset referred for bleeding (n=725)). The prevalences for the group
who collected were in general slightly higher but the relative ordering ofproblematic
aspects was very similar. The aspect closest in meaning to absolute volume ('lose too
much blood') was fifth in order ofprevalence in the group of all eligible women, and
fourth among collectors. Among collectors a severe problem with some aspect of
volume ofperiod was reported by 50%, ofpain around periods by 43%, and of cycle-
related changes by 45% (3, 3 and 2 items respectively, see methods).
8.3.5 Characteristics ofparticipants undergoing iron status tests
The disparity in haemoglobin and ferritin testing rates between Edinburgh and
Glasgow centres has already be reported (4-3-2-ii). Comparison of the demographic
characteristics and referral reasons of those tested compared with those not tested
therefore runs the risk of confounding by demographic factors associated with centre,
in particular age, deprivation and self-rated health. The initial overall analyses were
therefore checked by stratifying by centre, and where findings differed between
centres these are reported separately.
Haemoglobin testing was more likely if there had been referral for bleeding (overall
52% v 35%) and less likely if there had been referral for 'other' reason (overall 41%
v 52%). Haemoglobin testing increased with age in both centres, most strongly in
Edinburgh (25% to 49%) but also borderline in Glasgow (59% to 64%). In
Edinburgh there was a marked increase in haemoglobin testing with increasing parity
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(29% to 42%), and in Glasgow there was a moderate decrease in testing with greater
deprivation (72% to 59%). Ferritin testing also was more likely if there had been
referral for bleeding (overall 33% v 21%) and borderline less likely if there had been
referral for 'other' reason (overall 26% v 33%). However ferritin testing rates were
not found to be associated with age, deprivation or any of the other demographic
variables.
Haemoglobin and ferritin testing rates were found to be strongly associated with
extent of participation in the study. Figure 8.9 shows the prevalence of haemoglobin
and ferritin tests by extent ofparticipation, separately for the two centres. In Glasgow
those proceeding to research level 1 participation or more were about four times as
likely to have a haemoglobin test and seven to eight times as likely to have a ferritin
test. In Edinburgh there was modest excess likelihood of iron status testing if the
woman participated to Research 1 level (that is, completing in addition the MEQ,
quality-of-life, personality and psychiatric health questionnaires), but if she
participated fully then there was two to three times the likelihood of haemoglobin
testing and thirteen times the likelihood of ferritin testing.
Figure 8.9 Prevalence of haemoglobin and ferritin testing by extent of
participation in the study (level), separately by centre.
HAEMOGLOBIN "TESTING— FERRITIN TESTING
Edinburgh (n= 82, 357, 91) -©-Glasgow (n= 156, 130, 136)
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8.3.6 Characteristics ofparticipants subject to case-note review
The demographic characteristics of those followed up by case-note review (n=665)
were compared with those not followed up (comprising 83 whose notes could not be
obtained and 204 who were recruited too late). The distributions for the demographic
variables other than comparative self-reported health were as expected very similar
in the two groups followed up/not. There was no detectable association of follow-up
(or not) with any of the referral reasons, nor with any ofthe SF-36 scale scores.
For comparative health there was a weak trend for follow up to be more likely in
those with better self-reported health, going from 77% in those judging their health
better to 69% in those judging it the same and 67% in those judging it worse
(X2trend=4.03, ldf, n=944, p=0.045). This was examined further within centre, and it
was found the effect was confined to Edinburgh. Furthermore, within Edinburgh the
trend was more strongly evident, with follow-up rates going from 82% to 63%
(X2trend=8.6, ldf, n=526, p=0.003). Those not followed up comprised 136 ineligible
due to their recruitment being too recent and only 20 who should have been reviewed
but were missed. As far as could be judged (given the unequal division) the
distributions of comparative health ratings in these two subsets were very similar.
That the finding for comparative health reflected the population of referrals, and was
not an artefact of bias due to missed follow-up, was confirmed by examining
participants' comparative health reports across the time-course of recruitment. Age
group, deprivation group and referral or not for bleeding and/or pain were also
examined by time. Considering the entire study sample there were no detectable
differences, between those recruited before and after the follow up cut off date, in the
distributions of the four variables listed above. However, when the analysis was
repeated separately within centre, it was found that for comparative self-reported
health in Edinburgh there was a difference between those recruited before the cut of
date and those recruited afterwards, with the former subgroup reporting 14% worse
health than others, 66% same and 20% better, compared to 19%, 69% and 12%




The design of this research study embedded the menstrual collection within a cross-
sectional questionnaire survey of the background clinical population. One aim of the
design was to ensure that the background population ofwomen with menstrual
complaint and specifically with putatively heavy periods could be well described.
Another aim was it to enable checks as to the comparability ofwomen participating
to the various levels in the study. Key to this latter aim was the wish to be able to
check the representativeness of the subset agreeing to menstrual collection,
something that has never before been achieved.
On the whole those participating to a greater extent were very similar to those
participating minimally, at least for the data initially reported in Chapter 4. The
initially broad recruitment, including any menstrual complaint, was to ensure no
covert complaints of heavy bleeding were missed. It was always intended that
menstrual collection would be sought only lfom women with putatively heavy
periods (referred for or stating clinic attendance to be for bleeding problem, or
reporting menstrual loss as heavy or very heavy). This meant that there had to be
exclusion from full participation of those without putatively heavy periods. There
was therefore some increase, with greater participation level, in those referred for
bleeding (from 76% overall to 86% among those collecting) and some attrition
among those not referred for bleeding (which was found for PMS and 'other').
However there was no reduction in the proportion referred for pain, and indeed there
was an increase in the proportion referred for both bleeding and pain (14% to 19%).
This suggests pain with periods may have been a motivating factor to full
participation in the research, and raises the question ofwhether pain is an important
part of the complaint of heavy periods.
Other factors associated with greater participation were having been sterilised,
reporting experience ofminor symptoms in the last fortnight and having poorer SF-
36 Bodily Pain and Social Functioning scale scores. Among women with putatively
heavy periods there was a higher prevalence of female sterilisation in those
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undertaking menstrual collection, compared to those who stopped at level Research 1
(31% v 22%; n=454, 225; p=0.017). The possible scenarios explaining why sterilised
women appear to be over-represented in those participating to a greater extent are
that they are likely to have commenced recurrent 'natural' menstruation from the
time of sterilisation, and that they are likely to be ofhigher parity than other women
in the sample. Association of female sterilisation and menstrual blood loss volume
will be examined in chapter 9.
8.4.2 Case-note review follow-up and iron status testing
Although time-constraints meant follow-up was confined to the first 79% of women
recruited, it was not expected that this could introduce any sample bias. However, it
was found that the comparative health ofEdinburgh women differed between those
followed-up or not, although fortunately only a weak trend. This was established as
resulting from a change in case-mix with time.
There were marked differences between centres in the proportions being tested for
iron status, and the factors associated with testing. Therefore test results can not be
interpreted as indicative of iron status for the population ofwomen referred for
menstrual complaint and participating in the study. The main interest in iron status
was as an indicator of clinical menorrhagia, which can only be established by
menstrual blood volume measurement. Fortuitously, iron status testing was markedly
more frequent among those undertaking menstrual collection, so these data
nevertheless allow some examination of iron status in relation to measured menstrual
blood loss volume.
8.4.3 Comparisons between centres
There were many differences between the participant groups in two centres. The
most striking were in terms of the demographic factors age and deprivation. While
the differences in deprivation appeared to reflect a difference between the two local
populations, the differences in age were despite similar age distributions in the local
populations ofwomen. Furthermore, in Glasgow participants there was a correlation
between deprivation and young age that was not evident in the health board
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population. This may result partly from the fact that the Glasgow centre recruited
from two hospital clinics, one serving a deprived area and running a specialist
menstrual problem clinic (dealing with problems across the age range including a
good proportion of young women), the other serving a more affluent catchment and
offering a standard gynaecology outpatient clinic (which typically tends to have an
older referral population). That recruitment was predominantly from the first of these
two clinics may explain the younger demographic of Glasgow participants.
Many of the other differences between Edinburgh and Glasgow participants were
likely be a direct consequence of the differences in age and deprivation. For example,
the younger age distribution in Glasgow may well explain the fact that among
women not living with a partner, Glasgow women were more likely to be single,
Edinburgh women separated/divorced. Another finding was that relatively more of
the Edinburgh women were working (80% v 67%), and working full-time (49% v
39%). It may be thought that this too was due to differences in age, since older
women would tend to have older offspring and therefore would be freer to undertake
employment, and more extensive employment. However, the difference in extent of
working was also evident among nulliparous women, albeit not as strongly as among
parous women. Among parous women there was no detectable difference between
centres in extent ofworking in the most affluent women (codes 1&2, n=140). The
observed differences suggest that among less affluent and deprived women there may
be some fundamental difference between the centres in employment tendency or
opportunity. This reminds us that there may well be other ways in which the two
localities differ, for example in general practitioner referral style, and gynaecologist
management of menstrual complaint.
These findings demonstrate the complexity of the inter-relationships between age,
age at child-bearing and deprivation, and also alert to the need to check all
comparisons for demographic and reproductive differences. Differences that
persisted after adjusting for deprivation and age were higher prevalence of female
sterilisation and greater duration of use oforal contraceptive pill in Edinburgh.
However, even where differences can be explained in terms ofunderlying
differences in deprivation, as for example self-reported comparative health in
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Glasgow women, they may remain of relevance to complaint, and to management in
the outpatient clinic. That is, a woman suffering indifferent health, perhaps largely
because of the deprivation of her circumstances, may very reasonably find heavy
periods less tolerable, and it may well be that her menstrual condition warrants more
radical treatment, because of her multiple morbidity. Other health deficits among
Glasgow women that were very likely explained by deprivation were greater
prevalence ofpast treatment for depression or anxiety, more long-term illnesses,
more minor symptoms, and poorer scores for all SF-36 quality of life scores other
than Vitality and Health Transition. The impression gained from these early
descriptive analyses is that for many women living in considerable deprivation and
suffering poor health, their menstrual complaint must be almost the least of their
problems. Perhaps though it is the only aspect of their lives that is amenable to
remedy.
8.4.4 Overview
There were concerns at the design stage regarding the difficulties in recruiting
women to undertake menstrual collection purely for research purposes, and to
complete such a battery of questionnaires. It is therefore reassuring that those
recruited to the study differ so little from those who were not - as reported in
Chapter 4 -, and that the subgroups participating to a lesser or greater extent within
the study differ in relatively few ways from each other.
Those subject to case note review, essentially those recruited before February 1998,
were as expected on the whole similar to those not reviewed. However, iron status
tests should be interpreted with caution as both rates of and the indications for testing
appear to have differed markedly between centres, and across participation levels in
both centres. The most striking finding was the difference between Edinburgh and
Glasgow participants in terms of demographic and health characteristics.
This is of concern because of the potential association of these factors with menstrual
complaint, and with the management possibilities for such complaint. Some of the
differences reflected the background population, but this may have been exacerbated
by the client specialism of the main recruiting clinic in Glasgow, and perhaps also by
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general differences in referral practice between Edinburgh and Glasgow. Therefore
great care needs to be taken in all analyses to check for confounding by centre and/or
by associated factors.
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8.5 CHAPTER SUMMARY
8.5.1 Comparison between participants recruited in Edinburgh and
Glasgow
There was a difference between centres in referral reason, with more Edinburgh recruits
having been referred for excess bleeding (80% v 71%), and fewer for PMS (3% v 12%). The
two centres were similar in terms of parity, height, BMI, past use of the oral contraceptive
pill, abortions and miscarriages, but they differed as follows:
• There was considerably more deprivation among Glasgow women (53% in codes 6&7,
compared to 6% of Edinburgh women).
• The Glasgow women were younger, with fewer women aged 40 to 49 years (40% in
Glasgow v 58% in Edinburgh), and more under 30 years of age (14% v 6%).
• The parity distributions were very similar in the two centres, despite the age difference,
because in general childbearing occurs at a younger age in Glasgow.
• Relatively more of the Edinburgh women were working (80% v 67%), and working
full-time (49% v 39%), this being evident among nulliparous women and even more
strongly among parous women.
• Glasgow women had poorer self-reported health (26% v 15% rating themselves in
'worse' health than other women their age), more long term illnesses (mainly arthritis,
high blood pressure and migraine) and reported more minor symptoms.
• In terms of the SF-36 quality-of-life measure, Edinburgh women had more favourable
scores for all scales except for Vitality and Health Transition but these differences
largely disappeared if there was stratification by deprivation and long-term illnesses.
• More Edinburgh women were sterilised (32% v 20%) and even if age, parity or
deprivation were controlled for, a difference in female sterilisation rate persisted in the
oldest age band, in the most deprived women, and in the least parous (para 0/1).
• Edinburgh women reported a greater duration of use of the oral contraceptive pill (on
average two years).
• Glasgow women were more likely to have had past treatment for depression and/or





• Compared to local health board population data participants tended to be aged nearer 49
than 25 years, suggesting that referral for menstrual complaint is associated with age
over 34 years. However, this effect was much more marked in Edinburgh than Glasgow.
• In each centre the deprivation distribution of participants was very similar to local
health board population data.
• Compared to Lothian (Edinburgh) the Glasgow population deprivation distribution was
skewed to the deprived end of the range. Therefore the differences in deprivation
between the two centres reflect differences in the background populations.
• As would be expected for an outpatient population, the SF-36 quality-of life scale
scores for participants showed poorer health status/functioning than population norms
for women the same age, for all scales but most markedly for Pain, Role-Physical and
Role-Emotional.
8.5.2.ii Participation to a lesser or greater extent
• Given the attrition in numbers participating through the study levels, from Basic
(n=952) to Full participation (menstrual collection, n=226), there was surprisingly little
shift in the characteristics of the study sample, in terms of the background data
summarised in chapter 4.
• The eligibility criterion for Full participation, having 'putatively heavy periods', meant
that referral for bleeding increased from 76% for the entire study sample to 86% of
those participating fully. Referral for PMS or 'other' decreased, but there was no
reduction across levels in referral for pain. Referral for bleeding and pain, jointly,
increased from 14% in the study sample to 19% of those undertaking menstrual
collection.
• With regard to the remaining characteristics checked, women participating 'fully':
- were more likely to have reported experiencing minor symptoms in the previous
two weeks (backaches, diarrhoea and feeling sad differed by > 8 percentage
points), and had worse SF-36 Bodily Pain and Social Functioning scores
(difference in medians of 10 scale points for both).
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- Were less likely to be sterilised (22% v 31 %) and had been using their current
method of contraception for a slightly shorter period of time (median 7 v 8
years).
8.5.2.iii Iron status blood testing
• Iron status testing was more likely if there had been referral for bleeding (haemoglobin
52% v 35%, ferritin 33% v 21%) and was more common in Glasgow than Edinburgh
(62% v 37% for haemoglobin and 52% v 13% for ferritin).
• Iron status testing rates among those participating fully were higher, and were much
more nearly equal across the two centres than they were for the entire group of
participants. For haemoglobin testing rate, the difference between centres of 37% v 62%
overall, improved to 68% v 88% in those participating fully, and for ferritin the change
was from 13% v 52% to 56% v 86%.
8.5.2.iv Case-note review
• Rates of follow-up review were similar in Edinburgh and Glasgow (70% & 69%).
• There were no detectable differences between those reviewed or not reviewed, except in
respect of self-reported comparative health in Edinburgh participants. Those who judged
their health 'better' than others were more likely to have been reviewed (82% v 68%), but







In Chapters 4 to 6, the study participants have been described, in terms of the basis
for referral to gynaecology clinic, their current menstrual symptoms, background
characteristics, health history, menstrual history, current quality-of-life, an extensive
menstrual assessment, clinical management and outcome, and quantification of
menstrual loss. All 952 participants provided data on referral reason and presenting
complaint, and successively smaller subsets completed the additional measures, with
226 ultimately having measured menstrual loss. In Chapter 8 it was shown that those
recruited were representative ofall referrals, and that those participating to further
levels of the study were representative of those who would have been eligible to do
so. In the present chapter integrative analyses will be reported, linking together
background information, presenting complaint, subjective report ofperiods,
menstrual assessment and quantification of menstrual loss.
9.1.1 Pathway through research study
We can envisage the pathway to the gynaecology clinic (and hence involvement in
the study) to have 'stages' as shown below:
i. The woman judges her periods to be intolerable and so consults her GP.
ii. The GP refers her to a gynaecology clinic - giving referral reason(s).
iii. The woman attends clinic and is recruited into study:
a) completing CQ, which ascertains basic details of periods, including:
heaviness
her account of the reasonfor clinic attendance
how problematic each of16 aspects ofperiods is, and
which of these had been the cause ofhelp-seeking (up to three coded).
b) If agreeable to further participation, she completes MEQ, MBQ, SF-36.
c) If she has 'putatively heavy periods', has completed the above
questionnaires, and is agreeable to doing so, she undertakes menstrual
collection and menstrual charting.
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Across these stages a rich set of data variables has been collected, giving diverse
'assessments' of subjective rating of heaviness ofperiod, perception ofproblems
experienced with aspects of menstruation, which of these have been cause of help-
seeking, and both externally-judged (GP) and self-stated reasons for clinic
attendance now. These data can provide insights to complaint of menorrhagia and to
menstrual problem more broadly.
9.1.2 Research questions
It is has been reported that menstrual problems often occur in combination (Bancroft
et al. 1993). Therefore the first question to be asked of the data (in 9.3.1) is:
How concordant are the GP referral reason andpatient's self-stated reason for
clinic attendance?
The remaining questions to be asked of these data address measured menstrual loss,
that sine qua non of menorrhagia thinking, and subjective menorrhagia complaint.
Regarding measured menstrual loss, the questions to be addressed first (in 9.3.2) are:
What factors are associated with measured menstrual blood volume?
Can measured blood loss be predictedfromfeatures of the clinical history?
Is measured blood volume over 80mL important in identifying complaint and
determining management?
Regarding subjective menorrhagia complaint, loosely defined, questions to be
addressed (in 9.3.3) are:
Whatfactors are associated with reporting ofperiods as 'very heavy'?
Whatfactors are associated with citing volume ofperiods as 'cause' ofhelp-
seeking?
From the GP andpatient perspectives, whatpatientfactors are associated with
referral to gynaecology clinicfor excessive bleeding?
These three questions may seem similar but they are distinct, as will be discussed
further in conjunction with the results. An alternative conceptualisation of subjective
menorrhagia complaint is in terms of the principal component scores derived from
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responses to MEQ questions 22 and 23. Therefore the final questions, to be
addressed in 9.3.4, are:
What are the associations ofsubjective menorrhagia complaint, defined in terms
ofmenstrual experience component scores, with demographic, health and other
factors?
To what extent is measured menstrualfluid volume associated with principal
component scores?
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9.2 METHODS FOR THIS CHAPTER
9.2.1 Key variables
Key menstrual variables ascertained along the pathway can be cross-referenced to the
list outlined in 9.1, as follows:
Stage (if) GP referral reasons, coded as four separate binary variables reflecting
whether one of the two reasons extracted from the letter was (or was not) each of
heavy bleeding, pain, cyclic symptoms, or 'other' (see 3.8.5.i).
Stage (iii a)
Self-stated reasons for clinic visit, coded as four separate binary variables reflecting
whether one of the two reasons for clinic attendance given by the woman in free-text
item on CQ was (or was not) heavy bleeding, pain, cyclic symptoms, or 'other' (see
3.8.5.ii).
Extent of problems with 16 aspects of periods, as they are, as 5-level response
variables, and also re-coded (see 5.2.2.i) as:
- 16 separate binary variables for each aspect indicating severe problem
reported (or not);
- four separate variables indicating how many severe problems have been
reported around excessive bleeding (maximum of 3 possible), pain
(maximum 3), cyclic mood and physical symptoms (maximum 2), or cyclic
symptoms including feeling 'unwell/tired because ofperiods' (maximum 3);
- count variable as to how many of the 16 aspects have been rated as a
marked or sever problem.
Aspects that have been cause of help-seeking, cited in response to the prompt
'Which of these has been the main cause ofyour coming to this clinic?'and coded
(see 5.2.2.ii) as:
- 16 separate binary variables for each aspect indicating whether (or not) that
aspect has been cited as a cause of help-seeking;
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- four separate variables indicating how many 'causes' have been cited (same
maxima as above for severe problems) that could be categorised as
excessive bleeding, pain, cyclic mood and physical symptoms, or cyclic
symptoms including feeling 'unwell/tired because of periods'.
Stage (iii b) Managing periods (see 5.3.4.i).
- one score each for home and workfacilities for dealing with periods;
- 5 principal component scores each for dealing with periods and forfeelings
about periods.
Stage (iii c) Quantification of menstrual loss
- Measured menstrual blood loss and totalfluid volume (see 6.2.1.iv);
- Menstrual chart data (see 6.2.2.iii),
Other menstrual demographic, health and quality-of-life data, were ascertained via
CQ, MEQ, MBQ and SF-36 (stages iiia & iiib on the pathway list in 9,1).
9.2.2 Operationalising 'subjective menorrhagia complaint'
Variables considered as potential indicators of subjective menorrhagia complaint are
listed below, the main ones being given distinguishing 'complaint' labels:
• referral for excessive bleeding
- GP reason for referral (stage ii) - 'GP-judged complaint'
- self-stated reason for clinic attendance (stage iiia) - lay complaint'
• 'very heavy' periods (stage iii) - 'subjective judgement ofheavinessnot
complaint
• citing volume aspect(s) ofperiods as cause ofhelp-seeking (stage iiic)
- specifically relevant, theoretically: citing 'lose too much blood' (n=205)
- more broadly: citing as cause any one or more of three volume aspects
'losing too much blood', 'difficulty avoiding accidents' and 'periods going on
too long' (n=365) - 'volume complaint'.
Chapter 9: Modelling Menorrhagia 329
In addition, the principal component scores of5.3.1.iv will be considered as potential
descriptors of degree ofcomplaint.
9.2.3 Summarising association
The data to be analysed in this chapter comprise continuous variables with
approximately normal distributions, other continuous variables with skewed
distributions, and ordinal variables for which the methods suited to continuous data
can not be used. It was therefore decided that the univariate summary ofassociation
to be applied to all pairs ofvariables would be the Spearman rank order correlation.
This method has been described in 3.8.3.
9.2.4 Logistic regression
To explore the association ofbinary outcome variables with the various menstrual
variables, socio-demographic variables and principal component scores, logistic
regression was used (Kirkwood & Sterne 2003) (pgl89).
Potential binary outcome variables are: subjective report of menstrual loss as 'very
heavy', versus the rest; citing an aspect ofvolume of loss as reason for help-seeking,
or not; referral by GP for excessive bleeding, or not; self-stating that the reason for
clinic attendance is excessive bleeding, or not; measured blood loss in excess of
80mL or not.
Potential explanatory variables were offered to the logistic regression model using
'inclusive' entry and removal criteria: entry criterion (p<0.15) and removal criterion
once in the model (p>0.20). The aim was to obtain a relatively stable model where
succinctness was not the main goal but rather a model that was descriptive in the
sense of including contending variables rather than excluding them. Iterative runs
were undertaken to check the linearity of multi-level variables, and where necessary
variables were re-defined as categorical, though in most cases a non-linear variable
could be simplified into a two-level (binary) variable, or sometimes a 3-level variable
was more appropriate. When entering a categorical variable in a model the lowest
category was set to be the reference category. (For categorical variables it is
preferable for the reference category to have an adequate n to ensure precision of
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estimation ofeffects in the remaining categories.) All factors with more than 2 levels
are linear unless indicated as being categorical.
Once the final model was obtained then the analysis was rerun offering only the
variables determined as 'included' in the model, to maximise n by avoiding
exclusion of cases due to missing data on variables that had been offered to the
analysis but were not ultimately needed in the model. For key variables with large
effects there was also checking for interaction effects.
'Goodness-of-fit' of the model was assessed by calculation of -21og likelihood,
which tests the model obtained against a hypothetical perfect model, which would
reproduce exactly the observed frequencies of the binary outcome variable. This can
be compared to the % distribution for the degrees of freedom remaining after fitting
the factors included in the model, to obtain a probability ofobtaining the frequencies
as predicted if the observed frequencies were the true situation (Tabachnick BG &
Fidell 1996a). This means that a small probability (a 'significant' result) suggests
that the model deviates from the hypothetical 'truth'. Therefore a non-significant
result is aimed for, indicating an adequate model in respect ofpredicted frequencies.
The predictive performance of the model is also reported: overall percent assigned to
the correct outcome category, and percentages correct within each outcome category.
In large analyses performance can be fairly good even when the model fails
(statistically significantly) to reproduce the observed frequencies.
The odds ratios (ORs) summarising the association of the outcome variable with
explanatory variables are those reflecting combined effects in the final model. The
univariate ORs ofassociation of single variables with dependent variables are not
generally presented, for reasons of space. An OR reported for a multi-variable model
represents the association for that (level of the) variable, adjusted for all other
variables in that model. For a woman with a specific profile ofexplanatory variable
values, her (combined) odds, relative to a woman with reference category values for
the variables concerned, for the outcome that is the focus of the modelling, can be
obtained by multiplying together the odds ratios corresponding to her values.
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9.2.5 Recoding variables
Principal component scores estimated in 5.3.1.iv were in general distributed in the
range -2 to +2, although as can be seen in Figures A5.2.1 and A5.2.2 there were
some individuals with more extreme scores. Component scores such as these have no
intrinsic meaning. The information derived from the score is the position of that
individual in the distribution of scores on that component for all individuals.
Therefore, if these scores were entered as linear variables in logistic regression
models the resulting ORs (per unit increase in component score) would be fairly
uninterpretable, without access to the distribution of each component's scores.
Furthermore, if the effect for a particular component score was not linear, recoding
of the score would then be required, to achieve a categorical variable. It was decided
that it would be helpful to reporting ifeach component was from the outset recoded
into 5 categories ofapproximately equal size (20% sub-divisions of the distribution).
Such a recoded 5-level variable could still be entered as a linear variable, if the effect
was linear, or if not it could be tested as a categorical variable. The quintiles were
obtained for the distributions ofthe 5 components on dealing with periods and 5 on
feelings about periods component scores. It was decided, for simplicity, to use
uniform cut off values for all component recodings. Across the 10 components the
first (bottom) quintile ranged from -0.99 for 'had enough ofperiods' to -0.71 for
'resource issues'. On the principle that the first category would be the reference
category for logistic regression, and that estimation advantage derives if this n is
adequate to generous, the value of -0.7 was chosen for the first cut off. This would
ensure the n for that category was at least 20% of the sample for every component.
The remaining cut-offs were chosen by reference to the corresponding quintiles, and
were -0.3, 0.4 and 0.9. This is shown in the top half ofTable 9.1. If such a 5-level
variable did not have a linear effect for the logistic regression model, and if the
categorical form of the variable entered in the model revealed that the effect showed
a step-wise increase between some neighbouring categories and the remainder, then
the variable could be further recoded as binary. An example of this is shown in the
bottom two rows ofTable 9.1. Sometimes recoding to a 3-level variable was more
appropriate to the observed profile of effect.
332 Menorrhagia Reconsidered
Table 9.1 Recoding of principal component scores, from original scores to
'fifths' of the distribution, and an example binary recoding
Values and distribution of component scores
Cut off used -0.7 -0.3 0.4 0.9
Category
scores











Bottom '3/5' (or '60%) Top '2/5' (or '40%')
Seven of the eight SF-36 scaled scores and the MEQ home and work facilities total
scores also were recoded into 5-level variables, with sub-category n's as similar as
possible (again, dividing the distributions into fifths). The very different
distributions across SF-36 scaled scores meant that for each scale score the specific
quintiles had to be used as cut-offs. Role Emotional had only 4 possible values, so
already comprised a 4 level variable, and Health Transition was a five-level variable,
The five categories for 'home facilities' were defined by scores of 0 to 1, 2, 3, 4 to 5
and >6, and the categories for 'work facilities' were defined by scores of 0 to 2, 3 to
4, 5 to 6, 7 to 9 and >10.
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9.3 RESULTS
9.3.1 Reason for clinic attendance
9.3.1.i Concordance between patient's reason and GP reason for referral
The GPs were more likely than women to give suspected pathologies as reason for
referral, for example 'fibroids' or Tow haemoglobin'. Both these reasons would be
coded as 'other', whereas in both cases the GP may have menorrhagia in mind. The
women were more likely to state 'symptom' reasons, such as 'irregular periods'
which was coded as 'other', or terms like 'flooding', 'pain' or 'PMS' which could be
coded directly as 'excessive bleeding', 'pain' or 'cycle' respectively.
Nevertheless, in terms of patient's self-stated reason for attendance at gynaecology
clinic, the overall prevalences of cycle-related changes and 'other' reason are very
similar to their prevalences as GP referral reasons, but bleeding was less often given
as a patient reason (60% v 76%), and pain more often cited (30% v 23%). For each
of the four reasons for clinic attendance, concordance between patient and her
referring GP was examined by means ofMcNemar's test for paired proportions.
Results for these analyses are presented in Table 9.2.
Table 9.2 Discordance between general practitioner referral reason and












Bleeding 27.4 4.01 (3.0-5.3) 93.2 <0.001
Pain 23.6 0.54 (0.4-0.7) 19.4 <0.001
Other 31.8 1.13 1.1 0.30
Cycle-related
changes
4.9 1.04 0.0 0.99
* only one of doctor or woman cites this reason
ratio = frequency doctor only cites reason + frequency woman only does so
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It was found that there was minimal discordance where cycle-related changes were
the reason, but that in around a quarter of cases the referring doctor and patient
disagreed whether bleeding was the reason. There was a similar level of
disagreement for pain, while for 'other' there was discordance in a greater
proportion, about a third of cases. For bleeding there was marked imbalance in the
direction of discordance, with a ratio of 4:1 that it would be the doctor rather than the
patient citing bleeding (p<0.001). In the case of pain as cited reason, discordance was
in the opposite direction but not as marked, with general practitioners significantly
less likely to mention pain (p<0.001). Despite the high level of discordance for
'other' reason there was no imbalance in the direction of discordance.
In 4.3.3.ix the distribution of the various combinations of referral reasons was
ascertained (as presented in Figure 4.16). The same summary was obtained for
patients' self-stated reasons for clinic attendance. Figure 9.1 shows the distribution
of combinations of patients' self-stated reasons for attendance at the gynaecology
outpatient clinic, compared against the distribution for combinations of referral
reasons cited by GP.
Figure 9.1 Prevalence of the various (combinations of) reasons for clinic
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By visual inspection it appears that participants were less likely than their referring
GPs to cite bleeding only, or bleeding plus other, more likely to cite 'other' only,
pain only and, marginally, bleeding with pain. This is generally consistent with the
findings for the independent McNemar's tests reported in Table 9.2. The percentage
and hence number ofwomen with a combination of bleeding and pain as reason for
clinic attendance was similar for both GP referral reasons and self-stated reasons
(n=130 & 139). However, this was despite considerable discordance, since only 42
women were common to both subgroups i.e. were classified as 'bleeding with pain'
for both GP referral reasons and self-stated reasons.
On the whole the associations of the patients' self-stated reasons for clinic attendance
with the demographic variables (age, deprivation, parity, self-reported comparative
health and extent ofworking) and sterilisation (either and female only) were very
similar to those reported for GP referral reason in 4.3.3.ix. The only notable
differences were that for self-stated reason there were stronger associations of
bleeding reason with age and parity, and ofpain with lower parity, and that there was
no detectable association with age of the combined reason 'bleeding and pain'.
9.3.1.ii Factors associated with discordance between self-stated and GP
reasons
The discordance for bleeding was evident across age-bands, deprivation and parity
categories and centres. It was more marked for women in deprivation areas 5 to 7,
for nuiiiparous women, for women aged 35 to 39 years, and for women with self-
reported health 'the same as others'. The discordance for pain was less evident in
women from areas with least deprivation (codes 1 and 2), in Edinburgh, aged under
40 years, who were para 3 or more, and with self-reported health 'the same as
others'.
9.3.1.iii Pathway to clinical care
Overall, of the 725 referred for excessive bleeding by their general practitioner, less
than half (46%) had noted volume as 'cause' ofhelp-seeking. Furthermore, this
differed by subgroup: bleeding was identified as cause ofhelp-seeking by 60% of the
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311 reporting it as a severe problem, but by only 34% of the 414 who did not. Figure
9.2 illustrates the healthcare pathway for menorrhagia (excessive bleeding),
separately for those who do and do not identify volume of bleeding as a health
problem in these ways. Among those who reported volume of bleeding as a health
problem (right-hand bar), that is as a severe problem and /or as 'cause' of help-
seeking, 89% were referred for bleeding, and the majority of these women also self-
stated bleeding as the reason for clinic attendance. Of those who reported volume
neither as a severe problem nor as 'cause' of help-seeking (left-hand bar), 63% were
nevertheless referred for bleeding, and in just over halfof these the woman stated
that bleeding was a reason for the clinic referral. Therefore discordance was more
prevalent in the latter subgroup (first column).
Figure 9.2 Frequency with which general practitioner (GP) and/or patient






reason for clinic visit
□ by GP only
□ by GP and patient
□ by patient only
□ by neither
Neither severe problem nor Severe problem and/or cited
cause of help-seeking as cause of help-seeking
(n=435) (n=515)
Patient reports volume of bleeding as:
Diagnosis of dysfunctional uterine bleeding was made for over a third of women who
neither reported periods as subjectively very heavy, nor reported excessive loss as
severe problem, nor gave bleeding as reason for clinic visit (35% of 165).
Considering the minority referred by their doctor for something other than excessive
bleeding, diagnosis of dysfunctional uterine bleeding was nevertheless made for a
third of them (30% of 150). Hysterectomy was more likely if there was diagnosis of
fibroids (39% of 85 with fibroids). Among the remainder, without this pathology as
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possible indication for surgery (n=545), hysterectomy was strongly associated with
referral for bleeding (RR 4.9, 95%CI 1.6-15.6, Fisher exact test p=0.001), but was
only marginally associated with reporting volume of loss a severe problem (RR 1.8,
1.02-3.2, p=0.051), and was not associated with excessive bleeding as patient's
reason for attendance (p=0.21).
9.3.2 Measured menstrual loss
9.3.2.i Associations between measured menstrual blood loss and clinical
factors
Referral by GP for bleeding was not indicative of significantly greater volume of loss
(54mL v 43mL, n=196 v 30, ratio of means 1.35, 95% CI 0.91 to 2.00, p=0.14) (see
6.2.3.Hfor explanation ofratio ofthe means). However, measured blood loss was
greater for women who believed their clinic attendance to be for excessive bleeding,
compared to the remainder (59mL v 39mL, n=160 v 66, ratio 1.54, 95% CI 1.15 to
2.06, p=0.004). The differences between centres in socio-demographic factors, and
possibly in blood loss determinations, and very likely also in local referral 'practice',
meant that checks of these comparisons separately within centre would be advisable.
It was found that separately within centre there were not significant differences in
mean blood volume between those referred by their GP for bleeding, and the
remainder (ratio ofback-transformed means for Edinburgh was 1.4 (95%CI 0.7 to
3.0) and for Glasgow 1.5 (95%CI 0.4 to 2.4).
With regard to self-stated reason for clinic attendance, there was no difference in
Edinburgh (ratio of means 1.0, 95%CI 0.7 to 1.6), but there was in Glasgow (2.0,
95%CI 1.4 to 2.9).
Table 9.3 gives the associations of blood loss volume with key clinical menstrual
variables, features that could be ascertained in the clinical history, and with
demographic factors. Volume of menstrual blood loss was weakly associated with
increasing age, and weakly negatively associated with deprivation, in that more
deprived clinic referrals tend to have lower volumes. It is noteworthy that measured
blood volume was not associated with female sterilisation in this sample.
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Subjective report of heaviness of period
At the group level the subjective judgement of heaviness of periods was supported,
with the mean loss of 64 mL for those rating periods 'very heavy' compared to 40mL
for the rest (predominantly 'heavy') (n=107 and 118, means back-transformed from
logged data, p<0.001). The average ratio of volumes was 1.61 (95% CI 1.23 to 2.10),
meaning losses that were 60% higher if periods were rated very heavy. However, it
should be noted that there is nevertheless substantial overlap in the ranges of
individual measured losses. For example, 25% ofwomen who rated their periods
'very heavy' had volume of loss less than 35mL, and 25% of those rating their
periods only as 'heavy' had loss exceeding 82mL.
Table 9.3 Association of blood loss volume with demographic/clinical
factors
Correlation
Effective n coeff. rho * P
Demoaraohics
Age group (youngest to oldest) 226 0.11 0.100
Deprivation (least to most) 222 -0.11 0.095
Number of babies (0 to 6) 226 0.11 0.109
Subjective heaviness of Deriod
Subjective rating of menstrual loss 225 0.23 <0.001
(moderate; heavy; very heavy)
Clots
Size of clots (none; 20p; 50p; or bigger)# 226 0.26 <0.001
Usual no. (per period) of clots > 50p# (0 to 28) 214 0.26 <0.001
Iron status
Ferritin ('low'; normal) 168 0.30 <0.001
Haemoglobin (<12g/dL; >12g/dL) 182 0.23 0.002
* Spearman rank order correlation
# UK coins: size (diameter) of 50p is 1.1inches and of 20p is 0.85 inches
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Clots and iron status
As can be seen in Table 9.3, the clinical features most strongly associated with blood
volume were low ferritin result (rho = 0.30, 95% CI 0.15 to 0.45); the size and
number of clots (for both rho = 0.26, 95% CI 0.12 to 0.40); and reported heaviness of
periods (rho = 0.23, 95% CI 0.11 to 0.35). There was evidence that low iron status
was associated with measured blood volume, for ferritin more strongly than for
haemoglobin.
Containment of period
Other information that could be ascertained by the clinician would be about efforts
required to contain the period. Table 9.4 shows the containment factors (ascertained
from MEQ and CQ) which were associated with blood volume.
Table 9.4 Association of blood loss volume with containment factors
Correlation
CONTAINMENT OF PERIOD Effective n coeff. rho * P
Quantity tampons/pads used in most recent period
(0 to 136)
207 0.30 <0.001
Time until next change needed, during 'full flow'
(> 3 hours; 2 hours; about an hour; shorter)
218 0.30 <0.001
How often periods...
...require protection changed during the night
(seldom; some periods; most)
226 0.26 <0.001
...leak through onto underclothes or bedding
(seldom; some periods; most)
226 0.23 <0.001
Usual days per period double protection required
(0 to 12)
221 0.25 <0.001
Number per period of leakage onto underclothes
(0 to 10)
223 0.16 0.015
* Spearman rank order correlation
The most strongly associated factors were: the shortness of the time interval before
another change of sanitary protection was needed, during full flow; the total number
of pads/ tampons used in the most recent period; and the need for changes of
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protection during the night (rho = 0.30, 0.30, 0.26; 95% CI 0.16 to 0.44). Figure 9.3
presents box-plots of measured volumes against the first two of these MEQ variables,
and shows the extent of overlap in ranges of volumes between the subgroups.
As detailed in Chapters 5 and 6 there were concerns about differences in blood loss
determinations between the two centres, so this is of concern when calculating
Spearman correlation coefficients overall (ignoring centre). Therefore the
associations presented in Tables 9.3 and 9.4 were checked separately within centre,
as far as was possible given the smaller n's for the strata (particular problem for
ferritin results in Edinburgh). It was found that the associations for age and
deprivation were stronger within strata than they appeared overall, possibly due to
confounding by centre suppressing the effect when ascertained 'overall'. Conversely,
the association with subjective heaviness was weaker within centres, suggesting that
confounding had inflated this effect. There was also some suggestion of effect
modification, since the effects for parity, low ferritin and leakage all showed
considerably weaker effects within Edinburgh compared to Glasgow.
Figure 9.3 Associations with measured blood volume: a) Changing rate









N = 49 91 51 27
3-hourly 2-hourly hourly more often
66 39 32 38 32
<21 21-29 30-32 33-44 45+
CHANGING REQUIRED DURING 'FULL FLOW' TOTAL SANITARY PRODUCTS USED
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Outcome
Considering the study group as a whole there was very little difference in volume of
loss between those proceeding or not to hysterectomy (median 59mL and inter¬
quartile range 21-140mL versus 53mL, 27 to 97mL). Table 9.5 shows that amongst
those diagnosed with fibroids (20/176, 11%), there were as expected slightly heavier
losses, and higher rates of poor iron status.









Yes 20 85 (38-168) 7/17 (41%) 5/18 (28%)
No - but hysterectomy
performed
25 53 (20-129) 5/16 (31%) 7/24 (29%)





64 63 (27-111) 6/46 (13%) 14/52 (27%)
Dysfunctional uterine
bleeding - irregular
43 41 (19- 83) 5/28 (18%) 8/33 (24%)
Other* 49 52 (27- 92) 4/37 (11%) 2/39 (5%)
Total 156
* Mainly anovulatory bleeding, polyps, endometriosis, polycystic ovary syndrome.
Among women without diagnosis of fibroids, there was little difference between
those proceeding or not to hysterectomy, in volume of blood loss (median 53 versus
52mL), but there was a trend for those having hysterectomy to have poorer iron
status (low ferritin: 31% versus 11%; haemoglobin <12: 29% versus 17%). Table 9.5
also gives the median blood loss and iron status for these women, by diagnosis.
9.3.2.ii Can blood volume over 80mL be predicted from clinical features?
A logistic regression model was fitted to predict losses exceeding 80mL, with
potential predictors the clinical and demographic variables described above (but not
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the chart data, which would not be available to the clinician unless charting was
undertaken, and even if so not until some weeks later). Structural variables entered
in the model were centre (Edinburgh or Glasgow), age group (under 40 years, or 40
plus). Additional variables required in the model to predict loss over 80mL were:
clots greater than 50p size; 'low' ferritin result; and the interval possible between
changes of sanitary protection during full flow. The model was rerun restricted to the
variables established as required in the model, which minimised exclusion ofwomen
due to missing data on any one of the variables being offered to the model. This
increased the number of useable cases to 161, producing the model in Table 9.6.
Table 9.6. Factors included in the logistic regression model predicting




OR 95% CI P
Factors entered in the model
Centre -Edinburgh 50 0.61 0.2 to1.5 0.287
Age - less than 40 years 82 0.97 0.6 to 1.5 0.873
Factors selected into model
Clots - > 50p size 32 4.80 1.9 to 12.2 0.001
Ferritin result - 'low' 25 5.71 1.9 to 17.4 0.002
Maximum time before change of
protection needed, during full flow:
0.006
3 hours or more 38 ref.
1 to 2 hours 104 1.10 0.6 to 1.9
Less than an hour 19 3.08 1.4 to 6.8
Total n for model =161
* For each of the 4 binary variables the n for the subgroup not shown can be obtained by
subtraction from 161. For the categorical factor (time between changes) all three
subgroups, including the reference category, are shown.
The prediction success of this model was 76% overall, correctly predicting 60% of
the 60 with measured losses exceeding 80mL, and 86% of the 101 with losses under
80mL. The coefficients and performance changed minimally from the initial model
based on 151 cases. Since relatively few women had ferritin tests, only 151 women
could be utilised to derive a model involving ferritin result (161 women once the
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impact of missing data was minimised by re-running the model specifying only the
variables needed in the model, as explained above). Nevertheless, the model
including ferritin performed better than one not including iron status test data, and
hence based on all collectors with complete data for the other model variables
(performance 71%, n=202, model was otherwise little changed).
This model was derived using variables ascertainable at the initial clinic
appointment. An alternative would be to request charting of the next period and use
the chart data provided to estimate of blood volume itself, rather than merely the
prediction ofblood loss more or less than 80mL. This has been reported in 6.3.3.
9.3.2.iii Is the 80-mL criterion useful in management of menorrhaqia?
The distribution of measured blood losses have been reported in 6.3. l.i; 46% of
women had losses less than 50ml, 20% 50 to 79 ml, 15% 60 to 119 ml and 19%
losses of 120ml or more (n=104, 45, 35 and 42). Figure 9.4 shows the prevalence of
reporting ofproblems with pain before or with periods, mood or general cyclical
changes, and unpredictability of onset ofperiods. All are significantly associated
with volume, but inversely, with problems greatest in those with lowest loss, in this
clinic group.
Figure 9.5a and 9.5b show two more sets ofassociations with blood loss group.
Apart from the aspects shown in Figure 9.4, the only problems with periods
significantly associated with blood loss were aspects of containment of flow, as
shown in Figure 9.5a. The major differences were between the lightest and heaviest
loss groups, with those on either side of the 80 ml criterion virtually
indistinguishable. Figure 9.5b shows some other aspects of menstruation that might
have been expected to be related to menorrhagia complaint. None increases
significantly with volume. The pattern for worry was u-shaped, most prevalent in
those with lightest and heaviest loss. Again there was little difference in prevalences
for groups either side of 80mL.
Figure 9.4 Severe problems with periods inversely related to volume of
loss: prevalences (%) by blood loss group for pain, cycle
changes and unpredictable onset.
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< 50 ml 50-79 ml 80-119 ml 120 ml +
Blood loss group
> Rain w ith periods (p=0.015)
o Pain before periods (p=0.003)
—©—Any pain around periods (p=0.003)
• Moods changes around periods (p=0.002)
o Any cyclical changes (p=0.007)
—A— Unpredictable onset of periods (p=0.012)
With regard to potential physiological and treatment consequences of heavy periods,
Figure 9.6 shows that the proportions with 'low' ferritin levels and haemoglobin
(below 120g/L) increases significantly across loss groups, but again no marked
increase from less than 80mL to more.
The pattern was very similar in Figure 9.7, which shows proportions diagnosed with
some pathology, or with fibroids specifically, and proportions recommended
tranexamic acid as treatment, or with decision to have hysterectomy. However for
these outcomes the trend is not statistically significant.
In all these blood group analyses checks were made for confounding by centre by
repeating the analyses within centre. This was necessary because of the difference in
blood loss volume determinations between the two centres.
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Figure 9.5 Prevalences (%) by blood loss group of severe problems with
periods, for:
(a) containment, extra washing and impact on daily life.
(All show significant z2 for trend - p values (1df) given in legend.)
(b) volume of bleeding, feeling unwell/tired, and worry something
is wrong.

















<50 ml 50-79 ml 80-119 ml
Blood loss group
o Accidents a severe problem (p<0.001)
o Impact on daily life cause of help-seeking (p=0.046)




















<50 ml 50-79 ml 80-119 ml
Blood loss group
120 ml +
- Losing too much bbod is severe problem
-Worry something w rong is cause of help-seeking
- Feeling unw ell/tired is a severe problem
Bleeding is a cause of help seeking
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Figure 9.6 Prevalences (%) by blood loss group of poor iron status: low
ferritin and haemoglobin <12 g/dL.
(Both show a significant %2 for trend -p values (1df) given in legend.)
Blood loss group
♦ Low ferritin (p<0.001,n=168) —®— HB<12 (p<0.007, n=182)
Figure 9.7 Clinic outcome by blood loss group: diagnosis of fibroids or any
pathology, tranexamic acid as treatment and performance of




—- _ /\ _■
1
<50 ml 50-79 ml 80-119 ml 120 ml +
Blood loss group
—X— Diagnosis of fibroids (n=176) o Hysterectomy w ithin 8 months (n=179)
—X—Diagnosis any pathology (n=176) ♦ Hysterectomy before end of study (n=179)
—B—Tranexamic acid recommmended (n=184)
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9.3.2.iv Associations between measured menstrual loss and prospectively
recorded menstrual chart variables
Associations with duration, product use, accidents and clots
The product usage variable used in Figure 9.3 was the patient's recall of number
products used for the most recent period, whereas for women who completed a
menstrual chart, the exact number ofproducts used for the period collected was
recorded on the chart. Similarly the containment factors reported in Table 9.4 were
as recalled for recent periods, whereas more relevant and probably also accurate
information was obtained on the Menstrual Chart. Table 9.7 present the associations
of measured blood volume and measured total menstrual fluid volume with
prospectively charted features of the period.
Table 9.7 Associations of measured menstrual volumes with menstrual
data prospectively recorded on the Menstrual Chart








Total number of changes
Days duration of period
Number of clots >50p size
Number of leaks onto outer clothes
or bedding













* Spearman rank order correlation.
It can be seen that the associations of blood volume with these prospectively
recorded variables are far stronger than for recalled 'typical' data, in particular with
the total number of products used. The number ofproducts must depend partly on the
duration of the period, independently of the volume of loss. For women who
completed a menstrual chart, the association between measured blood volume of that
period could be examined in relation to both the total duration of the period and the
number of products used in that time. This is shown in Figure 9.8. It can be seen that
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compared to Figure 9.3 (recall data), Figure 9.8 (recorded usage) showed a steeper
rise in volume across the levels of quantity of products used. (For recorded usage, the
distribution of number of products has been recoded into quarters, approximately.)
Therefore, the use of more than 25 products was indicative of heavy blood loss, but
not so strongly indicative if the use of many products occurred in the context of a
period lasting more than 6 days.
From Table 9.7 it can also be seen that the correlations were much stronger with
duration of period and number of products/changes required to contain the period
than with individual rates of cancelled activities. It is also noticeable that for all
variables other than clots the associations were stronger with total fluid volume than
with measured blood volume.
Figure 9.8 Box-plots of measured volume by duration of period and number




















N= 38 18 1 1
up to 4 days
17 46 28 10
5 or 6 days
12 19 17
7 or more days
Duration of period charted
Menstrual volumes by judgement of collected period compared to 'usual'
On CQ and MEQ most items addressing periods asked for responses to reflect
periods in the last 6 months. Each woman who undertook menstrual collection was
asked at the end of it to indicate on the Menstrual Chart how the period collected
compared to her periods in the last 6 months. She was asked to make this judgement
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with respect to five features: the amount of loss, prevention of usual activities,
leakage of period onto clothes, severity of period pain and tiredness. There was no
association between measured volumes and judgements about tiredness and leakages
relative to usual. Table 9.8 presents the associations of measured volumes with
judgements about how representative the other features were ofusual periods.
Measured blood volumes tended to be higher if loss was judged to be more than
usual and if there had been more interference with activities. There were similar but
stronger associations for total fluid volume. In contrast, if severity of pain was
judged to be more than usual then blood volume tended to be lower.
Table 9.8 Associations of measured menstrual volumes with Menstrual
Chart judgements of features of the collected period being more
rather than less than usual
















* Spearman rank order correlation.
With regard to judgement about amount of period, disregarding 17 women (7.6%)
who failed to complete this item, 5% of the remainder reported the collected period
as more in amount, 16% as about the same, 42% as a bit less, and 36% as much less.
The mean blood loss volumes differed significantly between those answering 'much
less' than usual and the rest (40.3 mL v 54.9 mL, n=73 v 126, ratio 0.74, 95% CI
0.54 to 0.99, p=0.04), as did the total fluid volumes (ratio 0.70, 95% CI 0.53 to 0.93,
p=0.02). This reduction in volume was more pronounced among certain subgroups:
the oldest women, those who had had most babies, and the least deprived (relatively
affluent). This is illustrated for blood volume by age group in Figure 9.9,
If the non-parametric associations ofblood volume with these demographic variables
were re-calculated excluding women whose collected period was 'much less than
usual', the correlations obtained were, despite the smaller n, stronger than reported in
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Table 9.3 for the entire group. That is, for age group rho=0.25, p<0.004; for number
of babies rho=0.24, p<0.007; and for deprivation rho = -0.19, p<0.037 (n=126 for all
three). There was however no improvement in the association between volume and
referral for bleeding.














N = 8 19 36 44 19
Much as usual
8 10 18 22 15
Much less than usual
'REPRESENTATIVENESS' OF COLLECTED PERIOD
9.3.3 Subjective menstrual complaint
9.3.3.i What are 'very heavy' periods?
A high proportion of study participants rated their periods as heavy (81%), but only
36% rated their periods as 'very heavy'. It is of interest to model the factors
associated with such a judgement. Logistic regression models were developed by
allowing the statistics program to select variables to be included in the model, as
explained in 9.2.4, Table 9.9 lists the variables 'offered' to the model, grouped into
broad categories.
Table 9.10 shows the model obtained for 'very heavy' periods, based on 540 women
who had non-missing data for all the variables included in the model (out of a
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potential n ostensibly 'completing' CQ and MEQ of 714. The model was adequate,
showing insignificant deviation from the hypothetical perfect model (-21og
likelihood=441, df=526, p>0.50). The predictive performance of the model was 81%,
better at prediction of the 342 with periods less than very heavy (89% correct) than
the 198 with very heavy periods (69%).







severe problems with aspects 'lose too much blood', 'difficulty preventing
accidents', periods go on too long'; frequency of leakages and of having to get
up at night to change; size of clots.
recall of total number of sanitary products used for most recent period; usual
number of days full flow; how frequently have to change during full flow;
frequency of use of double protection
'impact of volume', 'resource consequences'
'containment distress', 'resent resources used'
CQ
Chanqe in amount of loss






created variable indicating the number of severe problems reported for 3
aspects of period-type pain (with/ before periods, and 'all the time'); similarly for
3 aspects addressing cyclic mood/physical symptoms and feeling 'generally
unwell/tired because of periods'
regular (troublesome) symptoms /feelings around periods
'variable flow', 'unpredictable onset', 'unwell/irritable during period'




age, centre, deprivation category, self-rated comparative health
home facilities (for dealing with periods) deficit score
* CQ = Clinic Questionnaire; MEQ = Menstrual Evaluation Questionnaire; PCd = principal
components addressing 'dealing with periods' and PCf= components addressing
'feelings about periods' (PCs derived from MEQ data - see 5.3.1.iv)
Table 9.10 presents the factors in the model, grouped into variables relating to
absolute volume, change in volume, other menstrual aspects, and socio-demographic
factors. Within 'absolute volume' the variables can be further sub-divided into those
addressing volume itself, and those addressing the containment implications of
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volume. It can be seen that judgement ofperiods as 'very heavy' was more strongly
associated with the containment implications (first 5 variables listed), than absolute
volume itself (next 3 variables). In terms ofeffect size and subgroup n's, need to
change during the night was a key variable. The 225 women who had to get up at
night most periods had over 4 times the odds (relative to those who seldom had to do
so) of rating their periods very heavy. The 282 women (52%) with highest scores on
the component reflecting expressed distress regarding containment strain had double
the odds of rating their periods very heavy. So did the 100 women (19%) with most
extreme scores on the component 'impact ofvolume', reflecting the steps that have
to be taken to deal with flow.
With regard to volume per se, Table 9.10 shows that women 'losing too much
blood' had 2.5 times the odds ofjudging their periods very heavy, but there were
only 124 in this category. Rating periods as 'very heavy' was also associated with
finding increase in period a severe problem (doubled odds). However, a high home
facilities score (socio-demographic section), indicating deficit, was associated with,
ifanything, a reduction in odds of reporting periods very heavy (a halving of odds
for those with the worst facilities, that is scores >5), but with a wide confidence
interval, so that the null odds ratio of 1 is plausible. This nevertheless suggests that
women's judgement ofperiods as very heavy is not a consequence of inadequate
home facilities for dealing with periods.
With regard to other menstrual factors, finding a severe problem with periods going
on too long (n=142) was inversely associated, in that the odds of rating periods 'very
heavy' heavy was halved. The component reflecting symptoms of irritability and
'being unwell' during periods was related to 'very heavy', with doubled odds for the
199 (37%) with most extreme scores. Finally, there was a strong association with the
component indicating that the woman had 'had enough ofperiods', with trebled odds
of a 'very heavy' rating among the 199 (21%) with most extreme scores.
For a woman reporting severe problems with accidents and with losing too much
blood, and that she has to get up at night to change most periods, her odds of rating
her periods very heavy, relative to a woman with reference category values for all
variables in the model, is 37.
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Table 9.10 Model predicting subjective report of menstrual loss as 'very
heavy' (n=540)
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0.027 > 2 hours
<1 hour
371
169 1.75 (1.05 2.93)
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y *y *** pcd- principal component about management of periods (Appendix 5.2), PCf = PC
addressing feelings about periods (Appendix 5.2). The distributions were divided into
approximately 'fifths' at - 0.7, - 0.3, 0.4, 0.9, as explained in Table 9.1.
Footnotes to Table continued on next page.
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Footnotes to Table 9.10 continued
** Effect not linear but if recoded as binary, as shown, was a useful addition to the model.
*** Effect was not linear but if recoded as a 3-level variable, as shown, was a useful
addition to the model as a linear variable.
# For brevity results for these 5-level linear variables have been presented only for the
bottom fifth (OR not shown but taken as 1), the next fifth up, and the top fifth. For each
variable the ORs for the levels not shown can be obtained by squaring/cubing the first
OR reported. The levels not reported make the total n up to 540.
The modelling was also tried with the inclusion of the SF-36 quality-of-life scaled
scores and Health Transition score offered to the model. (The scaled scores were first
recoded into approximately fifths of the distribution, as for principal component
scores (9.1.1).) This inevitably resulted in a greater loss of cases to missing data.
The SF-36 scales included in the model were Physical Functioning, Vitality and
Mental Health, with good physical status and vitality, or poor mental health, making
rating ofperiods as very heavy more likely. Poor comparative health, and the
component addressing worry about changes, were also included in that model for
rating periods very heavy. Home facilities deficit score, containment distress and
severe problem with losing too much blood were no longer included in the model.
9.3.3.ii What kind of periods are associated with citing volume of period as
cause of help-seeking?
As was noted in the Introduction (9.1), citing one or more of the volume of loss
aspects ofperiods as the 'cause' of help-seeking is probably the closest we have to an
indicator of menorrhagia complaint. The three aspects considered as indicators of
volume issues, and hence as potential volume causes (if cited at the end ofquestion 5
ofCQ), were 'lose too much blood', 'difficulty preventing accidents' and 'periods go
on too long'.
For the binary 'volume as cause' variable a similar modelling process was
undertaken as for 'very heavy' periods. The variables offered to the model were as
already listed (Table 9.9), with the addition of the CQ variable 'heaviness of loss'
(which could not be in the 'very heavy' model as a binary form of it was the
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dependent variable for those analyses). Table 9.11 presents the model for 'volume
as cause of help-seeking', calculated on 524 cases.
Table 9.11 Model predicting citation of volume aspects of period as cause
of clinic attendance (n=524)
Variable P Levels n OR (95% CI)
Absolute volume








LOSE TOO MUCH BLOOD
during period?








How often use DOUBLE
PROTECTION







0.032 not v. troublesome
very troublesome
389
135 0.58 (0.35, 0.95)











102 0.47 (0.26, 0.87)
* PCd= principal component about management ofperiods (Appendix 5.2), PCf about
feelings about periods. The distributions were divided into approximately 'fifths' as
explained in Table 9.1. The effect was not linear but if recoded as binary variable, as
indicated, was a useful addition to the model.
The model shows significant deviation from the hypothetical perfect model (-2log
likelihood=588, df=516, p<0.02). The predictive performance of the model overall
was 72%, but better at prediction of the 327 who did not cite volume as cause (88%
correct) than the 197 who did (44%). The previous test informs that the frequencies
reproduced differ from those observed; it can be seen that the model was better at
exclusion ofvolume citation (88%), than predicting those who did cite volume
(44%).
It can be seen that citation of volume as cause ofhelp-seeking was strongly
associated with volume factors. Heaviness was in the model, with rating of periods as
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heavy, and even more so very heavy, increasing the odds of citation ofvolumes as
cause of help-seeking (OR 1.65 and 2.72 respectively). As has been shown in the
preceding section, rating of periods as very heavy is associated with a range of
factors, mainly encompassing containment consequences ofvolume, but also volume
itself 'losing too much blood'. Despite the inclusion of heaviness in this cause
model, 'losing too much blood' is also required, in the sense that it provides
information additional to 'heaviness' needed by the model. The 118 women finding
volume of loss a severe problem have trebled odds ofciting volume as cause.
Duration of the full flow phase of the period, and need for double protection, are also
associated (OR 2.4 and 1.4 respectively). Apart from these variables there are no
other variables positively associated with citation of cause as volume. Some other
menstrual variables are protective, in that high scores on these variables are
associated with lowered odds ofciting volume as cause (troublesome cyclic
symptoms, being irritable/unwell during period, feeling periods a burden, any of
which approximately halves the odds).
For a woman reporting very heavy periods, severe problem with losing too much
blood, and 'full flow' lasting more than 5 days, her odds of citing volume as cause of
help-seeking, relative to a woman with reference category values for all variables in
the model, is 21. However, if she is also unwell and irritable during her period, then
her odds ratio would be only 14.
The modelling was also tried with the inclusion of the SF-36 variables offered to the
model but none was included in the model.
It is of interest to compare the model for 'volume as cause of help-seeking' with that
for rating periods as 'very heavy' (both as presented in the tables, without SF-36
quality-of-life factors being offered to the models). A schematic diagram of the
models is presented in Figure 9.10. The factors in each model, and the degree of
association, are represented by the bars, red for 'very heavy' and blue for 'volume as
cause'. Bars to the right (0R>1) represent positive associations with outcome
variable, the length of the bar being the size of the OR for the most extreme
category/value in the relevant model (as reported in the corresponding table). Bars to
the left (0R<1) represent negative or protective associations. The asymmetric nature
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of the OR scale means that a negative (protective) association of OR=0 5 is of the
same degree as a positive association of 2 (=1/0.5).
Figure 9.10 Comparison of factors associated with reporting periods as 'very
heavy', and citing volume of loss as cause of help-seeking
HEAVINESS of period =very heavy
NIGHT changes needed most periods
Difficulty avoiding ACCIDENTS= sev. problem




CLOTS > 50p size
CHANGING INTERVAL <= 1 hr
IIVPACT OF VOLUME (PCd)
FULL FLOW >5 days







INCREASE in period = severe problem 1 Increase in loss
HAD ENOUGH OF PERIODS (Pa)
IRRITABLE/UNWELL (PCd)









0 1 2 3 4 5
OR
■ Cites volume as cause of help-seeking □ Reports bleeding as very heavy
Figure 9.10 shows that the 'cause' model has fewer factors included, and that these
are predominantly volume/containment variables. The variables offered to the two
models were the same, with the exception of the additional offer to the 'cause' model
of the 'heaviness' variable. As can be seen the model for very heavy (Table 9.10)
was strongly and broadly associated with containment factors. Once heaviness was
included in the 'cause' model there was apparently little need for further variables
reflecting containment strain. The same appears to apply to the component 'had
enough of periods' which was strongly associated only with 'very heavy'. Over and
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above the extent to which the component (or factors associated with it such as
intolerable periods) may be implicit in the rating ofvery heavy, it is not needed in
the 'cause' model. However, in the case of'losing too much blood', which was
included in the 'very heavy model' there was nevertheless need to have the factor
also in the 'cause' model, presumably because it provided additional predictive
information about citation of volume as cause. In the context of other variables in the
models, being unwell or irritable with the period was positively associated with
rating periods very heavy, but protective against citing volume as cause.
9.3.3.iii What kind of periods are associated with referral to gynaecology
clinic for bleeding?
Referral by GP for bleeding
GP reasons for referral (up to two reason per letter) were extracted from referral
letters and coded into categories, one ofwhich was excessive bleeding (3.8.3.i). For
the binary variable 'referred by GP for excessive bleeding' a similar modelling
process was undertaken as in the preceding sections. The variables offered to the
model were as already listed (Table 9.9), with the addition of the CQ variable
'heaviness of loss' (as in 9.3.3.ii), and the further addition of three variables
indicating citations as cause ofhelp-seeking. These were 'losing too much blood'
cited (or not) as cause; increase in amount ofperiod cited; and the variable indicating
how many of the 3 volume causes had been cited. (These could not be offered to the
'cause' model of the preceding section given the dependent variable for that model.)
Table 9.12 presents the model for 'referral by GP for excessive bleeding', calculated
on 666 cases with non-missing data for the relevant variables. The model was
adequate, showing insignificant deviation form the hypothetical perfect model (-21og
likelihood=571, df=653, p>0.50). The predictive performance of the model overall
was 81%, but much better at prediction of the 511 who were referred for bleeding
(94% correct) than the 155 who were not (39%).
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Table 9.12 Model predicting GP reason for referral as excessive bleeding
(n=666)
Variable P Levels n OR (95% CI)
Absolute volume
No. of VOLUME 'CAUSES'

















used for most recent period




PCd: IMPACT OF VOLUME






INCREASE IN PERIOD is
CAUSE of help-seeking?
0.055 not cause









289 0.50 (0.32, 0.79)































*/ ** PCd= principal component about management ofperiods (Appendix 5.2). The
distributions were divided into approximately 'fifths' as explained in Table 9.1.
** Effect was not linear but if recoded as binary, as shown, was a useful addition to the
model.
# For brevity results for these 5-level linear variables have been presented only for the
bottom fifth (OR not shown but taken as 1), the next fifth up, and the top fifth. For each
variable the ORs for the levels not shown can be obtained by squaring/cubing the first
OR reported. The levels not reported would make the total n up to 666.
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Referral by GP for excessive bleeding was strongly associated with both heaviness
and 'volume' being cited as cause ofhelp-seeking. The odds for referral for bleeding
were doubled if 'heavy' periods, trebled if 'very heavy', and the odds would be
further trebled if volume was also cited as a cause (resulting OR = 6.4 and 9.1
respectively). For the 336 women (just over half) with highest scores for 'impact of
volume on daily life' odds were doubled. Referral was also associated with periods
'going on too long' (OR 1.76), which was interesting as this feature is sometimes
included in the menorrhagia definition, but this variable was in the model for 'very
heavy periods' as a protective factor. That is, jointly with the other variables in that
model a problem with 'duration' tended to mean that periods would not be judged as
very heavy.
With regard to factors not clearly to do with menorrhagia or (absolute) volume of
menstrual loss, referral was also associated with increase in amount of period being
cited as cause ofhelp-seeking (OR 1.74). Problem with increased amount ofperiods
was in the model for 'very heavy', but not in that for volume as cause ofhelp-
seeking. Referral for bleeding was associated only weakly with the component
'variable flow', with near doubled odds for the 141 women (21%) with highest
scores for this component (but wide confidence interval, including 1). Severe
problems with cyclic symptoms were associated with reduced odds ofbeing referred
for bleeding (reduced by a half). 'Unpredictable onset' was also associated with
reduced odds of referral, but much less clearly. Finally, considered jointly with all
the other factors in the model, Edinburgh women were more likely to have been
referred for bleeding, as were women aged 40 years or over.
The modelling was also tried with the inclusion of the SF-36 quality-of-life scaled
scores and Health Transition score offered to the model. The SF-36 variables
included in the model were General Health scaled score and Health Transition, with
good general health, and more strongly, deterioration in health during the past year,
associated with referral for bleeding. Problem with avoiding menstrual accidents,
troublesome cyclic symptoms and 'had enough ofperiods', were also included in the
model. Heaviness, centre, and the two components that reduced odds of referral for
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bleeding, unpredictable onset and variable flow, were no longer included in the
model.
The patient's self-stated reason is bleeding
The patient's self-stated reason for coming to the clinic was coded from the response
to the first free-text item on CQ and coded as for GP referral reason into categories,
one of which was excessive bleeding (up to two reasons coded per woman, 3.8.3.ii).
For the binary variable 'self-stated reason is excessive bleeding' a similar modelling
process was undertaken as in the preceding sections. The variables offered to the
model were identical to the model for bleeding as GP referral reason (as in 9.3.3.iii),
Table 9.13 presents the model for 'referral by GP for excessive bleeding', calculated
on 569 cases with non-missing data for the relevant variables.
The model was adequate, showing insignificant deviation from the hypothetical
perfect model (-21og likelihood=469, df=551, p> 0.50). The predictive performance
of the model overall was 81%, and prediction was almost equally good for the 349
who self-stated bleeding as reason for clinic attendance (87% correct) and the 220
who did not (73% correct).
The variables most strongly associated with the patient self-stating excessive
bleeding as reason for clinic attendance were having cited one or more volume
aspects as cause (increasing the odds nearly seven-fold), and heaviness (for periods
rated heavy, trebling the odds, for 'very heavy' periods, quadrupling the odds). The
effect ofheaviness was not linear, so the variable was defined as categorical.
The other 'volume' variables included in the model were to do with containment.
Need for changes during the night and use ofmore than 32 products in the most
recent period were included in the model for 'very heavy'. The fact that they are
required in this 'reason for attendance' model, in addition to heaviness, suggests that
they provide extra information about reason for referral (self-stated). There was also
a strong association (nearly trebling of odds) with increase in amount ofperiod
having been cited as the cause ofhelp-seeking, reflecting a relative rather than
absolute judgement about volume of period.
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Table 9.13 Model for self-stating bleeding as reason for clinic attendance
(n=569)
Variable P Levels n OR (95% CI)
Absolute volume
No. of VOLUME 'CAUSES'

















used for most recent period































295 0.46 (0.26, 0.98)
Increase in volume


















316 0.54 (0.34, 0.84)


































*/ ** PCd- principal component about management ofperiods (Appendix 5.2), PCf about
feelings about periods. The distributions were divided into approximately 'fifths' as
explained in Table 9.1. The effects were non-linear. However, recoded as ** 3-level or
* binary variables, as shown, made useful additions to the model.
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Also included in this 'reason' model were the components reflecting emotional
reactions to containment and the resources involved, 'containment distress' (with
more than doubling of odds for the 295 women (52%) with highest scores) and
'resentment of resources used' (with odds increasing by a factor of2.45 for the 95
women (17%) with most extreme scores). This latter component reflects not just
resentment of cost but also embarrassment about changing rate and quantities of
supplies needed, and even a sense ofpersecution (see Appendix 5.2 Table A5.2.2).
In contrast to this positive association with bleeding as reason, the component
reflecting the resource consequences of heavy periods (as a fact of menstrual life
rather than in terms of feelings about this) was also included in the model, but as a
protective factor. Therefore, for a sub-group ofwomen these effects will almost
cancel each other out (2.45 x 0.46 = 1.1). The women with reduced odds for stating
bleeding as reason for clinic attendance are those who really can not 'resource'
periods, but who are not expressing a strong reaction of resentment/embarrassment
(OR 0.46). The women with increased odds for stating bleeding as reason for clinic
attendance are those who can 'resource' periods but nevertheless feel strong
embarrassment/ resentment about resources used (OR 2.45).
Table 9.13 shows that among non-volume-specific menstrual variables, cyclic
problems with well-being, and unpredictable onset ofperiods were protective against
self-stating bleeding as reason (odds halved). The same was true for the component
'feel periods a burden' considered jointly with all the other variables in the model.
An interpretation could be that if the other bleeding volume factors do not apply, and
all there is is a high score for 'burden', then it will not tend to be bleeding that is self-
stated as referral reason. However, the non-specific component 'had enough of
periods' was positively associated with self-stating bleeding as reason, very strongly
so for high scores (OR=3.6 for the 120 (21%) with highest scores). This implies that
over and above all the volume factors associated with bleeding as reason, an
expressed feeling ofhaving 'had enough ofperiods' provides important extra
information about the likelihood ofbleeding as self-stated reason for clinic
attendance. Similarly, the 116 women (20%) with a high home facilities deficit score
had more than double the odds of for self-stating bleeding as reason. Older women
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were more likely to give bleeding as their reason for clinic attendance, and
Edinburgh women were less likely to do so, in the context ofall the other factors in
the model.
The modelling was also tried offering the SF-36 variables. The only SF-36 variable
included was Role Physical (better scores were positively associated with bleeding as
reason). 'Resource consequences', 'burden' and cyclic well-being problems were no
longer needed (protective' factors), nor night changes and 'resent resources used'
(positively associated). 'Impact ofvolume' was brought into the model, positively
associated, and problems with period pain, as a protective factor.
It is of interest to compare the model for 'GP referral reason is excessive bleeding'
with that for patient's self-stated reason (both as presented in the tables, without SF-
36 quality-of-life factors being offered to the models). A schematic diagram
comparing the models is presented in Figure 9.11, similar to that presented for the
comparison of the 'very heavy' and 'volume as cause' models (9.3.3.ii),
The most striking feature is that the 'GP referral' model has no very strong factors.
The strongest factors for both models are 'volume causes cited' and 'very heavy'
periods. Considering these jointly, among women for whom both apply the odds
ratio for referral for bleeding by the GP would be 9, whereas the odds ratio for the
woman self-stating bleeding as reason for clinic attendance would be 27. For the
'self-stated bleeding reason' model there is stronger association with containment
factors. Both models show an association with increase in periods cited as cause of
help-seeking, but more strongly for excessive bleeding being the patient's self-stated
reason. With regard to other menstrual factors, bleeding as the GP referral reason
was associated with variable flow and periods going on too long, whereas for the
'self-stated bleeding reason' model there was a strong association with having 'had
enough ofperiods'. In the context ofall the other factors in the models, unpredictable
onset and cyclic problems with well-being were negatively associated with both
models ('protective') and if periods were felt to be a burden the woman was less
likely to self-state bleeding as reason.
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Figure 9.11 Comparison of factors associated with GP referral for excessive
bleeding and self-stated reason as bleeding
HEAVINESS of period-very heavy
VOLUME 'CAUSEfS)' cited
QUANTITY OF PADS/TAMPONS >32
IMPACT OF VOLUME (PCd)
Have to get up at NIGHT to change
RESENT RESOURCES used (Pa)
Periods a STRAIN ON RESOURCES (PCd)
CONTAINMENT distress (Pa)
INCREASE IN LOSS is CAUSE
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, Increase in volume
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With regard to socio-demographic factors, both outcomes were associated with age
over 40 years, and Edinburgh GPs were more likely to refer for bleeding while
Edinburgh patients were less likely to self state bleeding, all adjusted for other
factors. Self-statement of bleeding as reason was strongly associated with a high
deficit score for home facilities for dealing with heavy periods. This is contrary to the
effect on rating periods very heavy, where home facilities deficit score was
protective (negatively associated). Therefore, inadequate home facilities do not
appear to influence judgements about excessive heaviness, but are associated with
clinic attendance, and hence with self-stating bleeding as reason.
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9.3.4 Principal components of menstrual experience
9.3.4.i What are the associations of component scores with menstrual
symptoms, and other variables?
Demographic and menstrual variables
Tables 9.14a and 9.14b show the non-parametric associations of components with
menstrual and demographic variables. To save space, and for ease ofperusal, only
the strongest correlations have been shown (|rho| >0.1 for demographic variables,
|rho| > 0.2 for menstrual). All are statistically different from the null correlation of 0
(p<0.007). Correlations |rho| > 0.4 are highlighted in bold. The tables have been
arranged so that components addressing resources, being unwell during period, and
negative attitudes to periods ('burden' and 'had enough') are in Tables 9.14a and
those addressing volume, containment, onset, flow and worry are in Tables 9.14b.
On the whole components in Tables 9.14a are not strongly related to volume. The
only menstrual history variables with correlations |rho| > 0.2, and hence in the table,
were heaviness and duration ofproblem. For 'volume' aspects ofperiods as well, and
variables derived from them, there was scant association with these components.
Problems with accidents, laundry and cost were associated with affirmation of
'resource consequences' of periods, as were higher parity and greater deprivation,
whereas only cost was associated with 'resentment of resources used'.
With regard to being unwell/irritable with periods and feeling them to be a burden,
the longer the duration ofproblem (which, it should be remembered, may be
something other than excessive bleeding), the higher the scores tended to be. These
components were most strongly associated with period pain and, particularly, cyclic
symptoms, and also with a general propensity to find many aspects ofperiods a
marked or severe problem. They were also associated with younger age and greater
deprivation.
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Count sev. 'volume0 0.22 0.22 0.35
Pain with periods
Pain before periods

















Ct. sev. cyclic/unw. * 0.58 0.51
Extra laundry
Cost
















Total ct. > moderate ~ 0.22 0.42 0.46 0.28
* PCd = principal components 'dealing with periods' (n=712) and PCf = components
'feelings about periods' (n=687) (PCs derived from MEQ data - see 5.3.1.iv)
+ Spearman correlations /rho/ > 0.1 shown for demographic variables (for all p<0.007),
/rho/ >0.2 for remainder (for all p<0.001). For n's see * above (see 3.8.3).
if Counts of number of aspects rated 'severe problem' within groupings of aspects as
specified (volume, pain and cyclic/unwell, each comprising 3 aspects, see 5.2.2.i &
5.3.1.Hi).
Count of number out of all 16 aspects which are rated 'marked' or 'severe problem' (see
5.2.2A).
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Table 9.14b Association of principal component scores with menstrual and
socio-demographic variables
PCd* PCf* PCd* PCf* PCd*
Impact of Contain. Variable Worry re Unpred.
Volume Distress Flow Changes Onset
rho+ rho+ rho+ rho+ rho+
Parity 0.19
Deprivation 0.14
Heaviness 0.38 0.53 0.35 0.20
Duration problem 0.25 0.23 -0.17
Freq. periods leaks 0.33 0.46 0.28
Night changes 0.36 0.45
Usual duration period 0.24 0.42
Days double protection 0.24 0.37 0.35
Clots >50p size 0.34 0.44
Days full flow 0.27 0.44 0.22
Need freq. changes 0.34 0.43 0.28
Total prods, used 0.23 0.32
Know start next period -0.21
Aspects of periods
Lose too much 0.35 0.52 0.47 0.29
Go on too long 0.27 0.65 0.40
Accidents 0.40 0.63 0.44
Countsev. 'volume'* 0.22 0.40 0.48 0.35
Extra laundry 0.39 0.56 0.41 0.28
Cost 0.32 0.29
Loss increased 0.30 0.45 0.52 0.37
Worry something wrong 0.27 0.50
Irregular 0.35 0.26
Bleeding between 0.30 0.23
Pain with periods 0.29
Impact on daily life 0.58 0.51
Feel unwell/tired 0.32 0.24
Count > moderate ~ 0.36 0.44 0.44 0.28
Count sev. pain * 0.25 0.39
* + # ~ Please see footnotes to Table 9.14a.
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Of all the components in Table 9.14a, 'had enough of periods' was most strongly
associated with volume, with higher scores related to heavier periods, degree of
problem with losing too much blood and with number of severe problems with
volume aspects. However this component was even more strongly associated with
periods going on too long, increased loss, and worry about change in periods.
In contrast, Tables 9.14b shows the first three components related to many menstrual
variables and aspects addressing volume. 'Unpredictable onset' was related to only
two variables, with score on this component tending to be higher if the woman does
not know by counting when her next period is due, and if she has a degree of
problem with irregular periods. 'Worry re changes' was most strongly associated
with increased loss, periods going on too long, and the aspect addressing irregularity
and worry there may be something wrong. This component showed higher scores
where there was greater deprivation and if the duration ofproblem was shorter.
Table 9.14b also shows that 'variable flow' is strongly associated with a number of
volume variables, increased loss, periods 'going on too long', losing too much,
duration ofperiod, bleeding in between periods and number of products used, and
with higher parity.
'Impact ofvolume' and 'containment distress' had very similar patterns of
correlations to each other, and differed from 'variable flow' in being associated with
duration ofproblem, clots, impact on daily life, pain and feeling unwell/tired because
ofperiods. The differences between 'impact ofvolume' and 'containment distress'
were that 'impact ofvolume' was also associated with number ofproducts used for
most recent period, while 'containment distress' was more strongly associated than
'impact' with leaks, need for night changes, heaviness, clots and duration of full
flow, and with the extent of problem aspects: accidents, losing too much, increased
loss, going on too long, extra laundry.
IRON STATUS
The principal component scores were examined in relation to iron status. There were
significant differences by low haemoglobin status (<12g/dL) in scores on the 'impact
ofvolume', 'unwell/irritable during period' and 'containment distress' components
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(Mann Whitney z =2.6, - 2.4, 1.9 respectively, p= 0.007, 0.015, 0.05, n= 366, 366,
354). Therefore in this clinic population those with low haemoglobin tended to have
higher scores for impact of volume and containment distress, but lower scores for
'unwell/irritable during period). For ferritin also those with low values tended to
have lower scores on 'unwell/irritable' (Mann Whitney z = - 3.5, p<0.001, n= 230).
There was no significant difference by ferritin status for any other components, but
the n's were small (230 for dealing with periods components, 188 for feelings
components).
Quality-of-life
The principal component scores were examined in relation to SF-36 quality-of-life
scale scores. Associations |rho| > 0.2 are shown in Table 9.15, Higher scores for
'impact ofvolume' and 'containment distress' were associated with poorer 'quality-
of-life' for bodily pain, role physical and social functioning domains only. Higher
scores for 'unwell/irritable' and 'feeling periods a burden' were associated with
poorer 'quality-of-life' for all SF-36 scale scores other than 'Physical Functioning'
(not shown) and other than the SF-36 Health Transition variable.
Table 9.15 Principal component scores associated with SF-36 Quality-of-life


















Bodily Pain -0.33 -0.30 -0.40 -0.41
General Health -0.31 -0.32
Mental Health -0.38 -0.36
Role Emotional -0.31 -0.31
Role Physical -0.32 -0.24 -0.25 -0.37
Social Functioning -0.35 -0.33 -0.35 -0.49
Vitality -0.31 -0.34
* PCd = principal components 'dealing with periods' and PCf = components 'feelings
about periods' (n=687) (PCs derived from MEQ data - see 5.3.1.iv)
+ Spearman correlations /rhoj > 0.2; for all p<0.001; (n ranges from 581 to 587 for PCd
and from 561 to 567 for PCf).
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Health history
Principal component scores were examined in relation to current health and health
history, including recalled number of previous attendances at hospital gynaecology
clinic. Table 9.16 presents all correlations |rho| > 0.1, with correlations |rho| > 0.3
high-lighted in bold. The components 'unwell/irritable during period' and 'feel
periods a burden' were, among all components, most strongly associated with the
'health' variables. Ofthe five health variables, those most strongly associated with
the two components were the number previous visits to the GP about periods and the
number of minor physical symptoms experienced in the past 2 weeks (reported in
MBQ). High scores on the 'variable flow' component were associated only with the
number of past D&C's. Surprisingly, the strongest association with number of past
D&C's was with the component 'unwell/irritable during period'.
Table 9.16 Association of PC scores with current health and health history
PCd* PCf* PCd* PCf* PCf*
Resource Resent Unwell/ Periods a Had
Health history Consequ. Resource Irritable Burden Enough
variable * rho+ rho+ rho+ rho+ rho+
Worse health 0.19 0.11 0.25 0.23 0.10
No. minor symptoms 0.22 0.12 0.40 0.38 0.15
No. visits to GP re 0.15 0.30 0.35 0.17
periods
No. clinic visits 0.18 0.14 0.21 0.11
No. of past D&C's 0.14 0.12 0.13
PCd* PCf* PCd* PCf* PCd*
Impact of Contain. Variable Worry re Unpred.
Volume Distress Flow Changes Onset
rho+ rho+ rho+ rho+ rho+
No. minor symptoms 0.20 0.19 0.13
No. visits to GP re 0.16 0.11
periods
No. clinic visits 0.13 0.11
No. of past D&C's 0.11
* PCd = principal components 'dealing with periods' and PCf = components 'feelings
about periods' (PCs derived from MEQ data - see 5.3.1.iv)
+ Spearman correlations jrhoj >0.1; for 'worse health' n= 682 for PCf, 714 for PCd,
p<0.008 for all; for remainder n ranges 512 to 558, for all p<0.010.
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The principal component scores were also examined in relation to whether the
woman had ever been treated for depression or anxiety (response on MBQ, n=198
had been so treated). Component scores tended to be higher if the woman had ever
been treated for either of these conditions. There were significant associations for
'impact ofvolume', 'containment distress', 'irritable/unwell during period',
'resource consequences' and 'periods a burden' (Mann Whitney z = 4.0, 3.4, 3.4, 3.3,
2.6 respectively; p= <0.001, 0.001, 0.001, 0.001, 0.009; n= 578, 559, 578, 578, 559).
Therefore in this clinic population the higher the component scores for 'impact of
volume', particularly, and also for the other components listed, the more likely the
patient is to have a past history of treatment for depressive or anxiety illness.
'Complaint of Menorrhagia'
There has been consideration of the relative merits of various variables as
representing 'complaint of menorrhagia', and of the possibility that complaint of
menorrhagia could be reflected by one or more of the component scores. It would
therefore be of interest to examine the component scores in relation to the various
menorrhagia complaint variables so far considered: referral reason (given by GP and
self-stated by the woman), citation ofvolume aspect(s) of bleeding as cause of help-
seeking, and subjective report ofperiods as 'very heavy'. Comparisons were made
by Mann-Whitney, and the components which were most 'discriminating', in the
sense ofhaving most clear-cut differences between subgroups formed by the binary
'complaint' variables, are shown in Table 9.17.
All four 'complaint' variables' show greatest discrimination for containment distress
scores, and next greatest for either impact ofvolume or variable flow. 'Very heavy'
loss (or not) shows the strongest discrimination in 'containment distress' and 'impact
ofvolume' scores. Self-stated bleeding shows next best discrimination of these
component scores, but in addition is best at discriminating scores on 'variable flow'
and 'had enough ofperiods'. GP referral for bleeding is least effective at
discriminating 'had enough ofperiods' but best at discriminating 'worry'. Citing
volume of bleeding as reason for help-seeking appears to be indicative of
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'containment distress' and 'variable flow', with less discrimination for 'impact of
volume', 'worry' and 'had enough ofperiods'.
Table 9.17 Comparison of component scores by 'complaint' or not, for four

























12.0 <0.001 8.6 <0.001 6.6 <0.001 6.3 <0.001
Impact of volume 9.3 <0.001 6.8 <0.001 5.5 <0.001 3.3 0.001
Variable flow 6.7 <0.001 7.7 <0.001 6.4 <0.001 6.6 <0.001
Had enough of
periods
5.0 <0.001 5.6 <0.001 2.7 0.008 2.7 0.006
Worry re change 3.8 0.001 2.6 0.009 4.5 <0.001 2.8 0.005
+ z score for Mann-Whitney non-parametric comparison of scores in the two subgroups
n=687 except for 2nd and 3rd row components where n=721
9.3.4.ii Is measured menstrual loss associated with component scores?
If menorrhagia complaint is about excessive menstrual loss then it would be expected
that volume of menstrual loss would be associated with component scores most
closely reflecting volume/'complaint'. Non-parametric correlations of measured
volumes with component scores were calculated, and all those where |rho| > 0.15 are
presented in Table 9.18.
None of the correlations is very strong, but the strongest are with the components
'impact ofvolume' and 'containment distress'. Volumes are inversely correlated
with components 'unwell/irritable' and 'unpredictable onset', so the higher the scores
on these components the less likely the woman is to have high menstrual volume. It
is noteworthy that menstrual volumes were associated with only 5 out of the 10
components, and that 4 of the 5 are 'dealing with periods' rather than 'feelings about
periods' components.
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Table 9.18 Association of principal component scores with measured
menstrual loss volumes
PCd* PCf* PCd* PCd* PCd*
Impact of Contain. Resource Unwell/ Unpred.
Volume Distress Consequ. Irritable Onset
rho+ rho+ rho+ rho+ rho+
Blood Volume (mL) 0.22 0.26 0.15 -0.16 -0.16
Total fluid vol. (mL) 0.21 0.23 -0.15 -0.18
* PCd = principal components 'dealing with periods' and PCf = components 'feelings
about periods' (PCs derived from MEQ data - see 5.3.1.iv)
+ Spearman correlations /rho/ > 0.15; for PCd n= 189,190 for total fluid and blood
volumes respectively, for PCf n=190, 191; p<0.04 for all.
9.3.4.iii Associations between the two sets of principal components
The two sets of principal components, 'dealing with periods' and 'feelings about
periods' were obtained by independent analyses of separate multi-part questions
(MEQ questions 22 and 23 respectively). Within each set the method used to extract
and rotate components means that the 5 components in that set are orthogonal (not
correlated). However, there may be correlations between components in different
sets. Data presented so far suggests considerable similarity between 'impact of
volume' and 'containment distress', and also some similarity between the two
components addressing resource use. Correlations were calculated between the two
sets of components and all correlations |rho| > 0.2 are presented in Table 9.19.
The strongest correlation was as anticipated between 'impact of volume' and
'containment distress' (0.65). The other strong associations between pairs of
components have been highlighted in bold. ('Unpredictable onset' is not included in
the table as it was not associated to this degree with any of the feelings components.)
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Table 9.19 Associations between the two sets of principal components
'Dealing with periods' components
Impact of Variable Resource Unwell/
'Feelings about periods' Volume Flow Consequences Irritable
components rho+ rho+ rho+ rho+
Containment distress 0.65 0.31 0.21
Resent resources 0.49
Worry re change 0.52
Feel periods a burden 0.28 0.62
Had enough of periods 0.22 0.21
+ Spearman correlations jrhoj > 0.2; n= 617; allp<0.001; 95% CI within 0.08 either side.
Despite the strong association between 'impact' and 'containment distress' there
were women with high scores on one component and low scores on the other, and
vice versa. This is illustrated in Figure 9.12. Of those in the highest quartile for
'impact of volume', 10% (of 146) were nevertheless in the lower half of the
distribution of containment distress scores (bottom two quartiles). This suggests that
despite the extreme containment situation they were experiencing with their
menstrual flow these women had not developed a strong emotional reaction to it.
Similarly, of those in the third highest quartile for impact, 15% (of 149) nevertheless
had containment distress scores in the lowest quartile.
Conversely, of those in the lowest quartile for 'impact' score, 18% (of 159)
nevertheless expressed containment distress in the upper half of the distribution of
scores for that component. This suggests that despite their flow not apparently posing
a major containment challenge (relative to the study group), these women were
expressing a strong emotional reaction to the containment imposition resulting from
their periods. Similarly, of those in the second (lowest) quartile for impact, 10% (of
163) nevertheless had containment distress scores in the highest quartile.
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Figure 9.12 Distribution of 'Containment Distress' scores within subgroups
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9.4 DISCUSSION
9.4.1 Complaint and referral
There was striking discordance as to the rationale for referral to gynaecology clinics.
In over a quarter of cases the patient and general practitioner disagreed as to whether
excessive menstruation was a reason, with the doctor four times more likely to be the
only one citing bleeding. Approximately equal proportions ofwomen reported severe
problem with pain, volume of loss or cycle-related changes (37% to 40%), with
considerable overlap, and yet the predominant reason given for referral was bleeding
problems (76%). Furthermore this tendency for general menstrual complaint to be
re-framed as excessive bleeding appears to intensify within the clinic setting.
Dysfunctional uterine bleeding is defined as 'excessive uterine bleeding for which no
pathology can be found' (Fraser & Inceboz 2000). Yet diagnosis ofdysfunctional
uterine bleeding was made for 35% of women who had neither cited excessive
bleeding as a reason for attendance nor as a severe problem. Similarly, it was made
for 30% ofwomen whose doctors had not given bleeding problem as referral reason.
Variation in menorrhagia referral rates has been taken to reflect 'clinical uncertainty
about whether and how the problem should be treated' (Coulter 1995). Our data
suggest clinical uncertainty about the very concept of menorrhagia.
9.4.2 Measured menstrual loss
9.4.2.i Associations with blood loss volume
It has been shown that the clinical features most strongly associated with blood loss
volume are: required rate of changing sanitary protection during full flow, total
number ofproducts used, poor iron status, size of clots, and need to change
protection during the night. Other studies have found associations with number of
products (Fraser et al. 2001; Higham & Shaw 1999) and that with iron status is well
known (Gao et al. 1981; Hallberg et al. 1966; Haynes et al. 1977; Higham & Shaw
1999; Hope 2000; Janssen et al. 1998). It is noteworthy that these features are not
purely subjective, but either based on an objective test result (ferritin), or
'operational' (e.g. changing rate and clot size) and therefore less prone to
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measurement 'error'. In addition, strong evidence was found that volume of loss was
related to women's subjective judgement. Those rating their periods as 'very heavy'
had mean blood loss that was 61% higher than for the remainder (95%CI 23% to
110% higher). This is all the more striking given the restricted range, among
collectors, for subjective rating ofperiods - essentially just heavy or very heavy.
Hallberg commented, based on inspection of a graph of measured volume against
light/medium/heavy subjective ratings, that "The difficulties of evaluating the
menstrual blood loss on the basis ofpatient's own judgement are well known. The
results obtained in the present study emphasise this fact" (Hallberg et al. 1966). This
study is now often cited in support of the belief that women are poor judges of their
loss volumes, for example (Irvine & Cameron 1999). Two critiques could be made.
One is that the judgements of loss were elicited symptoms in a community survey,
and therefore these findings can not be extrapolated to the clinical situation. The
second critique hinges on the fact that calculation of the correlation from that
graphed data reveals very strong evidencefor an association in that study between
heaviness and volume (rho=0.34, n=474, p<0.0001) (Warner 1998), stronger even
than in the study reported herein (rho=0.24).
Taken overall our findings suggest that women's success in judgement of loss is
relative, and not calibrated to the clinical definition of menorrhagia. This is
unsurprising, given that few think of their periods in volumetric terms. When
required by a later questionnaire item to rate their usual period in terms ofoptions
formulated in volumes (teacup, mug, much more), the majority ofwomen instead
opted for the fourth response available, 'no idea' (55%). Still fewer women know of
the clinical importance of the 80mL threshold for blood volume, nor that their
menstrual blood loss is only about half by volume of the total menstrual loss, due to a
non-blood component (Fraser et al. 2001).
Given the consensus view that measurement ofblood loss is not practicable in
routine clinical care, the question arises as to how feasible it is to judge menorrhagia
from clinical/menstrual history. Our data suggest that management is minimally
related to measured volume of blood loss. In the absence ofany identifiable
pathology, dysfunctional uterine bleeding is virtually a default diagnosis, and is
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unrelated to actual loss. A similar picture is found for management of patients
without fibroids, as judged by performance of hysterectomy or not. Blood loss
measurements were not entered in patient notes, so either clinicians were unable to
make a judgement of loss from the clinical history, or they could, but felt volume of
loss had little bearing on management or diagnosis.
When menorrhagic blood loss (of 80mL or more) was modelled statistically, 76%
prediction success was achieved by a model including clots greater the 50p in size,
'low' ferritin result, and rate of change of sanitary protection. However, given that
predictive performance is ascertained against the same data that were used to derive
the model, this is likely to be an optimum figure of model performance. On the other
hand, the model is making predictions based on clinical history, and for a substantial
number of women (36%) the amount of loss for the period subsequently collected
was stated to be much less than the 'usual' described in the questionnaires. This
unusually low loss will not so clearly reflect the predictors reported (for the usual
heavy periods), so this sets the predictive model an almost impossible task, and a
statistical 'false positive' in this analysis may in fact be a clinical true positive, for
the woman's other periods. This was confirmed by the much stronger associations
found for measured volumes with prospectively recorded details of product usage,
duration or period, clots and adaptations to activities. It was also noticeable that the
correlations with prospective data were much stronger for duration ofperiod and
product usage (likely to be more directly the physical manifestation of a specific
flow) than with cancelled activities and leakages (which must involve an element of
individual coping with that flow, and which is likely to reflect context - home
circumstances/lifestyle/employment).
9.4.2.ii Utility of the 80mL menorrhaqia definition
The most striking finding is the clinical irrelevance of the established definition of
menorrhagia, blood loss in excess of 80mL. While there is a significant trend for
difficulties with containment of flow to become more prevalent with increasing
blood loss volume, this effect is largely due to the heaviest and lightest loss groups,
whereas the two groups with loss either side of 80mL are virtually indistinguishable.
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A similar pattern is observed for iron status, for diagnoses and for management. Our
data confirm that the 80mL cut-offpoint does not convey any especial prognostic
information: the 35% ofcollectors with losses between 50 and 119mL are fairly
homogeneous with respect to difficulties with containment ofperiods, compromised
iron status, pathological findings and management. This finding concurs with
qualitative research findings among women with complaint of menorrhagia
(Marshall 1998; O'Flynn & Britten 2000).
9.4.2.iii Associations with total menstrual fluid volume
The associations ofprospectively rated features of the period, and changes in impacts
ofperiod from usual, were stronger with total fluid volume than blood loss volume.
This is similar to the impression gained with other variables in previous research
(Fraser et al. 2001). Given the conceptual appeal of measuring the actual menstrual
loss, rather than a variable sub-component of it, and the more reliable and very much
simpler methodology involved, it is surprising that total fluid measurement has not
been more widely adopted.
9.4.3 Subjective menorrhagia complaint
Clinical menorrhagia complaint is clearly defined. With regard to subjective
menorrhagia complaint, judging by the confirmatory assessments that have been
applied it appears to have been assumed it is the woman's judgement of excessive
volume of loss. But is it? Subjective complaint may reflect adverse impact on daily
life through difficulties containing flow, or concern about other symptoms attributed
to periods, such as tiredness, and indeed this has been shown in qualitative research
(Marshall 1998; O'Flynn & Britten 2000). The problem may be acute unmanageable
flow in the first day or so rather than total volume over the entire period, as gushes
within the context of a less than excessive volume can cause accidents and social
disability. It could be that a change in periods has been noted (Marshall 1998;
O'Flynn & Britten 2000; Rees 1997), and which is causing concern that something
sinister is wrong, particularly if periods have become more or differently painful. In
support of this it has been reported that increase in amount ofperiod was a more
prevalent problem than absolute volume ofperiod. To explore the nature of
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subjective menorrhagia complaint four variables that could be construed as reflecting
the complaint have been modelled in terms of the menstrual data collected in this
study.
9.4.3.i Are 'very heavy', 'volume cause of help-seekinq', and/or referral for
heavy bleeding stand-ins for menorrhaqia complaint?
'VERY HEAVY'AND VOLUME AS 'CAUSE' OF HELP-SEEKING
'Heavy' is not unequivocally an adjective denoting volume, so women describing
their periods thus may well be conveying something more or other than the volume
of their periods. This was supported by modelling analyses, since 'very heavy' was
more strongly associated with containment aspects of volume rather than volume per
se. However, increase in volume was important to the judgement 'very heavy', and
so were (feelings) component scores regarding containment distress and burden of
periods, and being unwell with the period.
Citing volume aspects of periods as 'cause' ofhelp-seeking was thought to be
conceptually closest to the clinical definition of menorrhagia complaint, and this
opinion was supported by the findings. This model showed strongest association with
volume variables (but not increase in period) and 'very heavy', but no positive
associations with feelings about periods. (Interestingly, even if quality-of-life
variables were offered none were helpful to this model.) However, this was the least
satisfactory of the models in terms of fit.
Together these models suggest that very heavy is a broad judgement which does not
depend mainly on absolute volume and is tied in with feelings about periods as
currently experienced. Citing volume as cause appeared to reflect the clinical
menorrhagia definition better, and more 'purely', but the judgement could not be
reliably characterised by the available variables.
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excessive bleeding as reason for referral
Both models (GP and self-stated) were adequate and performed well overall (81%).
They were most strongly associated with volume variables, but also with increase in
period (the latter a particularly strong association for self-stated bleeding reason).
The model for self-stated bleeding reason performed better than that for GP reason,
in the sense that the GP model found it difficult to predict those not referred by GP
for bleeding (39% success). However, this was a small subgroup in this sample, so
arguably it was not well-characterised by the data. The GP model showed no very
strong associations and none with feeling about periods, whereas the self-stated
model was strongly associated with citing volume cause of help-seeking, heaviness,
having had enough ofperiods, increase in period and containment distress.
Overview of 'stand-in' complaint varaibles
The impression gained is that citing volume as cause ofhelp-seeking ('volume
complaint') is closest to the clinical definition of menorrhagia, being focused on
absolute volume and free ofassociation with impact and feelings. However, neither
the clinical menorrhagia complaint nor this 'volume complaint' reflect qualitative
research findings for menorrhagia (Marshall 1998; O'Flynn & Britten 2000).
The next closest was GP referral for bleeding ('GP-judged complaint'), which was
free ofemotional overlay, but did reflect increase in period, containment, duration
and variable flow, which are not necessarily features of absolute volume. The
remaining two models were fairly similar, except of course one was addressing a
judgement about loss (heaviness), and the other a reason for a health-care encounter
(lay complaint). 'Very heavy' captures volume and increase mainly, and incorporates
associated symptoms and emotional reactions to periods. Self-stated bleeding reason
('lay complaint') captures heaviness and volume/increase causes ofhelp-seeking,
mainly, plus emotional reactions to periods. In addition lay complaint reflects poor
facilities at home for dealing with periods.
For all models except 'volume complaint' older age was included in the model. This
suggests a reproductive-life-stage effect on heaviness, and GP-judged and lay
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complaint of menorrhagia, but not for 'volume complaint'. Increase in flow was
important to heaviness and lay complaint, while duration and variable flow were
important to GP-judged complaint.
9.4.3.ii Do principal component scores 'describe' complaint?
Overview
An alternative conceptualisation of subjective menorrhagia complaint is in terms of
the principal component scores derived from responses to MEQ questions 22 and 23.
Such principal components are believed to reflect underlying processes that have
given rise to the observed data. Thus the components represent structurally important
dimensions ofvariability for experience ofperiods and clinic attendance. As such
they, or a subset of them, may well encapsulate 'menorrhagia complaint' from the
woman's point of view.
Firstly the component scores were examined univariately in relation to demographic,
menstrual, quality-of-life and health history variables. Much of the pattern of
correlations would have been anticipated from results already reported, but this
exercise helped to elucidate the distinction between the components 'impact of
volume' and 'variable flow' (both are accounts ofmenstrual experience rather than
emotional reactions to it). 'Impact ofvolume' component was most strongly
associated with the aspects 'impact on daily life' and 'difficulty avoiding accidents',
and to a lesser extent with a range of volume and containment variables. In contrast
the 'variable flow' component was more strongly associated with all three volume
aspects, most particularly 'going on too long' (the strongest correlation at 0.65) and
increased loss. Particular differences between the two were that 'impact' only was
correlated with duration of problem, pain with periods and feel unwell/tired, whereas
'variable flow' only was correlated with going on too long (see above), days full
flow, days duration ofperiod, bleeding between periods and parity.
volume versus variability
Judged against an absolute criterion, only 34% ofcollectors had menstrual blood
losses exceeding 80mL. This may be partly explained by period-to-period variability,
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which has been demonstrated before in studies where women collected for more than
one period (Baldwin et al. 1961; Cole et al. 1971; Fraser et al. 2001; Flaynes et al.
1977). Ours is the first study to ask if the period collected was representative of
periods as reported (in the questionnaire). For 36% ofwomen the period collected
was 'much less than usual', and this was substantiated by a lower measured volume
in this subgroup. Considering only collected periods deemed to be much as usual, the
strong associations of greater volume with older age and increasing parity replicate
findings of a clinical study (Higham & Shaw 1999) and population research some
years ago (Cole et al. 1971). Both studies also found an association ofgreater losses
with having delivered heavier babies, which may partly explain our finding of
heavier losses in the more affluent women. The observation in the present study that
older parous subgroups were prone to heavy losses and marked variability in volume
suggests a distinct subtype of 'menorrhagia complaint'.
A 'normal' volume for the period collected, if due to variable loss, does not
necessarily invalidate complaint. It has been found that where variable losses occur it
is the heavier periods which are most representative of complaint (Fraser et al. 2001).
Excessive periods every few months may be more worrying than consistent losses,
and are almost as disabling, as every period has to be anticipated as if it might be one
of the heavier ones. Was this notion supported by these data?
The impression gained above, of two subtypes ofmenorrhagia complaint, was
reinforced by other differences found between the two components. Of the two, only
impact ofvolume was associated with (any) quality-of-life scores, with the number of
minor symptoms reported for the last two weeks, past treatment for depression, and
with measured volumes. It was correlated with all four putative complaint variables,
but most strongly with 'very heavy', and of the five feelings components it was most
strongly correlated with 'containment distress'. In contrast, variable flow only was
associated with number of past D&C's (and was not associated with minor
symptoms, depression, quality-of-life nor measured volumes). It was equally
correlated with all four putative complaint variables, but for 'volume complaint' it
was the component most strongly associated. Of the five feelings components it was
most strongly correlated with 'worry re change' (and indeed it was the only 'dealing
Chapter 9: Modelling Menorrhagia 385
with periods' component correlated with the worry component). Further study to
obtain a better understanding of the two subgroups with high scores on the two
different components could be illuminating.
9.4.4 Overview
Our data suggest that it is not just the 80 mL criterion that should be challenged, but
also the idea that volume of blood loss captures the essential nature of the prevailing
complaint of heavy periods. While our data do not support the wide-spread clinical
belief that women are poor judges of their volume of menstrual loss, they do raise
doubts about the calibration to 80mL. Furthermore, the findings raise doubts about
volume being key to complaint.
Various explorations of stand-in complaint models showed only 'volume' complaint
seems to reflect clinical menorrhagia (focused purely on volume). However it does
not reflect the complaint themes running through all the analyses (and previously
published qualitative research) - increase in loss, containment issues, emotional
reaction to the periods, disordered flow. Also, paradoxically, the 'volume' complaint
is only modestly associated with measured blood volume (rho = 0.014, compared to
0.23 for 'very heavy'). Part explanation of this may be that 'volume complaint' was
most strongly related to the variable flow component. Perhaps the poor showing in
terms ofvolume is because a number ofwomen in this complaint group had one of
their non-heavy periods for the collected period. A similar picture emerges if the
examination ofcomplaint is through the principal component scores, with 'impact of
volume' and 'variable flow' in place of 'very heavy' and 'volume complaint'
respectively.
This presents something of a dilemma. The patients whose 'volume complaint'
profile best matches clinical menorrhagia, have variable periods and so are relatively
unlikely to confirm menorrhagia objectively on one measured period, or on the
average of more than one. In contrast, those whose periods are most reliably of
relatively large volume, those with 'very heavy' periods, are not so much concerned
about the volume of their periods but about change in loss, containment issues, clots,
associated symptoms and how they feel about their periods. Surely both complaints
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are worthy ofa gynaecology response. This sub-grouping of menorrhagia complaint
would offer scope for aetiological hypothesis generation. This in turn may lead to the
development ofnew interventions, possibly more holistic.
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9.5 SUMMARY
9.5.1 Pathway to clinic
• There was discordance between GP and self stated reasons for referral to gynaecology
clinic, where this occurred GPs were 4 times as likely to cite bleeding and half as likely
to cite pain.
• Fewer than 46% of those referred for excessive bleeding had noted volume as a cause of
help-seeking.
• Diagnosis of dysfunctional uterine bleeding was made for over a third of women who
neither reported periods as subjectively very heavy, nor reported excessive loss as severe
problem, nor gave bleeding as reason for clinic visit (35% of 165).
• Examination of diagnosis and hysterectomy data suggests that clinicians either find it
difficult to judge volume from the clinical history, or do not consider volume as key to
management. Among those without fibroids, hysterectomy was strongly associated with
referral for bleeding, but was only marginally associated with reporting volume of loss a
severe problem.
9.5.2 Measured menstrual loss
• Volume of blood loss was strongly associated with rating loss 'very heavy' (volume
60% higher), and weakly associated with age and inversely associated with parity.
• Volume of blood loss over 80mL could be predicted (76% success) by clots, low ferritin
result and changing rate needed during full flow.
• The 80 ML criterion is of dubious clinical utility as it is neither sensitive nor specific for
adverse impact of periods, compromised iron status, or for pathology. There were no
marked differences in volume, accidents, impact and containment variables, iron status
or clinic outcome for blood loss groups on either side of the 80mL threshold (50 to
79mL v 80 to l l9mL).
• Volumes were more strongly correlated with prospectively recorded (Menstrual Chart)
parameters, than with retrospective CQ and MEQ data, and total fluid volume was more
strongly correlated than blood volume.
• Of those collecting, 78% stated that the period was less or much less than usual, and
these women had lower blood volume than the remainder of collectors.
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9.5.3 Menorrhagia complaint
• Modelling of 'citing volume as cause of help-seeking' (volume complaint) showed it to
be associated almost solely with aspects of volume.
• Modelling 'very heavy' periods showed that this reflects containment aspects of volume
more than volume per se, increase in period, symptoms and feelings about periods.
• Both models for reason for referral (GP-judged complaint and self-stated or 'lay
complaint') were most strongly associated with volume variables, but also with increase.
• Increase in flow was important to heaviness and lay complaint, while duration and
variable flow were to GP judged complaint.
• Examination of associations for the two sets of principal components (dealing with
periods and feelings about periods) revealed two subtypes of 'menorrhagia complaint':
- impact ofvolume was associated with rating periods very heavy, measured
volumes, aspects 'impact on daily life' and 'difficulty avoiding accidents',
quality-of-life scores, number of minor symptoms reported in past 2 weeks
and past treatment for depression, and was strongly associated with feelings
component 'containment distress'.
- variableflow was not associated with measured volumes, 'impact on daily
life' aspect, period pain, quality-of-life scores, number of minor symptoms in
past 2 weeks, nor past treatment for depression, but was strongly associated
with all three volume aspects (most particularly 'going on too long'), count of
severe problems with volume aspects, increased period and 'volume cited as
cause', and furthermore, this (variable flow) component only was associated
with duration of period, number of days full flow, number of past D&C's, and
with the feelings component 'worry re change'.







There has been discussion of findings and methods throughout the data chapters. The
aim of this final chapter is not to reprise the earlier discussion, but rather to discuss
key points drawing on and integrating the findings and discussion of the earlier
chapters.
10.1.1 Methodological issues in menstrual research
The study design and methods will be discussed under 4 sub-headings: the design,
the sample, the questionnaire measures used, and quantification of menstrual loss.
Within each section limitations will be considered.
lO.l.l.i Design
The embedding of the menstrual collection study within a cross-sectional survey
provided comprehensive background data on all women with measured menstrual
loss. This is relatively uncommon in menstrual research, but has proved illuminating.
What has been revealed is a picture ofpoor health status among many women
referred to gynaecology clinics, with wide-spread experience of multiple minor
general health symptoms, a high rate ofchronic health problems and
overweight/obesity and, often, multiple menstrual morbidity, typically over many
years.
The wider survey also made it possible to ascertain that those who agreed to collect
were in terms of the main socio-demographic characteristics similar to those eligible
to collect who declined. To have such an epidemiological context for clinical
menstrual research is rare, despite the important part this should play in interpreting
findings and comparing them with other studies. Ifwe imagine the hypothetical but
possible situation that the two centres within the present study had instead been two
independent studies following very similar protocols, but neither ascertaining the
extent ofbackground information that the present study actually has, then it would be
almost impossible to make sense ofdifferences in the research reports that would
have emerged from the two 'studies'.
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The two-centre aspect of our study design has brought both pain and pleasure. The
very disparate socio-demographic and health profiles ofpatients at the two centres,
and even more so the differences that emerged in the blood loss determinations, have
complicated analysis and reporting, and diminished power. However, they have led
to new insights about associations and disassociations in the study material, and have
also revealed some very important methodological issues. So what could have been
construed as a weakness has proved to be a bonus, maybe even a strength, not just
for the present study, but also in alerting to potential dangers for menstrual research
generally.
The study design meant iron status data would have been gathered only for those
patients where the clinician had some concern about iron status, or some suspicion
that periods were not that heavy and so wished to rule out adverse impact on iron
status. While this observational approach ensured usual clinical practice was
unaffected, minimising bias in management and outcome data, it also resulted in
sparse data. In fact clinical management and outcome data were not a key part of this
study, so preservation of their integrity at the expense of iron testing coverage was
not such an advantage. With hindsight it would have been better to ensure resources
were available to test all participants, except where such imposition would be the
reason for an individual patient to decline to participate. It is likely an ethical case
could be made for this, given the clinical concern that heavy periods have adverse
impact on iron status and hence health and well-being, and the high prevalence
among participants of'feeling tired', and because such tests have a potential use as a
screening tests for physiological health concern, provided good evidence could be
produced to elucidate this issue.
10.1.1.ii Study sample
It had been noted in earlier research (Warner 1995) that there was some discordance
between referral reason and subjective report ofperiods. It was therefore felt that a
survey of menorrhagia, in the sense of troubling heavy periods, should not be
confined to patients referred with this complaint by general practitioners, otherwise
covert menorrhagia problems may be missed. In the event it was found that in this
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study there was substantial discordance between referral reasons given by GP and the
patient's self-stated reason for clinic attendance, or her report of heaviness (Warner
et al. 2001). It was thus a wise precaution to have included in the study all women
with putatively heavy periods, and not to have depended solely on referral letter to
identify the study sample.
The intention of confining study to women newly-referred to gynaecology clinics
had a sound rationale. A third ofwomen in the study had attended a gynaecology
clinic before, three-quarters of them for the 'same problem'. Median time from
previous attendance was 3 years. Many had a history of a range ofperiod problems
(75% reported a past severe problem with heavy periods, 58% with period pain). So,
women with 'intractable' problems were not entirely avoided. Indeed the data
suggest that recurrent and serial menstrual problem is something of a feature of the
gynaecology clinic population. A very small proportion ofwomen were recruited
despite clearly failing the criterion ofone year since last attendance (2% had less
than 10 months since last visit). However they were retained in the study as it was
felt that they were so few in number as to have small potential for biasing findings.
However the exclusion criterion did on the whole avoid the surveying of repeat-visit
existing patients with, for some reason, delay to discharge. By defining 'new
referrals' as those who have not attended the clinic for the same problem in the past
year it was ensured the study would better reflect the entire throughput ofpatients
referred to gynaecology clinics with period problems, and an over-representation of
atypical patients, needing multiple appointments over an extended period before they
could be discharged, was avoided.
lO.l.l.iii Study measures
Multiple questionnaires were included in the design to address the many and varied
causal attributions that have been advanced in the literature for women's menstrual
complaints, and because of the aim to develop an assessment of the impact of
menstrual problems on daily life. There was also a need to be able to compare
findings with research already published. However, not all women participating were
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able to complete all the questionnaires, and there are therefore concerns about
missing data.
Furthermore, for this thesis space has not allowed analysis and reporting ofall study
data. Intriguingly, there are a number of findings already identified that would
probably benefit from further elaborative analyses taking personality data or
psychological well-being data into account. For example, the discordance observed
between scores on 'impact of volume' and 'containment distress' may be explained
by personality. Women susceptible to negative affectivity are likely to predominate
in the subgroup with modest scores for containment challenge (impact) but
disproportionately high scores for containment distress, so perhaps a different
management approach would be helpful in that subgroup (Watson & Pennebaker
1989).
Despite the perhaps over-ambitious use ofquestionnaire assessment, the study does
enable multivariate analyses ofpsychosocial variables, subjective menstrual
variables and objective measurements, and these will inform future 'leaner' but
effective and pertinent research design.
lO.l.l.iv Quantif ication of menstrual loss
Menstrual blood loss measurement
The methodological fragility of menstrual blood loss measurement has been
demonstrated. Small perturbations to technique can have profound effects on
volumes ascertained. Even where the technique used is optimal and consistent, the
nature of the exercise (taking a ratio of two haematin concentrations, which are
themselves regression estimates from optical densities) means that imprecision for
individual measurements will be substantial. This makes it frankly 'unsafe' to
measure blood volume to compare against an absolute criterion value. The
methodological concerns will be much less for within-patient studies where repeat
measurements are made on the each patient to assess treatment response, prior to
averaging responses for the group, since any systematic laboratory effect will be
eliminated when the difference is taken between the before and after measurements,
and the 'grouping' will generate precision in estimation of the group effect.
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(However, with regard to a dilution strategy that tends to result in large errors in both
directions, as was also the case in Glasgow, this would remain, and tend to inflate
experimental error and reduce power to detect treatment effect.)
Incomplete collection of menstrual loss has been proposed as a possible contributory
factor for failure to confirm menorrhagia(Wyatt & O'Brien 2000). There have
recently been attempts to allow for this when measuring blood volume, by adjusting
for blood lost to the collection, because of clots or blood leakage into the toilet, or
onto clothes or bedding (Hurskainen et al. 1998). Among 154 women recruited into a
menorrhagia treatment trial the average adjustment to volume judged necessary,
based on diary recording ofuncollected menstrual loss, was an increase of20mL. For
many women the adjustment made was a surprisingly high proportion of the blood
successfully collected, 57% in one case. The validity of the adjustments made was
not demonstrated, so reassurance is required as to the rigour of this approach
(Hurskainen et al. 1998).
Two reservations need to be expressed about this development in objective
measurement menstrual blood loss. Firstly, even if the adjustments made could be
by chance exactly equal to blood missed from the collection, the rationale for such
adjustments is flawed. The volume criterion for menorrhagia was originally derived
in terms of statistical abnormality, as judged from a population distribution of
unadjusted menstrual collections (Hallberg et al. 1966). It can thus be properly
applied only to other unadjusted measured volumes.
Secondly, ifover half the 'measured volume' can arise from adjustments based on
subjective accounts ofclot size and leakages, then the 'objective' label begins to look
distinctly threadbare.
Total menstrual fluid volume
In this study total fluid volume measurement was undertaken in a very pragmatic
way, without weighing of individual products prior to use. It was anticipated that this
would inflate random error, and this seemed to be confirmed by the lower R2 for the
regression model, than had been obtained in previous research (Fraser et al. 2001).
(However, it should be remembered that diminished fit could arise equally, or partly,
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if the blood loss measurements in this study were more error-prone than in the
published study.) Nevertheless, in simple univariate analyses relating volumes to
prospectively-recorded Menstrual Chart data about products used, leaks and
cancelled activities, total fluid volume was marginally more strongly correlated with
them, than blood volume (Table 9.7). Furthermore, the goodness-of-fit of models for
predicting total fluid and blood volumes from Menstrual Chart product/soaking
pictogram data were very similar (6.3.3), and the fact that no coefficient for centre
was needed for total fluid prediction reassures that there was no systematic
difference in measurements between the two centres. If menstrual loss measurement
is required, total fluid measurement is the far more attractive proposition,
conceptually, methodologically and also, it seems, in terms ofutility.
MENSTRUAL CHARTING
Menstrual charts have been developed with the aim ofestablishing an alternative
method ofquantifying menstrual blood volume. This has been driven not by a wish
to circumvent the methodological dangers of blood loss measurement, which have
been largely unrecognised, but rather with the main aim of avoiding collection and
handling of used sanitary products, which is disliked by patients and laboratory staff.
Previously published charts have used a score per pictogram, summed over all
products used, with the total score being either the PBAC score, where a score of 100
equates to 80mL blood loss (Higham et al. 1990; Janssen et al. 1995), or converting
directly to millilitres of blood (Wyatt et al. 2001). In this study it was found that
such a 'summation' model does not fit the data distributions. Both pictogram counts
and volumes need to be log-transformed for best regression analysis, and this means
that the model that fits the data is, once back-transformed, exponentiated. This
finding may explain the observation that all three published charts have shown
increasing bias error between menstrual chart estimates and actual measured
volumes, with increasing volumes.
The modelling analyses presented in this thesis show that the menstrual chart
provides a less good estimate of blood volume than total fluid volume. Therefore the
menstrual chart is even less likely than objective measurement to provide a precise
enough estimate of true volume for use in the management of the individual patient.
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However, it has the potential to provide rich information about the menstrual
experience, and this may prove very helpful for discussion between patient and
clinician. Some women, particularly those in the more deprived areas, were unable to
complete the menstrual chart. If the menstrual chart was freed from its aim to
quantify menstrual blood loss, it could perhaps be made much easier to complete,
and clinically more useful.
10.1.2 Reconsidering menorrhagia
10.1.2.i What is menorrhaqia?
Menorrhagia definition
The origin of the clinical (objective) definition of menorrhagia has already been
explained. The criterion of 80 mL delimits the 3%-4% ofthe 'healthy' population
with greatest loss. It does not reflect impact on health or well-being. The clinical
utility of a definition depends on how predictive it is of adverse effects or pathology,
or how much it aids management.
Our data show that for the vast majority of women referred with 'heavy periods', the
81% with losses up to 119 mL, the precise volume of loss is immaterial. About 10%
will have fibroids, compromised iron status, or problem with impact on daily life;
around 20% will have some pathology; and about 40 to 70% problems with
containing flow.
rationale for quantification of menstrual loss
The first issue to be determined is the point of measurement. Does the woman have
to prove her malady, before she can be provided with health care? Or is it that her
menstrual blood volume is crucial to the management ofher complaint? Or does the
measurement enhance understanding of the complaint, so promoting improved
communication about the problem between doctor and patient?
The main driver for blood loss determination appears to be that it can provide an
objective confirmation of menorrhagia complaint. However, validity in terms of
measuring menstrual loss volume, either total fluid or blood, whatever is decided as
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relevant, is not necessarily the same as validity in terms of'measuring' menorrhagia
complaint. Measurement of blood volume has been possible for only six decades
whereas problems with 'heavy periods' have been documented going back nearly six
millennia. It is unlikely menorrhagia has ever been solely or even mainly about
volume ofblood loss.
A further factor militating against prospective measurement ofmenorrhagia
complaint is the delay this imposes on commencement of medication which may
alter (indeed, is intended to) that which is to be measured. In the case ofa woman
who has waited many months for an appointment at a gynaecology clinic, it is hardly
humane to delay intervention for a further 6 weeks to allow quantification for the
complaint. Furthermore, for women with variable losses, the measured period may
not be one ofthe troublesome ones. In this study 80% ofwomen reported the
collected period was less or much less than usual (so, presumably, no longer
representative of the complaint).
Over and above this issue, ifwomen's accounts of their complaint can not be trusted
and must be confirmed objectively, then what value can be placed on their
unconfirmed record ofproducts/soaking, clots and leakages (as would be supplied in
a menstrual chart, or in the case of the latter two eventualities, used to augment the
measurement) (Hurskainen et al. 1998; Wyatt et al. 2001).
10.1.2.ii Healthcare for menstrual problems
Many women are deterred from consulting at all, by reticence about discussing
menstrual problems, anxiety about investigations, or a lack of belief that medical
help will be forthcoming (Scambler & Scambler 1985). Health needs that remain
unvoiced within the consultation have been related to poor outcomes (Barry et al.
2000).
Referral for menstrual problem
It was found that there was substantial discordance between referral reasons given by
GP and patient. The GP referral reason was more likely, than the patient perception
of reason for clinic attendance, to be excessive bleeding and, conversely, less likely
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to be pain. On the other hand there were women with periods self-rated as very
heavy, or who cited excessive bleeding as cause ofhelp-seeking, who were not
referred for excessive bleeding. Of course some of these may have been specific
cases where the GP was concordant with the patient in knowing the 'complaint' to be
excessive bleeding, but because he/she suspected the cause of the bleeding to be
fibroids, fibroids was given as the referral reason, which would have been coded as
'other'. However, in terms of the general trend, we should question why this is
happening and whether it affects the quality of health care women receive? Perhaps
the partitioning into distinct and specific menstrual problems does not reflect the way
women experience their periods, nor how menstrual problems are perceived by them.
Where there is co-morbidity between menstrual complaints it may seem unimportant
which is selected as referral 'reason'. However, the divergence between menstrual
experience and reasons given for clinic attendance reflects a disproportionate focus
on the biomedical symptom of excessive bleeding, a tendency which is echoed
within the clinic setting. Is this re-framing partly a consequence of women's beliefs
that abnormal uterine bleeding is most worthy ofmedical attention? Or is there an
astute lay understanding ofwhat will be regarded by others as a valid reason for
clinic attendance? There is already some evidence to support this (Marshall 1998;
O'Flynn & Britten 2000; O'Flynn & Britten 2003), but further research is required to
understand the part played by the cultural beliefs of both women and clinicians.
Clinic outcome
It is of concern that pain around periods was so commonly found to be problematic
yet it was so 'invisible' in the referral and diagnostic pathways, and that
dysfunctional uterine bleeding was so commonly diagnosed, often in cases where the
women had given no indication on her questionnaires that absolute volume of
bleeding was a problem for her. Relatively deprived women were less likely to
receive diagnosis of fibroids, more likely to receive diagnosis ofdysfunctional
uterine bleeding, and more likely to fail to return to the clinic.
Among women free ofpathology (as possible indication for surgery) hysterectomy
was associated with referral for bleeding but not with volume ofperiod being
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reported as a problem. Perhaps referral for menorrhagia is strategic, based on the
knowledge that it is likely to lead to surgery (Coulter et al. 1991; Grant et al. 2000),
and aiming to increase the likelihood of this for a particular patient. Nevertheless,
this is an unsound process for healthcare resource allocation; it would be preferable
to reach a more explicit consensus regarding indications for such treatments.
10.1.2.iii What is menorrhaqia complaint?
WHAT ARE PROBLEM PERIODS?
Periods can cause significant distress and disability, in the absence of serious
pathology or risk to physical health (O'Flynn & Britten 2000; Thomas & Ellertson
2000). In an opinion poll of 1069 women, 60% espoused the view that not enough
attention is paid to problems with periods (Corrado 1990). Patients may hold
definitions ofhealth and health care need that differ from those of clinicians
(Hutchison 1993), perhaps more so in the case ofperiods, an intensely private ritual
beset with societal constraints. In the Introduction to this thesis it was noted that it is
usual for 'menstrual problem' to be sub-classified as excessive periods
(menorrhagia), period pain, or cycle-related changes in mood and/or physical health
(premenstrual syndrome). Irregular periods and/or inter-menstrual vaginal bleeding
tend also to be thought ofby women as menstrual problems. The explanation for the
original partitioning may lie in the separate physiological or psychosomatic pathways
presumed to lead to the problematic symptoms. However, the data presented here
suggest that this convention warrants critical review.
WHAT ARE HEAVY PERIODS?
A judgement that periods are heavy, or even very heavy, may not constitute a
complaint of excessive volume, or of problem. 'Heavy' can be simply a
straightforward value-free account ofhow the woman classifies the volume ofher
period, most probably in relation to her own previous experience, but possibly also
from type and quantity of sanitary protection required to contain the period, or from
discussions comparing experience with other women. The distinction between
absolute (and possibly intolerable) or relative symptom (and possibly associated with
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worry about change) is an important one for both clinical communication with the
patient and for research.
It is nevertheless of interest to explore the basis on which that judgement is made,
not least because it is a descriptor of menstrual loss that is in such universal use, both
in lay communication (O'Flynn & Britten 2000; O'Flynn & Britten 2003) and in
clinical encounters (O'Flynn & Britten 2003). Even in specialist guidelines for
management ofmenorrhagia there is recourse to the term 'heavy periods' as one
criterion for deciding management of menorrhagia complaint (Royal College of
Obstetrics & Gynaecologists 1998).
The fairly strong association between heaviness and measured volume reported in
this study, does not necessarily reassure that women are complaining about volume
itself - the association may be coincidental, because increase in volume is associated
in some way with the factors leading to complaint, such as worry about change,
accidents, containment burden. Rating loss 'very heavy' was modelled mainly on
variables reflecting containment challenge, and failure (accidents), and to a lesser
extent on problems with volume ofperiod and increase in period.
Given that the definition ofmenorrhagia is volume-based, the readiness with which
heavy periods are interpreted as 'menorrhagia' should raise concerns. Instead the
interpretation of'I have come about my periods, they are very heavy..' should
perhaps be 'Doctor, I am having awful trouble trying to contain my periods and
avoid accidents and I am totally fed up.'
WHAT IS THE MENORRHAGIA REFERRAL COMPLAINT?
Referral reason is often thought to be synonymous with complaint. This is not
necessarily the case, as exemplified by a recently published clinical scenario,' 10
minute consultation for menorrhagia' (Hope 2000). In fact the pathway to the GP
surgery, in the case described, arose due to a chance finding of anaemia when
donating blood, which led to a presumption ofmenorrhagia by the GP and a clinical
encounter (and journal article) driven by that presumption (Hope 2000). One
wonders what the referral letter would have said if the GP had referred the woman to
the gynaecology clinic? A further doubt as to whether GP referral reason is
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synonymous with complaint arises because general practitioners may feel daunted by
the need to cite a reason for referral of the patient, and what they cite may be
influenced by beliefs about what menstrual indications hospital gynaecologists will
deem professionally acceptable as referral reasons.
It has been proposed that citing ofvolume ofperiod as 'cause' ofhelp-seeking, is the
closest variable we have to menorrhagia complaint (complaint of excessive
bleeding). For maximum 'equivalence' it needs to be assumed that those with
complaint of menorrhagia would have no reticence in citing volume ofperiod as
'cause', that they would feel it is a valid reason to cite for help-seeking. There is
furthermore a reverse qualification to this definition. It assumes also that among
those who do cite volume ofbleeding as 'cause' of help-seeking, it truly is
menorrhagia complaint that is their main health concern. That there is not some other
aspect ofperiods (say, pain, cyclic symptoms) that is their true and troubling
complaint, but which they feel would be unacceptable or inappropriate to be declared
'cause'.
WHAT DOES MENORRHAGIA COMPLAINT ENCOMPASS?
The co-morbidity ofmenstrual complaints reported here suggests that the
conventional partitioned thinking about, and labelling of, menstrual problems will be
unhelpful in the vast majority of cases. Contemporary menorrhagia complaint
warrants reconsideration in terms of conceptualisation and assessment.
Models for referral by GP for bleeding, self-stating bleeding as reason for clinic
attendance, and citing one or more volume aspects ofperiods as cause of help-
seeking have been examined. The model for citing volume as cause was most clearly
related to volume with severe problem with 'losing too much blood' having the
strongest association. Both the models for referral to clinic are most strongly
associated with rating periods very heavy, and with citing volume aspects as cause of
help-seeking, but also with increased period a problem and being over 40 years of
age. The self-stating model was also associated with having 'had enough' ofperiods,
and containment variables. The impression is ofan internal logic for these models,
with home facilities deficit score for example having no part in the model for 'very
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heavy' rating ofperiods, but being positively associated with self-stating bleeding as
reason for clinic visit - a judgement that periods are not excessively heavy, but too
heavy given the home circumstances.
10.1.2.iv Assessment of menorrhaqia complaint
Guidelines for the management of menorrhagia make recommendations based on
trials where menorrhagia has been confirmed by traditional measurement ofblood
loss (American College ofObstetricians and Gynecologists 2000; Coulter 1995;
Prentice 1999b; Royal College of Obstetrics & Gynaecologists 1998), sometimes
more stringently enforced by being applied to the average over a number of
consecutive periods (Bonnar & Sheppard 1996). Strictly speaking, such trials, if
deemed to be of adequate quality, provide 'grade A' evidence only for similarly
selected patients. This is not how the medication is being prescribed, since
measurement of menstrual blood volume is rarely undertaken in routine clinical
practice.
Two important points need to be made. Firstly, if a reliable method became available
that was suitable for routine clinical use and could identify patients with true
menorrhagia (loss over 80 mL), there would remain an urgent need for trials of
treatment strategies for the remainder, the substantial majority ofpatients with
complaint of menorrhagia, but who have blood loss less than 80mL. Secondly, such a
method would help clinical management of referrals for excessive periods only if
volume of blood loss, and more specifically volume exceeding 80 mL, is the
predominant issue in menorrhagia complaint, and is critically important to optimum
care ofpatients.
The data show that volume of loss is only one among many concerns ofwomen
referred with putatively heavy periods, and not the main one, overall. This replicates
findings in qualitative research (Coulter 1997; Geller et al. 1999; Marshall 1998;
O'Flynn & Britten 2000). Two forms ofassessment used in this study have proved to
be very useful. The aspects ofperiods items were originally devised as a briefway of
ascertaining, via the minimal level participation questionnaire CQ, the extent of
problems for a broad scope ofaspects ofperiods, without partitioning. Responses on
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these items turned out to be very illuminating. It has the further advantage that it is
formulated in terms of both occurrence and problem, so that items avoid the
misunderstanding that occurs, for example, with the classic loss question 'How
heavy are your periods?'. The other assessment that showed great promise was the
MEQ, part ofwhich was converted into principal components, one set about 'dealing
with periods' and the other capturing 'feelings about periods'. Together these would
appear to encompass menorrhagia complaint, and also hint at intriguing subgroups of
patients. Impact (of volume) and containment distress components appear to be key
to rating periods very heavy, variable flow plus containment distress to self-stating
bleeding as reason, with having had enough ofperiods being fairly strongly
associated with both judgements. GP referral for bleeding was the judgement most
strongly associated with the worry component. Measured volumes were most
strongly associated with impact (ofvolume) and containment distress, and were not
associated with variable flow. So there appear to be two subtypes ofmenorrhagia
complaint, one with heavy losses and the other not, or perhaps only intermittently so.
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10.2 CONCLUSIONS
The themes for the menstrual data collection have been 'severity' of symptoms,
change in symptoms, associated worry, impact on daily life and well-being. These
appear to be more important dimensions for the women, than partitioning into
excessive volume of menstrual blood loss, period pain, and premenstrual syndrome.
This study can not give conclusive answers, but the wealth of data amassed allows
informative descriptive analyses and detailed modelling.
The study objectives have been achieved, and work has progressed on the aims. This
will continue, as there are further analyses to be undertaken utilising the personality
and psychological well-being data.
There was no evidence to support the notion that volume of blood loss is key to
complaint, or helpful to management, although there may be important clinical
reasons to measure blood loss in specific cases. Ifmeasurement is needed then total
fluid volume should be seriously considered, for conceptual, methodological and
resource reasons. If total fluid measurement is to be pursued, further research would
be valuable, with the aim of making measurement more reliable and the method
easier for women involved.
The principal component scores show great promise as an assessment, so the next
step would be to be refine the components, and reduce the number of items to be
answered. Given the prevalence of reports ofpain and cyclic symptoms,
consideration should be given to including more items addressing aspects other than
volume and containment. Validation in the context ofa prospective clinical study
would be the next step. The underlying complaint reflected by the component
'variable flow' warrants further attention. Qualitative interviews with women scoring
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I propose the following recruitment strategy, as a clarification of the study design
outlined in the proposal.
TERMS
Referral condition - what is on the referral letter
Presenting complaint - what patient says, on CQ, is her 'main reason' for coming to
clinic
Subjectively heavy periods - if she rates her loss at least as 'heavy' on CQ
Subjective menorrhagia - if she rates her loss as 'very heavy' on CQ
POTENTIAL RECRUITS
Level 1 - CQ + MEQ
Any woman aged 25 to 45 years, not a known drug addict nor satisfying any of the
exclusion criteria listed in the protocol, who has referral condition:
menorrhagia, ?metrorrhagia, dysmenorrhea, premenstrual syndrome or
unspecified 'menstrual problem'
Level 2 - detailed Q's
Any Level 1 woman with:
referral condition = menorrhagia, ?metrorrhagia, or heavy periods
or presenting complaint = menorrhagia, heavy periods, periods too
long/?oflen
or subjectively heavy periods or subjective menorrhagia
Level 3 / 4 - prospective
Any Level 2 woman prepared to participate to these levels.
This means that any women referred for menorrhagia, ?metrorrhagia , or heavy/
excessive periods will be potential recruits for ALL levels, regardless ofwhat they
report on CQ.
On the other hand, women with referral condition of dysmenorrhea, premenstrual
syndrome or unspecified 'menstrual problem', though eligible for Level 1 ofthe
study, will only be taken past Level 1 if they have a CQ presenting complaint of
menorrhagia or heavy periods, or in CQ rate their periods as heavy or very heavy.
Women with other menstrual referral conditions will not be recruited at all e.g.
irregular periods, oligomenorrhea, amenorrhea, dyspareunia, inter-menstrual
bleeding.
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Amenorrhea Dyspareunia ?Pelvicpain Other
CQnotdone
no
Instructions for Menstrual Collection
We are extremely grateful to you for agreeing to collect your usedproducts. This will be of
great value to our research, and is likely to benefit other women with the same problem as
yourself.
Here is a reminder of what we would like you to do:
1. Please use the products supplied - Bodyform Ultra Super Pads and
Super and Regular Tampons.
2. Every time you change your sanitary protection please:
i) put the used product(s) immediately into one of the storage bags supplied
ii) tie the neck of the bag in a knot so it is airtight
iii) as soon as possible afterwards, put the bagged product into the green courier bag
provided for your collection, inside the yellow plastic bag liner.
3. Ifyou use tampons, and you want to have a bath, or swim, please remove and 'collect'
the tampon you are wearing just before you get into the water. (Ifyou want to wear
another tampon while in the water that is fine, but it should just be discarded afteryou
have got out ofthe water.) Once you have got out of the water you can apply a new
tampon, which you will later 'collect' in the usual way.
4. As well as collecting your used products, please also complete the menstrual chart
throughout your period, to note the timing of product changes, the amount of soaking,
any clots, 'accidents' etc.
5. When you are sure your period has finished, please telephone the clinic nurse, on xxx
xxxx, to arrange the hand-over of your collection. Remember, you only need to hand in
your filled-in diaries and menstrual chart, and the green courier bag with all the used
products. You may keep any unused products.
Thank you, again.
What if I have to go out?
This is very likely, and shoidd not be a problem. Please just take spare products and
storage bags with you. Then ifyou need to change you can bag and tie your used
product, to take home with you later, forplacing in the collection.
What if I need to change and I have not any bags with me?
In an emergency any plastic bag will do, but please try to make it airtight.
What if I have not got any of the research-supplied pads/ tampons with me?
In an emergency use any product that you can get hold of, but please:
i) remember to 'collect' the product you arechanging, in the usual way
ii) notify us thatyou have had to use a different product, and exactly what it is.
If you have any difficulties, or second thoughts about the study
PLEASE DON'T WORRY about it




ASSESSMENT OF PERIOD PROBLEMS
Women referred to this clinic for period problems may be bothered by their periods in a
number of ways e.g. period pain, tiredness or irritability, heavy periods. Depending on their
circumstances, employment etc., their period problems may affect their lives in different
ways. This research study is intended to develop a standard questionnaire for assessing
period problems, and their effect on the women who have them.
We would be very grateful if you helped our research by completing some questionnaires.
The new assessment, the Menstrual Evaluation Questionnaire, covers how your periods
have been in recent months. The remaining questionnaires are important so we can check on
the value and reliability of the new questionnaire. They cover background information about
your circumstances, contraception, health and well-being, your way of dealing with day-to¬
day life, your attitudes to illness, any pregnancies you have had, and any period problems in
the past. In addition we would be grateful ifyou would give a blood sample, which will be
used only to testfor iron levels (haemoglobin andferritin), which can be an indicator ofthe
health impact ofheavy periods.
It would be preferable if you could complete our new Menstrual Evaluation Questionnaire,
before seeing the doctor. This will take only about 10 mins. The remaining questionnaires
may be completed in the clinic, or, ifyou prefer, may be taken away for completion at home,
and returned in the Freepost envelope which will be provided.
Our Research Sister, XXXXX, will explain the questionnaires to you and will be able to deal
with any queries you may have, either in person or by telephone.
All information given in the questionnaires will remain completely confidential. If at any
point you decide to withdraw, i.e. that you do not to want to answer the questions, it will not
affect your treatment in any way.
XXXXXX Dr Hilary Critchley Pamela Warner




Weekly Monitoring of Well-being & Charting of Period
You have been good enough to agree to completing the questionnaire part of our research
study into assessment of period problems, and we thank you for that.
A further very important part of checking of our new assessment questionnaire is to be able
to compare it to how a real-life period is for the woman, and to her general health and well-
being over a number of weeks.
Therefore, we are very keen that as many women as possible also monitor their next period
and their well-being over a time-span of 6 weeks. This would involve filling in, once a
week, a very brief questionnaire covering well-being and health in the week just past. In
addition, we ask that when their next period starts they chart the heaviness of flow, sanitary
protection used, and any 'accidents' or other relevant symptoms. Freepost envelopes would
be provided so these questionnaires/charts can be mailed back as soon as completed.
This monitoring is not difficult to do, can be quite interesting in terms of learning about
yourself, and would be very valuable to our research. Please do at least discuss the
possibility with our Research Sister, XXXXXr. She will explain the monitoring to you, show
you the questionnaires, and deal with any queries you may have.
All information obtained from this monitoring will remain completely confidential. If at any
point you decide to withdraw, i.e. that you do not to want to fill in the diaries and chart, it
will not affect your treatment in any way.
XXXXXX Dr Hilary Critchley Pamela Warner
Ifyou have any queries, concerns or difficulties do please contact us.
XXXXXX Phone no.: xxxxx
436 Appendix 3.11
InfoSheet-3 AssPerProb
Collection of Sanitary Protection
You have very generously agreed to completing the questionnaire part of our research study
into assessment of period problems, and to monitoring your next period and your health and
well being over the next 6 weeks. While we very much appreciate all this, there is one
further way in which you could help our research project
The final but really most important part of checking our new assessment questionnaire is to
be able to compare the information it gives to the woman's actual menstrual loss. For
example, what patterns of menstrual loss are common in which women, and with what
profiles of symptoms, etc...? As it happens menstrual loss can be measured, if all sanitary
protection used is kept for laboratory evaluation.
Therefore we are also very keen that as many women as possible agree to keep for us all the
sanitary protection they use during their next period. This may sound like an unusual
request, but please do consider helping in this way, as it is a crucial part of this project. We
have made every effort to ensure that the collection process would be as easy and discreet as
possible for you, and we would provide air-tight sealable bags, and all the packaging
required. At the end we would arrange collection, or re-imburse your travel costs if you
deliver the collection to the clinic.
Please do at least discuss the possibilty of sanitary products collection with our Research
Sister, Elaine Kacser. She will explain the process to you, show you the plastic bags and
packaging, and deal with any queries you may have. You may be interested to know that
this evaluation provides important information to help in treating heavy periods, and in many
cases, especially for some treatments, it can be a requirement, before treatment is decided.
All information obtained from this collection will remain completely confidential. If at any
point you decide to withdraw, i.e. that you do not to want to do the collection, it will not
affect your treatment in any way.
XXXXXX Dr Hilary Critchley Pamela Warner
Ifyou have any queries, concerns or difficulties do please contact us.




Assessment of Period Problems
I have read the description of this study (InfoSheet 1) and I have had the
opportunity to ask questions about it.
I understand that I am under no obligation to take part in this study and that
refusal to participate will not alter the treatment that I would normally receive.
I agree that notice be sent to my General Practitioner about my participation in
this study.
I understand that I can withdraw at any stage or refuse to answer questions if I
wish.
I agree to participate in the questionnaire stage of this study.
Signature of Subject:
Name of Sub ject:
Date:
Signature of Research Nurse:
Four copies to be made: Top copy to be retained by Investigator
Second copy to be retained by subject
Third copy to be sent to subject's General Practitioner
An additional copy to be filed in hospital case notes
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CONSENT FORM-2 AssPerProb
Monitoring of Well-being and Charting of Period
I have read the description of this stage of the study (InfoSheet 2) and I have had
the opportunity to ask questions about it.
I understand that I am under no obligation to take part in this and that refusal to
participate will not alter the treatment that I would normally receive.
• I agree that notice be sent to my General Practitioner about my participation in
this stage of the study.
• I understand that I can withdraw at any time or refuse to answer questions if I
wish.




Signature of Research Nurse:
Four copies to be made: Top copy to be retained by Investigator
Second copy to be retained by subject
Third copy to be sent to subject's General Practitioner
An additional copy to be filed in hospital case notes
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CONSENT FORM-3 AssPerProb
Collection of Sanitary Protection
I have read the description of this stage of the study (InfoSheet 3) and I have had
the opportunity to ask questions about it.
• I understand that I am under no obligation to take part in this and that refusal to
participate will not alter the treatment that I would normally receive.
I agree that notice be sent to my General Practitioner about my participation in
this stage of the study.
• I understand that 1 can withdraw at any time.
I agree to participate in the collection stage of this study.
Signature of Subject:
Name of Sub ject:
Date:
Signature of Research Nurse:
Four copies to be made: Top copy to be retained by Investigator
Second copy to be retained by subject
Third copy to be sent to subject's General Practitioner
An additional copy to be filed in hospital case notes
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Menorrhagia Reconsidered
4.1 RELIABILITY OF DATA ON CURRENT HEALTH, BETWEEN
QUESTIONNAIRES AND CASE NOTES
Out of the 517 women who completed MBQ and had case-note review there were 9
with either a self-reported or notes-recorded history of cancer, but in only 5 cases
was there concordance.
Current medication could be compared for the 517 women who completed MBQ and
who had case-note review. However, it should be noted that the data were not
directly comparable as in the case note review up to three medications were coded,
whereas on MBQ only one medication was coded, or if more than one was reported
then a special code for 'multiple medication' was assigned. Data for two medication
groups will be considered, gastro-intestinal and cardiovascular.
Ten women reported taking gastro-intestinal medications and of these only 4 had
gastro-intestinal medication recorded in their notes, so 6 out of 10 were missed in the
notes. This may be partly because some of the self-report was ofover-the-counter
remedies rather than prescriptions. Viewed from the perspective of the notes, 12
women were found to have gastro-intestinal medication recorded, and of these 4 self-
reported such medication (as noted above) and a further 5 reported multiple
medication which may well have included gastro-intestinal medication. Therefore in
only 3 out of 12 cases was there clear failure to self-report a medication recorded in
the notes.
For cardiovascular medication 22 women self-reported this and in only 14 of these
cases was it recorded in the notes, so 8 out of22 were missed in the notes. Viewed
from the perspective of the notes, 26 women were found to have cardio-vascular
medication recorded, 14 of these self-reported such medication (as noted above) and
a further 9 reported multiple medication which may well have included cardio¬
vascular medication. Therefore in only 3 out of26 cases was there clear failure to
self-report a cardio-vascular medication recorded in the notes.
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4.2 MEASUREMENT ISSUES IN CONTRACEPTIVE METHOD 'USED'
AND DURATION OF USE
4.2.1 Explorations of contraceptive method currently being 'used', as
reported on CQ
The perforce succinct wording on the questionnaire CQ meant that there was a risk
of misunderstanding by respondents to the item asking 'Do you use contraception
currently?'. By reference to responses on the 'importance ofpossibility of future
fertility' item on CQ (item 12), where one possible response was 'not applicable -
already sterilised', it was clear that a number of sterilised respondents (n=6) had
answered the CQ enquiry 'Do you use contraception currently? If so what method?'
by ticking 'None'. This would be an understandable mistake since no contraception
is actively used. These responses were therefore corrected to 'sterilised'.
Furthermore, for the 700 who had also completed MBQ, comparison was possible of
the CQ responses with those for the MBQ item on contraception, which offered more
detailed options and more examples. It was clear that some CQ respondents had
mistakenly understood 'Other e.g. condom, cap', as inferring that the examples given
were the only types of contraception comprising this category. Those who on CQ had
responded 'None' but on MBQ responded 'rhythm method' or 'Other' (unspecified,
but possibly withdrawal or spermicide) were therefore re-coded as 'Other' on the CQ
variable (n=6).
Finally, some who responded 'Partner vasectomy' on MBQ were found to have
responded 'None' or 'Other' for the CQ item, rather than 'Sterilisation - male or
female'. They may not have known vasectomy as 'sterilisation', or may not have
noticed the qualification 'male or female'. These (n=24) were therefore recoded as
sterilisation for the CQ variable. Clearly these latter two checks (and where
necessary corrections) were not possible for the 252 who completed only the CQ.
Therefore the proportions responding 'Sterilisation' and 'Other' on CQ may be an
under-estimate of the true figure (by 8 and 2 women respectively), and the proportion
answering 'None' may be an over-estimate (by about 10 women).
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4.2.2 Categorisation as having 'ever used oral contraception'
This was calculated by accumulating as 'ever-pill-users' all respondents to items
addressing current or past oral contraceptive use on CQ or MBQ. However
participants who were not current pill users and did not go on to complete MBQ
could only be identified as past pill users if they completed the 'years since stopping
the pill' item on CQ. Of the 190 women who were not current pill-users and who did
not answer the 'years since stopping item' on CQ, 135 went on to complete MBQ
while the remaining 55 women did not. Ofthose who did complete MBQ, 53 (39%)
gave answers indicative ofpast pill use. Therefore it is estimated that of the 55 who
did not go on to complete MBQ, a further 21 (39%) are likely also to have been past
pill users.
4.2.3 Missing responses for 'duration of use' of current method of
contraception
The large amount of missing responses (17%) for duration of current contraception
was predominantly women who had answered 'none' for current contraception, and
who presumably, and understandably, did not realise the duration item was
applicable to them (94 patients). There was also a tendency to non-response among
patients who had answered 'sterilisation', who possibly did not realise this could be
interpreted as a method being 'used', and as such required a response for duration of
use. For 6 of the 10 where it was the woman herself rather than her partner who had
been sterilised, it was possible to impute the duration of'use' from responses
regarding the time since (female) sterilisation item on CQ (second to last row of
table). This left 9 male sterilisations and 4 female with missing responses for time
'using' this method. In addition to the cumulative total of 107 non-responses in these
two categories, there were scattered across the other methods a further 4 who did not
record duration of use, and 6 who 'completed' MBQ but had not answered any
aspect of contraception.
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4.3 MEASUREMENT ISSUES IN PREGNANCY DATA
4.3.1 Excess responses regarding time since last pregnancy ended
There were more than expected responses regarding time since last pregnancy ended.
For this the potential n was calculated from information about births of babies, and
there may have been women who were nulliparous (in the sense ofbabies born) who
answered this item because they had experienced pregnancies, albeit not resulting in
births.
Pregnancy outcome
If she had had any pregnancy at all the woman was also asked to record the outcome
of the pregnancies, by providing counts for number of pregnancies resulting in each
of miscarriage, abortion, still birth and live birth. It was possible that for this item
there could have been mistakes in completion in the case of multiple pregnancies, if
the counts requested, for pregnancies, were substituted with numbers of still-born
and live born babies. That is, one twin pregnancy resulting in live births could have
been recorded instead as two live births, or if miscarrying as two miscarriages. Such
an error was almost inevitable if a twin pregnancy resulted in, say, one live birth and
one still birth. The occurrence of such errors could be checked by comparing the
overall number ofpregnancies reported, as shown in Figure 4.14, against the total of
the requested counts of the possible outcomes for the pregnancies (still birth,
miscarriage etc.). In 8 cases the total of the requested counts was one more than the
number ofpregnancies, suggesting this error due to multiple pregnancy. Therefore,
for presentation and analysis of the data for abortion and miscarriage/stillbirth, the
variables have been re-coded into binary form, signifying for each respondent the
occurrence or not of at least one pregnancy with such an outcome. Although the
precise number of failed pregnancies per respondent, miscarriage say, may in some
cases be biased upwards, as explained above, the fact of at least one failed pregnancy
of that type, as conveyed by the binary variable, should be correct.
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It should also be noted that it was possible, if there were multiple pregnancies, for the
number of babies to exceed the number ofpregnancies, which it did in 7 cases, but
not by more than one. Furthermore, a multiple pregnancy may have occurred even if
the number of babies equalled the number ofpregnancies, if one pregnancy failed.
By cross-referencing these variables 23 women were identified as having had
multiple pregnancies (4% of 569).
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4.4 RELIABILITY OF CONTRACEPTIVE AND OBSTETRIC HISTORY
DATA BETWEEN QUESTIONNAIRES AND CASE NOTES
Some of the discrepancy between the succinct question on contraception in CQ and
the more detailed question in MBQ has already been addressed (Appendix 4.2). Of
17 participants with current IUD use recorded in their notes, 3 did not confirm this
by their responses to the contraception items in CQ or MBQ. Of 172 participants
with sterilisation recorded in their notes, 8 did not confirm this by their responses to
the contraception items in CQ or MBQ. Ofthe 145 women for whom years since
sterilisation operation was recorded on CQ and extracted from the case note review,
the two durations agreed to within two years of each other in 86% ofparticipants,
and there were quite substantial discrepancies in a few cases.
The data on outcome ofpregnancies was ascertained on MBQ, and as already been
noted (Appendix 4.3), there was the possibility that women entered for pregnancies
resulting in 'live births' not the number ofpregnancies but the number of infants.
When the MBQ variable was cross-referenced to the corresponding parity data from
the case note review it was found that the MBQ live birth count matched the case
note version for 403 out of416 who had both items completed. (There were 417
women who had ever been pregnant who had completed MBQ and had case-note
review.) For 11 women the MBQ live birth count exceeded the corresponding case
note count by one, and for 2 was one less. The data were less complete for the other
parity variables, and less concordant. Of 369 women who had both miscarriage
variables completed, 15 women self-reported one less miscarriage than was recorded
in the case notes, and 24 reported miscarriages when the notes stated zero
miscarriages. Of 369 women who had both abortion variables completed, 8 women
self-reported no abortions when the case notes reported one, and 11 reported one or
two abortions when the notes stated zero abortions. Of 368 women who had both still
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birth variables completed, 1 woman self-reported no still birth when the case notes
reported one, and 7 reported a still birth when the notes stated none.
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Menorrhagia Reconsidered
5.1 ADDITIONAL TABULAR DATA ON SUBJECTIVE REPORT OF
MENSTRUAL LOSS, PAIN AND CYCLIC CHANGES
Table A5.1.1 Description of menstrual bleeding, ascertained from CQ & MEQ
n %
CQ data
Heaviness of periods, in last 6 months (n= 945, missing = 7)
Light loss 30 3
Moderate loss 152 16
Heavy loss 420 45
Very heavy loss 343 36
Does period include clots? (n=948, missing=4)
No 96 10
Yes- about 20p size 435 46
Yes - about 50p size 272 29
Yes - bigger than 50p size 145 15
MEQ data
How much do you think your whole period would measure?
(n=817)
No idea 448 55
Up to a teacupful 88 11
Full mug (half a pint) 122 15
Much more than a mug 159 19
Bleeding in between periods (n=821)
No 425 52
Some cycles 250 30
Nearly all cycles 146 18
Spotting in between periods (n=813)
No 440 54
Some cycles 256 32
Nearly all cycles 117 14
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Usual duration of period (days) 906 6 5 to 7 70
If varies, (a) longest period 737 9 7 to 14 90




732 4 2 to 8 86
Usual duration of period (days) 802 6 5 to 7 31
Usual number of days 'full flow' 811 3 2 to 4 50
Number of clots per period:
- up to 20p size 762 4 0 to 8 50
- about 50p size 770 0 0 to 4 50
- bigger than 50p 793 0 OtoO 30
- all three sizes totalled 725 6 3 to 12 65
Bleeding between periods (days) 307 3 2 to 6 30
Spotting between periods (days) 272 3 2 to 4 30
All responses apply to periods in last 6 months
456 Menorrhagia Reconsidered
Table A5.1.3 Anticipation of bleeding and planning for period, ascertained
from MEQ
n %
Do you know by counting days when your period is going to
start? (n= 822)
Hardly ever 286 35
Yes, half the time 188 23
Yes most times 348 42
Do you have other signs that tell you your period is due in a few
days?(n=820)
Yes 741 90
How does your period start? (n=818)
Spotting/streaks of blood 242 30
Very light bleeding 364 44
In a gush 212 26
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Table A5.1.4 Containment of menstrual loss, ascertained from CQ and MEQ
n %
CQ data
Sanitary protection used (n=946, missing=6)
Tampons only (all absorbencies) 114 12
Pads only ('mostly regular/super') 207 22
Pads only ('mostly super plus') 245 26
Tampons & Pads (both 'mostly regular/super') 167 18
Tampons & Pads (one or other 'mostly super plus') 115 12
Tampons & Pads (both 'mostly super plus') 98 10
Have to get up at night to change pads/tampons? (n= 952)
Very seldom 196 21
Some periods 353 37
Most periods 403 42
Periods leak through onto underclothes/bedding? (n= 952)
Very seldom 132 14
Some periods 378 40
Most periods 442 46




Do you ever use 'double' protection? e.g. two pads, or tampon &
pad together (n= 824)
No 251 31
Some periods 225 27
Most periods 348 42
How often do you have to change you tampon/pad when your
period is 'full flow'? (n= 819)
At least every 3 hours 246 30
Every 2 hours 303 37
Every hour 177 22
More often 73 11
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Days using double protection 927 2 0 to 4 30
MEQ data
Number of pads/tampons used in
most recent period:
- tampons (any) 794 2 Oto 22 100
(super to plus) 795 0 Oto 0 96
- pads (any) 779 18 9 to 30 164
(super to plus) 781 0 Oto 18 90
- total products (any) 772 30 20 to 40 164
(super-plus) 775 10 Oto 24 164
Number of leakages per period
onto:
- underclothes 781 3 2 to 5 50
- outer clothes 796 0 Oto 2 21
- bedding 785 1 Oto 2 21
# in last 6 months, unless otherwise stated
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Table A5.1.6 Description of pain around periods, ascertained from MEQ
n %
Do you have period-type pain around your periods? (n=827 )
Very seldom 98 12
Some periods 137 17
Most periods 592 72
Do you use pain-killers for pain around your periods? (n=829)
Very seldom 186 22
Yes, some periods 152 18
Yes, most periods 491 59
If so: (a) what type of painkiller? (n=710)
NSAID (paracetomol, profen etc.) 697 98
Codeine etc. 8 1
Others 5 1
(b) does your painkiller work i.e. control the pain? (n=740)
Not usually 95 13
About half the time 296 40
Yes most times 349 47
(Any) pain: usual total days ('before' + 'with' periods) (n=799)
None 98 12
1-2 days 111 14
3-4 days 172 22
5-6 days 155 19
7-10 days 158 20
>11 days 105 13
Severe pain: usual total days ('before' + 'with' periods) (n=806)
None 218 27
1-2 days 206 26
3-4 days 178 22
5-6 days 90 11
>7 days 114 14
Severe pain: usual number of davs with periods onlv (n=811)
None 229 28
1 -2 days 317 39
3-4 days 186 23
5-6 days 49 6
>7 days 30 3
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Table A5.1.7 Description of cycle-related symptoms, ascertained from MEQ
n %
Do you have other symptoms/feelings regularly around your
periods, much more than at other times? (n=797)
Very seldom 109 14
Yes, some periods 120 15
Yes, most periods 568 71
If yes, (a) are any of the symptoms troublesome to you? (n=741)
No, not really 179 24
Yes 378 51
Yes, very troublesome 184 25
(b) when are the symptoms most troublesome? (n=720)
Before period 217 30
Both equally 331 46
During period 172 24
(c) what are the worst symptoms for you:
(i) before your period starts? (n=652 *)
Bloating/weight gain/breast tenderness 226 35
Back ache/pain 209 32
Irritable/angry 140 21
Tiredness 109 17
Mood swings 106 16
Headache/migraine 86 13
Miserable/depressed/sad 65 10
(ii) during your period? (n=627#)
Backache/pain 329 53
Tiredness 197 31
Bloating/weight gain/breast tenderness 83 13
Headache/migraine 70 11
Irritable/angry 61 10
- Percentages were calculated independently for each symptom by dividing the number of
times a symptom was mentioned by the number of individuals answering the item (652).
Since 367 of the 652 respondents reported two symptoms, the total of all percentages
will be 156% (Note: only percentages of 10% or more are reported in the table).
* As above, but using 627 as denominator. Since 315 of the 627 respondents reported
two symptoms, the total of all percentages will be 150%.
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5.2 PRINCIPAL COMPONENT ANALYSIS OF ITEMS ABOUT
PERIODS
5.2.1 Overview ofprincipal components analysis
The goals ofprincipal components analysis are to:
■ Ascertain the minimum number of factors (axes) needed to position the variables.
■ Discover the nature of the factors (underlying processes) that result in the
observed values for the variables (Tabachnick BG & Fidell 1996b).
The first goal requires a decision about the number of factors to be retained in the
solution. The second requires a decision about which if any rotation method to use.
5.2.2 Methods used
5.2.2.i Choice of extraction method
In factor analysis only is there a need to invert the covariance matrix, making
collinearity between variables a serious problem for that method, but not for
principal components analysis. The main difference between factor analysis and
principal component analysis is in respect of the variance being analysed. In
principal component analysis all the variance is analysed, whereas in factor analysis
only the shared variance is analysed (after the unique variance and error variance
have been estimated and eliminated). For these reasons it was decided that principal
components analysis would be used.
5.2.2.ii Steps in principal components analysis
Extraction of components
The principal components method works on the correlation matrix for the p variables
being analysed. From this, a set ofp factors (components) is obtained which together
can reproduce all the variance in the correlation matrix. The components are
orthogonal to each other, that is, they comprise independent dimensions of
variability. The matrix calculations ensure that as much as possible of the variance in
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the variables is explained by the first component. Proportionately less variance is
accounted for by each successive component. The statistical software also provides a
factor loading matrix. This gives the correlations between the p factors and the p
variables. If a variable has a strong (negative or positive) correlation with a factor
then it is described as having a high (negative or positive) 'loading' on that factor.
The interpretation of each factor is made in terms of the variables that are most
highly correlated with it, and the directions of these correlations. Clearly this is
easiest in the case of a factor for which few variables have substantial loadings.
Deciding number of components
Next, a decision is made as to how many components are to be retained in the
solution. This is one of the most important decisions to be made in a factor (principal
component) analysis. Parsimony will not have been achieved unless the number of
factors in the final solution is less than the original number ofvariables. However, if
too few factors are retained then the solution may be a poor fit to the data. The
number of factors is decided on the basis of one or more of the following issues:
■ The purpose of the solution - the need to be succinct and simple versus the need
to encapsulate more of the underlying processes in the data.
■ The total proportion of the variance that it is felt should be reproduced by the
components.
■ The relative importance of an additional component that might be retained,
judged in terms ofthe variance accounted for by that component. If the
component accounts for less variance than one of the original variables then it is
unlikely to be more useful than the variable itself. (This is ascertained by the size
of the eigenvalue corresponding to the component. The eigenvalues represent
variance and are calculated in one of the intermediary matrices produced in the
course of the analysis. Since the standardised variance of a single variable is 1, a
component with eigenvalue less than 1 accounts for less variance than a variable.)
A scree plot, showing the sizes of successive eigenvalues, can be used to help
decide, by selecting the point where the slope flattens out. (Tabachnick BG &
Fidell 1996b)
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Once the number of factors to be retained is decided, say m, then the factor loading
matrix is recalculated, to give the correlations between the m factors and the p
variables. The interpretation of each factor is as described above, in terms of the
variables that are most highly correlated with it.
Rotating the solution
The factor solution can then be subjected to 'rotation'. This does not in any way
improve the mathematical fit of the factor analysis. The aim of rotation is merely to
simplify interpretation, by creating an alternative solution, accounting for the same
total variance as the m factors retained from the original extraction, but where the
variables have mainly very high or negligible loadings on factors. Rotation can be
orthogonal or oblique. In the case oforthogonal rotation, this is equivalent to moving
(rotating) the multidimensional axes, while keeping them all fixed (at 90°) in relation
to each other, until as many cases as possible are located along the various axes.
Therefore after rotation the factors remain orthogonal (uncorrelated). However,
sometimes the structure of a data set means that orthogonal rotation can not achieve a
'good' solution (with cases located along the axes). In such circumstances oblique
rotation may be used, which allows the angles between the axes to change. If this
method is used the resulting factors will no longer be orthogonal to (uncorrelated
with) each other, which can complicate the interpretation of subsequent analyses of
the factor scores. Ifa satisfactory solution can be obtained by orthogonal rotation
then this is the preferred method. After rotation a new 'rotated' factor loading matrix
is obtained, reflecting the polarised loadings. These factors are interpreted as before.
A number of methods oforthogonal and oblique rotation are available. The most
commonly used method oforthogonal rotation is 'varimax', which seeks to minimise
the complexity of components, and maximise the interpretability, by ensuring as few
variables as possible load on each component. Varimax rotation also tends to even
out the amount of variance accounted for across the m components in the solution,
resulting in equally 'important' components. The most commonly used method of
oblique rotation is 'oblimin' which seeks to simplify components by minimising the
cross products of loadings.
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Estimating factor scores
Once the final factor loading matrix is available, factor scores can be estimated for
each case. The factor scores are conceptualised as reflecting the underlying
processes, whereas the variable values are held to be the observed manifestation of
those processes. Therefore each variable is regarded as a weighted combination of
the subject's underlying factors.
5.2.2.iii Checks with regard to solution
Application of the principal components method requires a series of analyses
iterating to a solution. The solution ultimately interpreted should: be as consistent as
possible across variations in number of retained factors and rotation method used; be
interpretable; and should give scientifically useful results.
Variables should be checked for outliers - that is, variables that have low squared
multiple correlations with all other variables and with other factors. These may be
deleted from the analysis.
Ifany cases have extremely low or high factor scores they are termed case outliers.
The interpretation is that for these cases the factor solution is inadequate.
Examination of such cases may reveal a consistent pattern, and hence allow
description of the characteristics of cases for whom the current factor solution is
unsatisfactory.
5.2.3 Results
For both analyses undertaken in this chapter components with eigenvalues greater
than 1.1 were retained.
5.2.3.i MBQ question 22 items - 'Dealing with periods'
The results for this principal component analysis and rotation are presented in Table
A5.2.1, which presents only the 'substantial' factor loadings, those > 0.4. Since each
loading is the correlation between the corresponding MBQ item, and the underlying
component ofvariability in the data, the 'factor', the highest loadings give the best
sense ofwhat 'process' each component reflects. Other variables (items) also load on
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the factors, but only minimally or negligibly. Labels have been assigned to each
component, but it should be remembered that this is a subjective judgement, and
usually has to be a succinct simplification of the observed pattern of loadings. For
example, the first component has been labelled 'impact of volume' but items a,j, k
and s could equally well be coping strategies for very severe period pain.
Loadings < 0.4 are excluded from the table, for ease of perusal, but remain in the
formula estimating component scores for each respondent. A box-plot of estimated
component scores is given in Figure A5.2.1. These scores will be further analysed in
Chapter 9.
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Table A5.2.1 Loadings* for estimating component (factor) scores for 'dealing
with periods' - items from MBQ question 22 (n=721)
COMPONENTS (FACTORS) 5: Unpredictable onset
4: Loss of well-being
3: Resource issues
2 Variable flow
Item 1: Impact of volume
k During period I limit where I go .833
a Plan life to avoid outing when period .827
d I limit what I do to avoid accidents .773
i Cancel activities if unexpected period .709
s Have to rest during full flow .647
b Just can't prevent accidents .567
m Wear different clothes during period .560
r Spend a lot on pads etc. and washing .542
P Can not afford money spent on periods .809
q If run out difficult to get extra supplies .797
t Leakage causes problems laundering .671
c Feel unwell during period .760
e Irritable while period is happening .804
g Pattern of flow is unpredictable .767
n Heaviness varies period to period .723
f Period goes on too long .721
u Never sure when period is finished .672
o Periods have changed from normal .666
i Never sure when full flow is starting .465 .645
h Wear protection before in case .704
% variance accounted for by 21% 17% 13% 9% 6%
component
* each loading is the correlation between the coresponding item and factor, and for
simplicity only loadings greater than 0.4 are shown
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Figure A5.2.1 Distribution of estimated component scores for 'dealing with
periods', separately by self-statement or not of bleeding as
reason for clinic attendance









283 283 283 283 283
No
438 438 438 438 438
Yes
Bleeding is self-stated reason for clinic attendance?
Perusal of the box-plots show a number of outlier or extreme component scores,
plotted as circles or stars respectively. The suggested interpretation is that for these
cases the factor model is inadequate (Tabachnick BG & Fidell 1996b). Examination
of the individual data may yield insights as to why the cases (factor scores) are
outliers. In the meantime, for the analyses of Chapter 9, the scores have been
subjected to non-parametric statistical methods, or recoded into quintiles, so avoiding
undue influence by outlier scores.
5.2.3.ii MBQ question 23 items - 'Feelings about periods'
Similarly, the results for the principal component analysis for MBQ question 23 data,
addressing emotional reaction to menstrual experience, are presented in Table
A5.2.2, A box-plot of estimated component scores is given in Figure A5.2.2,
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Table A5.2.2 Loadings* for estimating component (factor) scores for 'feelings
about periods' - items from MBQ question 23 (n=687)
COMPONENTS (FACTORS) 5: Had enough of periods
4: Resent resources used
3: Worry about change in periods
2: Periods a burden
Item 1: Containment distress
a Upsets me no way to avoid accidents .748
c Worry all the time I need to change .698
y Blood leakage on clothes is embarrassing .689
r Worry if I will be able to avoid accidents .676
b Annoyed I have to wear different clothes .660
nn Dread difficulty of containing flow .660
w I find flow overwhelming .623
k Leakage onto bedding is embarrassing .607
dd Blood stains are a nuisance to deal with .599
aa Worrying about accidents is worse .565
u Embarrassing to have to keep changing .642 .416
P Feel abnormal buying such a lot of pads .502 .598
X Feel embarrassed buying such a lot .469 .643
bb Spend whole life thinking of changing .446 .400









d Annoyed at having to limit what I do .682 .523
s My periods are intolerable .407 .578
e
ii
I get upset by my period





II Feel bad family/friends are affected .764
ff My periods put a burden on family/friends .742
t My periods make me low/depressed .644
mm My periods have taken over my iife .618
j
1
Wish for someone to talk to re periods
My periods make me less healthy
.547
.542
q My periods make me tired .516 .412
pp My periods feel like a punishment .419 .493
ee Worries me my periods have changed .787
V Wish my periods could be how they were .691
kk Worry change means something serious .670
hh Difficult as never sure when full flow .534
cc Bothers me never sure when finished .513
JJ Sanitary protection is a waste of money .759
g Resent all the money spent on pads etc. .694
oo No more periods would be a great relief .834
z I just wish an end to periods .824
% variance accounted for by component 23% 17% 10% 10% 7%
* each loading is the correlation between item and factor, and for simplicity only loadings
greater than 0.4 are shown
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Figure A5.2.2 Distribution of estimated component scores for 'feelings about
periods', separately by self-statement or not of bleeding as
reason for clinic attendance
(low score = favourable, high score = adverse)
N = 268 268 268 268 268
No
419 419 419 419 419
Yes




^ periods a burden




□ had enough of
periods
These scores also show some evidence of outliers, but rather less than in the factor
model for 'dealing with periods'. In Chapter 9 the same analytic approach has been
taken for these components scores as for those presented in Figure A5.2.2,
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5.3 RELIABILITY OF QUESTIONNAIRE DATA ABOUT PERIODS
5.3.1 Overview
In this Appendix some issues ofdata reliability are considered.
5.3.2 Concordance of data from different questionnaires
The same question about duration ofperiod was asked in CQ and MEQ and, as can
be seen from Appendix Table A5.1.2, the distribution of durations of usual period
was very similar to that reported by the entire study group completing the CQ item.
There was also replication on MEQ (not reported) of the pattern for shortest and
longest periods shown on CQ and presented in Appendix Table A5.1.2.
Although the subset of 821 women completing MEQ were very similar to the entire
study sample in terms of their prevalence of use of double protection as reported on
CQ, 62% compared to 60%, their prevalence of use ofdouble protection as reported
on the MEQ item addressing this issue differed slightly from the CQ report (69% v
62%, n=819). This difference may be due to the different wording. The CQ item
posed a binary 'yes/no' question, whereas the MEQ item allowed some sense of the
frequency ofuse of double protection to be indicated. For this item format 42%
reported using double protection 'most periods', with another 27% reporting use
'some periods', and the remainder responded 'no'. A further difference was that the
MEQ item asked a matter-of-fact question, whereas the CQ item was worded as an
imposition 'Do you have to use..?'. Therefore responses on these two items would be
expected to differ.
5.3.3 Reliability of data about menstrual experience
There are concerns about some of the high values, for days bleeding, days use of
double protection, and for number of clots, all data intended to describe the usual
count, per period, over the last 6 months. Given the variable nature of periods for
most women, these data may be subject to recall error. In addition, it is possible that
some women may have misunderstood the purpose of the specification of a time
frame of the last 6 months, and thought a total count over this time was required,
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rather than 'usual per period'' over that time.. The positive skew of most of these
variables, and anecdotal reports of extreme values - such as 'bleeding continuously
for 6 weeks', makes it difficult to establish clear outliers by examination of the
distributions. Some internal checks are possible, but even where the conditions tested
are satisfied, this may merely indicate consistent reporting for a total of 6 months
across a number of the questionnaire items. However, for those women who
proceeded to menstrual collection, it will be possible to compare their prospective
recording of duration ofbleeding, sanitary protection use and clots against the
accumulated counts provided in the retrospective questionnaires.
As was seen in Appendix Table A5.1.2, from the maximum count for each clot size
(50, 50 and 30 respectively), some women reported very high numbers of clots. It is
possible that some of the high values arise because the question was misunderstood,
and reporting was for numbers ofclots for the 6 months in total, not as requested,
'per period'. However, these counts were not stark outliers. Although occurrence of
clots has been recorded in past research, for the purposes of calculating menstrual
blood loss, or for making adjustments to such calculations, these data have not been
reported. Therefore it is not possible to compare the counts for clots reported in this
study with past research.
For reported counts, especially where varying in occurrence and vaguely recalled,
there would be expected to be evidence ofdigit preference at multiples of 10 and to a
lesser extent 5. Ifwomen have totalled up counts for the 6 months it may be expected
that the values reported would be more likely to be multiples of 6 (provided that
respondents are familiar with the 6 times table). The histogram presented in Figure
A5.3.1 shows clear peaks at 10 and 20, but also some evidence of peaking at 6 and
12.
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Figure A5.3.1 Histogram of total number of clots per period - selected data,
all women completing MEQ, with between 1 and 21 clots in total
(n=673 of 725 completing item)
TOTAL NUMBER OF CLOTS PER PERIOD
For the 546 women who used double protection, the distribution of days' use
reported showed that relatively few used this strategy for just 1 day (5%), the
majority for 2 to 5 days (82%), and a further 12% for 6 to 15 days. The highest
values, such as the maximum of 30 days, and the next smaller value, 25 days, may
indicate a misunderstanding of the question, or errors in the data. The duration of use
of double protection was compared against the usual duration of bleeding. The
woman reporting 30 days double protection did not report her usual duration of
bleeding but did report 30 days of bleeding between periods (requiring sanitary
protection), and the woman reporting 25 days double protection reported her usual
duration of period as 30 days. Although these two values for double protection use
are therefore plausible, there were also 6 women for whom the days of double
protection reported exceeded the usual days of bleeding reported. Two of these also
completed MEQ, and recorded days of break-through bleeding requiring sanitary
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protection, so it is possible that containment of this unpredictable loss accounted for
some of the discrepancy, for them and for others who did not complete MEQ.
For those whose periods varied in duration, from cycle to cycle, and who recorded
duration of longest and shortest periods (n=732), the difference was for 50% of them
between 2 and 8 days (maximum 86 days). The woman reporting 70 days bleeding
did elaborate that her longest periods were 70 days and her shortest 2 days, so in this
case it would appear 70 days is not a totalling up of days bleeding over 6 months, but
an experienced duration ofwhat she understood to be a 'period'. On both CQ and
MEQ the usual duration ofperiods reported was 5 to 7 days (IQR), though there
were a very small number ofwomen who reported extremely long periods (31 days
or 70 days). It is possible some women were totalling up all days of bleeding over the
last 6 months, instead of reporting usual duration, in the last 6 months, of bleeding
per period. However, there were certainly some women who elsewhere reported
bleeding continuously, so such excessive 'durations' ofperiod may be possible.
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6.1 DETAILS OF OUTLIERS AND EXCLUDED CASES
Table A6.1.1 Further details of outliers and excluded cases in Chapter 6



























C 58 267 Used large number of products, a




D* 18 <1 Fluid measurement unreliable at low







E* 8 4 Fluid measurement unreliable as for







F* 9 18 Relatively large number of products




G 493 593 Relatively very small number (24) of







H* 2 47 Very low blood volume for fluid.




K* 107 57 Very high blood volume for fluid and
possible optical density error.




* These collections would have been excluded from Table 6.2 analyses 2 to 5 since those
analyses were restricted to cases with total fluid volume > 80mL.
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7.1 QUALITY CHECK 1: MEASUREMENT OF MENSTRUAL VOLUMES
7.1.1 Aim
To check process of measurement ofblood and total fluid volumes ofmenstrual
collections.
7.1.2 Method
A unit of fresh whole blood bank 'blood' was obtained and used to simulate three
menstrual collections, two each with blood volumes 25mL, 65mL and 110ml. In
addition six venous blood samples were 'created'. For each 'collection',
phosphorylated saline was mixed with the blood to make the total menstrual loss up
to likely total menstrual fluid losses (60mL, 125mL and 210mL respectively). Each
menstrual loss was poured onto a set ofsanitary pads, the number ofpads used being
roughly in proportion to the loss volume. Each 'collection' created was then placed
in a polythene bag, without recourse to nappy sacks to seal individual products, and
after about 10 minutes, sealed. The collections were then left to stand for two days.
Each nurse was provided with one collection of each volume, and asked to follow the
study procedure to ascertain the total collection weight and volume of blood loss.
Both nurses were blind to the volumes of blood and total fluid that had been
simulated.
7.1.3 Results
For this first quality check results for the total fluid measurement were excellent. The
total fluid volumes simulated were 60mL, 125mL and 210mL. Total fluid estimates
were within 0.6mL (1%) for the lightest loss (estimated volumes of 60.6mL and
59.5mL for Edinburgh and Glasgow respectively), within 2.3mL (1.8%) for the mid-
loss (volumes 127.3 mL and 124.5mL), and within 4.4mL (2%) for the heaviest loss
(volumes 214.4mL and 212.2mL).
The blood loss measurements however deviated disturbingly from the simulated
blood losses, with marked underestimates at both centres for the lower losses, and
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over-estimate for the heaviest. For the first two collections (25mL and 65mL blood
loss volumes), the blood volumes estimated were under by 14ml (56%) or more for
the lighter loss (estimated blood loss volumes at Edinburgh and Glasgow of 3mL and
I lmL respectively), and under by 24mL (37%) or more for the moderate loss
(volumes of41mL and 26mL respectively). For the highest blood loss collection,
II OmL, the last collection to be created, the estimate in Edinburgh was under by
9mL (8%) but the estimate in Glasgow over by 60mL (55%) (estimated volumes of
lOlmL and 170mL respectively).
7.1.4 Conclusions
Reflection on and discussion of these surprising blood extraction results led to the
realisation that the simulated losses which had been underestimated were those
which had been created first, the 25mL and 65mL losses, and the closer/over¬
estimates were for the last collections to be created. A possible mechanism was that
in the 'blood' obtained from the blood bank there had been settling of the red blood
cells in the blood pack, resulting in a lower proportion of red blood cells per volume
in the earliest collections to be created. The order of creation of two collections of
the same blood loss volume was not recorded, so it was not possible to check this
potential explanation within 'equal' collections, but it was felt this may explain the
one slightly under-estimate, and one grossly over-estimate in the two heaviest
collections, the last to be created. It was decided the quality check needed to be re¬
run.
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7.2 EXPERIMENT 1: TUBES, DILUTIONS AND SOAKING TIME
7.2.1 Aim
To evaluate the effects ofvenous sample tube and dilution, and soaking time.
7.2.2 Method
This factorial design required the measurement by each research nurse in her usual
laboratory setting of the optical density for two different venous blood samples, both
provided in each of two different tubes (purple cap or orange cap), but not labelled so
as to be able to be paired. Each nurse was to measure each of her 4 assigned samples
mixed with NaOH at two different dilutions (1 in 100 and 1 in 200). Spectro-
photometric measurement was to be undertaken at each of three time points after
mixing (48 hours, 4 weeks and 9 weeks). Therefore the design comprised 5 factors
(nurse/centre, blood sample, tube, dilution ofblood sample, delay to measurement)
and resulted in a total of 48 data values.
7.2.3 Results
Analysis of variance showed, as would be expected, that the optical densities differed
by dilution, but they also differed by centre (F=25, df=l,38, p<0.001), by delay to
spectro-photometry (F=6.3, df=2,38, p=0.004), and there was an interaction between
these last two factors (F=6.6, df=2,38, p=0.003). There was no effect of tube type,
and as it happened the haemaglobin levels of the two bloods used were fairly similar.
Interpreted, these findings were that Edinburgh optical densities were generally
higher, optical densities declined with time to 4 weeks, and if measurement was
delayed to 9 weeks after setting up then this pattern ofdecline in optical density
continued for Glasgow but was reversed at Edinburgh.
The average optical densities, respectively for the two bloods used, were at 48hrs
delay to measurement and 100ml dilution, 0.615 and 0.549 in Edinburgh and 0.539
and 0.562 in Glasgow, and at 200mL dilution 0.280 and 0.273 in Edinburgh and
0.272 and 0.272 in Glasgow.
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However, since blood loss determinations use the relative optical densities of two
solutions (menstrual and venous) measured within the same centre and after the
same time delay, the between centre and by time differences may not matter, as long
as the ratio of the optical densities for the two dilutions remains constant. Analysis
was undertaken of the ratios of the optical densities for the corresponding lOOmL
and 200mL dilutions of the same sample. Given ideal proportionality of the
relationship between optical density and concentration this ratio would be expected
to be 2, whereas the overall mean for the data from this experiment was 1.96. Non-
proportionality will be considered in Appendix 7.6. However, with regard to the
factors under consideration in this experiment, there were no significant differences
by centre, tube type, standing time or blood sample, nor any significant interactions
with centre. Table A7.2.1 shows the mean optical density ratios by centre and
standing time, and it can be seen that the ratios reduce slightly with time.
Table A7.2.1 Ratio of optical densities (1 in 100 diluted blood : 1 in 200) by
centre and standing time






Edinburgh 48 hours 2.11 1.88 2.34
4 weeks 1.91 1.68 2.14
9 weeks 1.83 1.60 2.06
Glasgow 48 hours 2.03 1.80 2.26
4 weeks 1.97 1.74 2.20
9 weeks 1.89 1.66 2.12
It should be noted that both blood samples used for the experiment had good
haemoglobin levels, and so these data apply to ratios of optical densities at the
corresponding points on the haematin concentration axis. For different
concentrations of similar blood (even if one sample is twice the dilution of the other,
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say 1 in 200 and 1 in 400), or for blood samples with different levels of
haemoglobin, the results might be very different. The confidence intervals reported
for the ratios in Table A7.2.1 are fairly narrow, but it should be remembered that
these are confidence intervals for the mean ratio, not for individual determinations.
The similarity of the patterns in Edinburgh and Glasgow, for ratios of 100:200mL
diluted optical densities, is in contrast to the disparity observed above with respect to
absolute optical densities, where Glasgow readings continued to decline between 4
weeks and 9 weeks but Edinburgh readings increased by 9 weeks. The differing time
patterns for absolute optical density readings and ratios, by centre and delay time,
suggests that some technical artefact may have disturbed the 9 week optical density
readings in Edinburgh. Fortunately it would appear, judged by the ratio of the
readings for the two dilutions, that the reading ratios were comparable with the ratio
for the same delay time in Glasgow, so the machine (or measuring process) appears
to have remained internally consistent.
A measurement task that would correspond to this simulated exercise would be that
of a collection with 80mL blood loss from a patient with normal haemoglobin levels,
soaked in 8L NaOH, being measured against a lmL blood sample diluted to 200mL.
Depending on the delay to spectro-photometry the ratios in Table A7.2.1 would
predict a trend in blood loss estimations with time delay, from 81 to 75mL in
Glasgow and from 84 to 73mL in Edinburgh.
The overall mean ratio at 48 hours (ignoring centre) was 2.07 (95% CI 1.9 to 2.2),
but for an individual blood loss determination, the 95% prediction interval for the
individual collection optical density ratio at the same time point (48 hours) is 1.62 to
2.46. For the measurement task described the previous paragraph this corresponds to
a blood loss determination, for 95% of such 80mL true blood volume collections,
ranging between 65 and 98mL.
7.2.4 Conclusions
Tube type had no bearing on optical densities. Optical densities did differ markedly
by centre and time to measurement, but when the within-sample optical density
ratios (lin 100 dilution to 1 in 200) were considered there was no detectable effect
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between centres nor across time. There was a trend for decline in optical density ratio
with time, albeit not statistically significant in the small experiment undertaken.
Optical density ratios varied quite markedly between individual readings, such that
an 80mL blood loss collection requiring spectro-photometric assessment of two
dilutions of blood (1 in 100 and 1 in 200) would in 95% of such determinations
estimate the blood volume as between 65mL and 98mL. These results do not inform
as to the situation at concentrations outside the range of 1:100 to 1:200 dilution of
blood of normal haemaglobin content, nor in situations where very similar
concentrations for venous blood and soaking solution are compared spectro-
photometrically (say 1:150 to 1:150).
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7.3 EXPERIMENT 2: VOLUME OF NAOH FOR SOAKING, AND
FILTRATION/ DILUTION OF SUPERNATANT
7.3.1 Aim
To evaluate the impact of actual menstrual blood loss volume, volume ofNaOH used
for soaking, filtration method, and subsequent dilution of filtrate on determination of
menstrual blood volume.
7.3.2 Methods
This simulation addressed the processes applied to the supernatant, with no sanitary
products involved. The relevant volume of venous blood was simply mixed with the
relevant volume ofNaOH. In fact, to reduce the volumes ofblood and NaOH needed
for the experiment, the mixing was done in proportion, to produce about 500mL of
each of the four differing 'supernatant solutions'.
The factorial design required the measurement by each research nurse in her usual
laboratory setting of the optical density for two simulated menstrual loss collections
(80mL and 120mL blood loss volume) soaked in differing volumes ofNaOH (2L and
4L). Each of these 4 samples of'supernatant' was to be filtered in two ways (through
double regular filter paper and through single stiffened filter paper). Spectro-
photometric measurement was then to be undertaken at 2 dilutions ofthe filtrate
(undiluted and diluted 1 in 5 - that is, 20 mL filtrate made up to lOOmL with NaOH).
Therefore the design comprised 5 factors (nurse/centre, volume ofblood loss in
collection, volume ofNaOH for soaking, filtering method, dilution or not of
supernatant prior to optical density measurement) and resulted in a total of 32 data
values. Two blood sources were used, one being used for the 120mL in 2L and 80ml
in 4L supernatants, the other for the 80mL in 2L and 120ml in 4L supematants, so
blood source needs to be taken account of in the analysis. The nurses were blind to
the 'collection' volumes of blood and non-blood fluid that were simulated.
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7.3.3 Results
Some high optical density readings were indicated by the spectrophotometer as
'unreliable', those for the samples with highest blood concentration (the samples
with 2L NaOH for 'soaking' and no secondary dilution). In addition, the readings for
120mL blood in 4L NaOH, undiluted, exceeded 1,which is beyond the range of the
optical density scale where reliable measurement is expected. Therefore it was felt it
would be advisable to restrict analysis to only the diluted supernatants, and the
undiluted supernatant with lowest concentration (and hence optical density readings
less than 1), that with 80mL blood in 4L NaOH. This left 20 readings in all for
analysis and prevented examination of the preservation ofproportionality when
diluting the supernatant by a factor of 5. (However, we have already seen in
Experiment 1 (Appendix 7.2) that the observed ODs suggested lack of
proportionality for pairs of readings where one of the pair of solutions was twice the
concentration of the other.)
To reduce the number of variables, the proportion of blood volume to total volume of
'supernatant', Blood Concentration, was calculated as
Volume blood
[(Volume NaOH + Volume Blood) x Dilution factor]
Regression analysis was undertaken of optical density by centre, blood source, filter
and blood concentration. The overall regression analysis gave F>4000, df4,19,
p<0.001, and revealed that as expected optical density was very strongly linearly
related to blood concentration [bbi0odconc. = 48.0 (95% CI= 47.2 to 48.8)]. It also
showed that the optical density was slightly reduced if double standard filter paper
was used [bdoubie niter paper= -0.014 (95% CI= -0.022 to -0.006)]. That is, in terms
of average optical densities, the optical density was lower by 0.014 if double filter
paper had been used.
7.3.4 Discussion
The effect of filter paper type on optical density must be a result of excess absorption
of heme chromogens in the double filter paper. Since in the formula for calculation
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ofblood volume, the optical density (for the menstrual solution) is multiplied by the
effective volume ofNaOH, the impact of the discrepancy in the OD due to filtration
method will depend on that volume. For measurement of a collection effectively
diluted in 4L ofNaOH, say a blood loss of 80 mL, use of double filter paper (rather
than stiffened) would result in the volume being under-estimated by 1.04mL. For a
collection with a soaking volume ofNaOH of20L, say losses of 80 orl20mL, the
under-estimation of the volume would be by 5.19mL.
7.3.5 Conclusions
It was found the double filter paper used in Edinburgh resulted in slight
underestimation of the blood volume. Since this affected only the collection optical
density, the extent ofunderestimation is multiplied up ifgreater effective volumes of
NaOH are used, from lmL underestimation to 5.2mL if the volume ofNaOH is
increased by a factor of 5. This study highlighted the importance ofNaOH volumes
that ensure low enough concentrations of haematin for reliable readings. The upper
limit of acceptable blood concentration is 80mL blood in 4L NaOH.
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7.4 QUALITY CHECK 2: MEASUREMENT OF MENSTRUAL VOLUMES
7.4.1 Aim
To check process ofmeasurement ofblood and total fluid volumes ofmenstrual
collections, in particular to check measurements when loss volumes were relatively
high.
7.4.2 Method
This was a re-run ofquality check 1, but taking care to stir the blood thoroughly prior
to creating each simulated loss. In addition 2 packs ofwhole blood were used, to
allow simulation of heavier collections. Three menstrual collections were created,
two each with blood volumes 70mL, 120mL and 190ml. For each 'collection',
phosphorylated saline was mixed with the blood to simulate the likely total menstrual
fluid losses (160mL, 260mL and 420mL respectively). In addition a 'venous blood
sample' was created for each collection. Each menstrual loss was poured onto a set
of sanitary pads, the number of pads used being roughly in proportion to the loss
volume, and each 'collection' created was then placed in a polythene bag, without
recourse to nappy sacks to seal individual products, and after about 10 minutes,
sealed. The whole blood was also used to provide simulated venous blood samples in
purple tubes. The collections were left to stand for two days and then each nurse was
provided with one collection ofeach volume, and asked to follow her usual study
procedure to ascertain the total collection weight and volume ofblood loss. Both
nurses were blind to the volumes ofblood and total fluid that had been simulated.
7.4.3 Results
For this second quality check, results for the total fluid measurement were not as
accurate as for the first. The total fluid volumes simulated were 160mL, 260mL and
420mL. Total fluid estimates for the 420mL collection were within 4% of actual
(under by 18mL in Edinburgh and lOmL in Glasgow), and for the 260mL collection
within 3% ofactual (exceeding the true value by 6mL and 3mL respectively). The
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estimates for the smallest collection (160mL) were over by 7mL (4%) in Edinburgh
and by 36mL (22%) in Glasgow.
The blood losses in the collections were 70, 120 and 190 mL, but as this was a full
simulation, using pads, it would be expected that there would not be complete
extraction ofall the blood loss into the soaking NaOH. [Hallberg reported an
extraction rate, per pad to which lOmL ofblood had been added, equivalent to a
mean underestimate of 3.7% (95% CI 2.7% to 4.7%) (Hallberg & Nilsson 1964).]
The blood loss measurements in Edinburgh on the whole showed more extreme
underestimation (-13%, -5% and -16% for the three simulated collections in order of
increasing blood volume). On the basis of Experiment 2 (described above) some
additional underestimation would be expected in Edinburgh due to the double filter
paper used, but no more extreme than 1 to 2 mL underestimate (a further 1%). The
Glasgow results however were puzzling and disturbing, in that blood volume was
over-estimated (+26%, +35% and +13% respectively, for the three collections in
ascending order of blood volume simulated).
7.4.4 Discussion
With regard to the total fluid volume measurement for the 160mL collection in
Glasgow, by over 22%, it is possible that this was due to a transcription error in
recording the total weight. If the 330.4 g total wet weight recorded was an erroneous
transcription of a 303.4g weight reading, then the correct reading would have
provided an estimate over by 9mL (6%).
With regard to blood volumes, some of the difference between Edinburgh and
Glasgow estimated volumes may be due to differences in physical extraction rates of
blood from the products into the soaking solution. With regard to the rest of the
measurement process, slight differences may be due to the filter paper used in
Edinburgh, as it has been shown in Experiment 1 (Appendix 7.2) that the double
filter paper causes underestimation of blood volume by about 1 to 3 mL.
A further contributing factor may be the range of the optical density scale 'used' for
calculations. The Edinburgh tests were undertaken at lOOmL dilutions of the venous
blood, and so optical densities for venous blood were in the range 0.44 to 0.58. The
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soaking volumes ofNaOH (3.9 to 6L), with subsequent dilution (1 in 2) of
supernatant in two collections, giving effective soaking volumes of 3.9 to 12L),
meant that the collection optical densities were in the range 0.654 to 0.762. In
contrast, in Glasgow optical densities were lower, for venous blood (diluted 1 in 200)
in the range 0.201 to 0.237. The soaking volumes ofNaOH (2 to 3L), with
subsequent dilution (1 in 10) of supernatant in all cases, giving effective soaking
volumes of 20 to 30L), meant that the collection optical densities were in the range
0.181 to 0.339. This is illustrated in Figure A7.4.1 where it can be seen that the
Edinburgh spectro-photometric tests were typically at a higher point on the scale, and
in addition that in Edinburgh there was greater separation between the collection
optical densities and the corresponding venous optical densities.









♦ OD venous Edinburgh (1 in 100)
—0— OD menstrual Ed. (vols 3.9, 7.8 & 12 L resp.)
-•—OD venous Glasgow (1 in 200)
-e— OD menstrual Gl. (vols 20, 25 & 30 L resp.)
Test collection
Accurate estimation depends on optical density being proportional to haematin
concentration, that is, that the relationship is a line through the origin. While for
ranges of the concentration the relationship may well be linear, it may nevertheless
be the case that the intercept is not zero. Furthermore, over the range of haematin
concentrations the precise nature of the linear relationship may vary, in terms of
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either or both of slope and intercept. This issue is further considered in 7.2.2.V and
7.3.I.V.
7.4.5 Conclusions
The total fluid measurements using standard pads and average weights were on the
whole satisfactory (within 4% of actual fluid volume). There was one aberrant
estimation, which was possibly due to a transcription error, the sort of error that
could occur for fluid or blood loss volume measurements. The blood loss
measurements were underestimated in Edinburgh (by 5 to 16%) and overestimated in
Glasgow (by 13 to 35%). Some under-estimation may have been due to failure to
extract all blood into the soaking solution, so consideration is required of the extent
to which this may have differed between Edinburgh and Glasgow. Mechanisms for
consistent overestimation are less easy to imagine. Further exploration is required of
the extent to which under-estimation and over-estimation may arise as a result of
failures in the proportionality between haematin concentration and optical density.
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7.5 BLOOD LOSS ESTIMATION AND ADJUSTMENT FOR
MENSTRUAL VOLUME
The formula for estimating blood volume in menstrual collection is based on the fact
that optical density (absorbance) if proportional to haematin concentration.
Ifall haemoglobin in the blood is converted to alkali haematin in the presence of
NaOH, then the concentration ofheme chromogens in the alkali solution, corrected
for volume ofalkali used, is a direct indicator of the volume ofhaemoglobin in the
blood contained in the solution. For an individual woman the concentration of
haemoglobin in her menstrual blood loss is assumed to be the same as that in the
venous blood. Using the following notation:
M = volume of menstrual blood loss to be estimated
h = concentration ofhaemoglobin in the woman's blood (per mL)
= amount of haematin in alkali solution, per 1 mL ofblood added
Vv = volume to which lmL of venous blood is diluted with NaOH
Vm = initial volume (mL) ofNaOH used to soak menstrual collection
s = secondary dilution factor, such that lmL of supernatant is diluted to s mL
with NaOH, with s=l if there is no secondary dilution
ODm = optical density (absorbance) of supernatant for menstrual collection, after
secondary dilution, if applied
ODv = optical density (absorbance) ofvenous blood diluted as per Vv
The standard formula used to estimate volume ofmenstrual blood, and attributed to
Hallberg (Hallberg & Nilsson 1964) is
M = (ODm x Vm x s) (i)
(ODvx Vv)
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Given that 1 mL venous blood produces h units of haematin (since concentration is h
per mL), and Vv dilution of it still contains onlylmL venous blood, then the diluted
venous blood solution contains h units of haematin.
Therefore concentration ofhaematin in Vv dilution is h / Vv .
Since optical density is proportional to concentration (ODv oc h / Vv),
ODv = k x h / Vv where k is a constant specific to a particular spectrophotometer.
So by manipulation,
kh = ODv x Vv (ii)
Considering now the solution of the collection, the amount of haematin due to the
menstrual blood loss will be M x h.
To establish the concentration of haematin in the supernatant we need to know the
total liquid volume. This is the volume ofNaOH added, plus the volume of blood in
the collection i.e. 'M' + Vm. (Assuming the menstrual loss is blood only, and so has
volume 'M'.) Therefore the concentration of haematin in the supernatant is (M x
h)/('M' + Vm), and
ODm = k x (M x h)/('M' + Vm) where k is the same constant (same machine)...(iii)
If secondary dilution is used, say 1 mL of supernatant diluted up to s mL with further
NaOH (with s=l if there is no secondary dilution), then the formula (iii) becomes,
ODm = k x (M x h) where k is the same constant (same machine).. .(iv)
s x ('M' + Vm)
Re-arranging (and assuming that 'M' = M) gives
M = (ODm x V„, x s)/( kh - s xODm)
And substituting for kh from (ii) this gives
M adjusted for blood volume — (ODm x Vm x S) (v)
[(ODvx Vv)-(ODmx s)]
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This differs from the formula generally used, by the extra term ODmx s' in the
denominator. Using this derived correction would make the denominator smaller and
hence M, the estimate of menstrual blood loss volume, bigger. So if the correction is
not used the blood volume will be under-estimated.
This correction does not take into account the total volume ofmenstrual fluid loss,
which as has been shown by Fraser is generally double the volume of the blood
component ( Fraser et al. 2001). If it was wished to correct for this, then if it is taken
that the
total menstrual fluid volume = 2M
and 2M is used instead of 'M' in equation (iii),
by the same sequence of re-arranging and substitution, a new formula is obtained:
M adjusted for TOTAL volume — (ODm X Vm X S) (vi)
[(ODv x Vv) — 20Dm x s]
This further diminishes the denominator, so the estimate for blood loss volume
becomes even higher. The extent of underestimation by the standard formula (i) can
be evaluated by taking the ratio of the standard formula to the adjusted formula (vi):
Estimation (%) — [(Mregular formula) / Madjusted for TOTAL volume] X 100
= (ODm X Vrn X s) / (ODtn X VmX S ) X 1 00
(ODv x Vv) [(ODv x Vv) - 2sODm]
= riODv X Vv) - 2sODml X 100
(ODv x Vv)
= 100[1 - 2 X s X ODnAODvX Vv)]
= 100[1 - 2 x M/(2M + Vm)] after substitutingfor the ODs ..(vii)
Therefore by subtracting from 100%, it can be derived that the percentage
underestimation due to ignoring the addition to the supernatant of the menstrual
blood volume and the roughly equal volume ofnon-blood in the menstrual loss:
Underestimation (%) = 2M x 100% using 2 x blood loss vol. (viii)
(2M + Vm)
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Or, ifwe do not wish to assume that the Total Menstrual Fluid volume (TMF mL) is
double the menstrual blood loss volume, and can measure TMF, then
Underestimation (%) = TMF x 100% using total menstrual volume ..(ix)
(TMF + Vm)
If, despite air-tight storage, there has been some evaporation of fluid from the used
products, which is likely, then the underestimation will not be as much as indicated
by the formulae above. However, evaporation is likely to be proportionately less in
the heaviest periods, due to lower surface area of'wetness'.
It should be noted that although it is the 'effective' volume of menstrual-NaOH
solution, Vm x s, that is used for the purposes of calculation of menstrual blood loss
volume (formula (i)), the volume ofNaOH that applies when calculating the extent
ofunderestimation due to menstrual fluid volume added to solution is Vm, the initial
soaking volume. This is because the key issue is the relative proportion of the
menstrual loss volume in the initial NaOH soaking, and the bias this introduces to
measurement. Subsequent secondary dilution will simply factor up the bias pro rata,
and so retain it. This is made clear in formulae for the estimation and
underestimation percentages (vii, viii and ix), which do not include any terms
involving s, the secondary dilution factor.
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7.6 BLOOD LOSS ESTIMATION AND FAILURE OF
PROPORTIONALITY
In Appendix 7.5 a necessary assumption for the estimation method was that optical
density is proportional to concentration ofhaematin (OD cc h / V). For example, for
the venous blood dilution h = haematin in 1 mL of blood and V = volume ofblood
and NaOH dilution/solution, then ODv = k x h / V.
If the relationship is linear but not proportional, then
ODv = a + bxh/V where a is a constant (the intercept) and b is the slope.
Assuming the model applies across the range ofconcentrations to be used, from the
equation for venous blood we get
bh = (ODv -a) x Vv (i)
From the equation for menstrual solution, if (as in Appendix 7.5) M=menstrual
blood volume, Vm= initial soaking volume ofNaOH, and s = secondary dilution
factor:
ODm = a + b x Mh / (s x Vm)
We have for the moment ignored the addition to the total menstrual solution volume
made by the liquid volume of the total menstrual loss (as considered in Appendix
7.5). Re-arranging the formula for ODm gives
M = (()!)„, -a) x s xVm/ bh
And substituting for bh from (i) this gives
M allowing for non-proportionality (ODm a) x sVm (ii)
(ODv-a) Vv
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Therefore, when proportionality does not in fact hold, application of the standard
formula would lead to an error in estimation of
Estimation Errorstandard -allowing for non-proportionality(mL)
()!)„, x sV„, - (ODm -a) x sVm
ODvx Vv (ODv-a) Vv
= a x (OP, ODm) x sVm (iii)
ODv (ODv -a) Vv
If the ratio of the optical densities for the menstrual: venous solutions is written as
p = ODm/ ODv, then substituting for p we get an alternative formula:
Estimation ErrOI"std. -adj. for non-proportionality(PlL) ^ X (p 1) X sVm 0^0
(ODv -a) Vv
If in formula (iii) we substitute for the optical densities, in terms of b, h and M, we
get a further alternative formula that is easier to interpret:
Estimation Errorstd.-adj. for non-proportionality(mL) -- a x[ sVm /Vv M] (v)
ODv
There are only three terms in the formula: a, ODv and the term in brackets. Clearly
estimation error will be zero if a is zero (proportionality applies). Ifnot, then the
error is greater in absolute terms for larger a (in absolute terms) and for smaller ODv.
With regard to the term in brackets, it is obtained by subtracting from the ratio of the
effective menstrual soaking solution volume sVm to the venous solution volume Vv,
the menstrual blood volume M. Vv contains lmL of the woman's blood and the
menstrual solution sVm contains MmL of blood, so if the sVm volume could be
chosen so that that solution had exactly the same blood concentration as the venous
solution, then the ratio of the solution volumes would have to be M. In that case the
difference would be zero, and hence the estimation error would be zero, even if non-
proportionality applied. In the more usual circumstance that the ratio is not exactly
equal to M, then estimation error will be greater for greater absolute difference
between M and the ratio of solution volumes.
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With regard to the direction of the estimation error, either or both of a and the term
in brackets can be negative or positive. If only one or other is negative then the
estimation error will be negative, meaning that the standard formula is under-
estimating the blood volume. In the case that a is positive, then if the ratio of
volumes of menstrual to venous solutions is less than M, as was typically the case in
Edinburgh blood loss determinations, then the term in brackets is negative.
Therefore, the estimation error is negative, meaning that there is under-estimation. If
a is negative then the situation is reversed, and there will be over-estimation.
If both a and the term in brackets are positive or both are negative, the estimation
error will be positive, meaning that the standard formula is over-estimating the blood
volume. In the case that a is positive, then if the ratio of volumes of menstrual to
venous solutions is greater than M, as was typically the case in Glasgow blood loss
determinations, then the term in brackets is positive. Therefore, the estimation error
is positive, meaning that there is over-estimation. If a is negative then the situation is
reversed, and there will be under-estimation.
Formula (v) is the easiest to interpret, since its three terms are on the whole
independent of each other. That is, a is a feature of the spectro-photometer, and
possibly also of the range of the optical densities that are being measured; ODv is a
reflection of the laboratory practice in terms ofdilution, and to a much lesser extent
also ofthe woman's haemaglobin concentration; and the term in brackets is a
reflection of the ratio of the menstrual:venous dilution volumes, and how this
compares to the actual menstrual blood volume being estimated, M. However, since
formula (v) is expressed in terms ofM it is not so helpful in the situation that
typically pertains, that the true value ofM is unknown. In that case it may be easier
to interpret formula (iii). The value for a, ifnon-zero, is almost certain to be close to
zero, certainly less than the ODv's that are likely to be obtained at even a 1 in 200
dilution. Therefore the bracketed term in the denominator, (ODv a) will almost
always be positive. As before (formula (v)), one or both ofa, and the numerator term
in brackets in formula (iii), can be negative. Therefore, when the intercept a is
greater than zero, then if ODm is greater than ODv there is a negative Estimation
Error (comparing the standard formula assuming proportionality to the adjusted form
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that should be used when there is non-proportionality, formula (ii)). This means that
the standard estimate will be an under-estimate. However, when ODm is less than
ODv, then the numerator term in brackets will positive, as will the estimation error.
So in this situation the standard estimate will be an over-estimate. Conversely, when
a is less than zero, the pattern ofunder- and over-estimation is reversed, as found
before with formula (v).
The absolute extent of deviation from the true value is less easy to judge by
examination of formula (iii), because the optical densities are dependent on the
choices of volumes for sVm and Vv. However, considered univariately, the absolute
size of the estimation error increases directly with the absolute size of a, with the
menstrual dilution volume sVm, and with the absolute size of the difference between
ODv and ODm. At the same time the absolute size of the estimation error decreases
directly with increases in the absolute size of ODv, in the venous dilution volume Vv,
and in the size of the difference between ODv and a. (Although probably only a
theoretical possibility, it is worth noting that if ODv 'approaches' a then the
estimation error would become 'infinite'.)
ODv is partly a reflection of the woman's haemoglobin level, but is also determined
by the dilution factor for venous sample. All three formulae show that absolute
estimation error increases with decreasing ODv. Since Glasgow typically used a
dilution factor for venous samples twice that in Edinburgh, this gave OD's
approximately halfwhat they would be in Edinburgh (and hence also closer to a). So,
all else being equal, greater absolute estimation error would be expected in Glasgow.
We have already seen that the size of the intercept a will influence the size of the
error, but it should also be remembered that if the intercept is negative the whole
pattern of error will be reversed, from under- to over-estimation.
The formulae (iii) to (v) were derived disregarding the addition to the menstrual
solution volume due to the total liquid volume of the menstrual loss. The formula for
the degree and direction ofestimation error due to non-proportionality, also taking
into account menstrual volume, corresponding to formula (v), would be:
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Estimation Errorstd. -adj. for non-proportionality & menstrual volume (l®L)
= a x[ sVm/Vv -M] - [M x TMF/(TMF + Vm)] (vi)
ODv
This comprises essentially two separate components, the error due to non-
proportionality, exactly as before, which may be positive or negative, and an
additional component in this formula (relative to formula (v)), due to the impact of
the menstrual volume added to the solution. This extra component is always negative
error (or zero if the collection has been allowed to evaporate completely), and hence
leads to a relative under-estimation.
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7.7 FURTHER REFLECTIONS ON SPECTROPHOTOMETRY
In this Appendix further reflections are made on the issues of spectro-photometry
and proportionality, in respect of Figure 7.5.
7.7.1 Extrapolation ofsimulation beyond the range of measured data
It should be noted that some of the Glasgow data have had to be extrapolated. The
lowest concentration measured for the original data (shown in Figure 7.1)
corresponded to a concentration of lmL blood in 200mL NaOH, and gave an OD of
0.261. In practice ODs less than this were common in Glasgow, with 84% and 91%
of menstrual and venous ODs there less than 0.261, in comparison to 27% and 2%
respectively in Edinburgh (see also Figure 7.3). For the purposes of this exploration,
of factors influencing errors in estimation, the same model used to fit the OD values
between concentrations 0.02 and 0.005, was extrapolated to calculate OD values also
for concentrations down to 0.0025. For the blood loss estimates made using the
Glasgow process (green line), the data points marked with a solid diamond used
fitted ODs corresponding closely to the measured data. The Glasgow data points
marked with open circles correspond to blood volume estimates derived from the
ODs extrapolated beyond the experimental data, albeit following the same linear
relationship.
7.7.2 Possibility of range effects
One of the observations with respect to the measured data (Figure 7.1) was that the
slope and intercept were not constant across the full range of the concentration
values. Yet for this exploration of measurement error the OD values for
concentrations lower than 0.005 have been obtained by extrapolation of the same
line. It would thus be salutary to reflect on the impact if the OD values did not
maintain the same line below concentration 0.005. Hence a second possible set of
ODs was imputed for these concentrations, using a model with a higher intercept and
flatter slope (a=0.06, b=38.5). Blood loss estimates calculated using these ODs are
plotted as red stars. It can be seen that, all else being equal (that is, dilution volumes
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and venous OD), if the intercept is higher then the estimation error is even more
extreme.
These reflections show that where proportionality fails quite marked estimation
errors can result, and that this is exacerbated for lower venous OD (as in Glasgow)
and as the absolute size of the intercept a increases. In particular, if a is positive
there will be over-estimation if the ratio ofeffective NaOH solution volumes sVm /Vv
is greater than the menstrual blood volume M (or equivalently, if venous OD exceeds
menstrual OD). This latter condition was more often the case in Glasgow.
7.7.3 Possibility of a spectro-photometer effect.
It should be noted that the measured ODs (and underlying regression line) used as
the basis for Figure 7.5 were obtained using the Glasgow spectrophotometer, and so
may not apply to the Edinburgh spectrophotometer. However, the graph does show
what the impact of the differing measurement practices would be if both employed
the Glasgow spectrophotometer operating in the way indicated by the observed data
presented in Figure 7.1.
Since the measured ODs used as the basis for this exercise were obtained using the
Glasgow spectrophotometer the observed linear relationship may not apply to the
Edinburgh spectrophotometer. If the intercept in Edinburgh were to be negative then
the estimation error would have been reversed, in terms of over- and under¬
estimation. While it is very likely that the moaei that best fits readings differs
between spectrophotometer machines, it is also possible that it can vary within
machine, from occasion to occasion. Experiment 1 (Appendix 7.2) showed that the
100 to 200 dilution OD ratios switched from over two to under two with standing
time of the solution prior to measurement. Regression analysis confirmed that for the
later data the intercept was negative. The best protection against measurement error
due to non-proportionality would be to have the two samples to be tested as near as
possible to each other in terms ofconcentration, and to have the venous blood not
overly dilute.
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7.8 EXPERIMENT 3: EVALUATION OF IMPACT ON BLOOD VOLUME
ESTIMATE OF SQUEEZING/WRINGING OF PRODUCTS PRIOR
TO SAMPLING FROM SUPERNATANT
7.8.1 Aim
To ascertain the extent of failure to extract entire blood loss if only soaking and
'prodding-stirring' are used.
7.8.2 Methods
The Edinburgh nurse was to undertake her next 5 collection measurements in her
usual way. However, after having sampled from the supernatant, for filtering and
spectro-photometric measurement, she was to don rubber gloves and squeeze/ agitate
the products to ensure all blood extracted. She was then to repeat the sampling,
filtering and measuring process, and re-calculate blood volume. (There would of
course be a very small biasing upwards of the concentration at the second measuring,
because some of the total volume ofNaOH solution would have been removed.
However this would be minimal, as only about 20 to 30mL need be removed for the
testing.)
7.8.3 Results
The five collections when measured in the usual (Edinburgh) way gave estimated
blood volumes of: 38.2, 46.1, 64.2, 69.9 and 111. lmL. On squeezing of products and
re-measurement, the blood volumes estimated were 45.1, 49.2, 57.0, 77.3, and
177.5mL respectively. Therefore compared to thorough squeezing the Edinburgh
process had estimated blood volume that differed from the squeezed estimate by
-29%, -6.4%, +11%, -10% and -37%, the absolute differences in blood volume
estimates being -7 mL, -3 mL, +7 mL, -7 mL and -66mL.
7.8.4 Discussion
Four out of five blood volume measurements were lower using the Edinburgh (non-
wringing) method. For blood volumes in the range 40 to 77mL the differences were
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within 7mL. However for the loss ofover 100 mL difference was marked, 66mL
(35% of the 'squeezed' estimate). The failure to mash or squeeze the products did
lead to underestimation of blood volume in Edinburgh, and it is possible this is
exacerbated for very heavy losses. In this case the heaviest loss comprised 14
tampons, as well as pads, and it is possible haematin does not extract as readily from
tampons by soaking. Furthermore, the OD for the 'unsqueezed' supernatant was at
the limit ofacceptability, being 0.945. For the 'squeezed' supernatant the blood
concentration was higher so the optical density exceeded 1. Therefore the
supernatant was diluted by half and the OD re-measured, and then doubled to
compensate. In fact this made little difference to the 'squeezed' blood volume
determination (in this case lowered it by 1%). Perhaps the measurement issue is not
just that there is greater non-proportionality for high optical densities but also that
there is greater unreliability in readings, and that this applies even at the top end of
the OD<l range. Then the apparently extreme difference due to squeezing for the
heaviest of these test determinations may have been accentuated by a biasing down
of the 'unsqueezed' estimate due to an optical density reading that was by chance
lower than it should have been.
7.8.5 Conclusion
The failure to mash or squeeze the products did lead to underestimation of blood
volume in Edinburgh, and it is possible this is exacerbated for very heavy losses.
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Referral for menstrual problems: cross sectional survey of
symptoms, reasons for referral, and management
















































Objectives To describe die menstrual experience of
women referred for menstrual problems, in particular
menorrhagia (excessive menstrual loss), and to assess
associations with reasons for referral given by their
general practitioners, the women's understanding of
the reasons for their attendance at die hospital clinics,
and clinic outcome.
Design Questionnaire survey, with partial review of
case notes after 8 months.
Setting Three hospital gynaecology clinics in Glasgow
and Edinburgh.
Participants 952 women completed the
questionnaire, and die first 665 were reviewed.
Outcome measures Reason for referral, women's
reported menstrual problems and reason for clinic
attendance, diagnosis, and treatment.
Results Only 38% (95% confidence interval 34% to
41%) ofwomen reported excessive menstrual loss as a
severe problem. However 60% (57-63%) gave it as
reason for attending a clinic, and 76% (73-79%) of
general practitioners gave it as reason for referral.
Reason for referral was significantly biased towards
bleeding (McNemar odds ratio 4.01,3.0 to 5.3,
PC0.001) and against pain (0.54,0.4 to 0.7, P< 0.001).
Dysfunctional uterine bleeding was diagnosed in 37%
(31 -42%) of the 259 women who gave as reason for
attendance something other than bleeding. Women
who were economically disadvantaged differed in
prevalence of the main diagnoses and were more likely
to fail to reattend. Hysterectomy was associated with
referral for bleeding (relative risk 4.9,1.6 to 15.6,
P < 0.001) but not with the patient stating bleeding as
the reason for clinic attendance.
Conclusions Intolerance of the volume of their
bleeding is not a key feature among women attending
clinics for bleeding problems. Broad menstrual
complaint tends to be refrained as excessive bleeding
at referral and during management. This may result, in
women receiving inappropriate care.
Conceptualisation and assessment of monorrhagia
requires reconsideration.
Introduction
Menstrual problems account for much of the morbid¬
ity that occurs in women of reproductive age, being
one of the four most common reasons for consulting a
general practitioner.' Specifically, menorrhagia (exces¬
sive menstrual loss) is one of the most common
reasons for referral to gynaecology clinics." Organic
disease is relatively uncommon with menorrhagia, but
treatment typically involves powerful drugs or invasive
surgery.14 The formal clinical definition of menor¬
rhagia is blood loss exceeding 80 ml per period, but
objective measurement is rarely undertaken in routine
clinical practice, despite reports that women are unreli¬
able judges of their menstrual loss/ Unease has been
expressed that management of menorrhagia is so
dependent on "the personal history of the patient.'"
Menstrual complaints typically present a complex
clinical picture. A population survey among women of
reproductive age found that 24% reported a recent
painful period and 20% a heavy period, with about half
experiencing both. " Mood changes around the time of
a period were reported by 56% of those with heavy
periods and 44% of those with pain. ' The overlap of
symptoms was similar in women referred to clinics
with menstrual problems." Such comorbidity among
the three main menstrual complaints is likely to
complicate healthcare seeking and management.
Indeed, substantial variation in referral rates for
menorrhagia has been reported, both nationally and
internationally, and discordance has been found
between symptoms and reasons for referral."' This is
of concern because referral for menorrhagia is associ¬
ated with a 60% probability of hysterectomy in the
ensuing 5 years/ The pathway to the care for
menorrhagia warrants careful study.
We undertook a cross sectional survey of women
referred for menstrual complaints to hospital gynae¬
cology clinics to assess the relation between symptoms,
referral, and early management of menstrual prob¬
lems. We aimed to ascertain whether patients and their
general practitioners are concordant as to the reason
for referral and whether subjectively reported exces¬




From 1996 to 1999 we undertook a cross sectiona
questionnaire survey of women aged 25 to 49 newf
BMJ VOI.L'ME .">2:> 7JUI.Y 2001 bmj.com
Primary care
referred for menstrual complaints to gynaecology clin¬
ics at Edinburgh and Glasgow Royal Infirmaries and
Glasgow Western Infirmary. Exclusion criteria were
attendance at the clinic for a menstrual problem in the
previous year and a history ofdrug misuse or known to
have HIV. or both. The ability to read simple English
was a requirement for completion ofthe questionnaire.
We followed up and reviewed the case notes of the
subset of women recruited early enough for eight
months to have elapsed between initial appointment
and the end of data collection. Our study was given ethi¬
cal approval, and participants received written infor¬
mation about the study and provided informed consent-
Methods
The questionnaire assessed menstrual experience in
several ways, including a subjective evaluation of blood
loss. Women were also asked to report how
problematic they considered various aspects of
menstruation and the main reason for seeking help.
We derived four summary variables from these
responses, indicating whether there was a "severe
problem" with volume of bleeding, pain, or cycle
related changes and whether volume of bleeding had
been noted as the reason for seeking help.
Reasons for referral were ascertained from the
referral letters received from the general practitioners:
as just over half (55%, 521 of 952) cited more than one
reason, the research nurses recorded and coded the
first two reasons. These codes were converted into four
variables, indicating referral or not for excessive bleed¬
ing, pain, cycle related changes, or other reasons (for
example, fibroids, endometriosis, irregular periods). In
the same way the patient's understanding of the reason
for attendance at the clinic was converted into four
indicators.
We derived a Carstairs deprivation score (1 to 7) for
each patient from their postcode sector." Deprivation
subgroups were combined as necessary to obtain fewer
but larger strata (1 with 2 (most affluent), 3 with 4, and
b with 7 (most deprived)). We reviewed the patients'
case notes to ascertain management, up to eight,
months after referral.
Statistical analysis
We tested for association in 2x2 tables by y~ with
correction for continuity, by Fisher's exact test, or by
McNemat 's test if data were paired, and in tables with
one binary and one ordinal variable by the x test for
trend (x"'In.lvl. df— 1). We used SPSS version 9.0. Data for
duration are reported as medians and interquartile
ranges. A small proportion (<4%) of information was
missing; we report the effective (non-missing) sample
size if different from the total sample size.
Results
Recruitment
We identified 1500 potential participants from the
referral letters (fig 1). Only 4% of those invited to par¬
ticipate refused, but of those consenting 28"/) (308 of
1320) took the questionnaire home and failed to com¬
plete it, despite being reminded by telephone or letter.
The 952 participants comprised 03% of eligible
patients. Table 1 summarises the personal characteris¬
tics of the patients. The participants were similar to the
554 referrals who did not participate for age, depriva-
Provided data in questionnaire
(n=952):
Recruitment too recent (n=204)
Case notes not found (n=83)
Case notes reviewed
(n=665)
Fig 1 Study profile






Age group (years) (n=952) (n=554)
25-29 90 (9) 58 (10)
30-34 164 (17) 93 (17)
35-39 224 (24) 124 (22)
40-44 257 (27) 152 (28)
45-49 217 (23) 127 (23)
Carstairs deprivation score (n=934) (n=544)
1 and 2 (least deprived) 179 (19) 91 (16)
3 and 4 327 (35) 179 (33)
5 183 (20) 135 (25)
6 and 7 (most deprived) 245 (26) 141 (26)
Parity (n=950)
No births 210 (22)
1-6 births 742 (78)




Very heavy 343 (36)
'Eligible but not asked, refused, or defaulted.
tion score, and main reasons for referral. We reviewed
the case notes of 665 (89%) of the 748 women
recruited early enough for eight months to have
elapsed before die completion of data collection.
Menstrual experience
A minority (36%; n = 343) of participants rated their
periods as "very heavy" (table 1). The median duration
of the current problem was two years (interquartile
range 10 months to six years). Roughly equal propor¬
tions of women reported a severe problem with exces¬
sive bleeding, pain, or cycle related changes (fig 2), with
considerable overlap between these. Overall, 587 of
948 (62%) reported at least one of these problems, 353
(37%) more than one, and 150 (16%) all three. A third
of the women (32%, 301 of 940) had previously
attended clinics for period problems, most of these
(75%, 222 of 285) for the "same problem" as now.
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None of these severe
38%
(361)
Fig 2 Percentages (numbers) of women experiencing as a "severe
problem" one or more of excessive bleeding, pain around periods, or
cycle related changes (n-948)
Table 2 Discordance between reason for referral by general










Ratio (95% CI) of
discordant reasons!
4,01t (3.0 to 5.3)
0.54+ (0.4 to 0.7)
1.04 (0.6 to 1.9)
'Either doctor or woman cites reason but not both.
fDoctor only divided by woman only (McNemar odds ratio).
tP<0.001 by McNemar's test.
Reasons for clinic attendance and referral by
general practitioner
Each participant, reported her belief as to the reason
for attendance at the clinic: 568 of 952 (60%) stated
bleeding problem, 283 (30%) period pains, and 67
(7%) cycle related changes, with 163 (17%) overall
mentioning two. Referral letters cited excessive
bleeding problems in 725 cases (76%), pain in 216
(23%), and cycle related changes in 68 (7%). In 27% of
cases the referring doctor and the patient disagreed as
to whether bleeding was the reason, and there was sig¬
nificant imbalance in the direction ofdiscordance, with
a ratio of4:1 that it would be the doctor rather than the
patient citing bleeding (table 2). There was a similar
level of discordance about pain, but in the opposite
direct ion, so that in discordant cases general practi tion¬
ers were significantly less likely to mention pain.
Figure 3 illusmit.es the pathway to referral for rnen-
orrhagia. Among those who reported bleeding neither
as a severe problem nor as a reason for seeking help,
63% were nevertheless referred for bleeding. Overall,
of the 725 women referred for excessive bleeding, less
than half (46%, n = 330) had noted it as reason for
seeking help, and this percentage breaks down as 60%
(187 of 311) of those who reported bleeding as a severe
problem compared with 34% (143 of 414) of those
who did not.
Clinic outcome
Eight months alter initial attendance at the clinic, no
cancers had been detected in the participants, 53%
(n = 353) had been discharged, and 15% (n = 98) failed
to return for a further appointment Table 3 shows that
failure to return was strongly related to deprivation
score, being more likely in disadvantaged groups,
whereas there was an opposite gradient for diagnosis of
fibroids, an association that persisted alter controlling
for age. Dysfunctional uterine bleeding (a diagnosis of
exclusion, that no disease, such as fibroids, had been
found that could account for reported abnormal bleed¬
ing) was the most common diagnosis (51%, 331 of 647;
175 with a "regular cycle" and 146 with an "irregular
cycle"). Alter failure to return for further appointments,
the most common final outcome was hysterectomy
(12%, 79 of 661), with dysfunctional uterine bleeding or
fibroids die most common indication.
Clinic outcome
Dysfunctional uterine bleeding was diagnosed for 31%
(60 of 174) of the women who neither reported periods
as very heavy nor reported excessive bleeding as a severe
problem nor gave bleeding as reason for attending (he
clinic In those referred by their doctor for something
other than excessive bleeding, dysfunctional uterine
bleeding was nevertheless diagnosed for 29% (16 of
158). Hysterectomy was likely if fibroids were diagnosed
(39%, 33 of the 85 patients with fibroids). Among the
remainder without fibroids as a possible indication for
surgery (n = 545), hysterectomy was strongly associated
with referral for bleeding (relative risk 1.9, 95%
confidence interval 1.6 to 15.6, Fisher's exact test
Bleeding given as reason lor clinic visit
EH By referring doctor only
□ By doctor and patient













nor basis for seeking help
(n=435)
Severe problem or
basis for seeking help
(n=515)
Patient's report of her bleeding
Fig 3 Frequency with which doctor, or patient, or both give
"excessive bleeding" as reason for clinic visit, separately for two
subgroups
Table 3 Failure to return for appointments and diagnosis of fibroids at eight months' follow up by deprivation subgroup
Did not return tor appointment Fibroids diagnosed
Deprivation subgroup No in subgroup No % (95% CI) No in subgroup No % (95% CI)
1 and 2 (affluent) 133 11 8.3 (4 to 13) 125 28 22.4 (15 to 29)
3 and 4 228 27 11.8 (8 to 16) 215 27 12.6 (8 to 17)
5 127 21 16.5 (10 to 23) 125 19 15.2 (9 to 21)
6 and 7 (deprived) 158 41 25.9 (19 to 33) 155 9 5.8 (2 to 9)
Overall 646 100 15.5 (13 to 18) 620 83 13.4 (11 to 16)
X2 trend df=1. 18.1, P<0.0005 yj trend df=1, 14.9. P<0.0005
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P< 0.001) but was only marginally associated with
reporting volume of loss a severe problem (1.8, 1.02 to
3.2. P = 0.051), and was not associated with excessive
bleeding as the patients reason tor attendance.
Discussion
We found discordance as to the rationale for referral of
women to gynaecology clinics. In over a quarter of
cases the patient and general practitioner disagreed as
to whether excessive menstruation was a reason, with
the doctor lour times more likely to be the only one
citing bleeding. The proportions of women who
reported severe problems with pain, volume of
bleeding, or cycle related changes were similar (37% to
'10%), with considerable overlap, and yet the predomi¬
nant reason given for referral was bleeding problems
(70%). Furthermore, this tendency for general men¬
strual complaint to be refrained as excessive bleeding
seems to intensify within the clinic setting. Dysfunc¬
tional uterine bleeding is defined as "excessive
bleeding for which no pathology can be found,'"" yet
dysfunctional uterine bleeding was diagnosed in 35%
of women who had cited excessive bleeding neither as
a reason for attendance nor as a severe problem. It was
also diagnosed in 30% of women whose doctors had
not given problematic bleeding as the reason for refer¬
ral. Variation in referral rates for menorrhagia has
been taken to reflect "clinical uncertainty about
whether and how the problem should be treated.'" Our
data suggest more fundamental uncertainty about the
coi icept of nlei i< >rrl uigia.
While acknowledging that objective measurement
of volume of bleeding is rarely undertaken in routine
clinical practice, guidelines on the management of
monorrhagia do not oiler alternative strategies for
assessment of the complaint.' 11 Rather, the require¬
ment lor a "convincing clinical history" is presumed to
he uniformly understood and implemented. Vet we
found that more than hall*(57%) of those referred for
bleeding do not even judge their periods as very heavy.
Perhaps this partly explains the "normal" measured
blood losses commonly reported in women referred
with menorrhagia.1 Ul'
Strengths and weaknesses
Reasons lor referral were extracted from general practi¬
tioners* letters, ensuring naturalistic data. The recording
ol two reasons when given, and the general brevity of the
letters, minimised the need for subjectivejudgment Par¬
ticipants were also asked their reason for attendance at
the clinic, because earlier research found divergence
between menstrual problems and presentation at a
clinic." That questionnaires were not returned by 28% of
those recruited raises concerns, but participants were
similar to non-participants for age, deprivation score,
and reason for referral. Questionnaire surveys can deter
those with poor literacy, but the questionnaire was brief
and support was provided by a research nurse, ensuring
broad participation. Deprivation scores have been
utilised as a proxy for individual socioeconomic status,
because the detail required for determination of social
class can not be gleaned from a brief questionnaire.
Although lime constraints meant follow up was
confined to the first 79% recruited, these women were
similar to the entire study group for all key variables.
What is already known on this topic
Excessive menstrual loss (menorrhagia) is one of the commonest
reasons for secondary referral of women, but there is no formalised
clinical assessment in routine use
Management typically involves potent drugs or invasive surgery, with
60% of women having hysterectomy within 5 years
Many women referred for menorrhagia have menstrual blood loss that
is not excessive
What this study adds
Discordance exists between symptoms and both referral and diagnostic
pathways, arising from a disproportionate focus on menstrual bleeding
Among women referred for menorrhagia, volume of bleeding is not a
key symptom
This raises concerns about conceptualisation and assessment of
menstrual complaint and the appropriateness of healthcare provision
Explanation of findings
Although there may be no underlying serious disease or
risk to physical health, periods can cause major distress
and disability.1"'' Many women are deterred from
consulting by reticence about discussing menstrual
problems, anxiety about investigations, or a lack of belief
that medical help will be forthcoming.|s Ln an opinion
poll of 1069 women, 60% espoused the view that not
enough attention Ls paid to problems with periods.'
Patients may hold definitions of health and healthcare
needs that differ from those ofclinicians,1" perhaps more
so with periods, an intensely private event beset with
societal constraints. Health needs that remain unvoiced
within the consultation have been related to poor
outcomes.'"' We found that pain around periods is com¬
monly reported as problematic yet relatively "invisible"
in the referral and diagnostic pathways, and also that the
more deprived women were less likely to be diagnosed
with fibroids, more likely to be diagnosed with dysfunc¬
tional uterine bleeding, and more likely to fail to return
to the clinic (table 3).
Where there is comorbidity between menstrual
complaints which one the doctor selects to give as the
reason for referral may seem unimportant. We found,
however, that among women free ofdisease (as a possi¬
ble indication for surgery) hysterectomy was associated
with referral for bleeding but not with volume of
bleeding being reported as problematic. Perhaps refer¬
ral for rnenorrhagia is strategic, based on the
knowledge that it is likely to lead to surgery and aiming
to increase the likelihood of this for a particular
patient/21 Nevertheless, this is an unsound process for
the allocation of healthcare resource; a more explicit
consensus regarding indications for such treatments
would be preferable.
The divergence between menstrual experience and
reasons given for refeiTal to and attendance at a clinic
reflects a disproportionate focus on excessive bleeding,
a tendency that is echoed within the clinic setting. Is
this reframing partly a consequence of women's beliefs
that abnormal uterine bleeding is most worthy of
medical attention? Or is there an astute lay
understanding of what will be regarded by others as a
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valid reason for attendance at a clinic? Assessment of
menstrual complaints needs to be improved, and
further research is required to understand die part
played by the cultural beliefs of both women and clini¬
cians. The comorbidity of menstrual complaints shows
that the conventional partitioned thinking about
menstrual problems will be unhelpful in most cases.
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Primary care groups
Progress in partnerships




















Partnership—between organisations, services, ancl
frontline staff—is widely promoted as an alternative to
large scale structural reorganisation of die relation
between the NHS and local government. However,
there is still relatively little evidence on the effectiveness
and outcomes of such partnerships. One of the
difficulties in establishing an evidence base is the wide
variety of relationships that can be described as
partnerships. A second difficulty is the risk that
working in partnership may be regarded as an end in
itself rather than as the means to an end. The Audit
Commission identified four potential areas offocus for
groups working in partnership in public services
(box).1 1 lowever, implementing these activities and
measuring progress is far from easy.
The Health Act 1999 imposed a duty on till NHS
organisations to work in partnership Nowhere has
working in partnership been given more backing than
in the relations between die NHS and local authorities,
where collaboration is required to tackle "wicked
issues"1—that is, complex problems like healdi improve¬
ment, community safety, and community care. Primary
care groups and trusts are required to give priority to
forming partnerships with local authorities' social
services departments, especially in developing services
2K
Summary points
Primary care groups and trusts are expected to
develop partnerships with local authorities,
particularly for commissioning services and
developing services for older people
Nearly half of the groups and trusts surveyed do
not routinely consult with social services when
commissioning community health services, and
even fewer consult with social services about
commissioning acute care
Relationships between frontline social services
staff and community based and practice based
health professionals are improving
The development of robust partnerships may be
threatened by disruption to established relations
as primary care groups merge or become trusts
for older people. In its plan for the N1 IS in Kngland,
the government announced that additional financial
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OBSTETRICS AND GYNECOLOGY: GYNECOLOGY
Menorrhagia I: Measured blood loss, clinical features,
and outcome in women with heavy periods:
A survey with follow-up data
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Objective: Menorrhagia is defined as blood loss of >80 mL, but in routine clinical practice mea¬
surement is seldom undertaken. Our aim was to identify the features of the clinical history that
best predict menorrhagic blood loss.
Study design: A questionnaire survey of 952 menstrual complaint referrals at 3 hospital gynecol¬
ogy clinics in Glasgow and Edinburgh included 226 women with putatively heavy periods who
also had consented to the measurement of their blood loss.
Results: Only 34% (95% CI, 28%-40%) of women had blood loss volume of >80 mL, but the
volume was associated with subjective heaviness of period. Logistic regression with ferritin status,
clots, and changing rate during full flow correctly predicts a loss of >80 mL for 76% of women
(n = 161 patients; sensitivity, 60%; specificity, 86%). Diagnosis and treatment of patients seem
unrelated to the volume of blood loss.
Conclusion: The subjective judgment of the volume of blood loss is better than has been believed.
Clinical features can be combined to predict losses of >80 mL.
© 2004 Elsevier Inc. All rights reserved.
The clinical definition of menorrhagia is blood loss
of>80 mL per period.1"5 Treatment trials for menorrha¬
gia usually involve laboratory measurement of blood
loss so that trial participants are women with objectively
confirmed menorrhagia. and changes in volume can be
used as outcome measure.'9 However, in the course of
screening patients for trials, it has been found that only
a minority of women who have been referred for menor-
Supported by the Chief Scientist's Office, Scotland (K/MRS/50/
C2472).
Reprints not available from the authors.
0002-9378/$ - see front matter © 2004 Elsevier Inc. All rights reserved
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rhagia have loss of>80 mL.6'8'10'" Concern has been
expressed that powerful drugs are prescribed and that
invasive surgery is undertaken on the basis of patients
accounts' only.12
Guidelines for the management of menorrhagia make
recommendations that are based on trials in which men¬
orrhagia has been confirmed by measurement,'•2-4-x13
with the definition sometimes more stringently enforced
by being applied to the average over a number of con¬
secutive periods.6 Such trials, if of adequate quality, pro¬
vide top-grade therapeutic evidence only for similarly
selected patients, not for all women presenting with
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menorrhagia. However, guidelines either acknowledge
that the measurement of blood loss is impracticable
for routine clinical use1'2'4'13 or do not discuss the assess¬
ment of menstrual volume.3 Instead, there is dependence
on clinical/menstrual history, but without guidance on
how to accumulate the clinical features to judge the like¬
lihood of menorrhagia in a particular patient. The ques¬
tion therefore arises as to how feasible it is to judge
menorrhagia from clinical history.
We collected comprehensive clinical data for women
who had been referred with menstrual problems and un¬
dertook the measurement of menstrual blood loss in
those women with putatively heavy periods. The aims
of this report were to describe the associations between
menstrual history, diagnosis, and measured volume of
loss and to explore the feasibility of the assessment of
the volume of loss by means of specific clinical features.
Methods
Study design
From 1996 to 1998, we surveyed 25- to 49-year-old
women who were newly referred for menstrual com¬
plaint to Scottish gynecologic clinics, at Edinburgh
and Glasgow Royal Infirmaries, and at Glasgow West¬
ern Infirmary.14 The goal was to measure the volume
of menstrual loss in women with "putatively" heavy pe¬
riods (that is, women who were subjectively reporting
heavy periods on the initial questionnaire or who were
referred for or stated that they were attending the gyne¬
cology clinic for excessive periods). Measurement of loss
requires the collection of used sanitary protection for 1
period; the women were told that this was specifically
for research purposes and not part of their clinical care.
Because menstrual collection is known to be unappeal¬
ing to women, it was anticipated that the subset of
women who would be providing such data would be rel¬
atively small. To be able to describe the characteristics
of collectors compared with the wider study group, there
was nested data collection to ensure that all eligible
women provided at least minimum data. Collectors
had to be eligible, in the sense of having putatively heavy
periods, but also had to have completed the preceding
questionnaire stages. Follow-up involved case note re¬
view 8 months after the initial appointment but, because
of the time constraint on the study, only for the first
79% of the women who were recruited. The study was
approved by the relevant local ethics committees; signed
consent was obtained for all stages.
Methods
A brief clinic questionnaire that was completed by all
women provided basic details of the menstrual com¬
plaint and patient background. A longer menstrual eval¬
uation questionnaire (MEQ), which was evaluated as
a potential tool for the clinical assessment of menorrha¬
gia, ascertained more details of the menstrual complaint;
90% of women (782/865) who were eligible to collect
completed the MEQ. Additional questionnaires that ad¬
dressed psychiatric well-being, quality of life, and per¬
sonality were also completed, but findings for these
and all but 4 items of MEQ will be reported separately.
The reason for referral was ascertained from the re¬
ferring physician's letter; terms for excessive bleeding
were menorrhagia, excessive or heavy periods, periods
going on too long, frequent periods, continuous bleed¬
ing, clots, and dysfunctional uterine bleeding.14 On the
clinic questionnaire, each woman reported, in her own
words, her understanding of the reason for the clinic
visit, which was categorized in a similar way. Over the
study period, 4 different ferritin assays were used in
the 3 hospitals; each ferritin value has been categorized
as low or not, in accordance with the specifications of
the relevant assay (details available from authors). He¬
moglobin results are categorized as < or > 12 g/dL, in
accordance with Milman et al.'3 Deprivation score (I
[most affluent] to 7 [most deprived]) was derived from
the postcode sector.16
Collectors were provided with tampons (regular and
super Tampax; Procter and Gamble, Brooklands,
Survey, UK) and sanitary pads (Bodyform Ultra Super
and Super plus sizes; Molnycke Ltd, trading as Sancella,
Aylesford, Kent, UK) as needed for use in the period of
the collection. The women were advised about how to
avoid the loss of menstrual blood when washing or using
the toilet, and they completed a menstrual chart about
the period during which the collection took place. To al¬
low calculation of menstrual blood volume by the
method of Hallberg and Nilsson17 with the use of spec¬
trophotometry comparison of a solution of the men¬
strual collection against venous blood, a venous blood
sample was taken close to the time of the period.
Analysis
SPSS software (version 9.0; SPSS lnc, Chicago, 111) was
used. There was a small proportion of nonresponse for
the questionnaires. The effective (not missing) number
is reported if it is different from the total number.
Skewed data are presented as median and interquartile
range and are plotted as box plots. Blood loss volumes
were log-transformed before parametric analysis (I-test
for independent groups). Group means of these logged
data are back-transformed for reporting as geometric
means. To provide confidence intervals for compari¬
sons between groups, each difference between groups
in mean logged volume (with confidence interval) is
back-transformed, which provided a ratio (of the geo¬
metric means) and confidence interval for the ratio.
The association between measured blood volume and
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Table I Description of women who undertook menstrual
collection and of women who were not collectors
Collector Declined*/
Sociodemographic factor (%) defaulted (%)
Age group
(n = 226 and 639 women,
respectively)
25-29 Y 8 9
30-34 Y 15 16
35-39 Y 27 23
40-44 Y 33 25
45-49 Y 17 26
Carstairs deprivation
code (n = 222 and
630 women, respectively)
Least deprived: 1 & 2 19 19
3 & 4 35 35
5 16 21
Most deprived: 6 & 7 31 25




Employment status (n = 226 and
632 women respectively)
No job 28 24
Part-time work 31 30
Full-time work 41 46
Factors used to determine
invitation to collect (n = 226
and 639 women, respectively)
Referral for excessive 87 83
bleeding








Very heavy 48 37
Total "heavy" 97 86
* Declined to complete further questionnaires or completed
questionnaires but then declined to undertake menstrual collection.
ordinal questionnaire variables is summarized by
Spearman rank correlation. Although 25 such tests
were undertaken, no adjustment for multiple testing
has been made, partly because the main purpose was
not hypothesis testing, but comparison of strength of
association within the variable set, and partly for sim¬
plicity. Table II reports only those associations with
a rho value of >0.11 (nominal P<.109). For succinct¬
ness, a cut-off point of 0.11 was chosen so that an im¬
portant variable (referral by general practitioner for
bleeding) would be reported.
Results
Recruitment and participation
Potential recruits were identified from referral letters; the
952 participants of the wider study are representative of
the entire group of 1506 suitable referrals, in terms of
age, deprivation code, and referral reason.'4 The 226
women who collected their used sanitary protection com¬
prised 26% of the 865 women who were eligible for collec¬
tion (that is, excluding the 87 women who were not
categorized as having putatively heavy periods). Table I
shows the sociodemographics of collectors and of those
who were eligible but did not collect. It can be seen that
the 2 subgroups are well-matched, except for slightly
fewer collectors aged 45 to 49 years and collectors being
slightly more likely to judge their periods very heavy. Al¬
though 97% of the collectors judged their periods to be
heavy or very heavy, this does not necessarily denote
a judgment of absolute volume. In the more detailed
MEQ, women were asked to judge their usual periods in
absolute volume. The following distribution of responses
were made by 751 women who had completed this item of
the MEQ (out of the 865 eligible women) up to a tea cup,
9%; about 1 mug (half-pint), 15%; and much more than
a mug, 21%, whereas 55% of the women chose the re¬
sponse "no idea." There was a striking similarity in the
distributions of responses to this item for the collecting
and noncollecting subgroups (data not shown; n = 226
and 525 women, respectively). We set out to obtain iron
status measures (hemoglobin and ferritin) for all patients
for whom the treating clinician judged that such a blood
test was required. The level of testing for iron status was
generally lower in Edinburgh compared with Glasgow
(among eligible women, 40% and 68%, respectively, un¬
derwent hemoglobin tests); the ferritin test was used rela¬
tively less often at the Edinburgh site than at the Glasgow
site (13% and 59%, respectively, underwent ferritin tests).
The proportion of low values was 16% for ferritin
(n = 168 women), and 20% of the women had a hemoglo¬
bin level of < 12 g/dL (n = 182 women).
Association of measured blood loss with clinical
features, demographics, and iron status
The distribution of measured blood losses for the 226
collectors is shown in Figure 1; the median loss was 53
mL (interquartile range, 27-101 mL), and 34% of the
women had losses of >80 ml. At the group level, the
subjective judgment of heaviness of periods is sup¬
ported, with a significantly greater mean loss for those
women who rated periods "very heavy" compared with
the rest (predominantly "heavy"; geometric mean vol¬
umes, 64 and 40 mL, respectively; t = 3.56; n = 107
and 118, respectively; /><.00I). The back-transformed
difference between means of logged data gives 1.61 as
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the ratio of means (very heavy:heavy; 95% CI, 1.23-
2.10). Measured blood loss was also greater for women
who believed that their clinic attendance was for excessive
bleeding, compared with the remainder (geometric
mean, 59 vs 39 mL; / = 2.94; n = 160 vs 66 women; P =
.004; ratio of means, 1.54; 95% CI, 1.15-2.06). How¬
ever, referral for bleeding was not indicative of signifi¬
cantly greater volume of loss (geometric mean, 54 vs
43 mL; / = 1.48; n = 196 vs 30 women; P = .14; ratio
of mean. 1.35; 95% CI, 0.91-2.00). Even where there is
significant difference at the group level, there is substan¬
tial overlap in the ranges of individual measured losses.
For example, 25% of women who rated their periods
"very heavy" had volume of loss of <35 mL, and
25% of those who rated their periods as only "heavy"
had loss of>82 mL.
Table II gives the associations of blood loss volume
with clinical/menstrual history variables. The clinical
features that were associated most strongly with blood
volume were the required rate of change of sanitary pro¬
tection during full flow and the total number of pads and
tampons used (rho = 0.29 and 0.30, respectively; both
P<.001). Figure 2 presents box-plots of measured vol¬
umes against these variables and shows the extent of
overlap in ranges of volumes between the subgroups.
Volume is also associated with the size of the clots with
periods, the number of clots>50-pence coin size (Fl¬
inch diameter) per period, and the need for changes of
protection during the night (rho = 0.26, 0.26, 0.26, re¬
spectively; all P<.001). There is strong evidence that
low iron status is associated with measured blood vol¬
ume, for ferritin more than for hemoglobin (rho = 0.30
[/5<.001] and rho = 0.23, [P = .002], respectively).
At the time of collection, each woman recorded how
the amount of the period that was just collected com¬
pared with her periods in the last 6 months (the time¬
frame for responses in the questionnaires). Seventeen
collectors (7.6%) failed to record this detail; however,
of the remaining 209 collectors, 5% reported the col¬
lected period as more in amount; 16% reported about
the same; 42% reported a bit less, and 36% reported
much less. Mean loss volume for those answering "much
less" differed significantly from that for the remainder
(40.3 vs 54.9 mL; n = 73 vs 126 women; P = .04; ratio,
0.74; 95% CI, 0.54-0.99). This reduction in volume was
more pronounced among older women, as shown in
Figure 3. The nonparametric associations of Table II
were recalculated after the women whose collected
period was "much less than usual" were excluded. This
yielded stronger associations of blood loss volume with
age, parity, and deprivation (n = 126 women; for age
group, rho = 0.25 [F><.004]; for number of babies,
rho = 0.24 [/^ < .007]; and for deprivation, rho = —0.19
]/><.037]) than were found for the entire group (Table
11). There was, however, no improvement in the associ¬
ation between volume and referral for bleeding.
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Figure 1 Histogram of measured blood loss, with super¬
imposed box plot (n = 226 participants).
Association of measured blood loss with
diagnosis and treatment
Overall, the volume of loss differed little between those
proceeding or not to hysterectomy (median, 59 mL, and
interquartile range, 21-140 mL, vs median, 53 mL, and in¬
terquartile range, 27-97 mL, respectively). Among those
women who were diagnosed with fibroid tumors (20/
176 women; 11%), there were slightly heavier losses and
higher rates of poor iron status (Table III). Even among
women with no diagnosis of fibroid tumors, there was lit¬
tle difference in volume of blood loss between those pro¬
ceeding or not to hysterectomy (median, 53 vs 52 mL).
However, there was a trend for those women who had un¬
dergone hysterectomy to have poorer iron status (low fer¬
ritin level, 31% vs 11%; hemoglobin level <12 g/dL,
29% vs 17%). Table 111 also gives the median blood loss
and iron status for women with other diagnoses.
Using clinical history to predict blood loss
of>80 mL
A logistic regression model was fitted to predict losses
that exceeded 80 mL, with the potential predictors of
the clinical and demographic variables described earlier.
Structural variables entered in the model were the center
(Edinburgh or Glasgow) and the age group (<40 years
old or >40 years old). Over and above these, the varia¬
bles that were required in the model to predict a loss
of>80 mL were clots > 50-pence in size, low ferrit¬
in level, and frequency during full flow of needing
to change sanitary protection. Although relatively few
women underwent ferritin testing (only 161 women
had complete data), the model that included ferritin per¬
formed better than the model without iron status test
data, which was based on all collectors with complete
data for the remaining model variables (performance,
71%; n = 202 women). There was otherwise little differ¬
ence between the models. Table IV shows the model that
includes ferritin level, which had a prediction success of
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Age group (youngest-oldest) 226 0.11 .100
Deprivation (least-most) 222 -0.11 .095
No. of babies (0-6) 226 0.11 .109
Pathway to clinic
Subjective heaviness of period (moderate; heavy; very heavy) 225 0.23 <.001
Patient believes clinic attendance is for bleeding (no; yes) 226 0.18 .006
Volume of loss cited as cause of seeking help (no; yes) 226 0.14 .034
General practitioner referred patient for bleeding (no; yes) 226 0.11 .109
Clots
Size of clots with period (none; 20-pence; >50-pence)* 226 0.26 <.001
Usual no. of clots (per period) bigger than 50 pence* (0-28) 214 0.26 <.001
Iron status
Ferritin level (low; normal) 168 0.30 <.001
Flemoglobin level (<12 g/dL; >12 g/dL) 182 0.23 .002
Containment of period
Usual total no. of tampons/pads used per period (0-136) 207 0.30 <.001
Rate of change of protection necessary during full flow 218 0.29 <.001
(every 3 hr or less often; every 2 hr; hourly; more often)
How often periods...
Require protection changed during the night (seldom; some periods; most) 226 0.26 <.001
Leak through on to underclothes or bedding (seldom; some periods; most) 226 0.23 <.001
Usual no. of days (per period) double protection is required (0-12) 221 0.25 <.001
No. of times per period that there is leakage on to underclothes (0-10) 223 0.16 .015
* UK coins: size (diameter) of 50 pence is 1.1 inches and of 20 pence is 0.85 inches.
76% overall, correctly predicting 60% of the 60 women
with measured losses of>80 mL and 86% of the 101
women with losses of <80 mL.
Comment
We have shown that the clinical features that are associ¬
ated most strongly with blood loss volume are the re¬
quired rate of changing sanitary protection during full
How, the total number of products used, poor iron sta¬
tus, the size of clots, and the need to change protection
during the night (Table 11). It is noteworthy that these
features are not purely subjective, but either based on
an objective test result (ferritin) or operational (eg,
changing rate and clot size) and therefore less prone to
measurement error. In addition, we found strong evi¬
dence that volume of loss is related to a woman's subjec¬
tive judgment: those women who rated their periods as
"very heavy" have a mean blood loss that is 61%
(23%-110%) higher than the remainder of the women.
In absolute terms, only 34% of the collectors had
menstrual blood losses of>80 mL. A partial explana¬
tion may be period-to-period variability.1x 21 Ours is
the first study to ask whether the period that was col¬
lected was representative of periods as reported. For
36% of the women, the period collected was "much less
than usual," which was substantiated by a lower mea¬
sured volume. Excessive periods once every few months
may be more worrying than consistent losses and are al¬
most as disabling, because every period has to be antic¬
ipated as if it might be 1 of the heavier ones.
Among those women who reported the period col¬
lected as "much as usual," only 38% had measured a loss
of>80 mL, which is lower than the prevalence that was
•» • *710 2"*lound in other measurement studies. " """ " This may
be because our study is the first to measure blood loss
in routine patients who were referred to a clinic with
heavy periods rather than women who were selected for
clinical trials. Alternatively, it may be because not all pa¬
tients who were referred with menorrhagia considered
their periods to be excessive. It has been reported that
there is a tendency for broad menstrual complaint, or
even pain specifically, to be refrained as "excessive bleed¬
ing" both at referral and at the gynecology clinic (that is,
the referring physician is much more likely than the
woman to cite excessive bleeding as the reason for clinic
attendance).14 This is supported by our finding that refer¬
ral by the family physician for excessive bleeding was not
prognostic for higher mean blood loss.
In contrast, a woman's subjective report of heaviness
was related to measured loss; therefore, our data contra¬
dict the widespread clinical belief that women are poor
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Figure 2 Box-plots of volume of blood loss by (A) changing rate of pads/tampons during full flow and (B) total number of
products used per period. Note: The axis in A applies to both graphs.
judges of their volume of menstrual loss.3-24 However,
the relatively low proportion of women with measured
loss of>80 mL does raise doubts about calibration to
the clinical definition of menorrhagia. This discordance
with the menorrhagia definition is unsurprising, given
that very few women know of it and only a minority
of women think of their periods in volumetric terms.
When required to rate their usual period in terms of
options that are formulated in volumes (teacup, mug,
much more), most women instead opted for the fourth
response available, "no idea" (55%).
Our data suggest that treatment is not related to mea¬
sured volume of blood loss. In the absence of any iden¬
tifiable disease, dysfunctional uterine bleeding is virtually
a default diagnosis and is unrelated to actual loss.
A similar picture is found for the treatment of patients
without fibroid tumors and with hysterectomy outcome
unrelated to volume of loss (Table III). Blood loss meas¬
urements were not entered in patient notes, so either
clinicians are unable to make a judgment of loss from
the clinical history or they feel that volume of loss has
little bearing on treatment or diagnosis.
When menorrhagic blood loss was modeled (>80 mL
versus <80 mL), 76% prediction success was achieved
by a model that included clots>50 pence in size (1.1-
inch diameter), low ferritin level, and rate of change of
sanitary protection. On the I hand, the performance of
76% may be an optimum figure, given that model per¬
formance is ascertained against the same data that are
used to derive the model. On the other hand, it may
be an underestimate of performance, in that the model
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Figure 3 Box-plots of measured volume by age-group and
representativeness of collected period.
an overview of recent months. For a substantial number
of women (36%), the amount of loss for the single pe¬
riod that was collected subsequently was stated to be
much less than the usual amount of loss that was de¬
scribed in the questionnaires. This unusually low loss
rate will not reflect so clearly the predictors that were
reported (for the usual heavy periods). Therefore, the
predictive model is set an almost impossible task, and
a statistical false-positive result in this analysis may be,
in fact, a clinical true-positive result for the woman's
other periods.
Two important points must be made. First, if a
method became available that was suitable for routine
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Table III Blood loss volume and iron status by diagnosis and with hysterectomy as outcome
Median blood Interquartile Low ferritin Hemoglobin level
N volume (mL) range level (n/N) <12 g/dL (n/N)
Diagnosis of fibroid tumors
Yes 20 85 38-168 7/17 (41%) 5/18 (28%)
No, but hysterectomy 25 53 20-129 5/16 (31%) 7/24 (29%)
performed
No, and no hysterectomy 131 52 27-93 10/95 (11%) 17/100 (17%)
Total 176
Other diagnoses
Dysfunctional uterine 64 63 27-111 6/46 (13%) 14/52 (27%)
bleeding—regular
Dysfunctional uterine 43 41 19-83 5/28 (18%) 8/33 (24%)
bleeding—irregular




Table IV Factors included in the logistic regression model that predicted blood loss of >80 mL
N (for subgroup) Odds ratio 95% CI P value
Factor entered
Center: Edinburgh 50
Age <40 years 82
Factors selected into model
Clots > 50-pence diameter* 32
Ferritin level: low 25
Required frequency of changing protection
<3 Hr 38
Every 1-2 hr 104




















UK coin size: 1.1 inch in diameter.
clinical use and that could identify patients with true
menorrhagia (loss of>80 mL), there would remain an
urgent need for trials of treatment strategies for the re¬
mainder of women, the substantial majority of patients
who are referred with heavy periods but who have blood
loss of <80 mL. Second, such a method would help clin¬
ical management of referrals for excessive periods only if
the volume of blood loss, and more specifically a volume
ol >80 mL, is the key issue for patients and is critically
important to optimum care. In a second article, we will
consider the clinical usefulness of the 80-mL threshold.25
Past evaluation of a woman's ability to judge men¬
strual loss volume may have been clouded by misleading
referral reasons or period-to-period variability in loss.
The volume of blood loss is associated more closely than
has been believed with subjective judgment of heaviness
and is even more strongly associated with specific clini¬
cal features. A loss of >80 mL can be predicted moder¬
ately well by a model that includes poor ferritin level,
clot size, and the changing rate of pads/tampons during
full flow. An examination of clinical outcome data sug¬
gests that clinicians either find it difficult to judge
volume from the clinical history or do not consider
volume as key to management. This raises a concern
about the implementation of current guidelines in unse-
lected patients.
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Objective: Menorrhagia is defined in terms of statistical"abnormality"as blood loss of >80 niL.
We examined the usefulness of this definition in women who were referred to gynecology clinics
with heavy periods.
Study design: A questionnaire survey of 952 menstrual complaint referrals at 3 hospital gynaecol¬
ogy clinics in Glasgow and Edinburgh included 226 women with heavy periods who had also con¬
sented to the measurement of their blood loss.
Results: Women reported a range of problems with their periods, but absolute volume (31.2%)
was less prevalent than period pain (37.5%), mood change (35.7%), and change in the amount
(volume) of the period (33.8%). Although there were associations with volume, these associations
were due to the heaviest and lightest of the loss groups, whereas the 2 groups with loss either side
of 80 mL were virtually indistinguishable.
Conclusion: The 80-mL criterion for menorrhagia is of limited clinical usefulness because it is
prognostic neither for problems nor iron status and apparently does not guide management.
© 2004 Elsevier Inc. All rights reserved.
Menorrhagia is defined as excessive menstrual loss
and accounts for a substantial proportion of health care
resources among women of reproductive age.1"'1 There
are 2 biomedical reasons that excessive periods warrant
clinical scrutiny: the risk to iron status and to health and
vigor that may ensue and the fact that increased loss
may be indicative of some serious disease that requires
Supported by the Chief Scientist's Office, Scotland (K/MRS/50/
C2472).
Reprints not available from the authors.
urgent intervention. However, even if neither of these
situations are pertinent, help may be warranted because
of the disability and handicap that the woman experien¬
ces as a consequence of her menstrual periods4"'
The formal definition of menorrhagia is blood loss in
excess of 80 mL per menstrual period.1'2'7 In research
studies in which blood loss has been measured in women
who were referred with menorrhagia, it has been found
that fewer than half of women experience a loss of > 80
mL.8"11 In our companion paper,12 we raised concerns
at the dearth of evidence to inform treatment of the
routine menorrhagia referral, because recommendations
0002-9378/$ - see front matter © 2004 Elsevier Inc. All rights reserved,
doi: 10.1016/j.ajog.2003.11.016
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in menorrhagia guidelines11314 are derived from trials
that involved women with generally much heavier men¬
strual loss (>80 mL, averaged over >2 periods). For ex¬
ample, in a recent drug trial only 20% of referrals for
menorrhagia satisfied the volumetric criterion for trial
entry that was applied.8
The fact that laboratory measurement of blood loss is
impracticable in routine clinical care raises the question
as to whether a volumetric definition that can so seldom
be implemented is a useful way of thinking about the
prevailing complaint of "heavy periods." More funda¬
mentally, some reflection is warranted as to whether
the contemporary menorrhagia complaint hinges on
the volume of blood loss or whether it is precipitated
by a broader adverse impact of menstruation. The clin¬
ical definition was formulated following a Swedish study
that measured blood loss in a population sample of 476
women.15 It found a significantly greater prevalence of
impaired iron status among women with losses of >60
mL. Using estimates of daily dietary intake for Swedish
women then (1966) and of likely daily and menstrual ex¬
cretion of iron, calculations showed that menstrual
blood loss of >63 mL endangered iron status. After ex¬
cluding women with abnormal iron status or who con¬
sidered themselves unhealthy or to have abnormal
menstruation, the 95th percentile of blood loss for the
183 healthy women was 76 mL. The authors concluded
that the upper limit of normal menstrual blood loss lay
between 60 and 80 mL,15 but subsequently the most ex¬
treme endpoint of this range (80 mL) was adopted as the
clinical threshold for menorrhagia.
To be of value in clinical care, the menorrhagia defi¬
nition should reflect the underlying complaint and be
prognostic for disease, for compromised iron status or
for adverse impact on quality of life, or it should lead
to more appropriate and effective clinical treatment.
The aims of this paper were to examine the performance
of the 80-mL definition for menorrhagia in respect of
prognosis and treatment and, more fundamentally, to
examine the nature of the problems that are experienced
by women who are referred for excessive periods, and to
ascertain whether absolute volume is the key issue.
Methods
Study design and methods
The basic study design and methods, including coding of
referral reason and patient reasons for clinic attendance,
were described elsewhere'6; blood loss collection and
measurement are described in a companion article.12
The self-completed clinic questionnaire asked each
woman to respond to 16 statements about menstrual ex¬
perience and to report for each experience whether it oc¬
curs in her case and, if so, how much of a problem it
poses (no/slight/marked/severe problem) and to note
which of these problems (<3) led her to seek help. Re¬
sponses were analyzed as binary variables (severe prob¬
lem vs the rest); binary variables were derived for each
aspect that indicated whether it had been cited as a cause
of seeking help.
Analysis
Association in 2 X 2 tables was tested by chi-squared
test, with correction for continuity. For tables with 1
variable binary and 1 ordinal, the chi-squared test for
trend was applied. SPSS software (version 9.0; SPSS
Inc, Chicago, 111) was used. There was a small propor¬
tion of nonresponse; therefore, the effective (nonmiss-
ing) number is reported if it is different from the total
number (except in Table, to be succinct). In Table, the
percentage of the missing responses, for all eligible
women, is <2% for most aspects and <3% for the re¬
mainder, except for "money spent," which has 4.6%
missing values. For collectors, the corresponding per¬
centages with missing responses are <1%, <2%, and
3.1%. Collectors were classified into 4 groups by mea¬
sured blood loss: <50 mL, 50 to 79 mL, 80 to 119
mL, and > 120 mL.
Results
Recruitment and participation
Recruitment for the wider study (952 participants) has
been reported,16 and the characteristics of the subset
who collected their used sanitary protection have been
described in the companion article.12 The 226 women
who collected their used sanitary protection comprised
26% of the 865 women who satisfied the criteria for col¬
lection, and 180 of these women were recruited early
enough for an 8-month follow-up by case note review
(80%).
Description of menstrual experience
The distribution of measured blood losses has been re¬
ported in the companion paper12; 46% of the women
had losses of <50 mL; 20% of the women had losses
of 50 to 79 mL; 15% of the women had losses of 60 to
119 mL, and 19% of the women had losses of >120
mL (n = 104, 45, 35, and 42, respectively). Table shows,
the prevalence of reporting the various aspects of men¬
struation as a severe problem for all women who were
eligible to collect and for the subset of women who ac¬
tually did the collecting. Pain with periods, mood
changes, and increased amount of period were most
problematic for all women who were eligible to collect
and for the subset of women who did the collecting,
and, although not shown, for all women in the study
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Table Prevalence of severe problem with aspects of menstruation for all women with putatively heavy periods* and for the subset of
women who collected
Aspects of periods (listed in order of prevalence
among all women who were eligible to collect)





Period-type pain with periods 33.0 37.5 1
Mood changes around periods 32.8 35.7 2
Amount of period more than it used to be 29.1 33.8 3
Periods keep on for too many days 25.3 28.9 6
Lose too much blood 24.6 31.2 4
Interruption to daily life 24.2 30.0 5
Feel unwell/tired because of periods 23.4 27.4 8
Other changes around periods 22.6 27.8 7
Difficulty in preventing blood leakage 20.1 23.0 9
Worry that something may be wrong 18.6 20.6 12
Period pain before periods 17.5 21.2 11
Unpredictable onset of periods 17.0 16.1 14
Periods cause extra washing 16.9 21.7 10
Pain all the time 15.0 18.1 13
Money spent on pads/tampons 12.6 14.2 15
Bleeding between periods 8.8 5.8 16
There are small amounts of missing data for some aspects (see "Analysis" in the Methods section of the text).
* Referred for excessive periods/attending for excessive periods/reporting periods heavy or very heavy.
' N = 865 women.
1 95% CIs are 3 percentage points either side of the figure that is reported for prevalences of >20% and 2 percentage points either side for those of
<20%.
s N = 226 women.
I! 95% CIs are 6 percentage points either side of the figure reported for prevalences of >24%, 5 percentage points either side of those from 23% to
14%, and 4 percentage points either side for those of <14%.
(n = 952) and for the subset of women who were re¬
ferred for bleeding (n = 725). The prevalences of severe
problems among the group of women who collected are
slightly higher in general, but the relative ranking is very
similar. It can be seen that absolute volume (lose too
much blood) is only fifth in the order of prevalence over¬
all and fourth among collectors. Among collectors, 50%
of women reported a severe problem with some aspect
of volume of bleeding (4th, 5th, or 9th aspects; Table),
43% of women reported pain around periods (1st, 11th,
or 14th aspects; Table), and 45% of women reported
cycle-related changes (2nd or 8th aspects; Table).
Prognostic value of the 80-mL cut-off for
menorrhagia
Figure 1 shows the prevalence of the reporting of prob¬
lems with pain before or with periods, mood or general
cyclical changes, and the unpredictability of the onset of
periods. All problems are associated significantly with
volume, but inversely, the problems in this clinic group
are greatest in those patients with lowest loss.
Apart from these aspects, the only problems with pe¬
riods that are associated significantly with blood loss
categorization are aspects of containment of blood flow
(Figure 2, A). The major differences are between the
lightest and heaviest loss groups, with those on
either side of the 80-mL criterion virtually indistinguish¬
able. Figure 2, B, shows some other aspects of menstru¬
ation that might have been expected to be related to
menorrhagia complaint; lose too much blood; worry
(that) something is wrong; feel unwell/tired because of
periods; and volume of bleeding is the reason for seeking
help (any of 4th, 5th, or 9th aspects as listed in Table).
None of these problems or reasons increases signifi¬
cantly with volume. The pattern for worry is U-shaped,
most prevalent in those women with the lightest and the
heaviest loss. Again, there is little difference in prevalen¬
ces for groups either side of 80 mL.
With regard to potential physiologic and treatment
consequences of heavy periods, Figure 3 shows that
the proportions with low ferritin levels and hemoglobin
(below 12 g/dL) increase significantly across loss groups,
but with no marked increase from <80 mL to >80 mL.
The pattern is very similar in Figure 4, which shows the
proportions of women who were diagnosed with some
disease or with fibroid tumors, specifically, and the pro¬
portions for whom tranexamic acid was recommended
as treatment or who made the decision to have hysterec¬
tomy. However, for these outcomes, the trend is not sta¬
tistically significant.
Warner et al 1227
•0 . ;
0 - V T ■.
« 50 trl 50-79 ml 80-n9 ml 120 mi >
Blood loss
Figure 1 Severe problems with periods that are related in¬
versely to volume of loss: prevalences (%) by blood loss
variable of pain, cycle changes, and unpredictable onset. All
data show significant chi-squared for trend. The open diamonds
denote the "pain with periods" variable (P = .015); the solid
line with an X denotes the "pain before periods" variable
(P = .003); the solid line with a dosed circle denotes the "any
pain around periods" variable (P = .003); the open squares
denote the "moods changes around periods" variable
(P = .002); the dashed line with llw closed circle denotes the
"unpredictable onset of periods" variable (P = .012); and the
light gray line with an X denotes the "any cyclic changes"
variable (P = .007).
Comment
The most striking finding is the clinical irrelevance of the
established threshold definition of menorrhagia, blood
loss in excess of 80 mL. Although there is a significant
trend for difficulties with containment of blood flow to
become more prevalent with increasing blood loss vol¬
ume, this effect is largely due to the heaviest and lightest
loss groups, whereas the 2 groups with loss either side of
80 mL are virtually indistinguishable. A similar pattern
is observed for iron status, for diagnoses, and for treat¬
ment. Our data confirm that the 80-mL cut-off point
does not convey any special prognostic information:
the 35% of collectors with losses between 50 and 119
mL are fairly homogeneous with respect to difficulties
with containment of periods, compromised iron status,
pathologic findings, and treatment.
The menorrhagia definition simply identifies those
women with blood loss in the upper 3% to 4% of
a healthy Swedish population in 1966. The well-recog¬
nized problem with a statistical definition of this sort
is that some women with abnormally heavy losses may
find them manageable, nevertheless, and that symptoms
(losses) that are less than this may be statistically fairly
common, but for some women not tolerable.17 Further¬
more, the secular changes in reproductive patterns and
diet since 1966 may mean the original iron risk calcula¬
tions no longer apply, possibly never did in some non-
Swedish communities. The clinical usefulness depends
on how much the definition aids management or how
predictive it is of adverse effects or disease. For the
81% of women in our study with losses of <119 mL,
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Figure 2 A, Prevalences (%) by blood loss variable of severe
problems with periods for containment, extra washing, and
impact on daily life. All data show significant chi-squared for
trend. The open circles denote the "accidents are a severe
problem" variable (P<.001); the closed diamonds denote the
"impact on daily life cause of seeking help" variable
(P = .046); and the X denotes the "extra laundry as a severe
problem" variable (P = .029). B, Prevalences (%) by blood
loss variable of severe problems with periods for volume of
bleeding, feeling unwell/tired, and worry that something is
wrong. None of the data show significant association nor trend
with volume. The closed diamonds denote the "losing too much
blood is a severe problem" variable; the open circles denote the
"worry that something is wrong is the cause of seeking help"
variable; the closed squares denote the "feeling unwell/tired is
a severe problem" variable; and the closed circles denote the
"bleeding is a cause of seeking help" variable.
10% of the women have fibroid tumors, compromised
iron status, or a problem with the impact on daily life;
approximately 20% of the women have some disease,
and approximately 40% to 70% of the women have
problems with containing blood flow.
Furthermore, our data suggest that not only the
80-mL criterion should be challenged but also that the
idea that volume captures the essential nature of the pre¬
vailing complaint of heavy periods. Heavy does not
unequivocally describe volume, so the complaint may
reflect adverse impact on daily life through difficulties
with the containment of blood flow or associated symp¬
toms.6 The problem may be acute unmanageable blood
flow in the first few days rather than total volume, or it
could be that a change in periods has been noted, which
leads to concern that something serious is wrong. In
support of this, we have reported that pain, mood
changes, and an increase in the amount of the period





Figure 3 Prevalences (%) by blood loss variable of poor iron
status: low ferritin level (dosed diamonds; P<.001; n = 168
women) and hemoglobin level <12 g/dL (open circles',
P<.001: n = 182 women). Both sets of data show significant
chi-squared for trend.
were reported more commonly as severe problems than
absolute volume and that pain around periods was more
often a problem in cases in which measured losses were
low. The association between heaviness and measured
volume that was reported elsewhere12 does not necessar¬
ily reassure that women are complaining about volume
itself; the association may be coincidental, because
greater volumes are associated in some way with the fac¬
tors that lead to the complaint.
Stirrat1X has highlighted a strong unease that, in the
case of menorrhagia, drugs are prescribed or invasive sur¬
gery undertaken on the basis of the patient's account of
her symptoms; the implication is that reported volume
of loss will be misleading. On the contrary, the unease that
should be felt is that the definition for menorrhagia takes
so little account of a woman's experience of heavy peri¬
ods, which is the menorrhagia complaint in its broader
sense. Few clinicians request measurement of menstrual
loss, and many clinicians take a holistic approach to the
treatment of menorrhagia, perhaps in tacit acknowledge¬
ment of the shortcomings of the definition. It is, however,
highly unsatisfactory that clinicians have to provide care
for so many patients outside of the menorrhagia guide¬
lines that address only I aspect of the problem and that
are applicable only to a minority of patients (those
women with blood losses of >80 mL over >2 periods).
Our data confirm that the volume of loss is only 1 concern
among many concerns of women who are referred with
heavy periods, and not the main one concern overall. This
replicates findings in qualitative research.1'4'6"19 It would
be better for the future care of women with menorrhagia
if the definition was reformulated to reflect this. Only then
can an appropriate research evidence base be built, to
provide guidelines for pragmatic treatment and shared
decision-making in women with heavy periods but with¬
out statistically abnormal volume of blood loss.
The 80-mL criterion is of dubious clinical usefulness
because it is neither sensitive nor specific for adverse im¬
pact of periods, compromised iron status, or disease.
Furthermore, the current focus on the volume of blood
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Figure 4 Clinic outcome by blood loss variable: prevalences
(%) of diagnosis of fibroid tumors (closed triangles', n = 176
women) or any pathologic evidence (open diamonds', n = 176
women), tranexamic acid as treatment (open squares: n = 184
women), and hysterectomy ( X denotes within 8 months
[n = 179 women]; closed diamonds denote before the end of
data collection [n = 179 women]). None of the data show
a significant association nor a trend with volume.
tients and clinicians, because it ignores the associated
symptoms and social disability that play a key role in
leading a woman to seek help. Appropriate research is
required to derive recommendations for assessment
and treatment of heavy periods, which should be con¬
ceptualized broadly.
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Study Number I ' L
CLINIC QUESTIONNAIRE
We wish to survey all women attending this Clinic.
This will be so we can check on the types of problems needing treatment, and
the numbers of women suffering these problems.
This will help us to plan our clinic service for the future, to ensure the
best possible treatment for all.
Please would you answer the following questions
about your attendance at this Clinic.
<sf o
U
How to Fill in this Questionnaire:
tick the answer that applies to you
write in a number answer, or 0 if none
write an answer in words
NOTE:
Your answers will be kept quite confidential.
This sheet will be unnamed, and it will not form part of your clinical notes.
We will simply combine the information from all women attending this clinic and then
computer-analyse it to obtain summary totals of their various answers.
We would very much appreciate your help.
Please tarn over
Clinic Questionnaire Page 2
Today's Date Please write in
Day Month Year
1. What problem, mainly, has brought you to this Clinic?
Please say in your awn words.
2. How long has this been bothering you? Please write in j I years months
3. Have you ever before attended a clinic for period problems?
Please tick one
If No, please go on to question 4.
If Yes:
Yes O No O
2 1
a) How long ago was your last attendance? I
b) Have you attended before for the same problem as now?
J yrs I I Ir i i i mths ago
Yes O No O
4. Please would you descibe your periods nowadays (the last 6 months):
a) How heavy are your periods?
Please tick one Light l°ss O Moderate O Heavy loss O Very Heavy loss O
b) How many days do your periods usually last?
Please write the usual number ofdays your period
has lasted (in the last 6 months).
Ifyour periods differ in length please also write in








c) What sanitary protection do you use, mainly?


















d) Do you have to use more than one pad/tampon at the same time?
If Yes, on how many days of the period, usually, do you use double protection?
Yes O No O
j I days
e) Does your period include clots (shiny dark red-black lumps)? please tick one
NoO Yes - About 20p sizeo Yes - About 50p size O Yes - Bigger than 50p O
HOW TO COMPLETE: O 0" tick one I—write a number say in words
Clinic Questionnaire Page 3
f) Do you have to get up at night to change your pads/tampons? Please tick one
Very seldom O Some periods O Most periods O
g) Does your period leak through onto your underclothes or bedding? Please tick one
Very seldom O Some periods O Most periods O
3 2 1
5. There are lots of different ways in which periods can be a nuisance, or a real problem.
Please tell us what happens in your case, and how much it bothers you.
Please tick one answer on each line. Does Happens Happens and is
not but no slight marked sever*
happen problem problem problem problei
a. You feel generally unwell/tired because of vour periods o o o o o
b. The amount of vour periods is more than it used to be, normally o o o o o
c. Your periods cause interruption to vour daily life o o o o o
e.g. work, sport, going out
d. You have bleeding in between periods o o o o o
e. Your periods are irregular i.e. don't know when to expect them o o o o o
f. You have period-tvpe pain with vour periods o o o o o
g- You have other bodilv changes before vour periods o o o o o
e.g. bloating, breast discomfort
h. The money you have to spend on sanitary pads &/or tampons o o o o
i. Your periods keep on for too manv davs o o o o o
j- You have period pain before vour periods o o o o o
k. You worry that recent change in your periods, from before, o o o o o
could be a sign that something might be wrong
1. You have difficulty in preventing accidents fblood leakage) o o o o o
m. Your periods cause extra washing, of bedding, clothes etc. o o o o o
n. You have period-type pain most of the time o o o o o
o. Mood changes around your periods e.g. irritability, depression o o o o o










Which of these has been the main cause of your coming to this clinic?
Please note in words, or by using the corresponding letter in the list above
You may note up to 3 reasons/ causes, but please put strongest reason first.
Please turn over
How to Complete: o <5f tick one t^i£j write a number say in words
Clinic Questionnaire Page 4
And finally, please would you give some background details about yourself.
6. What is your date of birth ? Please write in I—i—I I—i—I I—i—I
Day Month Year
7. How long did you continue with your education? Please tick one, the highest level reached
Left school by age 16 years O Studied A-levels, Highers O Full-time student at College/ University O
8. Are you currently living with a partner or with your husband? Yes O No O
If No, are you ? Separated/ divorced O Widowed O Single O
9. Do you work? Please tick one Yes" full-time O Yes - part-time O No job O
3 2 1
What is your job, or what was your job when you last worked?
10. How would you rate your general health, compared to other women about your age?
Please tick one Worse than most O About the same as others O Better than most O
3 2 1
11. Children and babies;
How many babies have you had altogether? Please write in how many, or 0 ifnone 1 I I births
How many of these children do you still have living with you? 1 i 1 at home still
Do you have any other children living with you (adopted etc.)? 1 i I others
What year did your most recent pregnancy end? Last pregnancy ended in I ^ i ^ i—i 1
Please leave blank ifno pregnancies
12. Is it important to have the possibility that you could, if you wanted, get pregnant in the future?
Not applicable - already sterilised O Not important O Fairly important O Very important O
4 3 2 1
If you have already been sterilised, how many years ago was the operation? 1 i 1 years ago
13. Do you use contraception currently? If so, what method? Please tick one
Hormonal e.g. 'the pill' or O Sterilisation O IUD (^) Other e.g. condom O None O
contraceptive Norplant s male or female \ 3 cap 2 l
If vou have used 'the pill' in the past how many years ago did you stop? 1 i 1 years ago
14. Do you currently smoke? Please write in how many cigarettes a day, usually I i 1 cigs. per day
Ifyou do not smoke please write 0
How TO COMPLETE: Q tick one write a number say in words










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































ASPECTS OF YOUR HEALTH SF-36
Study Number
The following questions ask for your views about your health and how you feel about life in general. If you are
unsure about how to answer any question, try and think about your overall health and give the best answer you
can. Do not spend too much time in answering as your immediate response is likely to be the most accurate.





2. Compared to one year ago, liovv would you rate your health in general now?
Much better than one year ago O 5
Somewhat better now than one year ago O 4
About the same Q 3
Somewhat worse now than one year ago O 2
Much worse now than one year ago Q 1
3. The following questions are about activities you might do during a typical day. Does your health limit
you in these activities? If so, how much?
Yes Yes No, not
limited limited limited
a lot a little at all
i. Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports.
O O O
ii. Moderate activities, such as moving a table,
pushing a vacuum cleaner, bowling or playing golf.
O O O
iii. Lifting or carrying groceries. O O O
iv. Climbing several flights of stairs O O O
v. Climbing one flight of stairs O O O
vi. Bending kneeling or stooping O O O
vii. Walking more than one mile O O O
viii. Walking half a mile O O O
ix. Walking 100 yards O O O
X. Bathing and dressing yourself O O O
4. During the past 4 weeks, have you had any of the following problems with your work or other regular
daily activities as a result of your physical health?
Yes No
i. Cut down on the amount of time you spent on work or o O
other activities
ii. Accomplished less than you would like o O
iii Were limited in the kind of work or other activities o O
iv 1 lad difficulty performing the work or other activities o O
(e.g. it took extra effort)
5. During the past 4 weeks, have you had any of the following problems with your work or other regular
daily activities as a result of any emotional problems (such as feeling depressed or anxious)?
Yes No
i. Cut down on the amount of time you spent on work or o O
other activities
o O
ii. Accomplished less than you would like




6. During the past 4 weeks, to what extent has your physical
health or emotional problems interfered with your normal
social activities with family, friends, neighbours or groups?
Not at all Os
Slightly 04
Moderately o3
Quite a bit O:
Extremely O,







8. During the past 4 weeks, how much did pain interfere with your normal work (including work both
outside the home and housework)?
Not at all o
A little bit o<
Moderately o
Quite a bit o
Extremely o,
l). These questions are about how you feel and how things have been with you during the past month,
(for each question please indicate the one answer that comes closest to the way you have been feeling).
How much time during All of Most A good Some A little None
the past month the of the bit of the of the of the of the
time time time time time time
i. Did you feel full of life? o o o o o o
ii. Have you felt particularly nervous? o o o o o o
iii. Have you felt so down in the dumps o o o o o o
that nothing could cheer you up?
iv. Have you felt calm and peaceful? o o o o o o
v. Did you have a lot of energy? o o o o o o
vi. Have you felt down-hearted and miserable? o o o o o o
vii. Did you feel worn out? o o o o o o
viii. Have you been happy? o o o o o o
ix. Did you feel tired? o o o o o o
x. Has your health limited your social activities o o o o o o
(like visiting friends or close relatives)? 6 5 4 3 2 1












i. I seem to get ill more than other people o o o o o
ii. 1 am as healthy as anybody 1 know o o o o o
iii. 1 expect my health to get worse o o o o o
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b.Ifyouhavet kenanypain-killerstoday,h wmanyit talt d y? c.Haveyout kennyoth rmedicationt y,becausefyourp riod? Ifso.what?Ple sewritt enam .
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jIpain-killers NoO
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HEALTH HISTORY, DIAGNOSES, TREATMENT & OUTCOME
I! Appendix 3.6
Study Number 1—•—'—'—I—1 • Today's date / /
1st clinic date / J / Date most recent appointment / /
Total no. of appointments with clinician during 8-mth period (including 1st clinic visit) ^ 1—^
HISTORY (to be completed for all study recruits)
No. of:
livebirths I 1—I miscarriages ^ 1—^ stillbirths ^ 1—I abortions I 1—^
Any recorded history of :
Yes No N/K Yes No N/K
abnormal smear O O O sterilisation O O O no. years ago
removal of ovary O O O use of IUD O O O previous / current
thyroid disease O O O (circle which one)
cancer O O O site
Any chronic medical condition (as noted in case notes)
Medication at time of referral:
(ie OC, NSAID's, tamoxifen etc)
Treatments tried by GP (list all trts mentioned in referral letter or in case notes at 1st visit):
* Please enter Hb and ferritin results (if available) for ALL study recruits (see below).
INVESTIGATIONS























Enter code, from list below, and date of all interim/final diagnosis/es made, upto 8 months:
I —I I —I — — I —I
1 dysfunctional uterine bleeding (DUB) 7 PID
(with regular cycle) 8 polyps
2 DUB - with irregular cycle 9 fibroids
3 polycystic ovary syndrome 10 carcinoma - endometrium
4 anovulatory bleeding without 11 carcinoma - cervix
evidence of 3 (above) 12 iatrogenic - IUCD




Tick all treatments given during 8 months since 1st clinic date, and date started or date of
procedure/surgery:
Name of drug Date
1 prostaglandin synthetase inhibitors / /
2 progestogens / /
3 OC / /
4 antifibrinolytic agents / /
5 clomiphene / /
6 (fdowhpliarte' / /
7 danazol / /
8 thyroid replacement treatment / /
9 HRT / /
10 LHRH analogue / /
11 other drugs / /
12 hysterectomy - abd/vag/LAVH (circle which one) / /
13 endometrial ablation / /
14 myomectomy (removal of fibroids) / /
15D&C / /
16 hormone-releasing IUCD / /
17 removal of IUCD / /
18 adjust anti-coag dosage __ / /
19 cancer trt / /
20 other / /
OUTCOME fat 8 months)
This patient: still under care O, discharged O, referral elsewhere (final) O
If discharged or referred elsewhere, enter date / /
Did patient fail to return (rather than be formally discharged)? Y/ N
Final diagnosis/es (if applicable): enter no. from above list ^ 1—I and date /
I 1—I and date /
Most recent treatment, at 8 month cut-off date, (enter no. from above list)
Anv subsequent treatment (after 8 months)
/
/
